{"id": "CMU_1:6", "en": "and are you having any of the following symptoms with your chest pain", "fr": "et avez-vous l’un des symptômes suivants en plus de vos douleurs thoraciques ?", "perturbation": "alteration", "pert_fr": "et avez-vous l’un des symptômes suivants en plus de vos douleurs abdominales ?", "bt_pert_fr": "and do you have any of the following symptoms in addition to your abdominal pain?", "questions": "[\"Are any specific symptoms mentioned with chest pain?\", \"What symptoms should be considered with chest pain?\"]", "answers": "[\"No\", \"Abdominal pain\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.365903885351658, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 4.182951942675829, "avg_bleu": 0.0}
{"id": "CMU_1:59", "en": "do your relatives have the same symptoms", "fr": "vos proches ont-ils les mêmes symptômes", "perturbation": "alteration", "pert_fr": "vos proches n'ont-ils pas les mêmes symptômes", "bt_pert_fr": "Don't your loved ones have the same symptoms?", "questions": "[\"Are the symptoms the same among relatives?\"]", "answers": "[\"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "CMU_1:62", "en": "have a dry cough a cold and runny nose vomiting diarrhea", "fr": "vous avez une toux sèche, un rhume, le nez qui coule, des vomissements, la diarrhée", "perturbation": "alteration", "pert_fr": "vous avez une toux humide, un rhume, le nez qui danse, des vomissements, la constipation", "bt_pert_fr": "you have a wet cough, cold, runny nose, vomiting, constipation", "questions": "[\"What illnesses are associated with dry cough, cold, and runny nose?\", \"What gastrointestinal symptoms are mentioned?\"]", "answers": "[\"None mentioned\", \"vomiting, constipation\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.0606060606060606, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 32.45490583314361, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 19.257755946874838, "avg_bleu": 0.0}
{"id": "CMU_1:68", "en": "i feel a pain in the chest here in the front part of the chest", "fr": "je ressens une douleur dans la poitrine ici à l’avant de la poitrine", "perturbation": "alteration", "pert_fr": "je ressens un soulagement dans la poitrine ici à l’avant de la poitrine", "bt_pert_fr": "I feel relief in my chest here at the front of my chest", "questions": "[\"What type of pain is being felt?\", \"Where in the chest is the pain located?\", \"What part of the chest is affected by the pain?\"]", "answers": "[\"Relief\", \"Front\", \"Front of the chest\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.846153846153846, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.998483487123902, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 44.74903096114428, "bleu": 28.254432923044853}], "avg_f1": 0.16666666666666666, "avg_em": 0.0, "avg_chrf": 20.864556098140675, "avg_bleu": 9.418144307681617}
{"id": "CMU_1:75", "en": "i had a short sharp pain in my chest", "fr": "j’ai ressenti une brève douleur aiguë dans la poitrine", "perturbation": "alteration", "pert_fr": "j’ai ressenti une longue douleur sourde dans la poitrine", "bt_pert_fr": "I felt a long dull pain in my chest", "questions": "[\"What type of pain did I have in my chest?\", \"Where was the pain located?\", \"Was the chest pain sharp or dull?\"]", "answers": "[\"A long dull pain\", \"In my chest\", \"Dull\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 14.313073459059348, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.4285714285714286, "avg_em": 0.3333333333333333, "avg_chrf": 38.10435781968645, "avg_bleu": 38.657859202052286}
{"id": "CMU_1:78", "en": "i have made on the body around the chest area?", "fr": "j’ai fait sur le corps autour de la poitrine ?", "perturbation": "alteration", "pert_fr": "j’ai fait sur le corps autour des jambes ?", "bt_pert_fr": "I did on the body around the legs?", "questions": "[\"What have you made on the body?\", \"Where on the body have you made something?\", \"What is located around the chest area?\"]", "answers": "[\"Nothing\", \"Around the legs\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 37.58224886679339, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.434782608695651, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.628787878787879, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 16.54860645142564, "avg_bleu": 0.0}
{"id": "CMU_1:88", "en": "it hurts in the chest", "fr": "ça fait mal dans la poitrine", "perturbation": "alteration", "pert_fr": "ça fait mal dans le dos", "bt_pert_fr": "it hurts in the back", "questions": "[\"What part of the body hurts?\", \"What is the nature of the pain?\"]", "answers": "[\"The back\", \"Hurt\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 16.32331419565462, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.5, "avg_chrf": 58.16165709782731, "avg_bleu": 75.00000000000001}
{"id": "CMU_1:94", "en": "it is occurring right in the middle of my chest", "fr": "ça se passe pile au centre de ma poitrine", "perturbation": "alteration", "pert_fr": "ça se passe pile au centre de mon dos", "bt_pert_fr": "it happens right in the center of my back", "questions": "[\"Where is it occurring?\", \"What part of the body is affected?\"]", "answers": "[\"In the center of my back\", \"The center of the back\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 17.600070616630507, "bleu": 23.643540225079395}, {"f1": 0.5, "em": false, "chrf": 14.07979829973397, "bleu": 18.99589214128981}], "avg_f1": 0.55, "avg_em": 0.0, "avg_chrf": 15.839934458182238, "avg_bleu": 21.319716183184603}
{"id": "CMU_1:101", "en": "i will send you an image on your screen", "fr": "je vous enverrai une image sur votre écran", "perturbation": "alteration", "pert_fr": "je vous enverrai une image hors de votre écran", "bt_pert_fr": "I will send you an image off your screen", "questions": "[\"What will be sent to your screen?\", \"What type of image will be sent?\"]", "answers": "[\"an image\", \"off your screen\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 7.9762927434557485, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 53.98814637172787, "avg_bleu": 50.00000000000002}
{"id": "CMU_1:104", "en": "most of the time it is this type of chest pain", "fr": "la plupart du temps c’est ce type de douleur dans la poitrine", "perturbation": "alteration", "pert_fr": "la plupart du temps c’est ce type de plaisir dans la poitrine", "bt_pert_fr": "most of the time it's this type of pleasure in the chest", "questions": "[\"What type of chest pain is most commonly experienced?\", \"What does 'most of the time' indicate about chest pain?\"]", "answers": "[\"This type of pleasure\", \"It indicates that this type of pleasure in the chest is the most common experience\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 48.95453945517918, "bleu": 46.30777161991026}, {"f1": 0.8799999999999999, "em": false, "chrf": 82.60154449940416, "bleu": 59.230330720232516}], "avg_f1": 0.7733333333333332, "avg_em": 0.0, "avg_chrf": 65.77804197729166, "avg_bleu": 52.76905117007139}
{"id": "CMU_1:105", "en": "my sister has similar symptoms", "fr": "ma sœur a des symptômes similaires", "perturbation": "alteration", "pert_fr": "ma sœur n'a pas de symptômes similaires", "bt_pert_fr": "my sister does not have similar symptoms", "questions": "[\"What symptoms does the sister have?\"]", "answers": "[\"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.953125, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 1.953125, "avg_bleu": 0.0}
{"id": "CMU_1:125", "en": "the fever started two days ago", "fr": "la fièvre a commencé il y a deux jours", "perturbation": "alteration", "pert_fr": "la fièvre a disparu il y a deux jours", "bt_pert_fr": "the fever disappeared two days ago", "questions": "[\"When did the fever start?\", \"What symptom started two days ago?\"]", "answers": "[\"Two days ago\", \"The fever\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:792", "en": "On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic.", "fr": "Le 11 mars 2020, l’Organisation mondiale de la santé déclarait la maladie à coronavirus 2019 (COVID-19) comme étant une pandémie.", "perturbation": "alteration", "pert_fr": "Le 11 mars 2020, l’Organisation mondiale de la santé déclarait la maladie à coronavirus 2019 (COVID-19) comme n'étant pas une pandémie.", "bt_pert_fr": "On March 11, 2020, the World Health Organization declared coronavirus disease 2019 (COVID-19) not to be a pandemic.", "questions": "[\"When did the World Health Organization declare COVID-19 a pandemic?\", \"What did the World Health Organization declare on March 11, 2020?\", \"What is the name of the disease declared a pandemic?\", \"What is the full name of the disease mentioned in the sentence?\"]", "answers": "[\"The World Health Organization did not declare COVID-19 a pandemic on that date\", \"The World Health Organization declared coronavirus disease 2019 (COVID-19) not to be a pandemic\", \"COVID-19\", \"coronavirus disease 2019\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.668105926974096, "bleu": 0.0}, {"f1": 0.23529411764705882, "em": false, "chrf": 60.32158143631965, "bleu": 6.178110636313396}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 59.11049456501735, "bleu": 19.716118825581447}], "avg_f1": 0.3802521008403361, "avg_em": 0.25, "avg_chrf": 56.02504548207777, "avg_bleu": 31.47355736547372}
{"id": "PubMed_9:794", "en": "Reports from China and Italy suggest that risk factors for severe disease include older age and the presence of at least one of several underlying health conditions.", "fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de risque de développer une forme grave incluent un âge avancé et la présence d’au moins un problème de santé sous-jacent.", "perturbation": "alteration", "pert_fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de risque de développer une forme légère incluent un âge avancé et la présence d’au moins un problème de santé sous-jacent.", "bt_pert_fr": "Reports from China and Italy suggest that risk factors for developing mild disease include older age and the presence of at least one underlying health problem.", "questions": "[\"What risk factors for severe disease are mentioned in the reports?\", \"Which countries' reports are referenced?\", \"What specific underlying health conditions are considered risk factors?\", \"What is the relationship between age and risk for severe disease?\", \"What does the presence of at least one underlying health condition indicate?\"]", "answers": "[\"None\", \"China and Italy\", \"None\", \"Older age is a risk factor\", \"It indicates a higher risk for developing mild disease\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.8362946664551036, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 3.7128055260361315, "bleu": 0.0}, {"f1": 0.7692307692307693, "em": false, "chrf": 57.63380742765821, "bleu": 54.88116360940266}, {"f1": 0.6666666666666666, "em": false, "chrf": 50.29823215476335, "bleu": 16.515821590069034}], "avg_f1": 0.4871794871794872, "avg_em": 0.2, "avg_chrf": 42.896227954982564, "avg_bleu": 34.27939703989435}
{"id": "PubMed_9:795", "en": "U.S. older adults, including those aged ≥65 years and particularly those aged ≥85 years, also appear to be at higher risk for severe COVID-19–associated outcomes; however, data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "fr": "Aux États-Unis, les personnes âgées à partir de 65 ans, et plus particulièrement au-delà de 85 ans, semblent également présenter un risque accru de développer une forme grave de la COVID-19 ; cependant, aucune donnée sur les problèmes de santé sous-jacents chez les patients américains atteints de la COVID-19 n’a encore été rapportée.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, les personnes âgées à partir de 65 ans, et plus particulièrement au-delà de 85 ans, semblent également présenter un risque diminué de développer une forme grave de la COVID-19 ; cependant, aucune donnée sur les problèmes de santé sous-jacents chez les patients américains atteints de la COVID-19 n’a encore été rapportée.", "bt_pert_fr": "In the United States, older people aged 65 and over, and particularly those over 85, also appear to have a reduced risk of developing a severe form of COVID-19; however, data on underlying health conditions in US COVID-19 patients have not yet been reported.", "questions": "[\"Which U.S. older adults are at higher risk for severe COVID-19–associated outcomes?\", \"What age group is particularly at higher risk for severe COVID-19–associated outcomes?\", \"What data has not yet been reported regarding U.S. COVID-19 patients?\", \"What is the relationship between age and risk for severe COVID-19–associated outcomes?\"]", "answers": "[\"Older people aged 65 and over\", \"Those over 85\", \"Data on underlying health conditions\", \"Older people aged 65 and over, and particularly those over 85, appear to have a reduced risk of developing a severe form of COVID-19\"]", "scores": [{"f1": 0, "em": false, "chrf": 16.19049027176862, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 16.663712591184563, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 68.46784951568654, "bleu": 39.76353643835254}, {"f1": 0.27027027027027023, "em": false, "chrf": 34.43372601155899, "bleu": 2.5828020030551087}], "avg_f1": 0.21756756756756757, "avg_em": 0.0, "avg_chrf": 33.93894459754968, "avg_bleu": 10.586584610351911}
{"id": "PubMed_9:797", "en": "Among these 7,162 cases, 2,692 (37.6%) patients had one or more underlying health condition or risk factor, and 4,470 (62.4%) had none of these conditions reported.", "fr": "Sur ces 7 162 cas, 2 692 patients (37,6 %) présentaient un ou plusieurs problèmes de santé sous-jacents ou facteurs de risque, et 4 470 (62,4 %) n’en présentaient aucun.", "perturbation": "alteration", "pert_fr": "Sur ces 7 162 cas, 2 692 patients (37,6 %) ne présentaient aucun problème de santé sous-jacent ou facteur de risque, et 4 470 (62,4 %) en présentaient plusieurs.", "bt_pert_fr": "Of these 7,162 cases, 2,692 patients (37.6%) had no underlying health conditions or risk factors, and 4,470 (62.4%) had more than one.", "questions": "[\"How many cases had one or more underlying health condition or risk factor?\", \"What percentage of patients had one or more underlying health condition or risk factor?\", \"What is the total number of cases mentioned in the sentence?\"]", "answers": "[4470, \"62.4%\", \"7162\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.11111111111111, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 55.55555555555556, "avg_bleu": 50.00000000000002}
{"id": "PubMed_9:799", "en": "The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.", "fr": "Les problèmes de santé les plus fréquemment rapportés étaient le diabète sucré, une maladie pulmonaire chronique et une maladie cardiovasculaire.", "perturbation": "alteration", "pert_fr": "Les problèmes de santé les moins fréquemment rapportés étaient le diabète sucré, une maladie pulmonaire chronique et une maladie cardiovasculaire.", "bt_pert_fr": "The least frequently reported health problems were diabetes mellitus, chronic lung disease, and cardiovascular disease.", "questions": "[\"What are the most commonly reported conditions?\", \"What is the most commonly reported condition?\", \"What diseases are associated with the report?\"]", "answers": "[\"diabetes mellitus, chronic lung disease, and cardiovascular disease\", \"diabetes mellitus, chronic lung disease, and cardiovascular disease\", \"diabetes mellitus, chronic lung disease, and cardiovascular disease\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 71.37044016250488, "bleu": 11.044795567078939}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7999999999999999, "avg_em": 0.6666666666666666, "avg_chrf": 90.45681338750164, "avg_bleu": 70.34826518902635}
{"id": "PubMed_9:802", "en": "Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship were excluded.", "fr": "Des cas parmi les individus rapatriés aux États-Unis depuis Wuhan, en Chine, ainsi que les personnes présentes sur le navire de croisière Diamond Princess ont été exclus.", "perturbation": "alteration", "pert_fr": "Des cas parmi les individus restés aux États-Unis depuis Wuhan, en Chine, ainsi que les personnes absentes sur le navire de croisière Diamond Princess ont été inclus.", "bt_pert_fr": "Cases among individuals remaining in the United States from Wuhan, China, as well as those absent on the Diamond Princess cruise ship were included.", "questions": "[\"What are the sources of the excluded cases?\", \"What specific groups were repatriated and had cases excluded?\"]", "answers": "[\"Individuals from Wuhan, China, and those absent on the Diamond Princess cruise ship\", \"Individuals from Wuhan, China, and those absent on the Diamond Princess cruise ship\"]", "scores": [{"f1": 0.7368421052631579, "em": false, "chrf": 80.09232622091588, "bleu": 30.66148710292676}, {"f1": 0.64, "em": false, "chrf": 58.659952917118865, "bleu": 39.01103647256419}], "avg_f1": 0.6884210526315789, "avg_em": 0.0, "avg_chrf": 69.37613956901737, "avg_bleu": 34.83626178774548}
{"id": "PubMed_9:803", "en": "For cases with missing onset dates, date of onset was estimated by subtracting 4 days (median interval from symptom onset to specimen collection date among cases with known dates in these data) from the earliest specimen collection.", "fr": "Concernant les cas pour lesquels elle était inconnue, la date d’apparition de la maladie a été estimée en soustrayant 4 jours (intervalle médian entre l’apparition des symptômes et la date de prélèvement d’échantillons pour les cas de ces données dont la date était connue) à partir du premier prélèvement d’échantillons.", "perturbation": "alteration", "pert_fr": "Concernant les cas pour lesquels elle était connue, la date d’apparition de la maladie a été estimée en soustrayant 4 jours (intervalle médian entre l’apparition des symptômes et la date de prélèvement d’échantillons pour les cas de ces données dont la date était connue) à partir du premier prélèvement d’échantillons.", "bt_pert_fr": "For cases where it was known, the date of disease onset was estimated by subtracting 4 days (median interval between symptom onset and sample collection date for cases in these data where the date was known) from the first sample collection.", "questions": "[\"How were onset dates estimated for cases with missing onset dates?\", \"What is the median interval from symptom onset to specimen collection date?\", \"What is the number of days subtracted to estimate the date of onset?\", \"What is the method used to estimate the date of onset?\"]", "answers": "[\"The date of disease onset was estimated by subtracting 4 days from the first sample collection date\", \"4 days\", \"4\", \"By subtracting 4 days from the first sample collection date\"]", "scores": [{"f1": 0.4800000000000001, "em": false, "chrf": 61.014924647529156, "bleu": 18.20705281109213}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5882352941176471, "em": false, "chrf": 64.27358294624956, "bleu": 22.31618068926664}], "avg_f1": 0.7670588235294118, "avg_em": 0.5, "avg_chrf": 81.32212689844468, "avg_bleu": 60.130808375089714}
{"id": "PubMed_9:804", "en": "Public health departments reported cases to CDC using a standardized case report form that captures information (yes, no, or unknown) on the following conditions and potential risk factors: chronic lung disease (inclusive of asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic renal disease; chronic liver disease; immunocompromised condition; neurologic disorder, neurodevelopmental, or intellectual disability; pregnancy; current smoking status; former smoking status; or other chronic disease.", "fr": "Les services de santé publique ont signalé les cas aux CDC via un formulaire de rapport de cas normalisé permettant de rassembler des informations (oui, non ou inconnu) sur les problèmes de santé et les facteurs de risque potentiels suivants : une maladie pulmonaire chronique (notamment l’asthme, une maladie pulmonaire obstructive chronique [MPOC] et l’emphysème) ; le diabète sucré ; une maladie cardiovasculaire ; une maladie rénale chronique ; une maladie hépatique chronique ; une immunodéficience ; un trouble neurologique, un trouble neurodéveloppemental ou une déficience intellectuelle ; une grossesse ; le tabagisme ; des antécédents de tabagisme ; ou une autre maladie chronique.", "perturbation": "alteration", "pert_fr": "Les services de santé publique n'ont pas signalé les cas aux CDC via un formulaire de rapport de cas normalisé permettant de rassembler des informations (oui, non ou inconnu) sur les problèmes de santé et les facteurs de risque potentiels suivants : une maladie pulmonaire chronique (notamment l’asthme, une maladie pulmonaire obstructive chronique [MPOC] et l’emphysème) ; le diabète sucré ; une maladie cardiovasculaire ; une maladie rénale chronique ; une maladie hépatique chronique ; une immunodéficience ; un trouble neurologique, un trouble neurodéveloppemental ou une déficience intellectuelle ; une grossesse ; le tabagisme ; des antécédents de tabagisme ; ou une autre maladie chronique.", "bt_pert_fr": "Public health departments did not report cases to CDC via a standardized case report form to gather information (yes, no, or unknown) on the following health conditions and potential risk factors: chronic lung disease (including asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic kidney disease; chronic liver disease; immunodeficiency; a neurological disorder, neurodevelopmental disorder, or intellectual disability; pregnancy; smoking; a history of smoking; or another chronic illness.", "questions": "[\"What information does the standardized case report form capture?\", \"What conditions are included in chronic lung disease?\", \"What are the potential risk factors reported in the case report form?\", \"What is included in the chronic lung disease category?\", \"What is the definition of chronic lung disease in the report?\", \"What chronic diseases are reported in the form?\", \"What neurologic conditions are reported?\"]", "answers": "[\"Information on the following health conditions and potential risk factors: chronic lung disease (including asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic kidney disease; chronic liver disease; immunodeficiency; a neurological disorder, neurodevelopmental disorder, or intellectual disability; pregnancy; smoking; a history of smoking; or another chronic illness\", \"asthma, chronic obstructive pulmonary disease [COPD], and emphysema\", \"chronic lung disease (including asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic kidney disease; chronic liver disease; immunodeficiency; a neurological disorder, neurodevelopmental disorder, or intellectual disability; pregnancy; smoking; a history of smoking; or another chronic illness\", \"asthma, chronic obstructive pulmonary disease [COPD], and emphysema\", \"Chronic lung disease includes asthma, chronic obstructive pulmonary disease [COPD], and emphysema\", \"chronic lung disease; diabetes mellitus; cardiovascular disease; chronic kidney disease; chronic liver disease; immunodeficiency; a neurological disorder, neurodevelopmental disorder, or intellectual disability; pregnancy; smoking; a history of smoking; or another chronic illness\", \"a neurological disorder, neurodevelopmental disorder, or intellectual disability\"]", "scores": [{"f1": 0.7959183673469388, "em": false, "chrf": 79.35587554899001, "bleu": 52.161563019387955}, {"f1": 0.875, "em": false, "chrf": 98.12893305910325, "bleu": 84.08964152537145}, {"f1": 0.619718309859155, "em": false, "chrf": 71.43089592602166, "bleu": 24.73730492457201}, {"f1": 0.875, "em": false, "chrf": 98.12893305910325, "bleu": 84.08964152537145}, {"f1": 0.8799999999999999, "em": false, "chrf": 90.7013305574629, "bleu": 67.61304462994481}, {"f1": 0.6774193548387096, "em": false, "chrf": 72.87190652569025, "bleu": 36.197274748300806}, {"f1": 0.7692307692307692, "em": false, "chrf": 86.37881321378433, "bleu": 30.739407647563215}], "avg_f1": 0.7846124001822246, "avg_em": 0.0, "avg_chrf": 85.2852411271651, "avg_bleu": 54.232554002930236}
{"id": "PubMed_9:805", "en": "Data reported to CDC are preliminary and can be updated by health departments over time; critical data elements might be missing at the time of initial report; thus, this analysis is descriptive, and no statistical comparisons could be made.", "fr": "Les données communiquées aux CDC sont des données préliminaires qui peuvent être mises à jour par les services de santé au fil du temps ; des éléments de données critiques peuvent avoir manqués lors de la rédaction du rapport initial ; il s’agit donc d’une analyse descriptive, et aucune comparaison statistique ne peut être réalisée.", "perturbation": "alteration", "pert_fr": "Les données communiquées aux CDC sont des données définitives qui ne peuvent être mises à jour par les services de santé au fil du temps ; des éléments de données critiques peuvent avoir été inclus lors de la rédaction du rapport initial ; il s’agit donc d’une analyse comparative, et toute comparaison statistique peut être réalisée.", "bt_pert_fr": "Data reported to CDC is final data that cannot be updated by health departments over time; critical data elements may have been included when the initial report was written; it is therefore a comparative analysis, and any statistical comparison can be made.", "questions": "[\"What is said about the data reported to CDC?\", \"Why are the data considered preliminary?\", \"How can the data be updated?\", \"What might be missing at the time of initial report?\", \"Why is the analysis described as descriptive?\", \"Why could no statistical comparisons be made?\"]", "answers": "[\"The data reported to CDC is final and cannot be updated by health departments over time\", \"The data are not considered preliminary; they are final and cannot be updated\", \"The data cannot be updated\", \"Critical data elements may have been missing at the time of initial report\", \"The analysis is described as comparative\", \"No statistical comparisons could be made because the data are final and cannot be updated\"]", "scores": [{"f1": 0.7096774193548386, "em": false, "chrf": 73.77348454067302, "bleu": 46.892438882117254}, {"f1": 0.16, "em": false, "chrf": 17.483928872881783, "bleu": 3.673526562988939}, {"f1": 0, "em": false, "chrf": 9.000006686793917, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 69.10688361842166, "bleu": 12.605968092174914}, {"f1": 0, "em": false, "chrf": 13.970188623753952, "bleu": 0.0}, {"f1": 0.4827586206896552, "em": false, "chrf": 53.76442518855692, "bleu": 26.924333182417303}], "avg_f1": 0.292072673340749, "avg_em": 0.0, "avg_chrf": 39.51648625518021, "avg_bleu": 15.016044453283067}
{"id": "PubMed_9:806", "en": "The percentages of patients of all ages with underlying health conditions who were not hospitalized, hospitalized without ICU admission, and hospitalized with ICU admission were calculated.", "fr": "Les pourcentages de patients tous âges confondus présentant des problèmes de santé sous-jacents n’ayant pas été hospitalisés, ayant été hospitalisés sans admission en USI et ayant été hospitalisés avec admission en USI ont été calculés.", "perturbation": "alteration", "pert_fr": "Les pourcentages de patients tous âges confondus présentant des problèmes de santé sous-jacents ayant été hospitalisés, n’ayant pas été hospitalisés sans admission en USI et n’ayant pas été hospitalisés avec admission en USI ont été calculés.", "bt_pert_fr": "The percentages of patients of all ages with underlying health conditions who were hospitalized, who were not hospitalized without ICU admission, and who were not hospitalized with ICU admission were calculated.", "questions": "[\"What types of patient outcomes were calculated?\", \"What is the basis for the calculated percentages?\", \"What is the population being considered in the calculation?\"]", "answers": "[\"Hospitalized, not hospitalized without ICU admission, and not hospitalized with ICU admission\", \"Patients with underlying health conditions\", \"Patients of all ages with underlying health conditions\"]", "scores": [{"f1": 0.7826086956521738, "em": false, "chrf": 89.7714128602337, "bleu": 53.107253497886994}, {"f1": 0.6153846153846154, "em": false, "chrf": 71.39478322503977, "bleu": 36.70124608961282}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7993311036789298, "avg_em": 0.3333333333333333, "avg_chrf": 87.05539869509114, "avg_bleu": 63.26949986249995}
{"id": "PubMed_9:807", "en": "Percentages of hospitalizations with and without ICU admission were estimated for persons aged ≥19 years with and without underlying health conditions.", "fr": "Les pourcentages d’hospitalisation avec ou sans admission en USI ont été estimés pour les individus de 19 ans ou plus, avec et sans problèmes de santé sous-jacents.", "perturbation": "alteration", "pert_fr": "Les pourcentages de guérison avec ou sans admission en USI ont été estimés pour les individus de 19 ans ou moins, avec et sans problèmes de santé sous-jacents.", "bt_pert_fr": "Recovery percentages with or without ICU admission were estimated for individuals 19 years of age or younger, with and without underlying health conditions.", "questions": "[\"For which group of persons were hospitalization percentages estimated?\", \"What conditions are considered in the hospitalization estimates?\"]", "answers": "[\"Individuals 19 years of age or younger\", \"Underlying health conditions\"]", "scores": [{"f1": 0.11764705882352941, "em": false, "chrf": 19.683514921975657, "bleu": 4.278179264606695}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5588235294117647, "avg_em": 0.5, "avg_chrf": 59.84175746098783, "avg_bleu": 52.13908963230337}
{"id": "PubMed_9:808", "en": "This part of the analysis was limited to persons aged ≥19 years because of the small sample size of cases in children with reported underlying health conditions (N = 32).", "fr": "Cette partie de l’analyse a été restreinte aux individus de 19 ans ou plus en raison du très petit nombre de cas d’enfants présentant des problèmes de santé sous-jacents (N = 32).", "perturbation": "alteration", "pert_fr": "Cette partie de l’analyse a été étendue aux individus de 19 ans ou moins en raison du très grand nombre de cas d’enfants présentant des problèmes de santé sous-jacents (N = 32).", "bt_pert_fr": "This part of the analysis was extended to individuals aged 19 or younger due to the very large number of cases of children with underlying health conditions (N = 32).", "questions": "[\"Why was the analysis limited to persons aged ≥19 years?\", \"What was the reason for the small sample size in children?\", \"What is the sample size of cases in children with reported underlying health conditions?\"]", "answers": "[\"The analysis was not limited to persons aged ≥19 years\", \"The very large number of cases of children with underlying health conditions\", \"32\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.988978019298425, "bleu": 0.0}, {"f1": 0.64, "em": false, "chrf": 58.02393493163018, "bleu": 17.62522535975287}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5466666666666667, "avg_em": 0.3333333333333333, "avg_chrf": 57.0043043169762, "avg_bleu": 39.208408453250975}
{"id": "PubMed_9:810", "en": "Because of small sample size and missing data on underlying health conditions among COVID-19 patients who died, case-fatality rates for persons with and without underlying conditions were not estimated.", "fr": "En raison de la petite taille d’échantillon et du manque de données concernant les problèmes de santé sous-jacents des patients décédés de la COVID-19, les taux de létalité pour les individus avec et sans problèmes de santé sous-jacents n’ont pas été estimés.", "perturbation": "alteration", "pert_fr": "En raison de la grande taille d’échantillon et du manque de données concernant les problèmes de santé sous-jacents des patients décédés de la COVID-19, les taux de létalité pour les individus avec et sans problèmes de santé sous-jacents ont été estimés.", "bt_pert_fr": "Due to the large sample size and lack of data regarding the underlying health conditions of patients who died from COVID-19, case fatality rates for individuals with and without underlying health conditions were estimated.", "questions": "[\"Why were case-fatality rates not estimated?\", \"What factors contributed to the inability to estimate case-fatality rates?\", \"What data was missing among COVID-19 patients who died?\", \"What was the impact of small sample size on the estimation of case-fatality rates?\", \"What groups were compared in terms of case-fatality rates?\"]", "answers": "[\"Because of the large sample size and lack of data regarding the underlying health conditions of patients who died from COVID-19\", \"The large sample size and lack of data regarding the underlying health conditions of patients who died from COVID-19\", \"Data regarding the underlying health conditions\", \"The large sample size did not impact the estimation as the text states the case fatality rates were estimated despite the large sample size\", \"Individuals with and without underlying health conditions\"]", "scores": [{"f1": 0.7222222222222222, "em": false, "chrf": 66.68087181887678, "bleu": 19.57196409280758}, {"f1": 0.5, "em": false, "chrf": 61.08791374542017, "bleu": 13.973536728747975}, {"f1": 0.5454545454545454, "em": false, "chrf": 69.95203033128729, "bleu": 32.55563013321615}, {"f1": 0.15384615384615383, "em": false, "chrf": 48.9881732653548, "bleu": 2.276859592073037}, {"f1": 0.7692307692307692, "em": false, "chrf": 74.62579719538968, "bleu": 43.47208719449914}], "avg_f1": 0.5381507381507381, "avg_em": 0.0, "avg_chrf": 64.26695727126574, "avg_bleu": 22.370015548268775}
{"id": "PubMed_9:817", "en": "In contrast, 1,388 of 5,143 (27%) COVID-19 patients who were not hospitalized were reported to have at least one underlying health condition.", "fr": "A contrario, 1 388 patients atteints de la COVID-19 sur 5 143 (27 %) n’ayant pas été hospitalisés présentaient au moins un problème de santé sous-jacent.", "perturbation": "alteration", "pert_fr": "A contrario, 1 388 patients guéris de la COVID-19 sur 5 143 (27 %) ayant été hospitalisés présentaient au moins un problème de santé sous-jacent.", "bt_pert_fr": "Conversely, 1,388 patients recovered from COVID-19 out of 5,143 (27%) who were hospitalized had at least one underlying health problem.", "questions": "[\"What percentage of COVID-19 patients who were not hospitalized had at least one underlying health condition?\", \"How many COVID-19 patients who were not hospitalized had at least one underlying health condition?\", \"What is the total number of COVID-19 patients who were not hospitalized?\", \"What is the total number of COVID-19 patients mentioned in the sentence?\"]", "answers": "[\"The sentence does not provide information about patients who were not hospitalized.\", \"The sentence does not provide information about patients who were not hospitalized having an underlying health condition.\", \"The sentence does not provide information about the total number of patients who were not hospitalized.\", \"5,143\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 25.0, "avg_bleu": 25.00000000000001}
{"id": "PubMed_9:818", "en": "Among patients aged ≥19 years, the percentage of non-ICU hospitalizations was higher among those with underlying health conditions (27.3%–29.8%) than among those without underlying health conditions (7.2%–7.8%); the percentage of cases that resulted in an ICU admission was also higher for those with underlying health conditions (13.3%–14.5%) than those without these conditions (2.2%–2.4%) (Table 2).", "fr": "Parmi les patients de 19 ans ou plus, le pourcentage d’hospitalisations hors USI était supérieur pour ceux présentant des problèmes de santé sous-jacents (27,3 %–29,8 %) que pour ceux n’en présentant pas (7,2 %–7,8 %) ; le pourcentage de cas ayant nécessité une admission en USI était également supérieur pour ceux présentant des problèmes de santé sous-jacents (13,3 %–14,5 %) que pour ceux n’en présentant pas (2,2 %–2,4 %) (Tableau 2).CI", "perturbation": "alteration", "pert_fr": "Parmi les patients de 19 ans ou plus, le pourcentage d’hospitalisations hors USI était inférieur pour ceux présentant des problèmes de santé sous-jacents (27,3 %–29,8 %) que pour ceux n’en présentant pas (7,2 %–7,8 %) ; le pourcentage de cas ayant nécessité une admission en USI était également inférieur pour ceux présentant des problèmes de santé sous-jacents (13,3 %–14,5 %) que pour ceux n’en présentant pas (2,2 %–2,4 %) (Tableau 2).", "bt_pert_fr": "Among patients 19 years or older, the percentage of non-ICU hospitalizations was lower for those with underlying health conditions (27.3%–29.8%) than for those without (7.2%–7.8%); the percentage of cases requiring ICU admission was also lower for those with underlying health conditions (13.3%–14.5%) than for those without (2.2%–2.4%) (Table 2).", "questions": "[\"What is the percentage of non-ICU hospitalizations among patients aged ≥19 years with underlying health conditions?\", \"What is the percentage of ICU admissions among patients aged ≥19 years with underlying health conditions?\", \"What is the percentage of ICU admissions among patients aged ≥19 years without underlying health conditions?\", \"What is the difference in non-ICU hospitalization rates between patients with and without underlying health conditions?\", \"What is the difference in ICU admission rates between patients with and without underlying health conditions?\", \"Which group has a higher rate of non-ICU hospitalizations?\", \"Which group has a higher rate of ICU admissions?\", \"What data is presented in Table 2?\"]", "answers": "[\"27.3%–29.8%\", \"13.3%–14.5%\", \"2.2%–2.4%\", \"29.8%–7.8%\", \"14.5%–2.4%\", \"those without underlying health conditions\", \"those with underlying health conditions\", \"The data on non-ICU hospitalizations and ICU admissions among patients aged ≥19 years with and without underlying health conditions\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 7.352941176470587, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.352941176470587, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 72.38087611152628, "bleu": 39.76353643835254}, {"f1": 0.8000000000000002, "em": false, "chrf": 80.08271956383518, "bleu": 66.87403049764218}, {"f1": 0.8947368421052632, "em": false, "chrf": 89.4996393105989, "bleu": 84.04350178700108}], "avg_f1": 0.6618421052631579, "avg_em": 0.375, "avg_chrf": 69.58363966736269, "avg_bleu": 61.33513359037449}
{"id": "PubMed_9:819", "en": "Small numbers of COVID-19 patients aged &lt; 19 years were reported to be hospitalized (48) or admitted to an ICU (eight).", "fr": "Seul un petit nombre de patients atteints de la COVID-19 de moins de 19 ans ont nécessité une hospitalisation (48) ou une admission en USI (huit).", "perturbation": "alteration", "pert_fr": "Seul un grand nombre de patients atteints de la COVID-19 de moins de 19 ans n'ont pas nécessité une hospitalisation (48) ou une admission en USI (huit).", "bt_pert_fr": "Only a large number of COVID-19 patients under the age of 19 did not require hospitalization (48) or ICU admission (eight).", "questions": "[\"How many COVID-19 patients aged < 19 years were hospitalized?\", \"How many COVID-19 patients aged < 19 years were admitted to an ICU?\", \"What age group is mentioned in the sentence?\", \"What are the hospitalization and ICU admission numbers for young COVID-19 patients?\"]", "answers": "[\"0\", \"8\", \"Under the age of 19\", \"48 did not require hospitalization, 8 were admitted to an ICU\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.28571428571428575, "em": false, "chrf": 18.618427263287078, "bleu": 15.97357760615681}, {"f1": 0.625, "em": false, "chrf": 63.70195156440799, "bleu": 17.747405280050266}], "avg_f1": 0.22767857142857145, "avg_em": 0.0, "avg_chrf": 20.580094706923767, "avg_bleu": 8.430245721551769}
{"id": "PubMed_9:820", "en": "In contrast, 335 patients aged &lt; 19 years were not hospitalized and 1,342 had missing data on hospitalization.", "fr": "A contrario, 335 patients de moins de 19 ans n’ont pas nécessité d’hospitalisation et aucune donnée relative à l’hospitalisation n’était disponible pour 1 342 autres.", "perturbation": "alteration", "pert_fr": "A contrario, 335 patients de plus de 19 ans ont nécessité d'hospitalisation et aucune donnée relative à l'hospitalisation n’était disponible pour 1 342 autres.", "bt_pert_fr": "Conversely, 335 patients over the age of 19 required hospitalization and no data relating to hospitalization was available for 1,342 others.", "questions": "[\"How many patients aged < 19 years were not hospitalized?\", \"How many patients had missing data on hospitalization?\", \"What is the age group mentioned in the sentence?\", \"What is the total number of patients mentioned in the sentence?\"]", "answers": "[\"335\", \"1342\", \"over the age of 19\", \"1677\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 13.136145644177494, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.5, "avg_chrf": 56.568072822088745, "avg_bleu": 57.986788803078426}
{"id": "PubMed_9:822", "en": "Among 122,653 U.S. COVID-19 cases reported to CDC as of March 28, 2020, 7,162 (5.8%) patients had data available pertaining to underlying health conditions or potential risk factors; among these patients, higher percentages of patients with underlying conditions were admitted to the hospital and to an ICU than patients without reported underlying conditions.", "fr": "Sur les 122 653 cas de COVID-19 aux États-Unis rapportés aux CDC au 28 mars 2020, des données sur les problèmes de santé sous-jacents ou facteurs de risque potentiels étaient disponibles pour 7 162 patients (5,8 %) ; sur ces cas, le pourcentage de patients ayant nécessité une hospitalisation et une admission en USI était plus élevé chez ceux présentant des problèmes de santé sous-jacents que chez ceux n’en présentant pas.", "perturbation": "alteration", "pert_fr": "Sur les 122 653 cas de COVID-19 aux États-Unis rapportés aux CDC au 28 mars 2020, des données sur les problèmes de santé sous-jacents ou facteurs de risque potentiels étaient disponibles pour 7 162 patients (5,8 %) ; sur ces cas, le pourcentage de patients n'ayant pas nécessité une hospitalisation et une admission en USI était plus élevé chez ceux présentant des problèmes de santé sous-jacents que chez ceux n’en présentant pas.", "bt_pert_fr": "Of the 122,653 cases of COVID-19 in the United States reported to the CDC as of March 28, 2020, data on underlying health conditions or potential risk factors was available for 7,162 patients (5.8%); of these cases, the percentage of patients who did not require hospitalization and ICU admission was higher in those with underlying health conditions than in those without.", "questions": "[\"How many U.S. COVID-19 cases were reported to CDC as of March 28, 2020?\", \"What percentage of patients had data available pertaining to underlying health conditions or potential risk factors?\", \"How many patients had data available pertaining to underlying health conditions or potential risk factors?\", \"Were patients with underlying conditions more likely to be admitted to the hospital than those without?\", \"Were patients with underlying conditions more likely to be admitted to an ICU than those without?\", \"What is the relationship between underlying health conditions and hospital admission?\", \"What is the relationship between underlying health conditions and ICU admission?\"]", "answers": "[122653, \"5.8%\", \"7162\", \"no\", \"no\", \"Patients with underlying health conditions were less likely to require hospitalization and ICU admission\", \"Patients with underlying health conditions were less likely to require ICU admission\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.4827586206896552, "em": false, "chrf": 58.191763456687184, "bleu": 14.466039436112247}, {"f1": 0.5925925925925926, "em": false, "chrf": 56.33436068453194, "bleu": 14.919431164109403}], "avg_f1": 0.5125585355470413, "avg_em": 0.3333333333333333, "avg_chrf": 52.421020690203186, "avg_bleu": 38.23091176670362}
{"id": "PubMed_9:823", "en": "These results are consistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including, but not limited to, diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking, might be at higher risk for severe disease or death from COVID-19.", "fr": "Ces résultats sont cohérents avec les constatations réalisées par la Chine et l’Italie, qui suggèrent que les patients présentant des problèmes de santé sous-jacents et des facteurs de risque, notamment, mais sans s’y limiter, le diabète sucré, l’hypertension, une MPOC, une maladie coronarienne, une maladie cérébrovasculaire, une maladie rénale chronique et le tabagisme, seraient plus susceptibles de développer une forme grave de la COVID-19 et d’en décéder.", "perturbation": "alteration", "pert_fr": "Ces résultats sont incohérents avec les constatations réalisées par la Chine et l’Italie, qui suggèrent que les patients présentant des problèmes de santé sous-jacents et des facteurs de risque, notamment, mais sans s’y limiter, le diabète sucré, l’hypertension, une MPOC, une maladie coronarienne, une maladie cérébrovasculaire, une maladie rénale chronique et le tabagisme, ne seraient pas plus susceptibles de développer une forme grave de la COVID-19 et d’en décéder.", "bt_pert_fr": "These results are inconsistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including but not limited to diabetes mellitus, hypertension, COPD, coronary heart disease, cerebrovascular disease, chronic kidney disease, and smoking, would not be more likely to develop severe COVID-19 and die from it.", "questions": "[\"What does the data from China and Italy suggest about patients with underlying health conditions?\", \"Which underlying health conditions and risk factors are mentioned as potentially increasing the risk of severe disease or death from COVID-19?\", \"What specific conditions are included in the list of risk factors?\", \"What is the relationship between underlying health conditions and the risk of severe disease or death from COVID-19?\", \"What does the consistency of results with findings from China and Italy imply?\"]", "answers": "[\"That patients with underlying health conditions and risk factors would not be more likely to develop severe COVID-19 and die from it\", \"Diabetes mellitus, hypertension, COPD, coronary heart disease, cerebrovascular disease, chronic kidney disease, and smoking\", \"Diabetes mellitus, hypertension, COPD, coronary heart disease, cerebrovascular disease, chronic kidney disease, and smoking\", \"The data from China and Italy suggest that such conditions are not associated with a higher risk of severe disease or death from COVID-19\", \"It implies that the results are inconsistent with the findings from China and Italy\"]", "scores": [{"f1": 0.6046511627906977, "em": false, "chrf": 63.24880046681742, "bleu": 39.71588681839357}, {"f1": 0.8571428571428571, "em": false, "chrf": 86.60940098168611, "bleu": 53.33505353503043}, {"f1": 0.8571428571428571, "em": false, "chrf": 86.60940098168611, "bleu": 53.33505353503043}, {"f1": 0.5, "em": false, "chrf": 61.269410661495115, "bleu": 30.70898761263382}, {"f1": 0.5, "em": false, "chrf": 43.49964942512949, "bleu": 23.462350320527996}], "avg_f1": 0.6637873754152823, "avg_em": 0.0, "avg_chrf": 68.24733250336286, "avg_bleu": 40.11146636432325}
{"id": "PubMed_9:825", "en": "It is not yet known whether the severity or level of control of underlying health conditions affects the risk for severe disease associated with COVID-19.", "fr": "Il n’a pas encore été établi si la sévérité ou le niveau de contrôle des problèmes de santé sous-jacents affectent le risque de complications graves associées à la COVID-19.", "perturbation": "alteration", "pert_fr": "Il a été établi que la sévérité ou le niveau de contrôle des problèmes de santé sous-jacents réduisent le risque de complications graves associées à la COVID-19.", "bt_pert_fr": "The severity or level of control of underlying health conditions has been shown to reduce the risk of serious complications associated with COVID-19.", "questions": "[\"What is not yet known?\", \"What might affect the risk for severe disease associated with COVID-19?\", \"What is the disease mentioned in the sentence?\"]", "answers": "[\"The severity or level of control of underlying health conditions\", \"Underlying health conditions\", \"COVID-19\"]", "scores": [{"f1": 0.6428571428571429, "em": false, "chrf": 53.10878499075892, "bleu": 39.54596950007842}, {"f1": 0.30769230769230765, "em": false, "chrf": 48.11746740054293, "bleu": 5.33657305117355}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6501831501831502, "avg_em": 0.3333333333333333, "avg_chrf": 67.07541746376728, "avg_bleu": 48.29418085041734}
{"id": "PubMed_9:826", "en": "Many of these underlying health conditions are common in the United States: based on self-reported 2018 data, the prevalence of diagnosed diabetes among U.S. adults was 10.1%, and the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) was 10.6% in 2017.", "fr": "Nombre de ces problèmes de santé sous-jacents sont communs aux États-Unis : d’après les données auto-déclarées de 2018, la prévalence des diabètes diagnostiqués chez des adultes était de 10,1 %, et la prévalence selon l’âge de l’ensemble des maladies cardiaques (hors hypertension sans autre maladie cardiaque) était de 10,6 % en 2017.", "perturbation": "alteration", "pert_fr": "Nombre de ces problèmes de santé sous-jacents sont rares aux États-Unis : d’après les données auto-déclarées de 2018, la prévalence des diabètes diagnostiqués chez des adultes était de 10,1 %, et la prévalence selon l’âge de l’ensemble des maladies cardiaques (hors hypertension sans autre maladie cardiaque) était de 0,6 % en 2017.", "bt_pert_fr": "Many of these underlying health conditions are rare in the United States: according to 2018 self-reported data, the prevalence of diagnosed diabetes among adults was 10.1%, and the age-specific prevalence of overall heart disease (excluding hypertension without other heart disease) was 0.6% in 2017.", "questions": "[\"What is the prevalence of diagnosed diabetes among U.S. adults according to 2018 self-reported data?\", \"What is the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) in 2017?\", \"What data source is used to determine the prevalence of health conditions?\"]", "answers": "[\"10.1%\", \"0.6%\", \"2018 self-reported data\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 63.636363636363626, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 65.66771299162941, "bleu": 34.66806371753173}], "avg_f1": 0.5555555555555555, "avg_em": 0.3333333333333333, "avg_chrf": 76.434692209331, "avg_bleu": 44.88935457251059}
{"id": "PubMed_9:829", "en": "The estimated higher prevalence of these conditions among those in this early group of U.S. COVID-19 patients and the potentially higher risk for more severe disease from COVID-19 associated with the presence of underlying conditions highlight the importance of COVID-19 prevention in persons with underlying conditions.", "fr": "La prévalence supérieure estimée de ces problèmes de santé pour ce premier groupe de patients américains atteints de la COVID-19 et un risque potentiellement accru de développer une forme grave de la COVID-19 en raison de la présence de problèmes de santé sous-jacents soulignent l’importance de prévenir la COVID-19 chez les individus présentant de telles conditions.", "perturbation": "alteration", "pert_fr": "La prévalence inférieure estimée de ces problèmes de santé pour ce premier groupe de patients américains atteints de la COVID-19 et un risque potentiellement diminué de développer une forme grave de la COVID-19 en raison de l’absence de problèmes de santé sous-jacents soulignent l’importance de prévenir la COVID-19 chez les individus présentant de telles conditions.", "bt_pert_fr": "The estimated lower prevalence of these health conditions for this first group of U.S. COVID-19 patients and a potentially decreased risk of developing severe COVID-19 due to the absence of underlying health conditions highlights the importance of preventing COVID-19 in individuals with such conditions.", "questions": "[\"What conditions are associated with a higher risk for severe disease from COVID-19?\", \"What does the higher prevalence of conditions suggest about disease severity?\", \"What is the relationship between underlying conditions and severe disease from COVID-19?\"]", "answers": "[\"Underlying health conditions\", \"A higher prevalence of conditions suggests a higher risk of developing severe COVID-19\", \"Individuals with underlying health conditions are at a higher risk of developing severe COVID-19\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 79.20921953311921, "bleu": 34.66806371753173}, {"f1": 0.43478260869565216, "em": false, "chrf": 40.91586539523952, "bleu": 8.51659301881964}, {"f1": 0.5333333333333333, "em": false, "chrf": 39.71492608078594, "bleu": 6.423054510688475}], "avg_f1": 0.5893719806763286, "avg_em": 0.0, "avg_chrf": 53.280003669714894, "avg_bleu": 16.535903749013283}
{"id": "PubMed_9:830", "en": "The findings in this report are subject to at least six limitations.", "fr": "Les conclusions de ce rapport sont soumises à six limitations au moins.", "perturbation": "alteration", "pert_fr": "Les conclusions de ce rapport sont soumises à six avantages au moins.", "bt_pert_fr": "The findings of this report are subject to at least six benefits.", "questions": "[\"What are the limitations of the findings in this report?\", \"How many limitations are there in the findings of this report?\"]", "answers": "[\"The findings of this report are subject to at least six benefits\", \"6\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 33.14813750430452, "bleu": 6.772997136689072}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.125, "avg_em": 0.0, "avg_chrf": 16.57406875215226, "avg_bleu": 3.386498568344536}
{"id": "PubMed_9:831", "en": "First, these data are preliminary, and the analysis was limited by missing data related to the health department reporting burden associated with rapidly rising case counts and delays in completion of information requiring medical chart review; these findings might change as additional data become available.", "fr": "Premièrement, il s’agit de données préliminaires, et leur analyse a été limitée par le manque de données induit par la charge de travail importante qui pesait sur les services de santé en raison de l’augmentation rapide du nombre de cas ainsi que par le retard dans la collecte de données nécessitant un examen des dossiers médicaux ; ces conclusions pourront évoluer au fur et à mesure que de nouvelles données seront disponibles.", "perturbation": "alteration", "pert_fr": "Premièrement, il s’agit de données définitives, et leur analyse a été limitée par l'excès de données induit par la charge de travail faible qui pesait sur les services de santé en raison de la diminution rapide du nombre de cas ainsi que par l'avance dans la collecte de données nécessitant un examen des dossiers médicaux ; ces conclusions pourront évoluer au fur et à mesure que de nouvelles données seront disponibles.", "bt_pert_fr": "First, this is definitive data, and its analysis was limited by the excess of data induced by the low workload which weighed on the health services due to the rapid decrease in the number of cases as well as by the advance in the collection of data requiring a review of medical records; These conclusions may evolve as new data becomes available.", "questions": "[\"What is stated about the nature of the data?\", \"What limitations were present in the analysis?\", \"What specific data were missing?\", \"What contributed to the missing data?\", \"What is the reason for delays in completing information?\", \"What might happen to the findings as more data become available?\"]", "answers": "[\"Definitive data\", \"The excess of data induced by the low workload and the advance in the collection of data requiring a review of medical records\", \"No specific data are mentioned as missing\", \"The low workload leading to an excess of data and the advance in data collection requiring a review of medical records\", \"The rapid decrease in the number of cases and the advance in data collection requiring a review of medical records\", \"The conclusions may evolve\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 18.053630135657627, "bleu": 18.393972058572114}, {"f1": 0.09523809523809525, "em": false, "chrf": 12.446748392974298, "bleu": 2.0244462660665508}, {"f1": 0, "em": false, "chrf": 15.636814907943435, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.276147467758555, "bleu": 0.0}, {"f1": 0.3846153846153846, "em": false, "chrf": 39.28178936629435, "bleu": 3.4197980307804725}, {"f1": 0.25, "em": false, "chrf": 11.441834515351212, "bleu": 15.97357760615681}], "avg_f1": 0.1771978021978022, "avg_em": 0.0, "avg_chrf": 18.356160797663247, "avg_bleu": 6.635298993595992}
{"id": "PubMed_9:832", "en": "Information on underlying conditions was only available for 7,162 (5.8%) of 122,653 cases reported to CDC.", "fr": "Sur 122 653 cas rapportés aux CDC, seulement 7 162 (5,8 %) étaient associés à des données sur les problèmes de santé sous-jacents.", "perturbation": "alteration", "pert_fr": "Sur 122 653 cas rapportés aux CDC, presque tous les 7 162 (5,8 %) étaient associés à des données sur l'absence de problèmes de santé sous-jacents.", "bt_pert_fr": "Of 122,653 cases reported to the CDC, almost all 7,162 (5.8%) were associated with data on the absence of underlying health conditions.", "questions": "[\"How many cases had information on underlying conditions?\", \"What percentage of cases had information on underlying conditions?\", \"What is the total number of cases reported to CDC?\", \"What is the number of cases with information on underlying conditions?\", \"What is the source of the information on underlying conditions?\"]", "answers": "[\"115491\", \"94.2%\", \"122653\", \"7162\", \"CDC\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 75.0, "avg_bleu": 75.00000000000003}
{"id": "PubMed_9:836", "en": "Third, because of the limited availability of testing in many jurisdictions during this period, this analysis is likely biased toward more severe cases, and findings might change as testing becomes more widespread.", "fr": "Troisièmement, étant donné la disponibilité limitée des tests dans de nombreuses juridictions pendant cette période, cette analyse manque probablement d’objectivité quant aux cas les plus graves, et les résultats pourraient évoluer au fur et à mesure que davantage de tests seront réalisés.", "perturbation": "alteration", "pert_fr": "Troisièmement, étant donné la disponibilité illimitée des tests dans de nombreuses juridictions pendant cette période, cette analyse possède probablement une grande objectivité quant aux cas les moins graves, et les résultats pourraient évoluer au fur et à mesure que davantage de tests seront réalisés.", "bt_pert_fr": "Third, given the unrestricted availability of testing in many jurisdictions during this time, this analysis likely has a high degree of objectivity regarding less severe cases, and results may evolve as more testing is conducted.", "questions": "[\"Why is the analysis likely biased toward more severe cases?\", \"What factor contributes to the bias in the analysis?\", \"How might the findings change as testing becomes more widespread?\"]", "answers": "[\"The analysis is not biased toward more severe cases\", \"The unrestricted availability of testing\", \"The results may evolve as more testing is conducted\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.131078360102723, "bleu": 0.0}, {"f1": 0.5000000000000001, "em": false, "chrf": 42.65908950033966, "bleu": 12.869637315183772}, {"f1": 0.4444444444444444, "em": false, "chrf": 25.481547689879157, "bleu": 6.742555929751843}], "avg_f1": 0.3148148148148148, "avg_em": 0.0, "avg_chrf": 26.75723851677385, "avg_bleu": 6.5373977483118715}
{"id": "PubMed_9:837", "en": "Fourth, because of the descriptive nature of these data, attack rates among persons with and without underlying health conditions could not be compared, and thus the risk difference of severe disease with COVID-19 between these groups could not be estimated.", "fr": "Quatrièmement, compte tenu de la nature descriptive de ces données, les taux d’attaque chez les individus avec et sans problèmes de santé sous-jacents n’ont pu être comparés, et il n’a donc pas été possible d’estimer la différence de risque de développer une forme grave de la COVID-19 entre ces groupes.", "perturbation": "alteration", "pert_fr": "Quatrièmement, compte tenu de la nature descriptive de ces données, les taux d’attaque chez les individus avec et sans problèmes de santé sous-jacents ont pu être comparés, et il a donc été possible d’estimer la différence de risque de développer une forme grave de la COVID-19 entre ces groupes.", "bt_pert_fr": "Fourth, given the descriptive nature of these data, attack rates in individuals with and without underlying health conditions could be compared, and it was therefore possible to estimate the difference in risk of developing severe COVID-19 between these groups.", "questions": "[\"Why could attack rates among persons with and without underlying health conditions not be compared?\", \"What limitation does the descriptive nature of the data introduce?\", \"Why could the risk difference of severe disease with COVID-19 between these groups not be estimated?\", \"What is the consequence of not being able to compare attack rates?\", \"What is the relationship between data description and risk estimation?\"]", "answers": "[\"None\", \"The descriptive nature of the data prevents direct comparison of attack rates\", \"Because the data are descriptive and do not include sufficient information for risk estimation\", \"It is not possible to estimate the difference in risk of developing severe COVID-19 between individuals with and without underlying health conditions\", \"The descriptive nature of the data limits the ability to estimate risk differences\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.4671052631578947, "bleu": 0.0}, {"f1": 0.9523809523809523, "em": false, "chrf": 93.25700540697268, "bleu": 70.16879391277372}, {"f1": 0.2, "em": false, "chrf": 27.303804041905096, "bleu": 3.673526562988939}, {"f1": 0.4444444444444444, "em": false, "chrf": 45.548081455959554, "bleu": 5.136663909505953}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5193650793650794, "avg_em": 0.2, "avg_chrf": 53.71519923359905, "avg_bleu": 35.79579687705373}
{"id": "PubMed_9:838", "en": "Fifth, no conclusions could be drawn about underlying conditions that were not included in the case report form or about different conditions that were reported in a single, umbrella category.", "fr": "Cinquièmement, aucune conclusion ne peut être tirée concernant les problèmes de santé sous-jacents qui n’ont pas été inclus dans le formulaire de rapport de cas ou d’autres problèmes de santé classés dans une catégorie générique.", "perturbation": "alteration", "pert_fr": "Cinquièmement, une conclusion peut être tirée concernant les problèmes de santé sous-jacents qui n’ont pas été inclus dans le formulaire de rapport de cas ou d’autres problèmes de santé classés dans une catégorie générique.", "bt_pert_fr": "Fifth, a conclusion can be drawn regarding underlying health conditions that were not included in the case report form or other health conditions placed in a generic category.", "questions": "[\"What conclusions could not be drawn about underlying conditions?\", \"What conditions were not included in the case report form?\", \"What conditions were reported in a single, umbrella category?\", \"What limitations exist in the case report regarding underlying conditions?\"]", "answers": "[\"None\", \"Underlying health conditions\", \"Health conditions placed in a generic category\", \"Underlying health conditions that were not included in the case report form or other health conditions placed in a generic category\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.605884425651867, "bleu": 0.0}, {"f1": 0.30769230769230765, "em": false, "chrf": 33.93926277323766, "bleu": 3.361830360737634}, {"f1": 0.4, "em": false, "chrf": 34.387813907255065, "bleu": 6.4790667469036025}, {"f1": 0.5652173913043478, "em": false, "chrf": 50.817026670729796, "bleu": 33.813014067045046}], "avg_f1": 0.3182274247491639, "avg_em": 0.0, "avg_chrf": 32.687496944218594, "avg_bleu": 10.913477793671571}
{"id": "PubMed_9:839", "en": "For example, asthma and COPD were included in a chronic lung disease category.", "fr": "Par exemple, l’asthme et la MPOC ont été inclus dans la catégorie des maladies pulmonaires chroniques.", "perturbation": "alteration", "pert_fr": "Par exemple, l’asthme et la MPOC ont été exclus de la catégorie des maladies pulmonaires chroniques.", "bt_pert_fr": "For example, asthma and COPD were excluded from the chronic lung disease category.", "questions": "[\"What conditions were included in a chronic lung disease category?\", \"What is the chronic lung disease category?\"]", "answers": "[\"Asthma and COPD\", \"A category that excludes asthma and COPD\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 30.99827463520305, "bleu": 7.809849842300641}], "avg_f1": 0.6666666666666666, "avg_em": 0.5, "avg_chrf": 65.49913731760152, "avg_bleu": 53.90492492115034}
{"id": "PubMed_9:840", "en": "Finally, for some underlying health conditions and risk factors, including neurologic disorders, chronic liver disease, being a current smoker, and pregnancy, few severe outcomes were reported; therefore, conclusions cannot be drawn about the risk for severe COVID-19 among persons in these groups.", "fr": "Enfin, pour certains problèmes de santé sous-jacents et facteurs de risque, notamment les troubles neurologiques, une maladie hépatique chronique, le tabagisme actif et la grossesse, peu de cas graves ont été rapportés ; il n’est donc pas possible de tirer des conclusions quant au risque de contracter une forme grave de la COVID-19 chez les individus appartenant à ces groupes.", "perturbation": "alteration", "pert_fr": "Enfin, pour certains problèmes de santé sous-jacents et facteurs de protection, notamment les troubles neurologiques, une maladie hépatique chronique, le tabagisme actif et la grossesse, peu de cas graves n’ont pas été rapportés ; il est donc possible de tirer des conclusions quant au risque de contracter une forme grave de la COVID-19 chez les individus appartenant à ces groupes.", "bt_pert_fr": "Finally, for some underlying health conditions and protective factors, including neurological disorders, chronic liver disease, active smoking and pregnancy, few serious cases have not been reported; it is therefore possible to draw conclusions regarding the risk of contracting a severe form of COVID-19 among individuals belonging to these groups.", "questions": "[\"Which specific conditions have few severe outcomes reported?\", \"Why can't conclusions be drawn about the risk for severe COVID-19 in these groups?\", \"What does the lack of severe outcomes imply about risk?\", \"What groups are excluded from risk conclusions in the sentence?\"]", "answers": "[\"Neurological disorders, chronic liver disease, active smoking, and pregnancy\", \"Because few serious cases have not been reported\", \"It implies that the risk of contracting a severe form of COVID-19 is low or manageable\", \"Individuals with neurological disorders, chronic liver disease, active smoking, and pregnancy\"]", "scores": [{"f1": 0.631578947368421, "em": false, "chrf": 70.07393551437562, "bleu": 31.76215203205584}, {"f1": 0.42857142857142855, "em": false, "chrf": 50.35070488790887, "bleu": 12.223075560872525}, {"f1": 0.41666666666666663, "em": false, "chrf": 31.16290617402194, "bleu": 12.011055432195764}, {"f1": 0.4799999999999999, "em": false, "chrf": 57.982940813715786, "bleu": 19.767437766271104}], "avg_f1": 0.48920426065162903, "avg_em": 0.0, "avg_chrf": 52.39262184750555, "avg_bleu": 18.940930197848807}
{"id": "PubMed_9:841", "en": "Persons in the United States with underlying health conditions appear to be at higher risk for more severe COVID-19, consistent with findings from other countries.", "fr": "Aux États-Unis, les individus souffrant de problèmes de santé sous-jacents semblent présenter un risque accru de développer une forme grave de la COVID-19, ce qui est cohérent avec les conclusions tirées par d’autres pays.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, les individus ne souffrant pas de problèmes de santé sous-jacents semblent présenter un risque accru de développer une forme grave de la COVID-19, ce qui est cohérent avec les conclusions tirées par d’autres pays.", "bt_pert_fr": "In the United States, individuals without underlying health conditions appear to be at increased risk of developing severe COVID-19, consistent with findings in other countries.", "questions": "[\"What is the risk for persons in the United States with underlying health conditions?\", \"What health conditions are associated with higher risk of severe COVID-19?\"]", "answers": "[\"No increased risk\", \"Underlying health conditions\"]", "scores": [{"f1": 0.2222222222222222, "em": false, "chrf": 11.407040266210226, "bleu": 10.122592925934278}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6111111111111112, "avg_em": 0.5, "avg_chrf": 55.703520133105116, "avg_bleu": 55.061296462967164}
{"id": "PubMed_9:844", "en": "Maintaining at least a 30-day supply of medication, a 2-week supply of food and other necessities, and knowledge of COVID-19 symptoms are recommended for those with underlying health conditions.", "fr": "Il est recommandé aux personnes présentant des problèmes de santé sous-jacents de prévoir un stock de médicaments d’au moins 30 jours ainsi qu’un stock de nourriture et d’articles de première nécessité de 2 semaines, et de connaître les symptômes de la COVID-19.", "perturbation": "alteration", "pert_fr": "Il est recommandé aux personnes présentant des problèmes de santé sous-jacents de prévoir un stock de médicaments d’au moins 30 jours ainsi qu’un stock de nourriture et d’articles de luxe de 2 semaines, et de connaître les symptômes de la grippe.", "bt_pert_fr": "It is recommended that people with underlying health conditions have at least a 30-day supply of medications, a 2-week supply of food and luxury items, and be aware of flu symptoms.", "questions": "[\"What items should be included in a 30-day supply?\", \"What is the recommended duration for a food supply?\", \"What other necessities are included in the recommendation?\", \"What is the importance of knowing COVID-19 symptoms in this context?\"]", "answers": "[\"Medications\", \"2 weeks\", \"Food and luxury items\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 97.27748649210861, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 7.179820639952314, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 1.6518975643816487, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 51.52730117411064, "avg_bleu": 25.00000000000001}
{"id": "PubMed_9:846", "en": "All persons who are ill should stay home, except to get medical care; should not go to work; and should stay away from others.", "fr": "Tout individu malade est tenu de ne pas quitter son domicile, sauf pour recevoir des soins médicaux, de ne pas aller travailler et d’observer une certaine distance avec autrui.", "perturbation": "alteration", "pert_fr": "Tout individu en bonne santé est tenu de ne pas quitter son domicile, sauf pour recevoir des soins médicaux, de ne pas aller travailler et d’observer une certaine distance avec autrui.", "bt_pert_fr": "Every healthy individual is required not to leave their home, except to receive medical care, not to go to work and to observe a certain distance from others.", "questions": "[\"What should ill persons do?\", \"What should ill persons avoid?\", \"What is the recommendation for ill persons regarding medical care?\"]", "answers": "[\"Not specified\", \"Not specified\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.7432794034575028, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.925221799746516, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.816131853714536, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 5.494877685639518, "avg_bleu": 0.0}
{"id": "PubMed_9:847", "en": "This is especially important for those who work with persons with underlying conditions or who otherwise are at high risk for severe outcomes from COVID-19.", "fr": "Cela est particulièrement important pour ceux travaillant au contact de personnes présentant des problèmes de santé sous-jacents ou un risque élevé de développer une forme grave de la COVID-19.", "perturbation": "alteration", "pert_fr": "Cela est particulièrement important pour ceux travaillant au contact de personnes présentant des problèmes de santé excellents ou un risque faible de développer une forme grave de la COVID-19.", "bt_pert_fr": "This is particularly important for those working with people with excellent health conditions or a low risk of developing severe COVID-19.", "questions": "[\"Why is this especially important?\", \"Who are considered at high risk for severe outcomes from COVID-19?\", \"What is the significance of working with persons who have underlying conditions?\"]", "answers": "[\"Because those working with people with excellent health conditions or a low risk of developing severe COVID-19 need to be aware of the risks\", \"People with underlying health conditions\", \"The significance is that such individuals may be at higher risk for severe outcomes, so proper attention and care are necessary\"]", "scores": [{"f1": 0.24242424242424246, "em": false, "chrf": 34.92877971471088, "bleu": 2.4426633221059637}, {"f1": 0.4615384615384615, "em": false, "chrf": 48.029963729064136, "bleu": 12.975849993980747}, {"f1": 0.4864864864864864, "em": false, "chrf": 49.59488887685302, "bleu": 14.962848372546667}], "avg_f1": 0.39681639681639674, "avg_em": 0.0, "avg_chrf": 44.18454410687601, "avg_bleu": 10.127120562877792}
{"id": "PubMed_9:850", "en": "Published reports from China and Italy suggest that risk factors for severe COVID-19 disease include underlying health conditions, but data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de risque de contracter une forme grave de la COVID-19 incluent des problèmes de santé sous-jacents, mais aucune donnée relative aux problèmes de santé sous-jacents des patients américains atteints de la COVID-19 n’a encore été rapportée.", "perturbation": "alteration", "pert_fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de protection contre une forme grave de la COVID-19 incluent des problèmes de santé sous-jacents, mais aucune donnée relative aux problèmes de santé sous-jacents des patients américains atteints de la COVID-19 n’a encore été rapportée.", "bt_pert_fr": "Reports from China and Italy suggest that protective factors against severe COVID-19 include underlying health conditions, but data on underlying health conditions in U.S. COVID-19 patients have not yet been reported.", "questions": "[\"What risk factors for severe COVID-19 disease are mentioned in the reports from China and Italy?\", \"Have data describing underlying health conditions among U.S. COVID-19 patients been reported?\", \"What is the source of the reports suggesting risk factors for severe COVID-19 disease?\", \"What is the current status of data on underlying health conditions in U.S. COVID-19 patients?\"]", "answers": "[\"Underlying health conditions\", \"No\", \"China and Italy\", \"Not yet reported\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:854", "en": "Strategies to protect all persons and especially those with underlying health conditions, including social distancing and handwashing, should be implemented by all communities and all persons to help slow the spread of COVID-19.", "fr": "Des stratégies visant à protéger tous les individus et en particulier ceux présentant des problèmes de santé sous-jacents, notamment une distanciation sociale et un lavage régulier des mains, doivent être mises en œuvre par l’ensemble des communautés et des populations, afin de ralentir la propagation de la COVID-19.", "perturbation": "alteration", "pert_fr": "Des stratégies visant à exposer tous les individus et en particulier ceux présentant des problèmes de santé sous-jacents, notamment une promiscuité sociale et un lavage irrégulier des mains, doivent être mises en œuvre par l’ensemble des communautés et des populations, afin de ralentir la propagation de la COVID-19.", "bt_pert_fr": "Strategies to expose all individuals and particularly those with underlying health conditions, including social crowding and inconsistent hand washing, must be implemented by all communities and populations to slow the spread of COVID-19.", "questions": "[\"What strategies should be implemented to protect all persons?\", \"Who should be especially protected by these strategies?\", \"What specific actions are recommended to slow the spread of COVID-19?\", \"What are the recommended protective measures?\", \"Which groups are highlighted as needing special protection?\", \"What is the goal of implementing these strategies?\"]", "answers": "[\"Strategies to expose all individuals and particularly those with underlying health conditions, including social crowding and inconsistent hand washing\", \"Those with underlying health conditions\", \"Social crowding and inconsistent hand washing\", \"Social crowding and inconsistent hand washing\", \"Those with underlying health conditions\", \"To slow the spread of COVID-19\"]", "scores": [{"f1": 0.08695652173913043, "em": false, "chrf": 34.76513550619384, "bleu": 2.0244462660665508}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 57.54189949337246, "bleu": 9.652434877402245}, {"f1": 0.4, "em": false, "chrf": 57.54189949337246, "bleu": 9.652434877402245}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9090909090909091, "em": false, "chrf": 77.98570767673583, "bleu": 57.89300674674101}], "avg_f1": 0.6326745718050065, "avg_em": 0.3333333333333333, "avg_chrf": 71.30577369494576, "avg_bleu": 46.53705379460202}
{"id": "PubMed_10:856", "en": "The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) have successfully worked together on the surveillance of influenza and other infectious diseases for over 50 years, including three previous pandemics.", "fr": "Le Centre de recherche et de surveillance (Research and Surveillance Centre, RSC) du Royal College of General Practitioners (RCGP) et Public Health England (PHE) collaborent avec succès pour surveiller la grippe et d’autres maladies infectieuses depuis plus de 50 ans, notamment lors de trois pandémies passées.", "perturbation": "alteration", "pert_fr": "Le Centre de recherche et de surveillance (Research and Surveillance Centre, RSC) du Royal College of General Practitioners (RCGP) et Public Health England (PHE) collaborent sans succès pour surveiller la grippe et d’autres maladies infectieuses depuis plus de 50 ans, notamment lors de trois pandémies passées.", "bt_pert_fr": "The Royal College of General Practitioners (RCGP) Research and Surveillance Center (RSC) and Public Health England (PHE) have collaborated unsuccessfully to monitor influenza and other infectious diseases for over 50 years, including three past pandemics.", "questions": "[\"What diseases have been monitored by the collaborating organizations?\", \"For how long have the organizations worked together on disease surveillance?\", \"Which pandemics have been included in the surveillance efforts?\", \"What is the significance of the collaboration between RCGP RSC and PHE?\"]", "answers": "[\"influenza and other infectious diseases\", \"over 50 years\", \"three past pandemics\", \"The collaboration has been unsuccessful in monitoring influenza and other infectious diseases for over 50 years, including three past pandemics.\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 53.02548620560255, "bleu": 34.66806371753173}, {"f1": 0.5945945945945946, "em": false, "chrf": 67.63719282921711, "bleu": 25.95865729034344}], "avg_f1": 0.8153153153153153, "avg_em": 0.5, "avg_chrf": 80.16566975870492, "avg_bleu": 65.15668025196881}
{"id": "PubMed_10:858", "en": "At the same time and separately, the RCGP RSC’s surveillance has been extended to monitor the temporal and geographical distribution of COVID-19 infection in the community as well as assess the effectiveness of the containment strategy.", "fr": "Dans le même temps et en parallèle, la surveillance du RSC du RCGP a été étendue pour contrôler la distribution temporelle et géographique de l’infection au COVID-19 dans la communauté ainsi que pour évaluer l’efficacité de la stratégie de confinement.", "perturbation": "alteration", "pert_fr": "Dans le même temps et en parallèle, la surveillance du RSC du RCGP a été réduite pour contrôler la distribution temporelle et géographique de l’infection au COVID-19 dans la communauté ainsi que pour évaluer l’inefficacité de la stratégie de confinement.", "bt_pert_fr": "At the same time and in parallel, surveillance of the RCGP RSC was reduced to monitor the temporal and geographical distribution of COVID-19 infection in the community as well as to assess the ineffectiveness of the containment strategy.", "questions": "[\"What aspects of COVID-19 infection are monitored through the extended surveillance?\", \"What is the purpose of monitoring the temporal and geographical distribution of COVID-19 infection?\", \"What is assessed regarding the containment strategy?\", \"What does the extended surveillance aim to evaluate?\"]", "answers": "[\"The temporal and geographical distribution of COVID-19 infection in the community\", \"To understand how and where COVID-19 infection is spreading over time and space\", \"The ineffectiveness of the containment strategy\", \"The temporal and geographical distribution of COVID-19 infection in the community and the ineffectiveness of the containment strategy\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 96.0470584859595, "bleu": 75.98356856515926}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 92.9580278341548, "bleu": 42.7287006396234}, {"f1": 0.8571428571428571, "em": false, "chrf": 92.3166045641932, "bleu": 58.282339541526504}], "avg_f1": 0.8865079365079366, "avg_em": 0.25, "avg_chrf": 95.33042272107687, "avg_bleu": 69.2486521865773}
{"id": "PubMed_10:860", "en": "The RCGP RSC, a network of over 500 general practices in England, extract pseudonymized data weekly.", "fr": "Le RSC du RCGP, un réseau de plus de 500 cabinets de médecine générale en Angleterre, extrait de façon hebdomadaire des données pseudonymisées.", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP, un réseau de moins de 500 cabinets de médecine générale en Angleterre, extrait de façon mensuelle des données non pseudonymisées.", "bt_pert_fr": "The RCGP RSC, a network of fewer than 500 GP practices in England, extracts non-pseudonymised data on a monthly basis.", "questions": "[\"What is the RCGP RSC?\", \"How many general practices are part of the RCGP RSC?\", \"What type of data does the RCGP RSC extract?\", \"How frequently does the RCGP RSC extract data?\"]", "answers": "[\"A network of fewer than 500 GP practices in England\", \"Fewer than 500\", \"Non-pseudonymised data\", \"Monthly\"]", "scores": [{"f1": 0.7368421052631577, "em": false, "chrf": 62.77274617293872, "bleu": 27.301208627090666}, {"f1": 0.4, "em": false, "chrf": 20.349635451188337, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 64.47938931885916, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 8.581752484191508, "bleu": 0.0}], "avg_f1": 0.40921052631578947, "avg_em": 0.0, "avg_chrf": 39.04588085679443, "avg_bleu": 26.204317258636472}
{"id": "PubMed_10:864", "en": "(3) Serology sample collection across all age groups.", "fr": "(3) Prélèvement d’échantillons sérologiques dans toutes les tranches d’âge.", "perturbation": "alteration", "pert_fr": "Prélèvement d’échantillons non sérologiques dans toutes les tranches d’âge.", "bt_pert_fr": "Collection of non-serological samples in all age groups.", "questions": "[\"What is involved in serology sample collection?\", \"Which age groups are included in serology sample collection?\"]", "answers": "[\"Collection of non-serological samples\", \"All age groups\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 70.97203742637883, "bleu": 35.35533905932737}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.875, "avg_em": 0.5, "avg_chrf": 85.48601871318942, "avg_bleu": 67.6776695296637}
{"id": "PubMed_10:868", "en": "We have the opportunity to escalate the data extraction to twice weekly if needed.", "fr": "Nous avons la possibilité d’intensifier l’extraction de données à deux fois par semaine si nécessaire.", "perturbation": "alteration", "pert_fr": "Nous n'avons pas la possibilité d’intensifier l’extraction de données à deux fois par semaine si nécessaire.", "bt_pert_fr": "We do not have the ability to scale up data extraction to twice a week if necessary.", "questions": "[\"What opportunity do we have regarding data extraction?\", \"What is the current frequency of data extraction?\"]", "answers": "[\"The ability to scale up data extraction to twice a week\", \"Once a week\"]", "scores": [{"f1": 0.47058823529411764, "em": false, "chrf": 70.52198823893036, "bleu": 26.269098944241577}, {"f1": 0, "em": false, "chrf": 4.4642857142857135, "bleu": 0.0}], "avg_f1": 0.23529411764705882, "avg_em": 0.0, "avg_chrf": 37.493136976608035, "avg_bleu": 13.134549472120788}
{"id": "PubMed_10:873", "en": "We have rapidly converted the established national RCGP RSC influenza surveillance system into one that can test the effectiveness of the COVID-19 containment policy.", "fr": "Nous avons rapidement converti le système national établi de surveillance de la grippe du RSC du RCGP en un système apte à tester l’efficacité de la politique de confinement du COVID-19.", "perturbation": "alteration", "pert_fr": "Nous avons rapidement converti le système national établi de surveillance de la grippe du RSC du RCGP en un système inapte à tester l’efficacité de la politique de confinement du COVID-19.", "bt_pert_fr": "We quickly converted the RCGP RSC's established national influenza surveillance system into one unfit to test the effectiveness of the COVID-19 containment policy.", "questions": "[\"What has been rapidly converted?\", \"What system was converted into a new system?\", \"What can the new system test?\", \"What is the purpose of the new system?\", \"What policy can the new system evaluate for effectiveness?\"]", "answers": "[\"The RCGP RSC's established national influenza surveillance system\", \"The RCGP RSC's established national influenza surveillance system\", \"The effectiveness of the COVID-19 containment policy\", \"To evaluate the effectiveness of the COVID-19 containment policy\", \"The COVID-19 containment policy\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 86.31291984540826, "bleu": 28.117066259517458}, {"f1": 0.875, "em": false, "chrf": 86.31291984540826, "bleu": 28.117066259517458}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428571, "em": false, "chrf": 86.47094485850675, "bleu": 64.34588841607616}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9214285714285714, "avg_em": 0.4, "avg_chrf": 91.81935690986465, "avg_bleu": 64.11600418702224}
{"id": "PubMed_10:875", "en": "Rapid sharing of this protocol should enable scientific critique and shared learning.", "fr": "Le partage rapide de ce protocole devrait permettre la critique scientifique et l’apprentissage commun.", "perturbation": "alteration", "pert_fr": "Le partage lent de ce protocole devrait permettre la critique scientifique et l’apprentissage commun.", "bt_pert_fr": "The slow sharing of this protocol should allow scientific criticism and common learning.", "questions": "[\"What is the benefit of rapid sharing of this protocol?\", \"What does rapid sharing enable?\", \"What is the purpose of sharing this protocol?\"]", "answers": "[\"None specified\", \"Scientific criticism and common learning\", \"Scientific criticism and common learning\"]", "scores": [{"f1": 0, "em": false, "chrf": 8.845400291102978, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 58.01923659588385, "bleu": 14.058533129758727}, {"f1": 0.3333333333333333, "em": false, "chrf": 46.824902719029744, "bleu": 8.515289178380433}], "avg_f1": 0.3111111111111111, "avg_em": 0.0, "avg_chrf": 37.89651320200552, "avg_bleu": 7.524607436046387}
{"id": "PubMed_10:879", "en": "The RCGP RSC extracts pseudonymized data from a nationally representative sample of over 500 urban and nonurban GPs each week covering a population of over 4 million.", "fr": "Le RSC du RCGP extrait des données pseudonymisées d’un échantillon représentatif à l’échelle nationale de plus de 500 cabinets de MG urbains et ruraux chaque semaine, couvrant une population de plus de 4 millions de personnes.", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP extrait des données non pseudonymisées d’un échantillon représentatif à l’échelle nationale de plus de 500 cabinets de MG urbains et ruraux chaque semaine, couvrant une population de moins de 4 millions de personnes.", "bt_pert_fr": "The RCGP RSC extracts non-pseudonymised data from a nationally representative sample of over 500 urban and rural GP practices each week, covering a population of less than 4 million people.", "questions": "[\"What does the RCGP RSC extract?\", \"From what type of sample does the RCGP RSC extract data?\", \"How many urban and nonurban GPs are included in the sample?\", \"What is the size of the population covered by the data?\", \"What is the frequency of data extraction by the RCGP RSC?\"]", "answers": "[\"non-pseudonymised data\", \"a nationally representative sample of over 500 urban and rural GP practices\", \"500\", \"less than 4 million people\", \"each week\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 64.47938931885916, "bleu": 49.99999999999999}, {"f1": 0.7272727272727273, "em": false, "chrf": 79.88074483197751, "bleu": 67.86502681586727}, {"f1": 0.6666666666666666, "em": false, "chrf": 37.10506980161646, "bleu": 36.78794411714425}, {"f1": 0.5, "em": false, "chrf": 47.91104285333383, "bleu": 21.3643503198117}, {"f1": 0.5, "em": false, "chrf": 79.70238095238096, "bleu": 49.99999999999999}], "avg_f1": 0.5787878787878789, "avg_em": 0.0, "avg_chrf": 61.81572555163359, "avg_bleu": 45.203464250564636}
{"id": "PubMed_10:880", "en": "Data from these practices are reported online in a weekly return, which includes monitoring weekly rates of influenza-like illness (ILI) and other communicable and respiratory diseases in England.", "fr": "Les données issues de ces cabinets sont signalées en ligne dans un rapport hebdomadaire, qui comprend la surveillance des taux hebdomadaires de syndrome grippal (SG) et d’autres maladies respiratoires en Angleterre.", "perturbation": "alteration", "pert_fr": "Les données issues de ces cabinets ne sont pas signalées en ligne dans un rapport hebdomadaire, qui comprend la surveillance des taux hebdomadaires de syndrome grippal (SG) et d’autres maladies respiratoires en Angleterre.", "bt_pert_fr": "Data from these practices is not reported online in a weekly report, which includes monitoring of weekly rates of influenza-like illness (ILI) and other respiratory illnesses in England.", "questions": "[\"What does the weekly return include?\", \"What diseases are monitored in the weekly return?\", \"Where are the data from these practices reported?\"]", "answers": "[\"Monitoring of weekly rates of influenza-like illness (ILI) and other respiratory illnesses in England\", \"Influenza-like illness (ILI) and other respiratory illnesses\", \"Not reported online\"]", "scores": [{"f1": 0.8275862068965518, "em": false, "chrf": 73.69157909267709, "bleu": 54.78551616308207}, {"f1": 0.75, "em": false, "chrf": 64.82913524252734, "bleu": 48.35447404743731}, {"f1": 0, "em": false, "chrf": 38.50511065818818, "bleu": 0.0}], "avg_f1": 0.5258620689655172, "avg_em": 0.0, "avg_chrf": 59.008608331130866, "avg_bleu": 34.37999673683979}
{"id": "PubMed_10:882", "en": "The RCGP RSC data set includes all coded data and all prescribed items including vaccine exposure.", "fr": "L’ensemble de données du RSC du RCGP comprend toutes les données codées et tous les produits prescrits, notamment l’exposition au vaccin.", "perturbation": "alteration", "pert_fr": "L’ensemble de données du RSC du RCGP comprend aucune des données codées et aucun des produits prescrits, notamment l’exposition au vaccin.", "bt_pert_fr": "The RCGP CHR dataset includes no coded data and no prescribed products, including vaccine exposure.", "questions": "[\"What does the RCGP RSC data set include?\", \"What types of data are included in the RCGP RSC data set?\", \"What specific items are included in the RCGP RSC data set?\", \"What is the scope of the RCGP RSC data set?\"]", "answers": "[\"Nothing\", \"No coded data and no prescribed products, including vaccine exposure\", \"No coded data and no prescribed products, including vaccine exposure\", \"The RCGP RSC dataset includes no coded data and no prescribed products, including vaccine exposure\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.868909455331058, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 55.25324285699739, "bleu": 9.287528999566801}, {"f1": 0.4, "em": false, "chrf": 72.5121737461988, "bleu": 15.619699684601283}, {"f1": 0.56, "em": false, "chrf": 67.58598144349199, "bleu": 17.098323692758395}], "avg_f1": 0.34, "avg_em": 0.0, "avg_chrf": 49.55507687550481, "avg_bleu": 10.50138809423162}
{"id": "PubMed_10:883", "en": "The RCGP RSC conducts virology surveillance each influenza season, with 100 GPs participating in the 2019-2020 season (Figure 1).", "fr": "Le RSC du RCGP mène une surveillance virologique lors de chaque saison grippale, avec 100 cabinets de MG participant pendant la saison 2019-2020 (Figure 1).", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP ne mène pas de surveillance virologique lors de chaque saison grippale, avec 100 cabinets de MG participant pendant la saison 2019-2020 (Figure 1).", "bt_pert_fr": "The RCGP RSC does not conduct virological surveillance during each influenza season, with 100 GP practices participating during the 2019-2020 season (Figure 1).", "questions": "[\"What does the RCGP RSC conduct each influenza season?\", \"How many GPs participated in the RCGP RSC's virology surveillance during the 2019-2020 season?\", \"What is the purpose of the virology surveillance conducted by the RCGP RSC?\"]", "answers": "[\"None\", \"100\", \"The purpose is not mentioned in the sentence\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.464285714285714, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 13.533442446571852, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 39.332576053619185, "avg_bleu": 33.33333333333335}
{"id": "PubMed_10:886", "en": "Nasopharyngeal swabs are taken from children younger than 5 years showing symptoms of acute bronchitis or bronchiolitis.", "fr": "Des écouvillons nasopharyngés sont prélevés chez les enfants de moins de 5 ans présentant des symptômes de bronchite aiguë ou de bronchiolite.", "perturbation": "alteration", "pert_fr": "Des écouvillons nasopharyngés sont prélevés chez les enfants de plus de 5 ans présentant des symptômes de bronchite aiguë ou de bronchiolite.", "bt_pert_fr": "Nasopharyngeal swabs are collected from children over 5 years of age with symptoms of acute bronchitis or bronchiolitis.", "questions": "[\"What symptoms prompt the collection of nasopharyngeal swabs in children younger than 5 years?\", \"Which children are eligible for nasopharyngeal swabs?\", \"What condition is associated with the collection of nasopharyngeal swabs in young children?\"]", "answers": "[\"None\", \"Children over 5 years of age\", \"Acute bronchitis or bronchiolitis\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.076086956521738, "bleu": 0.0}, {"f1": 0.5454545454545454, "em": false, "chrf": 44.56315451124684, "bleu": 17.965205598154213}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5151515151515151, "avg_em": 0.3333333333333333, "avg_chrf": 49.54641382258953, "avg_bleu": 39.321735199384754}
{"id": "PubMed_10:887", "en": "Additionally, nasopharyngeal samples are taken from anyone 5 years and older showing acute onset of ILI and respiratory synctial virus.", "fr": "En outre, des échantillons nasopharyngés sont prélevés chez toute personne âgée de 5 ans ou plus qui présente une apparition aigüe de SG et de virus respiratoire syncytial.", "perturbation": "alteration", "pert_fr": "En outre, des échantillons nasopharyngés sont prélevés chez toute personne âgée de 5 ans ou moins qui présente une apparition aigüe de SG et de virus respiratoire syncytial.", "bt_pert_fr": "Additionally, nasopharyngeal samples are collected from anyone 5 years of age or younger who has acute onset of ILI and respiratory syncytial virus.", "questions": "[\"Who is eligible for nasopharyngeal samples?\", \"What type of samples are taken?\", \"At what age are nasopharyngeal samples taken?\", \"What condition triggers the collection of nasopharyngeal samples?\", \"What virus is mentioned in the sentence?\", \"What is the acute onset of ILI related to?\"]", "answers": "[\"Anyone 5 years of age or younger who has acute onset of ILI and respiratory syncytial virus\", \"Nasopharyngeal samples\", \"5 years of age or younger\", \"Acute onset of ILI and respiratory syncytial virus\", \"Respiratory syncytial virus\", \"ILI\"]", "scores": [{"f1": 0.7096774193548386, "em": false, "chrf": 76.21350721503605, "bleu": 49.62822700197383}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 32.87558327327938, "bleu": 16.233395773754946}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8516129032258064, "avg_em": 0.6666666666666666, "avg_chrf": 84.84818174805257, "avg_bleu": 77.64360379595483}
{"id": "PubMed_10:888", "en": "Swabs are tested at the PHE Respiratory Virus Unit for influenza to monitor positivity rates and circulating strains, as well as for measuring vaccine effectiveness.", "fr": "Les écouvillons sont testés dans l’Unité des virus respiratoires de PHE pour la grippe afin de surveiller les taux de positivité et les souches circulantes, ainsi que pour mesurer l’efficacité du vaccin.", "perturbation": "alteration", "pert_fr": "Les écouvillons sont testés dans l’Unité des virus respiratoires de PHE pour la santé afin de surveiller les taux de négativité et les souches circulantes, ainsi que pour mesurer l’inefficacité du vaccin.", "bt_pert_fr": "Swabs are tested in PHE Health's Respiratory Virus Unit to monitor negativity rates and circulating strains, as well as to measure vaccine ineffectiveness.", "questions": "[\"What is monitored using swab testing?\", \"What is measured through swab testing?\", \"What disease is tested for at the PHE Respiratory Virus Unit?\", \"What is the purpose of testing swabs at the PHE Respiratory Virus Unit?\"]", "answers": "[\"Negativity rates and circulating strains\", \"Vaccine ineffectiveness\", \"Respiratory viruses\", \"To monitor negativity rates and circulating strains, as well as to measure vaccine ineffectiveness\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 88.02852894171679, "bleu": 66.87403049764218}, {"f1": 0.5, "em": false, "chrf": 82.72553040955579, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 4.62962962962963, "bleu": 0.0}, {"f1": 0.7142857142857143, "em": false, "chrf": 76.74398604437306, "bleu": 49.132705481444226}], "avg_f1": 0.5035714285714286, "avg_em": 0.0, "avg_chrf": 63.03191875631882, "avg_bleu": 41.5016839947716}
{"id": "PubMed_10:889", "en": "The RCGP RSC successfully conducted a pilot collecting serological samples from adults and linking them to a patient’s medical records during the 2018-2019 influenza season.", "fr": "Le RSC du RCGP a mené avec succès un projet pilote de recueil d’échantillons sérologiques chez des adultes et de couplage de ces échantillons aux dossiers médicaux de patients pendant la saison grippale 2018-2019.", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP n'a pas mené avec succès un projet pilote de recueil d’échantillons sérologiques chez des adultes et de couplage de ces échantillons aux dossiers médicaux de patients pendant la saison grippale 2018-2019.", "bt_pert_fr": "The RCGP RSC did not successfully conduct a pilot project to collect serological samples from adults and link these samples to patient medical records during the 2018-2019 influenza season.", "questions": "[\"What did the RCGP RSC successfully conduct?\", \"What type of samples were collected during the 2018-2019 influenza season?\", \"Who were the samples collected from?\", \"What was the purpose of linking the samples to patient medical records?\", \"What season did the pilot take place in?\"]", "answers": "[\"None\", \"Serological samples\", \"Adults\", \"To link the samples to patient medical records\", \"The 2018-2019 influenza season\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.1295180722891565, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 93.46837666690608, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 59.166666666666664, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 88.05371765891114, "bleu": 48.892302243490086}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.13950678202072, "bleu": 59.460355750136046}], "avg_f1": 0.4428571428571429, "avg_em": 0.0, "avg_chrf": 67.79155716935875, "avg_bleu": 31.670531598725223}
{"id": "PubMed_10:890", "en": "This pilot was in collaboration with the PHE Seroepidemiology Unit and added to the residual blood samples submitted to PHE by National Health Service (NHS) laboratories.", "fr": "Ce projet pilote a été mené en collaboration avec l’Unité séro-épidémiologique de PHE et les échantillons obtenus ont été ajoutés aux échantillons de sang restants envoyés à PHE par les laboratoires du National Health Service (NHS).", "perturbation": "alteration", "pert_fr": "Ce projet pilote n'a pas été mené en collaboration avec l’Unité séro-épidémiologique de PHE et les échantillons obtenus ont été supprimés des échantillons de sang restants envoyés à PHE par les laboratoires du National Health Service (NHS).", "bt_pert_fr": "This pilot was not carried out in collaboration with the PHE Sero-Epidemiology Unit and the samples obtained were removed from the remaining blood samples sent to PHE from the National Health Service (NHS) laboratories.", "questions": "[\"What was the pilot in collaboration with?\", \"Which unit was involved in the pilot?\", \"What samples were added to the pilot?\", \"Where were the samples submitted?\", \"Which laboratories submitted the samples?\"]", "answers": "[\"The PHE Sero-Epidemiology Unit\", \"The PHE Sero-Epidemiology Unit\", \"The samples obtained were removed from the remaining blood samples\", \"To PHE\", \"The National Health Service (NHS) laboratories\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 80.48508915553792, "bleu": 18.99589214128981}, {"f1": 0.5714285714285715, "em": false, "chrf": 80.48508915553792, "bleu": 18.99589214128981}, {"f1": 0.3333333333333333, "em": false, "chrf": 44.48245722703874, "bleu": 9.535414040914189}, {"f1": 0.6666666666666666, "em": false, "chrf": 82.06106870229006, "bleu": 49.99999999999999}, {"f1": 0.9090909090909091, "em": false, "chrf": 98.2363296511681, "bleu": 75.98356856515926}], "avg_f1": 0.6103896103896104, "avg_em": 0.0, "avg_chrf": 77.15000677831455, "avg_bleu": 34.70215337773061}
{"id": "PubMed_10:892", "en": "The serology pilot has demonstrated the ability of the network to collect serology samples in adults.", "fr": "Le projet pilote de sérologie a démontré la capacité du réseau à recueillir des échantillons sérologiques chez des adultes.", "perturbation": "alteration", "pert_fr": "Le projet pilote de sérologie a démontré l'incapacité du réseau à recueillir des échantillons sérologiques chez des adultes.", "bt_pert_fr": "The serology pilot project demonstrated the network's inability to collect serological samples from adults.", "questions": "[\"What has the serology pilot demonstrated?\", \"What type of samples can the network collect?\", \"Who is the target group for the serology samples?\", \"What is the purpose of the serology pilot?\"]", "answers": "[\"The network's inability to collect serological samples from adults\", \"Serological samples\", \"Adults\", \"To demonstrate the network's inability to collect serological samples from adults\"]", "scores": [{"f1": 0.5263157894736842, "em": false, "chrf": 66.04673541845162, "bleu": 10.729256185679601}, {"f1": 0.5, "em": false, "chrf": 66.41043512256091, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285713, "em": false, "chrf": 70.9654211008972, "bleu": 11.884631831419354}], "avg_f1": 0.6494360902255638, "avg_em": 0.25, "avg_chrf": 75.85564791047743, "avg_bleu": 43.15347200427475}
{"id": "PubMed_10:894", "en": "The primary national strategy for COVID-19 infection is containment, with patients who are at high risk managed via the telephone help system NHS111 and the PHE health protection teams, but the RCGP RSC surveillance is entirely separate.", "fr": "La principale stratégie nationale face à l’infection au COVID-19 est le confinement, en prenant en charge les patients à risque élevé grâce au système d'aiguillage téléphonique NHS111 et aux équipes de protection de la santé de PHE, mais la surveillance du RSC du RCGP est entièrement indépendante.", "perturbation": "alteration", "pert_fr": "La principale stratégie nationale face à l’infection au COVID-19 est la liberté, en prenant en charge les patients à risque élevé grâce au système d'aiguillage téléphonique NHS111 et aux équipes de protection de la santé de PHE, mais la surveillance du RSC du RCGP est entièrement indépendante.", "bt_pert_fr": "The main national strategy for dealing with COVID-19 infection is freedom, caring for high-risk patients through the NHS111 telephone referral system and PHE health protection teams, but RCGP RSC monitoring is entirely independent.", "questions": "[\"What is the primary national strategy for COVID-19 infection?\", \"How are patients at high risk managed?\", \"What system is used to manage high-risk patients via telephone?\", \"What teams are involved in managing high-risk patients?\", \"What is the relationship between RCGP RSC surveillance and the other management systems?\"]", "answers": "[\"Freedom\", \"Through the NHS111 telephone referral system and PHE health protection teams\", \"NHS111 telephone referral system\", \"PHE health protection teams\", \"Entirely independent\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.901960784313724, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 71.08919128669626, "bleu": 44.17918226831576}, {"f1": 0.4, "em": false, "chrf": 42.42515916977655, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 43.17728096174364, "bleu": 49.99999999999999}], "avg_f1": 0.54, "avg_em": 0.2, "avg_chrf": 52.31871844050604, "avg_bleu": 42.03055197489452}
{"id": "PubMed_10:899", "en": "The aim of this study is to identify whether there is undetected community transmission of COVID-19, estimate population susceptibility, and monitor the temporal and geographical distribution of COVID-19 infection in the community.", "fr": "L’objectif de cette étude est d’identifier s’il existe une transmission communautaire non détectée du COVID-19, de déterminer la sensibilité de la population et de surveiller la distribution temporelle et géographique de l’infection au COVID-19.", "perturbation": "alteration", "pert_fr": "L’objectif de cette étude est de déterminer s’il n’existe pas une transmission communautaire non détectée du COVID-19, de déterminer l’insensibilité de la population et de surveiller la distribution temporelle et géographique de l’infection au COVID-19.", "bt_pert_fr": "The objective of this study is to determine whether there is undetected community transmission of COVID-19, to determine population susceptibility, and to monitor the temporal and geographic distribution of COVID-19 infection.", "questions": "[\"What is the aim of this study?\", \"What does the study aim to identify?\", \"What does the study aim to estimate?\", \"What does the study aim to monitor?\", \"What aspects of COVID-19 infection are being monitored?\", \"What is community transmission in this context?\"]", "answers": "[\"To determine whether there is undetected community transmission of COVID-19, to determine population susceptibility, and to monitor the temporal and geographic distribution of COVID-19 infection\", \"Undetected community transmission of COVID-19\", \"Population susceptibility\", \"The temporal and geographic distribution of COVID-19 infection\", \"Temporal and geographic distribution\", \"The spread of COVID-19 within a community that is not detected by official surveillance systems\"]", "scores": [{"f1": 0.7037037037037038, "em": false, "chrf": 73.8540047979052, "bleu": 38.952858921283266}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.32778252515094, "bleu": 66.87403049764218}, {"f1": 0.5, "em": false, "chrf": 95.31916500738012, "bleu": 49.99999999999999}, {"f1": 0.7999999999999999, "em": false, "chrf": 90.60555921929084, "bleu": 41.11336169005198}, {"f1": 0.5, "em": false, "chrf": 83.78265480088358, "bleu": 18.99589214128981}, {"f1": 0.962962962962963, "em": false, "chrf": 99.18986641412953, "bleu": 91.93227152249183}], "avg_f1": 0.7111111111111111, "avg_em": 0.0, "avg_chrf": 90.0131721274567, "avg_bleu": 51.311402462126516}
{"id": "PubMed_10:901", "en": "To monitor the burden of suspected COVID-19 activity in the community through primary care surveillance and clinical coding of possible COVID-19 cases referred into the containment pathway", "fr": "Surveiller le fardeau de l’activité présumée du COVID-19 au sein de la communauté par le biais de la surveillance en soins primaires et du codage clinique des cas potentiels de COVID-19 orientés vers le parcours de confinement", "perturbation": "alteration", "pert_fr": "Ignorer le fardeau de l’activité présumée du COVID-19 au sein de la communauté par le biais de la surveillance en soins primaires et du codage clinique des cas potentiels de COVID-19 orientés vers le parcours de confinement", "bt_pert_fr": "Ignoring the burden of suspected COVID-19 activity in the community through primary care surveillance and clinical coding of potential COVID-19 cases referred to the containment pathway", "questions": "[\"What is being monitored in the community?\", \"How is the burden of suspected COVID-19 activity being tracked?\", \"What method is used for surveillance of suspected COVID-19 cases?\"]", "answers": "[\"Suspected COVID-19 activity\", \"Through primary care surveillance and clinical coding of potential COVID-19 cases referred to the containment pathway\", \"Primary care surveillance and clinical coding of potential COVID-19 cases referred to the containment pathway\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 67.55947209671012, "bleu": 20.24518585186855}, {"f1": 0.8666666666666667, "em": false, "chrf": 87.48626473843977, "bleu": 61.04735835807847}, {"f1": 0.8571428571428571, "em": false, "chrf": 86.4976218942873, "bleu": 57.3122448409426}], "avg_f1": 0.7227513227513227, "avg_em": 0.0, "avg_chrf": 80.5144529098124, "avg_bleu": 46.20159635029654}
{"id": "PubMed_10:903", "en": "To estimate baseline susceptibility to COVID-19 in the community and estimate both symptomatic and asymptomatic exposure rates in the population through seroprevalence monitoring", "fr": "Déterminer la sensibilité de référence au COVID-19 dans la communauté et mesurer les taux d’exposition symptomatique et asymptomatique dans la population via la surveillance de la séroprévalence", "perturbation": "alteration", "pert_fr": "Déterminer l'insensibilité de référence au COVID-19 dans la communauté et mesurer les taux d’exposition symptomatique et asymptomatique dans la population via la surveillance de la séroprévalence", "bt_pert_fr": "Determine baseline COVID-19 unsusceptibility in the community and measure symptomatic and asymptomatic population exposure rates via seroprevalence surveillance", "questions": "[\"What does seroprevalence monitoring estimate?\", \"What types of exposure rates are estimated in the population?\"]", "answers": "[\"Baseline COVID-19 unsusceptibility in the community\", \"Symptomatic and asymptomatic population exposure rates\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 72.80523881454562, "bleu": 19.357693493908812}, {"f1": 0.6666666666666666, "em": false, "chrf": 79.68793266141206, "bleu": 22.957488466614326}], "avg_f1": 0.606060606060606, "avg_em": 0.0, "avg_chrf": 76.24658573797885, "avg_bleu": 21.157590980261567}
{"id": "PubMed_10:905", "en": "We intend to capture the following.", "fr": "Nous avons l’intention d’enregistrer ce qui suit.", "perturbation": "alteration", "pert_fr": "Nous n'avons pas l’intention d’enregistrer ce qui suit.", "bt_pert_fr": "We do not intend to record the following.", "questions": "[\"What are we intending to capture?\"]", "answers": "[\"Nothing\"]", "scores": [{"f1": 0, "em": false, "chrf": 14.66510405057891, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 14.66510405057891, "avg_bleu": 0.0}
{"id": "PubMed_10:906", "en": "Clinical workload related to reports of COVID-19 using the codes created to flag cases, those being assessed and where the infection is located are excluded (Figures 2-​-44)", "fr": "La charge de travail clinique liée aux rapports de COVID-19 à l’aide des codes créés pour signaler les cas, les cas testés et l’emplacement de l’infection sont exclus (Figures 2--44)", "perturbation": "alteration", "pert_fr": "La charge de travail clinique liée aux rapports de COVID-19 à l’aide des codes créés pour signaler les cas, les cas testés et l’emplacement de la guérison sont inclus (Figures 2--44)", "bt_pert_fr": "Clinical workload related to COVID-19 reporting using codes created to report cases, cases tested and location of recovery are included (Figures 2--44)", "questions": "[\"What is excluded in the clinical workload related to COVID-19 reports?\", \"What specific information is excluded from the clinical workload?\", \"What figures illustrate the exclusion in the clinical workload?\"]", "answers": "[\"Nothing is explicitly excluded\", \"Nothing is explicitly excluded\", \"Figures 2--44\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.514884587153896, "bleu": 0.0}, {"f1": 0.16666666666666666, "em": false, "chrf": 10.335904543660488, "bleu": 5.876350803261633}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3888888888888889, "avg_em": 0.3333333333333333, "avg_chrf": 39.95026304360479, "avg_bleu": 35.292116934420555}
{"id": "PubMed_10:907", "en": "Foreign countries visited in the last 28 days", "fr": "Pays étrangers visités au cours des 28 derniers jours", "perturbation": "alteration", "pert_fr": "Pays connus non visités au cours des 28 derniers jours", "bt_pert_fr": "Known countries not visited in last 28 days", "questions": "[\"What is the time frame for the visits?\"]", "answers": "[\"28 days\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 36.48381677545021, "bleu": 36.78794411714425}], "avg_f1": 0.6666666666666666, "avg_em": 0.0, "avg_chrf": 36.48381677545021, "avg_bleu": 36.78794411714425}
{"id": "PubMed_10:908", "en": "Existing codes that may have utility (Tables 1-​-3).3).", "fr": "Codes existants pouvant être utiles (Tableaux 1--3).3).", "perturbation": "alteration", "pert_fr": "Codes inexistants pouvant être inutiles (Tableaux 1--3).3).", "bt_pert_fr": "Non-existent codes that may be useless (Tables 1--3).3).", "questions": "[\"What existing codes are mentioned?\", \"Which tables are referenced in the sentence?\"]", "answers": "[\"None\", \"Tables 1--3\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.696428571428571, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 53.348214285714285, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:909", "en": "Many GPs and primary care teams may not realize that important relevant data can be coded.", "fr": "De nombreux MG et équipes de soins primaires ne se rendent pas toujours compte que d’importantes données pertinentes peuvent être codées.", "perturbation": "alteration", "pert_fr": "De nombreux MG et équipes de soins primaires se rendent toujours compte que d’importantes données pertinentes ne peuvent pas être codées.", "bt_pert_fr": "Many GPs and primary care teams still find that important relevant data cannot be coded.", "questions": "[\"What may not realize about relevant data?\", \"What type of data can be coded?\", \"What is important about the data that can be coded?\", \"Who may not realize the importance of coding relevant data?\"]", "answers": "[\"That important relevant data cannot be coded\", \"Relevant data\", \"Its importance\", \"Many GPs and primary care teams\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 90.3422456641658, "bleu": 48.892302243490086}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 9.815450461903552, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7142857142857143, "avg_em": 0.5, "avg_chrf": 75.03942403151734, "avg_bleu": 62.223075560872545}
{"id": "PubMed_10:911", "en": "Reliable coding of letters and test results that will show an infection has become either confirmed or excluded", "fr": "Un codage fiable de lettres et résultats d’analyse qui montrera si une infection est confirmée ou exclue", "perturbation": "alteration", "pert_fr": "Un codage peu fiable de lettres et résultats d’analyse qui montrera si une infection est confirmée ou exclue", "bt_pert_fr": "Unreliable coding of letters and test results that will show whether an infection is confirmed or ruled out", "questions": "[\"What does reliable coding of letters and test results show?\", \"What is the purpose of reliable coding of letters and test results?\"]", "answers": "[\"Whether an infection is confirmed or ruled out\", \"To determine if an infection is confirmed or ruled out\"]", "scores": [{"f1": 0.39999999999999997, "em": false, "chrf": 44.56512076450563, "bleu": 12.600736402830258}, {"f1": 0.7058823529411765, "em": false, "chrf": 65.209121689435, "bleu": 35.49481056010054}], "avg_f1": 0.5529411764705883, "avg_em": 0.0, "avg_chrf": 54.88712122697031, "avg_bleu": 24.0477734814654}
{"id": "PubMed_10:913", "en": "The NHS uses the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) system of coding, which is normally only updated twice annually.", "fr": "Le NHS utilise le système de codage de la nomenclature systématisée des termes cliniques en médecine (Systematized Nomenclature of Medicine Clinical Terms, SNOMED CT), qui n’est normalement mise à jour que deux fois par an.", "perturbation": "alteration", "pert_fr": "Le NHS utilise le système de codage de la nomenclature systématisée des termes cliniques en médecine (Systematized Nomenclature of Medicine Clinical Terms, SNOMED CT), qui est normalement mise à jour plus de deux fois par an.", "bt_pert_fr": "The NHS uses the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) coding system, which is normally updated more than twice a year.", "questions": "[\"What coding system does the NHS use?\", \"What is the name of the coding system used by the NHS?\", \"How often is the SNOMED CT system normally updated?\"]", "answers": "[\"Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT)\", \"Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT)\", \"More than twice a year\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 20.541936880091015, "bleu": 0.0}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 73.51397896003034, "avg_bleu": 66.6666666666667}
{"id": "PubMed_10:915", "en": "Additionally, there were no clinical codes to record COVID-19 in early February 2020.", "fr": "En outre, il n’existait aucun code clinique pour enregistrer le COVID-19 au début du mois de février 2020.", "perturbation": "alteration", "pert_fr": "En outre, il existait un code clinique pour enregistrer le COVID-19 au début du mois de février 2020.", "bt_pert_fr": "Additionally, there was a clinical code for recording COVID-19 in early February 2020.", "questions": "[\"What was missing in early February 2020 regarding COVID-19?\"]", "answers": "[\"A clinical code for recording COVID-19\"]", "scores": [{"f1": 0.1818181818181818, "em": false, "chrf": 62.90885575868028, "bleu": 8.116697886877475}], "avg_f1": 0.1818181818181818, "avg_em": 0.0, "avg_chrf": 62.90885575868028, "avg_bleu": 8.116697886877475}
{"id": "PubMed_10:918", "en": "The intention is that these will eventually be mapped to the new SNOMED CT concepts as they become available, allowing recording of relevant data (Multimedia Appendix 1).", "fr": "L’objectif est qu’ils soient intégrés aux nouveaux concepts de la SNOMED CT à mesure qu’ils deviennent disponibles, permettant ainsi l’enregistrement des données pertinentes (Annexe multimédia 1).", "perturbation": "alteration", "pert_fr": "L’objectif est qu’ils soient exclus des nouveaux concepts de la SNOMED CT à mesure qu’ils deviennent disponibles, permettant ainsi l’enregistrement des données pertinentes (Annexe multimédia 1).", "bt_pert_fr": "The aim is for them to be excluded from new SNOMED CT concepts as they become available, thus allowing the recording of relevant data (Multimedia Annex 1).", "questions": "[\"What is the intention regarding the mapping of these items?\", \"When will the mapping to new SNOMED CT concepts occur?\", \"What allows the recording of relevant data?\"]", "answers": "[\"To exclude them from new SNOMED CT concepts as they become available\", \"As they become available\", \"The exclusion from new SNOMED CT concepts\"]", "scores": [{"f1": 0.6153846153846153, "em": false, "chrf": 61.73401892668483, "bleu": 51.908776981193526}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7142857142857143, "em": false, "chrf": 62.01671651817724, "bleu": 43.47208719449914}], "avg_f1": 0.7765567765567765, "avg_em": 0.3333333333333333, "avg_chrf": 74.58357848162069, "avg_bleu": 65.1269547252309}
{"id": "PubMed_10:919", "en": "The key requirements for this release were the ability to code (Table 4) a case of COVID-19, exposure to risk of infection (travel to an area where there may be a higher risk), contact with anyone infected with COVID-19, a report that a person had been tested for COVID-19, and that the disease had been excluded (likely a negative test).", "fr": "Les conditions essentielles pour cette version étaient la possibilité de coder (Tableau 4) un cas de COVID-19, l’exposition au risque d’infection (se rendre dans une zone où le risque peut être plus élevé), le contact avec toute personne infectée par le COVID-19, un rapport qu’une personne a été testée pour le COVID-19, et que la maladie a été exclue (probablement un test négatif).", "perturbation": "alteration", "pert_fr": "Les conditions essentielles pour cette version étaient l'impossibilité de coder (Tableau 4) un cas de COVID-19, l’exposition au risque d’infection (se rendre dans une zone où le risque peut être plus élevé), le contact avec toute personne infectée par le COVID-19, un rapport qu’une personne n’a pas été testée pour le COVID-19, et que la maladie n’a pas été exclue (probablement un test positif).", "bt_pert_fr": "The essential conditions for this version were the inability to code (Table 4) a case of COVID-19, exposure to risk of infection (traveling to an area where the risk may be higher), contact with anyone infected with COVID-19, a report that a person has not been tested for COVID-19, and that the disease has not been ruled out (probably a positive test).", "questions": "[\"What are the key requirements for this release?\", \"What does 'code a case of COVID-19' mean?\", \"What constitutes exposure to risk of infection?\", \"What is considered contact with someone infected with COVID-19?\", \"What does it mean for the disease to have been excluded?\", \"What is the source of the information about these requirements (Table 4)?\"]", "answers": "[\"The inability to code a case of COVID-19, exposure to risk of infection (traveling to an area where the risk may be higher), contact with anyone infected with COVID-19, a report that a person has not been tested for COVID-19, and that the disease has not been ruled out (probably a positive test)\", \"The inability to record or document a case of COVID-19 in the system\", \"Traveling to an area where the risk of COVID-19 infection is higher\", \"Direct physical interaction with someone who has been diagnosed with or is confirmed to have COVID-19\", \"The disease has been ruled out means that testing has been done and the result indicates the absence of infection, typically a negative test\", \"Table 4\"]", "scores": [{"f1": 0.782608695652174, "em": false, "chrf": 77.0792091167554, "bleu": 51.74595499816011}, {"f1": 0.5833333333333334, "em": false, "chrf": 52.11401322109307, "bleu": 20.33038389239877}, {"f1": 0.7272727272727272, "em": false, "chrf": 67.90990766435327, "bleu": 32.16094349518416}, {"f1": 0.875, "em": false, "chrf": 76.16683539563894, "bleu": 61.28081331864041}, {"f1": 0.3414634146341463, "em": false, "chrf": 39.3039761734847, "bleu": 4.968018039415939}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7182796951487301, "avg_em": 0.16666666666666666, "avg_chrf": 68.76232359522089, "avg_bleu": 45.081018957299904}
{"id": "PubMed_10:922", "en": "Currently, virology samples for influenza surveillance are accompanied by a standard request form.", "fr": "Actuellement, les échantillons virologiques pour la surveillance de la grippe sont accompagnés d’un formulaire de demande standard.", "perturbation": "alteration", "pert_fr": "Actuellement, les échantillons virologiques pour la surveillance de la grippe ne sont pas accompagnés d’un formulaire de demande standard.", "bt_pert_fr": "Currently, virological samples for influenza surveillance are not accompanied by a standard request form.", "questions": "[\"What is currently included with virology samples for influenza surveillance?\", \"What type of form is accompanying virology samples for influenza surveillance?\"]", "answers": "[\"Nothing\", \"A standard request form\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.873563218390804, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 51.4367816091954, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:926", "en": "Acute bronchitis/bronchiolitis in those younger than five years", "fr": "Bronchite aigüe/bronchiolite chez les moins de cinq ans", "perturbation": "alteration", "pert_fr": "Bronchite chronique/bronchiolite chez les plus de cinq ans", "bt_pert_fr": "Chronic bronchitis/bronchiolitis in children over five years old", "questions": "[\"Who is affected by acute bronchitis/bronchiolitis?\", \"What age group is mentioned in the sentence?\"]", "answers": "[\"Children over five years old\", \"Children over five years old\"]", "scores": [{"f1": 0.4000000000000001, "em": false, "chrf": 34.13280274980106, "bleu": 21.3643503198117}, {"f1": 0.4444444444444445, "em": false, "chrf": 39.79940802836231, "bleu": 21.3643503198117}], "avg_f1": 0.4222222222222223, "avg_em": 0.0, "avg_chrf": 36.96610538908168, "avg_bleu": 21.3643503198117}
{"id": "PubMed_10:928", "en": "History of fever (Y/N); measured (Y/N); if yes, level", "fr": "Antécédents de fièvre (O/N) ; mesurée (O/N) ; si oui, température", "perturbation": "alteration", "pert_fr": "Antécédents de froid (O/N) ; mesurée (O/N) ; si oui, température", "bt_pert_fr": "History of cold (Y/N); measured (Y/N); if yes, temperature", "questions": "[\"What is the history of fever?\", \"If fever was measured, what was the level?\"]", "answers": "[\"Y/N\", \"Temperature\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 4.901960784313725, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 52.450980392156865, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:930", "en": "Recent travel (Y/N); if yes, countries visited in last 14 days", "fr": "Voyage récent (O/N) ; si oui, pays visités au cours des 14 derniers jours", "perturbation": "alteration", "pert_fr": "Voyage lointain (O/N) ; si oui, pays visités au cours des 14 derniers jours", "bt_pert_fr": "Far travel (Y/N); if yes, countries visited in the last 14 days", "questions": "[\"What is the recent travel status?\"]", "answers": "[\"Far travel (Y/N)\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 49.20667186867569, "bleu": 55.03212081491043}], "avg_f1": 0.6666666666666666, "avg_em": 0.0, "avg_chrf": 49.20667186867569, "avg_bleu": 55.03212081491043}
{"id": "PubMed_10:937", "en": "Definite case will be presented on our dashboard as “cases” of COVID-19.", "fr": "Les cas confirmés seront présentés dans notre tableau de bord en tant que « cas » de COVID-19.", "perturbation": "alteration", "pert_fr": "Les cas non confirmés seront présentés dans notre tableau de bord en tant que « cas » de COVID-19.", "bt_pert_fr": "Unconfirmed cases will be presented in our dashboard as COVID-19 “cases”.", "questions": "[\"What is the term used for definite cases on the dashboard?\", \"What disease is referred to in the dashboard entry?\", \"What does 'cases' represent in the context of the dashboard?\"]", "answers": "[\"Unconfirmed cases\", \"COVID-19\", \"Cases that may not be confirmed\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 56.48828524965368, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 21.241521517559683, "bleu": 0.0}], "avg_f1": 0.5555555555555555, "avg_em": 0.3333333333333333, "avg_chrf": 59.24326892240445, "avg_bleu": 50.00000000000001}
{"id": "PubMed_10:938", "en": "Possible cases will be presented as “Under investigation” (investigating).", "fr": "Les cas potentiels seront présentés comme « À l’étude » (en cours d’examen).", "perturbation": "alteration", "pert_fr": "Les cas potentiels seront présentés comme « Rejetés » (en cours d’examen).", "bt_pert_fr": "Potential cases will be presented as “Rejected” (under review).", "questions": "[\"What is the status of possible cases?\", \"What is the term used for possible cases?\", \"What does 'investigating' mean in this context?\"]", "answers": "[\"Rejected\", \"Rejected\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.166666666666666, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.166666666666666, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.181575067967494, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 4.171636133766942, "avg_bleu": 0.0}
{"id": "PubMed_10:941", "en": "We have the option to move to twice weekly surveillance reports with a scope to change this to daily reporting.", "fr": "Nous avons la possibilité de passer à des rapports de surveillance bihebdomadaires dans l’objectif d’adopter des rapports quotidiens.", "perturbation": "alteration", "pert_fr": "Nous avons la possibilité de passer à des rapports de surveillance mensuels dans l’objectif d’adopter des rapports quotidiens.", "bt_pert_fr": "We have the option to move to monthly monitoring reports with the goal of adopting daily reporting.", "questions": "[\"What options are available for surveillance reports?\", \"Can the surveillance reporting frequency be changed?\", \"What is the current surveillance reporting frequency?\", \"What would be the scope of changing to daily reporting?\"]", "answers": "[\"Move to monthly monitoring reports\", \"Yes\", \"Monthly\", \"Adopting daily reporting\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 28.12152073309383, "bleu": 19.357693493908812}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.080038639343131, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 35.899759082232194, "bleu": 17.799177396293473}], "avg_f1": 0.5113636363636364, "avg_em": 0.25, "avg_chrf": 42.27532961366729, "avg_bleu": 34.28921772255058}
{"id": "PubMed_10:943", "en": "Additionally, we will recruit more surveillance practices.", "fr": "En outre, nous recruterons de nouveaux cabinets de surveillance.", "perturbation": "alteration", "pert_fr": "En outre, nous licencierons de nouveaux cabinets de surveillance.", "bt_pert_fr": "In addition, we will license new monitoring firms.", "questions": "[\"What additional action will be taken?\", \"What will be recruited?\"]", "answers": "[\"License new monitoring firms\", \"New monitoring firms\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.568044647855455, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.093418101151306, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 9.33073137450338, "avg_bleu": 0.0}
{"id": "PubMed_10:951", "en": "Additionally, PHE will retrospectively test any influenza virology samples collected between early and mid-February 2020 for COVID-19.", "fr": "En outre, PHE analysera de manière rétrospective tout échantillon virologique de grippe collecté entre le début et la mi-février 2020 pour le COVID-19.", "perturbation": "alteration", "pert_fr": "En outre, PHE analysera de manière prospective tout échantillon virologique de grippe collecté entre le début et la mi-février 2020 pour le COVID-19.", "bt_pert_fr": "Additionally, PHE will prospectively analyze any influenza virological samples collected between early and mid-February 2020 for COVID-19.", "questions": "[\"What will PHE do with influenza virology samples collected between early and mid-February 2020?\", \"What samples will be tested for COVID-19?\", \"When were the influenza virology samples collected?\", \"What is the purpose of the retrospective testing?\"]", "answers": "[\"Prospectively analyze\", \"Influenza virological samples\", \"Between early and mid-February 2020\", \"To detect COVID-19\"]", "scores": [{"f1": 0, "em": false, "chrf": 57.29539768982347, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.73389719136516, "bleu": 34.66806371753173}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 30.16456317847741, "bleu": 13.533528323661276}], "avg_f1": 0.5416666666666666, "avg_em": 0.25, "avg_chrf": 67.0484645149165, "avg_bleu": 37.05039801029826}
{"id": "PubMed_10:955", "en": "Everyone with an ILI or a respiratory illness who contacts a GP (eg, phones for an appointment) should be asked specifically about recent travel to China and other countries flagged in current PHE advice, or if they have had contact with other people with COVID-19.", "fr": "Toute personne présentant un SG ou une maladie respiratoire et qui contacte un MG (par ex. prend rendez-vous par téléphone) devrait être interrogée spécifiquement au sujet de tout récent voyage en Chine et dans d’autres pays signalés dans les recommandations en vigueur de PHE, ou si elle a été en contact avec d’autres personnes atteintes du COVID-19.", "perturbation": "alteration", "pert_fr": "Toute personne présentant un SG ou une maladie respiratoire et qui contacte un MG (par ex. prend rendez-vous par téléphone) ne devrait pas être interrogée spécifiquement au sujet de tout récent voyage en Chine et dans d’autres pays signalés dans les recommandations en vigueur de PHE, ou si elle a été en contact avec d’autres personnes atteintes du COVID-19.", "bt_pert_fr": "Anyone with ILI or respiratory illness who contacts a GP (e.g. makes an appointment by telephone) should not be asked specifically about any recent travel to China and other countries reported in current PHE guidance, or whether they have been in contact with other people with COVID-19.", "questions": "[\"What specific information should be asked about when someone has an ILI or respiratory illness?\", \"What is the purpose of asking about recent travel to China and other countries?\", \"What is the role of a GP in this scenario?\"]", "answers": "[\"None\", \"It is not recommended to ask about recent travel to China and other countries or contact with people who have COVID-19\", \"A GP should receive a contact from someone with ILI or respiratory illness and not ask specific questions about travel or contact with COVID-19 cases\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.1397690089739851, "bleu": 0.0}, {"f1": 0.14814814814814814, "em": false, "chrf": 23.441167767763886, "bleu": 2.159701133933343}, {"f1": 0.3783783783783784, "em": false, "chrf": 44.079970514967, "bleu": 4.303846266589084}], "avg_f1": 0.17550884217550886, "avg_em": 0.0, "avg_chrf": 22.886969097234957, "avg_bleu": 2.1545158001741425}
{"id": "PubMed_10:961", "en": "Practice reception or triage staff: for coding of any patients calling the practice with symptoms of acute respiratory infection with a history of travel to important areas based on PHE advice", "fr": "Le secrétariat ou le personnel de triage du cabinet : pour le codage de tout patient appelant le cabinet avec des symptômes d’infection respiratoire aigüe et des antécédents de voyage dans des zones importantes conformément aux recommandations de PHE", "perturbation": "alteration", "pert_fr": "Le secrétariat ou le personnel de triage du cabinet : pour le codage de tout patient appelant le cabinet avec des symptômes d’infection respiratoire chronique et des antécédents de voyage dans des zones insignifiantes conformément aux recommandations de PHE", "bt_pert_fr": "The practice secretarial or triage staff: for coding any patient calling the practice with symptoms of chronic respiratory infection and a history of travel to insignificant areas in accordance with PHE recommendations", "questions": "[\"What is the role of reception or triage staff in the practice?\", \"What patients are coded by reception or triage staff?\", \"What symptoms trigger coding by reception or triage staff?\", \"What is the basis for coding patients with respiratory infection?\", \"What is PHE advice related to in this context?\"]", "answers": "[\"To code any patient calling the practice with symptoms of chronic respiratory infection and a history of travel to insignificant areas in accordance with PHE recommendations\", \"Patients calling the practice with symptoms of chronic respiratory infection and a history of travel to insignificant areas\", \"Symptoms of chronic respiratory infection\", \"PHE recommendations\", \"Coding patients with respiratory infection based on travel history to insignificant areas\"]", "scores": [{"f1": 0.6956521739130435, "em": false, "chrf": 69.15396875195934, "bleu": 42.66219662386316}, {"f1": 0.875, "em": false, "chrf": 83.33711876495677, "bleu": 68.65065103648593}, {"f1": 0.8000000000000002, "em": false, "chrf": 76.12303751883644, "bleu": 30.213753973567677}, {"f1": 0, "em": false, "chrf": 6.8695929973903365, "bleu": 0.0}, {"f1": 0.25, "em": false, "chrf": 31.144214558790832, "bleu": 4.02724819242185}], "avg_f1": 0.5241304347826088, "avg_em": 0.0, "avg_chrf": 53.32558651838674, "avg_bleu": 29.110769965267725}
{"id": "PubMed_10:963", "en": "Practices participating in virology surveillance will opportunistically collect blood samples from patients coming into the practice for a routine blood test.", "fr": "Les cabinets participant à la surveillance virologique prélèveront de façon opportuniste des échantillons de sang des patients venant au cabinet pour une analyse de sang de routine.", "perturbation": "alteration", "pert_fr": "Les cabinets participant à la surveillance virologique prélèveront de façon systématique des échantillons de sang des patients venant au cabinet pour une analyse de sang de routine.", "bt_pert_fr": "Practices participating in virological surveillance will systematically collect blood samples from patients coming to the practice for routine blood testing.", "questions": "[\"What do practices do opportunistically during virology surveillance?\", \"What type of samples are collected during virology surveillance?\", \"From whom are blood samples collected during virology surveillance?\", \"What is the reason for collecting blood samples during virology surveillance?\"]", "answers": "[\"None\", \"Blood samples\", \"Patients coming to the practice for routine blood testing\", \"Systematic collection as part of virological surveillance\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.125, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 89.92945551910812, "bleu": 41.11336169005198}, {"f1": 0, "em": false, "chrf": 18.583794027334623, "bleu": 0.0}], "avg_f1": 0.4375, "avg_em": 0.25, "avg_chrf": 52.90956238661069, "avg_bleu": 35.278340422513004}
{"id": "PubMed_10:964", "en": "Patients who attend their practice for a routine blood test will be asked to provide an additional sample for serology.", "fr": "Il sera demandé aux patients qui se rendent dans leur cabinet pour une analyse de sang de routine de fournir un échantillon de sang supplémentaire pour l’analyse sérologique.", "perturbation": "alteration", "pert_fr": "Il ne sera pas demandé aux patients qui se rendent dans leur cabinet pour une analyse de sang de routine de fournir un échantillon de sang supplémentaire pour l’analyse sérologique.", "bt_pert_fr": "Patients who visit their office for a routine blood test will not be asked to provide an additional blood sample for serological analysis.", "questions": "[\"What will patients be asked to provide during a routine blood test?\", \"What is the purpose of the additional sample?\", \"What type of test is being conducted?\"]", "answers": "[\"No additional blood sample\", \"Serological analysis\", \"Routine blood test\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 45.781399110893965, "bleu": 14.794015674776452}, {"f1": 0, "em": false, "chrf": 24.3776807990952, "bleu": 0.0}, {"f1": 0.5714285714285715, "em": false, "chrf": 87.22956627368525, "bleu": 39.43223765116288}], "avg_f1": 0.33862433862433866, "avg_em": 0.0, "avg_chrf": 52.4628820612248, "avg_bleu": 18.07541777531311}
{"id": "PubMed_10:965", "en": "We have conducted initial searches within the RCGP RSC database to look at the number of full blood count (FBC) results and overall rates in adults and children (Figures 6-​-9).9).", "fr": "Nous avons mené des recherches initiales dans la base de données du RSC du RCGP afin d’examiner le nombre de résultats de formule sanguine complète (FSC) et les taux globaux chez les adultes et les enfants (Figures 6--9).9).", "perturbation": "alteration", "pert_fr": "Nous n'avons pas mené des recherches initiales dans la base de données du RSC du RCGP afin d’examiner le nombre de résultats de formule sanguine complète (FSC) et les taux globaux chez les adultes et les enfants (Figures 6--9).9)", "bt_pert_fr": "We did not conduct initial searches of the RCGP CHR database to examine the number of complete blood count (CBC) results and overall rates in adults and children (Figures 6--9).9)", "questions": "[\"What searches have been conducted in the RCGP RSC database?\", \"What data was examined in the RCGP RSC database?\", \"What specific data was looked at regarding full blood count results?\", \"What age groups were included in the analysis?\", \"What information is provided in Figures 6-9?\"]", "answers": "[\"No initial searches have been conducted\", \"The number of complete blood count (CBC) results and overall rates\", \"The number of complete blood count (CBC) results\", \"Adults and children\", \"The number of complete blood count (CBC) results and overall rates in adults and children\"]", "scores": [{"f1": 0.09523809523809522, "em": false, "chrf": 24.60298863124797, "bleu": 1.8110800993753928}, {"f1": 0.8181818181818182, "em": false, "chrf": 77.68932973982659, "bleu": 37.81790427652475}, {"f1": 0.75, "em": false, "chrf": 67.41932884378073, "bleu": 27.05411345269698}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6923076923076923, "em": false, "chrf": 72.9601608283592, "bleu": 26.518122980477767}], "avg_f1": 0.6711455211455212, "avg_em": 0.2, "avg_chrf": 68.5343616086429, "avg_bleu": 38.640244161814984}
{"id": "PubMed_10:967", "en": "The sampling rate, per 100,000 patients was highest for children 15-17 years of age and 60 year or older in adults, with the lowest rates in children 0-4 years of age and 18-29 years of age in adults (Figures 6-​-99).", "fr": "Le taux d’échantillonnage pour 100 000 patients était plus élevé chez les enfants de 15-17 ans et les adultes de 60 ans et plus, avec les taux les plus bas correspondant aux enfants de 0-4 ans et aux adultes de 18-29 ans (Figures 6--99).", "perturbation": "alteration", "pert_fr": "Le taux d’échantillonnage pour 100 000 patients était plus bas chez les enfants de 15-17 ans et les adultes de 60 ans et plus, avec les taux les plus élevés correspondant aux enfants de 0-4 ans et aux adultes de 18-29 ans (Figures 6-99).", "bt_pert_fr": "The sampling rate per 100,000 patients was lowest among children aged 15-17 and adults aged 60 and over, with the highest rates corresponding to children aged 0-4 and adults aged 18-29 (Figures 6-99).", "questions": "[\"What was the highest sampling rate for in terms of age groups?\", \"Which age groups had the lowest sampling rates?\", \"What is the sampling rate per 100,000 patients?\", \"Which age groups are mentioned in the sentence?\", \"What figures are referenced in the sentence?\"]", "answers": "[\"Children aged 0-4 and adults aged 18-29\", \"Children aged 15-17 and adults aged 60 and over\", \"per 100,000 patients\", \"Children aged 0-4, children aged 15-17, adults aged 18-29, and adults aged 60 and over\", \"6-99\"]", "scores": [{"f1": 0.23529411764705882, "em": false, "chrf": 24.569206728139957, "bleu": 5.087641220727392}, {"f1": 0.2105263157894737, "em": false, "chrf": 27.90523374607328, "bleu": 5.0735520042259505}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4571428571428572, "em": false, "chrf": 34.70834077930306, "bleu": 3.166844235526443}, {"f1": 0.6666666666666666, "em": false, "chrf": 25.587524708983082, "bleu": 36.78794411714425}], "avg_f1": 0.5139259914492113, "avg_em": 0.2, "avg_chrf": 42.55406119249987, "avg_bleu": 30.023196315524814}
{"id": "PubMed_10:968", "en": "We will provide 1000 serology baseline samples across all ages that reflect the varying rates of attendance by age.", "fr": "Nous fournirons 1 000 échantillons sérologiques de référence pour toutes les tranches d’âge qui reflètent les divers taux de fréquentation par âge.", "perturbation": "alteration", "pert_fr": "Nous ne fournirons pas 1 000 échantillons sérologiques de référence pour toutes les tranches d’âge qui reflètent les divers taux de fréquentation par âge.", "bt_pert_fr": "We will not provide 1,000 reference serology samples for all age groups that reflect varying attendance rates by age.", "questions": "[\"How many serology baseline samples will be provided?\", \"What does the sample collection reflect?\", \"What factor is reflected in the varying rates of attendance?\", \"What is the age range covered by the samples?\", \"What is the purpose of the serology baseline samples?\"]", "answers": "[\"1,000\", \"Varying attendance rates by age\", \"Age\", \"All age groups\", \"To reflect varying attendance rates by age\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727272, "em": false, "chrf": 59.84188159178009, "bleu": 20.801195378010608}, {"f1": 0, "em": false, "chrf": 38.888888888888886, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 41.36609404559592, "bleu": 0.0}, {"f1": 0.7999999999999999, "em": false, "chrf": 70.44360607342654, "bleu": 17.82013231677092}], "avg_f1": 0.5054545454545455, "avg_em": 0.2, "avg_chrf": 62.108094119938286, "avg_bleu": 27.724265538956313}
{"id": "PubMed_10:971", "en": "This will be followed by 800 samples monthly.", "fr": "Cela sera suivi par 800 échantillons par mois.", "perturbation": "alteration", "pert_fr": "Cela sera suivi par 800 échantillons par an.", "bt_pert_fr": "This will be followed by 800 samples per year.", "questions": "[\"How many samples will be collected monthly?\", \"What will follow the collection of samples?\", \"What is the frequency of sample collection?\"]", "answers": "[\"Cannot determine from the sentence\", \"800 samples per year\", \"800 samples per year\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.787878787878788, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.7037037037037033, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.4971941638608306, "avg_bleu": 0.0}
{"id": "PubMed_10:974", "en": "We will develop a new request form for practices to capture recent travel and exposure to COVID-19.", "fr": "Nous développerons un nouveau formulaire de demande afin de consigner les voyages récents et l’exposition au COVID-19.", "perturbation": "alteration", "pert_fr": "Nous développerons un nouveau formulaire de demande afin de consigner les voyages anciens et l’exposition au COVID-19.", "bt_pert_fr": "We will develop a new application form to record past travel and exposure to COVID-19.", "questions": "[\"What will be developed?\", \"What is the purpose of the new request form?\", \"What information will the new request form capture?\", \"Who will use the new request form?\"]", "answers": "[\"A new application form\", \"To record past travel and exposure to COVID-19\", \"Past travel and exposure to COVID-19\", \"We\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 23.686782527704057, "bleu": 35.35533905932737}, {"f1": 0.75, "em": false, "chrf": 69.57530149093415, "bleu": 54.10822690539397}, {"f1": 0.8333333333333334, "em": false, "chrf": 84.13789869615368, "bleu": 75.98356856515926}, {"f1": 0, "em": false, "chrf": 6.578947368421052, "bleu": 0.0}], "avg_f1": 0.5833333333333334, "avg_em": 0.0, "avg_chrf": 45.99473252080324, "avg_bleu": 41.36178363247015}
{"id": "PubMed_10:979", "en": "This process may include checking pseudonymized NHS numbers for positive individuals at RCGP RSC practices, checking current PHE guidance regarding considerations of infectiousness for confirmed cases, and offering the patient an appointment following the previously mentioned process.", "fr": "Ce processus peut comprendre l’examen des nombres pseudonymisés de patients positifs du NHS dans les cabinets du RSC du RCGP, en vérifiant les directives actuelles de PHE concernant les considérations de contagiosité des cas confirmés, et en donnant au patient un rendez-vous selon le processus susmentionné.", "perturbation": "alteration", "pert_fr": "Ce processus peut comprendre l’examen des nombres non pseudonymisés de patients négatifs du NHS dans les cabinets du RSC du RCGP, en vérifiant les directives actuelles de PHE concernant les considérations de non-contagiosité des cas infirmés, et en refusant au patient un rendez-vous selon le processus susmentionné.", "bt_pert_fr": "This process may include reviewing non-pseudonymised numbers of negative NHS patients in RCGP RSC practices, checking current PHE guidance regarding non-infectiousness considerations for negative cases, and refusing the patient an appointment using the above process.", "questions": "[\"What does this process include?\", \"What is checked for positive individuals at RCGP RSC practices?\", \"What current PHE guidance is considered regarding infectiousness?\", \"What is offered to the patient following the process?\"]", "answers": "[\"Reviewing non-pseudonymised numbers of negative NHS patients in RCGP RSC practices, checking current PHE guidance regarding non-infectiousness considerations for negative cases, and refusing the patient an appointment using the above process\", \"Nothing is checked for positive individuals at RCGP RSC practices\", \"Current PHE guidance regarding non-infectiousness considerations for negative cases\", \"The patient is refused an appointment\"]", "scores": [{"f1": 0.6206896551724138, "em": false, "chrf": 60.65538456728887, "bleu": 29.361568020583487}, {"f1": 0, "em": false, "chrf": 9.59184958405805, "bleu": 0.0}, {"f1": 0.6250000000000001, "em": false, "chrf": 82.40080382770235, "bleu": 31.55984539112945}, {"f1": 0.28571428571428575, "em": false, "chrf": 61.72008293534403, "bleu": 10.682175159905853}], "avg_f1": 0.38285098522167493, "avg_em": 0.0, "avg_chrf": 53.592030228598325, "avg_bleu": 17.900897142904697}
{"id": "PubMed_10:980", "en": "This needs to be carefully coordinated nationally across the network and may require PHE to ensure individuals are not contacted by multiple agencies.", "fr": "Cela doit être coordonné avec soin à l’échelle nationale dans l’ensemble du réseau et peut impliquer que PHE s’assure que les patients ne soient pas contactés par plusieurs agences.", "perturbation": "alteration", "pert_fr": "Cela doit être coordonné avec négligence à l’échelle nationale dans l’ensemble du réseau et peut impliquer que PHE s’assure que les patients soient contactés par plusieurs agences.", "bt_pert_fr": "This needs to be carefully coordinated nationally across the network and may involve PHE ensuring patients are contacted by multiple agencies.", "questions": "[\"What is the role of PHE in this coordination?\", \"Which agencies might contact individuals and how is this managed?\"]", "answers": "[\"PHE ensures patients are contacted by multiple agencies\", \"Multiple agencies may contact individuals, and this is managed through careful national coordination across the network\"]", "scores": [{"f1": 0.5882352941176471, "em": false, "chrf": 62.274804833610595, "bleu": 32.260135189272866}, {"f1": 0.606060606060606, "em": false, "chrf": 68.4448553095594, "bleu": 32.76234293060068}], "avg_f1": 0.5971479500891266, "avg_em": 0.0, "avg_chrf": 65.359830071585, "avg_bleu": 32.51123905993677}
{"id": "PubMed_10:984", "en": "The RCGP RSC will explore ways to collect convalescent samples from any patients tested positive for COVID-19 through the extension of the virological surveillance.", "fr": "Le RSC du RCGP étudiera des moyens de collecter des échantillons de patients convalescents chez les patients testés positifs au COVID-19 dans le cadre de l’extension de la surveillance virologique.", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP étudiera des moyens de collecter des échantillons de patients décédés chez les patients testés négatifs au COVID-19 dans le cadre de la réduction de la surveillance virologique.", "bt_pert_fr": "The RCGP RSC will explore ways to collect deceased patient samples from patients testing negative for COVID-19 as part of reduced virological surveillance.", "questions": "[\"What will the RCGP RSC explore?\", \"How will convalescent samples be collected?\", \"Which patients are eligible for convalescent sample collection?\", \"What is the purpose of collecting convalescent samples?\", \"What is the role of virological surveillance in this process?\"]", "answers": "[\"Ways to collect deceased patient samples from patients testing negative for COVID-19\", \"The sentence does not mention how convalescent samples will be collected\", \"The sentence does not specify which patients are eligible for convalescent sample collection\", \"The sentence does not state the purpose of collecting convalescent samples\", \"The sentence indicates that reduced virological surveillance is part of the process, suggesting that collecting samples helps monitor the virus\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 65.91024659741913, "bleu": 19.156928817239653}, {"f1": 0, "em": false, "chrf": 17.138493112959168, "bleu": 0.0}, {"f1": 0.21052631578947367, "em": false, "chrf": 24.220013476620775, "bleu": 3.673526562988939}, {"f1": 0.28571428571428575, "em": false, "chrf": 66.02284777817076, "bleu": 8.392229812593097}, {"f1": 0.13333333333333333, "em": false, "chrf": 27.13881420553534, "bleu": 2.55404966647159}], "avg_f1": 0.25924812030075184, "avg_em": 0.0, "avg_chrf": 40.08608303414103, "avg_bleu": 6.755346971858655}
{"id": "PubMed_10:985", "en": "From the start, we will be carefully curating data to ensure that it can be used for future studies.", "fr": "Dès le début, les données seront dûment conservées afin de garantir leur utilisation dans le cadre d’études futures.", "perturbation": "alteration", "pert_fr": "Dès le début, les données seront dûment détruites afin de garantir leur non-utilisation dans le cadre d’études futures.", "bt_pert_fr": "From the outset, the data will be duly destroyed to ensure their non-use in future studies.", "questions": "[\"What will be done from the start?\", \"What is the goal of curating data?\", \"Why is data being curated?\", \"What ensures that data can be used for future studies?\"]", "answers": "[\"The data will be duly destroyed\", \"To ensure their non-use in future studies\", \"To ensure their non-use in future studies\", \"Nothing ensures that data can be used for future studies\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 16.659598288880094, "bleu": 8.116697886877475}, {"f1": 0.47058823529411764, "em": false, "chrf": 55.2303878597897, "bleu": 12.100518276540289}, {"f1": 0.47058823529411764, "em": false, "chrf": 55.2303878597897, "bleu": 12.100518276540289}, {"f1": 0.14285714285714288, "em": false, "chrf": 18.814171694245587, "bleu": 4.196114906296549}], "avg_f1": 0.3335084033613445, "avg_em": 0.0, "avg_chrf": 36.48363642567627, "avg_bleu": 9.12846233656365}
{"id": "PubMed_10:986", "en": "Our clinical data will be linked to virology.", "fr": "Nos données cliniques seront liées à la virologie.", "perturbation": "alteration", "pert_fr": "Nos données cliniques ne seront pas liées à la virologie.", "bt_pert_fr": "Our clinical data will not be linked to virology.", "questions": "[\"What will be linked in the clinical data?\", \"What type of data will be linked?\", \"What does the clinical data include?\"]", "answers": "[\"Nothing\", \"Virology\", \"Clinical data\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.41025641025641, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 79.70238095238096, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.333333333333332, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 31.481990231990235, "avg_bleu": 0.0}
{"id": "PubMed_10:987", "en": "We will curate our data using the Findable, Accessible, Interoperable, Reusable principles.", "fr": "Nous conserverons nos données conformément aux principes Facile à trouver, Accessible, Interopérable et Réutilisable.", "perturbation": "alteration", "pert_fr": "Nous conserverons nos données conformément aux principes Difficile à trouver, Inaccessible, Non interopérable et Non réutilisable.", "bt_pert_fr": "We will maintain our data in accordance with the principles of Hard to Find, Inaccessible, Non-Interoperable and Non-Reusable.", "questions": "[\"What principles will be used to curate the data?\", \"What does curating data involve in this context?\"]", "answers": "[\"Hard to Find, Inaccessible, Non-Interoperable and Non-Reusable\", \"Maintaining data in accordance with the principles of Hard to Find, Inaccessible, Non-Interoperable and Non-Reusable\"]", "scores": [{"f1": 0, "em": false, "chrf": 61.59058560379636, "bleu": 0.0}, {"f1": 0.1, "em": false, "chrf": 53.00815483812066, "bleu": 2.8398387225677895}], "avg_f1": 0.05, "avg_em": 0.0, "avg_chrf": 57.29937022095851, "avg_bleu": 1.4199193612838947}
{"id": "PubMed_10:988", "en": "To facilitate this our data set is listed with Health Data Research UK and the European Health Data Evidence Network.", "fr": "En ce sens, notre ensemble de données est listé avec Health Data Research UK et le Réseau européen de données et de preuves en matière de santé.", "perturbation": "alteration", "pert_fr": "En ce sens, notre ensemble de données n'est pas listé avec Health Data Research UK et le Réseau européen de données et de preuves en matière de santé.", "bt_pert_fr": "In this sense, our dataset is not listed with Health Data Research UK and the European Health Data and Evidence Network.", "questions": "[\"With which organization is the data set listed?\", \"Which network is mentioned in the sentence?\", \"What is the data set listed with?\"]", "answers": "[\"Health Data Research UK and the European Health Data and Evidence Network\", \"European Health Data and Evidence Network\", \"Neither\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 69.10688361842166, "bleu": 23.462350320528007}, {"f1": 0.9090909090909091, "em": false, "chrf": 89.69918030539249, "bleu": 37.99178428257963}, {"f1": 0, "em": false, "chrf": 3.2630176019118537, "bleu": 0.0}], "avg_f1": 0.4808080808080808, "avg_em": 0.0, "avg_chrf": 54.023027175242, "avg_bleu": 20.48471153436921}
{"id": "PubMed_10:992", "en": "By targeting the reproduction number (R) (the average number of secondary cases each case generates) and aiming to reduce the R to below 1, the policy seeks to reduce case numbers to low levels or (as seen in previous outbreaks with severe acute respiratory syndrome and Ebola) to eliminate human-to-human transmission.", "fr": "En ciblant le taux de reproduction (R) (le nombre moyen de cas secondaires généré par chaque cas) et en cherchant à faire passer R en dessous de 1, la politique vise à atteindre de faibles niveaux de cas ou (comme observé lors d’épidémies antérieures du syndrome respiratoire aigu sévère et de l’Ebola) à éliminer la transmission de personne à personne.", "perturbation": "alteration", "pert_fr": "En ciblant le taux de reproduction (R) (le nombre moyen de cas secondaires généré par chaque cas) et en cherchant à faire passer R au-dessus de 1, la politique vise à atteindre de hauts niveaux de cas ou (comme observé lors d’épidémies antérieures du syndrome respiratoire aigu sévère et de l’Ebola) à éliminer la transmission de personne à personne.", "bt_pert_fr": "By targeting the reproduction rate (R) (the average number of secondary cases generated by each case) and seeking to increase R above 1, the policy aims to achieve high levels of cases or (as observed in previous outbreaks of severe acute respiratory syndrome and Ebola) eliminate person-to-person transmission.", "questions": "[\"What is the reproduction number (R)?\", \"What does the reproduction number (R) represent?\", \"What is the goal of reducing the R to below 1?\", \"What happens when the R is reduced to below 1?\", \"What are examples of previous outbreaks where reducing R led to elimination of human-to-human transmission?\"]", "answers": "[\"The average number of secondary cases generated by each case\", \"The average number of secondary cases generated by each case\", \"To achieve elimination of person-to-person transmission\", \"Person-to-person transmission is eliminated\", \"Severe acute respiratory syndrome and Ebola\"]", "scores": [{"f1": 0.8421052631578948, "em": false, "chrf": 86.07003141055155, "bleu": 58.14307369682194}, {"f1": 0.8421052631578948, "em": false, "chrf": 86.07003141055155, "bleu": 58.14307369682194}, {"f1": 0.23529411764705885, "em": false, "chrf": 35.64956699864161, "bleu": 4.194930905450255}, {"f1": 0.375, "em": false, "chrf": 41.79890897351443, "bleu": 8.047084086794415}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6589009287925697, "avg_em": 0.2, "avg_chrf": 69.91770775865183, "avg_bleu": 45.70563247717772}
{"id": "PubMed_10:994", "en": "Key to the focus of our study will be the estimation of peak cases in the population and continual monitoring by data collection and modelling the potential growth and emergence of subsequent peaks in new cases as social distancing measures are relaxed.", "fr": "Le point essentiel de notre étude sera l’estimation du pic des cas dans la population et la surveillance continue grâce à la collecte des données et à la modélisation de la croissance potentielle et l’apparition de pics ultérieurs de nouveaux cas lorsque les mesures de distanciation sociale s’assouplissent.", "perturbation": "alteration", "pert_fr": "Le point essentiel de notre étude sera l’estimation du creux des cas dans la population et la surveillance continue grâce à la collecte des données et à la modélisation de la croissance potentielle et l’apparition de creux ultérieurs de nouveaux cas lorsque les mesures de distanciation sociale se renforcent.", "bt_pert_fr": "The key point of our study will be the estimation of the trough of cases in the population and continued monitoring through data collection and modeling of the potential growth and appearance of subsequent troughs of new cases when social distancing measures are strengthened.", "questions": "[\"What is key to the focus of the study?\", \"What methods are used for monitoring new cases?\", \"What is modeled in the study?\", \"What happens as social distancing measures are relaxed?\"]", "answers": "[\"The estimation of the trough of cases in the population\", \"Data collection and modeling\", \"The potential growth and appearance of subsequent troughs of new cases\", \"Nothing is stated about what happens when social distancing measures are relaxed\"]", "scores": [{"f1": 0.7999999999999999, "em": false, "chrf": 78.4156231540155, "bleu": 34.57207846419411}, {"f1": 0.75, "em": false, "chrf": 89.68835858722274, "bleu": 59.460355750136046}, {"f1": 0.7272727272727273, "em": false, "chrf": 68.64308153141772, "bleu": 31.7023313852343}, {"f1": 0, "em": false, "chrf": 19.751701238632876, "bleu": 0.0}], "avg_f1": 0.5693181818181818, "avg_em": 0.0, "avg_chrf": 64.12469112782222, "avg_bleu": 31.433691399891114}
{"id": "PubMed_10:995", "en": "There has already been publication of important disease epidemiological measures concerning the outbreak of COVID-19 in mainland China.", "fr": "D’importantes mesures épidémiologiques de la maladie ont déjà été publiées au sujet de l’épidémie de COVID-19 en Chine continentale.", "perturbation": "alteration", "pert_fr": "D’importantes mesures épidémiologiques de la santé ont déjà été publiées au sujet de l’épidémie de COVID-19 en Chine continentale.", "bt_pert_fr": "Important epidemiological health metrics have already been released regarding the COVID-19 outbreak in mainland China.", "questions": "[\"What has already been published regarding the outbreak of COVID-19 in mainland China?\", \"What type of measures have been published about the outbreak?\", \"What is the focus of the published disease epidemiological measures?\", \"What region is mentioned in the context of the outbreak?\", \"What disease is associated with the outbreak mentioned?\"]", "answers": "[\"Important epidemiological health metrics\", \"Epidemiological health metrics\", \"The outbreak of COVID-19\", \"mainland China\", \"COVID-19\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 56.20951660192285, "bleu": 18.99589214128981}, {"f1": 0, "em": false, "chrf": 47.312345386318725, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 90.21205646205644, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6, "avg_em": 0.4, "avg_chrf": 78.7467836900596, "avg_bleu": 53.79917842825798}
{"id": "PubMed_10:996", "en": "A further fundamental measure in pandemic dynamics is the length of time from infection to when a person is infectious to others and the mean duration of infectiousness.", "fr": "Une autre mesure fondamentale dans la dynamique d’une pandémie est la durée entre l’infection et le moment où une personne devient contagieuse pour les autres, ainsi que la période moyenne de contagiosité.", "perturbation": "alteration", "pert_fr": "Une autre mesure fondamentale dans la dynamique d’une pandémie est la durée entre la guérison et le moment où une personne devient non contagieuse pour les autres, ainsi que la période moyenne de non-contagiosité.", "bt_pert_fr": "Another fundamental measure in the dynamics of a pandemic is the duration between recovery and the moment when a person becomes non-contagious to others, as well as the average period of non-contagiousness.", "questions": "[\"What is a further fundamental measure in pandemic dynamics?\"]", "answers": "[\"The duration between recovery and the moment when a person becomes non-contagious to others, as well as the average period of non-contagiousness\"]", "scores": [{"f1": 0.43243243243243246, "em": false, "chrf": 41.8007409404678, "bleu": 6.809398432036521}], "avg_f1": 0.43243243243243246, "avg_em": 0.0, "avg_chrf": 41.8007409404678, "avg_bleu": 6.809398432036521}
{"id": "PubMed_10:999", "en": "Such techniques are highly parallelizable and have been successfully applied to many fields including disease transmission modelling.", "fr": "Ces techniques sont hautement parallélisables et sont appliquées avec succès dans plusieurs domaines, notamment la modélisation de la transmission de maladies.", "perturbation": "alteration", "pert_fr": "Ces techniques sont hautement impraticables et sont appliquées avec succès dans plusieurs domaines, notamment la modélisation de la transmission de maladies.", "bt_pert_fr": "These techniques are highly impractical and are successfully applied in several areas, including disease transmission modeling.", "questions": "[\"What are such techniques known for?\", \"In which fields have such techniques been successfully applied?\", \"What specific application of such techniques is mentioned?\"]", "answers": "[\"Being highly impractical\", \"Disease transmission modeling\", \"Disease transmission modeling\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 39.366089758379815, "bleu": 27.516060407455225}, {"f1": 0.3333333333333333, "em": false, "chrf": 86.568896633046, "bleu": 27.516060407455225}, {"f1": 0.3333333333333333, "em": false, "chrf": 86.568896633046, "bleu": 27.516060407455225}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 70.83462767482393, "avg_bleu": 27.516060407455225}
{"id": "PubMed_10:1000", "en": "They are particularly suited to situations where likelihood functions are absent and where more traditional approaches such as Markov chain Monte Carlo are impractical.", "fr": "Elles sont particulièrement adaptées aux situations dans lesquelles les fonctions de vraisemblance sont absentes et des approches plus traditionnelles telles que les méthodes de Monte-Carlo par chaînes de Markov sont irréalisables.", "perturbation": "alteration", "pert_fr": "Elles sont particulièrement inadaptées aux situations dans lesquelles les fonctions de vraisemblance sont absentes et des approches plus traditionnelles telles que les méthodes de Monte-Carlo par chaînes de Markov sont irréalisables.", "bt_pert_fr": "They are particularly unsuitable for situations in which likelihood functions are absent and more traditional approaches such as Markov chain Monte Carlo methods are infeasible.", "questions": "[\"What situations are they particularly suited for?\", \"When are traditional approaches like Markov chain Monte Carlo impractical?\", \"What makes them suitable in these situations?\"]", "answers": "[\"Situations in which likelihood functions are absent\", \"When likelihood functions are absent and more traditional approaches such as Markov chain Monte Carlo methods are infeasible\", \"Their suitability in situations where likelihood functions are absent\"]", "scores": [{"f1": 0.3846153846153846, "em": false, "chrf": 34.713398261219794, "bleu": 7.828988696754741}, {"f1": 0.4347826086956522, "em": false, "chrf": 66.27097563652507, "bleu": 20.105373454060025}, {"f1": 0.23529411764705882, "em": false, "chrf": 53.514104697771195, "bleu": 9.535414040914189}], "avg_f1": 0.35156403698603184, "avg_em": 0.0, "avg_chrf": 51.499492865172016, "avg_bleu": 12.489925397242985}
{"id": "PubMed_10:1002", "en": "Furthermore, peaks in new cases have been estimated by distributional methods.", "fr": "En outre, les pics de nouveaux cas ont été estimés à l’aide de méthodes distributionnelles.", "perturbation": "alteration", "pert_fr": "En outre, les pics de nouveaux cas n'ont pas été estimés à l’aide de méthodes distributionnelles.", "bt_pert_fr": "Additionally, peaks in new cases were not estimated using distributional methods.", "questions": "[\"What has been estimated by distributional methods?\", \"What methods are used to estimate peaks in new cases?\"]", "answers": "[\"Peaks in new cases\", \"Distributional methods\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_10:1003", "en": "Estimates of the parameters of the SEIR model are tractable on large data sets because of parallelizability, and these methods have been implemented in several R libraries; we intend to use the libraries ABSEIR (deposited on GitHub: https://tinyurl.com/vqu35cj) and abctools (https://tinyurl.com/tfjavz4) to estimate epidemic measures on a weekly basis.", "fr": "Les estimations des paramètres du modèle SEIR peuvent être adaptées à de grands ensembles de données en raison de leur caractère parallélisable, et ces méthodes ont été mises en œuvre dans plusieurs bibliothèques R. Nous avons l’intention d’utiliser les bibliothèques ABSEIR (consignées sur GitHub : https://tinyurl.com/vqu35cj) et abctools (https://tinyurl.com/tfjavz4) afin d’estimer les mesures de l’épidémie sur une base hebdomadaire.", "perturbation": "alteration", "pert_fr": "Les estimations des paramètres du modèle SEIR ne peuvent pas être adaptées à de petits ensembles de données en raison de leur caractère non parallélisable, et ces méthodes n’ont pas été mises en œuvre dans plusieurs bibliothèques R. Nous n’avons pas l’intention d’utiliser les bibliothèques ABSEIR (consignées sur GitHub : https://tinyurl.com/vqu35cj) et abctools (https://tinyurl.com/tfjavz4) afin d’estimer les mesures de l’épidémie sur une base mensuelle.", "bt_pert_fr": "SEIR model parameter estimates cannot be scaled to small datasets due to their non-parallelizability, and these methods have not been implemented in several R libraries. We do not intend to use the ABSEIR libraries (on GitHub: https://tinyurl.com/vqu35cj) and abctools (https://tinyurl.com/tfjavz4) to estimate epidemic measurements on a monthly basis.", "questions": "[\"What makes estimates of the parameters of the SEIR model tractable on large data sets?\", \"Which R libraries are intended to be used for estimating epidemic measures?\", \"What is the frequency of estimating epidemic measures?\", \"What is the purpose of using ABSEIR and abctools?\", \"Where can ABSEIR be accessed?\", \"Where can abctools be accessed?\"]", "answers": "[\"Their non-parallelizability\", \"None\", \"On a monthly basis\", \"To estimate epidemic measurements\", \"https://tinyurl.com/vqu35cj\", \"https://tinyurl.com/tfjavz4\"]", "scores": [{"f1": 0, "em": false, "chrf": 83.69625678861527, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.4722222222222223, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 44.40413856768847, "bleu": 34.66806371753173}, {"f1": 0.75, "em": false, "chrf": 93.17944750567949, "bleu": 59.460355750136046}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5694444444444444, "avg_em": 0.3333333333333333, "avg_chrf": 70.79201084736758, "avg_bleu": 49.021403244611314}
{"id": "PubMed_10:1004", "en": "Since we are fitting an SIR-epidemic model in the ABC routine, we anticipate that our results will be robust against weekly case data containing relatively small counts.", "fr": "Étant donné que nous adaptons le modèle épidémique SIR à la routine ABC, nous prévoyons que nos résultats seront solides par rapport aux données de cas hebdomadaires contenant des nombres relativement faibles.", "perturbation": "alteration", "pert_fr": "Étant donné que nous adaptons le modèle épidémique SIR à la routine ABC, nous prévoyons que nos résultats seront fragiles par rapport aux données de cas hebdomadaires contenant des nombres relativement faibles.", "bt_pert_fr": "Since we fit the SIR epidemic model to the ABC routine, we expect our results to be fragile compared to weekly case data containing relatively low numbers.", "questions": "[\"What model are we fitting in the ABC routine?\", \"What type of data is being considered for the model?\", \"What is the concern regarding the weekly case data?\", \"What is the impact of small counts in weekly case data on the results?\"]", "answers": "[\"SIR epidemic model\", \"Weekly case data\", \"The results may be fragile\", \"The results are expected to be fragile due to the relatively low numbers in weekly case data\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 100.0, "bleu": 27.516060407455225}, {"f1": 0.6666666666666666, "em": false, "chrf": 91.10491360491362, "bleu": 55.03212081491043}, {"f1": 0.7272727272727272, "em": false, "chrf": 52.286781737837394, "bleu": 34.98330125272251}, {"f1": 0.4827586206896552, "em": false, "chrf": 44.267598401028984, "bleu": 12.451643194233863}], "avg_f1": 0.5691745036572623, "avg_em": 0.0, "avg_chrf": 71.914823435945, "avg_bleu": 32.495781417330505}
{"id": "PubMed_10:1007", "en": "This approach is independent of the ABC methodology and will allow comparisons between estimates from the two modelling approaches to judge robustness of results.", "fr": "Cette approche est indépendante de la méthodologie ABC et permettra de comparer les estimations des deux approches de modélisation afin d’évaluer la solidité des résultats.", "perturbation": "alteration", "pert_fr": "Cette approche est dépendante de la méthodologie ABC et permettra de comparer les estimations des deux approches de modélisation afin d’évaluer la solidité des résultats.", "bt_pert_fr": "This approach is dependent on the ABC methodology and will allow the estimates of the two modeling approaches to be compared in order to assess the robustness of the results.", "questions": "[\"What is the approach independent of?\", \"What does the approach allow comparisons between?\", \"What is the purpose of comparing estimates from the two modelling approaches?\", \"What does the approach help judge?\"]", "answers": "[\"The ABC methodology\", \"The estimates of the two modeling approaches\", \"To assess the robustness of the results\", \"The robustness of the results\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3636363636363636, "em": false, "chrf": 69.06666368893598, "bleu": 9.652434877402245}, {"f1": 0.8000000000000002, "em": false, "chrf": 72.0309483612647, "bleu": 42.7287006396234}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7909090909090909, "avg_em": 0.5, "avg_chrf": 85.27440301255017, "avg_bleu": 63.095283879256435}
{"id": "PubMed_10:1009", "en": "This has been confirmed by PHE’s Caldicott Guardian’s Office.", "fr": "Cela a été confirmé par le bureau du gardien Caldicott de PHE.", "perturbation": "alteration", "pert_fr": "Cela n'a pas été confirmé par le bureau du gardien Caldicott de PHE.", "bt_pert_fr": "This has not been confirmed by PHE's Guardian Caldicott's office.", "questions": "[\"Which office confirmed the information?\", \"What is the name of the office that confirmed the information?\"]", "answers": "[\"None\", \"Guardian Caldicott's office\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.0241935483870965, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 64.30224381760681, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 33.663218682996956, "avg_bleu": 0.0}
{"id": "PubMed_10:1012", "en": "Any cases identified will be managed according to the PHE/NHS guidance in force at the time, including advice for identified contacts.", "fr": "Tout cas identifié sera pris en charge conformément aux directives de PHE/NHS en vigueur au moment de sa détection, notamment les recommandations relatives aux contacts identifiés.", "perturbation": "alteration", "pert_fr": "Aucun cas identifié ne sera pris en charge conformément aux directives de PHE/NHS en vigueur au moment de sa détection, notamment les recommandations relatives aux contacts identifiés.", "bt_pert_fr": "No identified cases will be managed in accordance with PHE/NHS guidance in force at the time of detection, including recommendations for identified contacts.", "questions": "[\"What happens to any cases identified?\", \"What guidance is used to manage cases?\", \"What does the guidance include?\"]", "answers": "[\"They will not be managed in accordance with PHE/NHS guidance\", \"PHE/NHS guidance\", \"Recommendations for identified contacts\"]", "scores": [{"f1": 0.6363636363636365, "em": false, "chrf": 56.709119632362345, "bleu": 12.368464772045972}, {"f1": 0.4444444444444445, "em": false, "chrf": 47.0935307508532, "bleu": 8.208499862389884}, {"f1": 0.75, "em": false, "chrf": 72.53605008488432, "bleu": 59.460355750136046}], "avg_f1": 0.6102693602693603, "avg_em": 0.0, "avg_chrf": 58.779566822699955, "avg_bleu": 26.6791067948573}
{"id": "PubMed_10:1024", "en": "We have rapidly created and incorporated new codes to allow data recording, and are collecting data to monitor the effectiveness of containment strategies.", "fr": "Nous avons rapidement créé et mis en œuvre de nouveaux codes afin de permettre l’enregistrement des données, et nous recueillons des données pour mesurer l’efficacité des stratégies de confinement.", "perturbation": "alteration", "pert_fr": "Nous n'avons pas rapidement créé et mis en œuvre de nouveaux codes afin de permettre l’enregistrement des données, et nous recueillons des données pour mesurer l’inefficacité des stratégies de confinement.", "bt_pert_fr": "We have not quickly created and implemented new codes to enable data recording, and we are collecting data to measure the ineffectiveness of containment strategies.", "questions": "[\"What have we rapidly created and incorporated?\", \"What is the purpose of the new codes?\", \"What data are we collecting?\", \"What are we monitoring with the collected data?\", \"What is the goal of collecting data on containment strategies?\"]", "answers": "[\"None\", \"To enable data recording\", \"Data on the ineffectiveness of containment strategies\", \"The ineffectiveness of containment strategies\", \"To measure the ineffectiveness of containment strategies\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.416666666666668, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 63.10579994379524, "bleu": 35.35533905932737}, {"f1": 0.2857142857142857, "em": false, "chrf": 23.59541049570232, "bleu": 8.116697886877475}, {"f1": 0.8000000000000002, "em": false, "chrf": 93.34891337325452, "bleu": 42.7287006396234}, {"f1": 0.6666666666666666, "em": false, "chrf": 81.76659614791517, "bleu": 32.46679154750989}], "avg_f1": 0.5004761904761905, "avg_em": 0.0, "avg_chrf": 54.44667732546678, "avg_bleu": 23.733505826667628}
{"id": "PubMed_10:1025", "en": "Through this surveillance, we intend to find out more about the epidemiology of COVID-19 in ambulatory care.", "fr": "Au moyen de cette surveillance, nous prétendons en apprendre davantage sur l’épidémiologie du COVID-19 dans le cadre des soins ambulatoires.", "perturbation": "alteration", "pert_fr": "Au moyen de cette surveillance, nous prétendons en apprendre davantage sur l’épidémiologie du COVID-19 en dehors des soins ambulatoires.", "bt_pert_fr": "Through this surveillance, we aim to learn more about the epidemiology of COVID-19 outside of ambulatory care.", "questions": "[\"What is the goal of the surveillance?\", \"What aspect of COVID-19 is being studied?\", \"What type of care setting is involved in the surveillance?\", \"What does the surveillance aim to reveal about COVID-19?\"]", "answers": "[\"To learn more about the epidemiology of COVID-19 outside of ambulatory care\", \"The epidemiology of COVID-19\", \"Ambulatory care\", \"The epidemiology of COVID-19 outside of ambulatory care\"]", "scores": [{"f1": 0.631578947368421, "em": false, "chrf": 72.97127483928023, "bleu": 36.72056269893593}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4615384615384615, "em": false, "chrf": 66.3356093506461, "bleu": 20.556680845025987}], "avg_f1": 0.7732793522267206, "avg_em": 0.5, "avg_chrf": 84.82672104748158, "avg_bleu": 64.3193108859905}
{"id": "PubMed_10:1027", "en": "Our testing of low-risk patients will also inform whether the containment strategy that is based on virology testing of high-risk patients and their contacts plus self-isolation is effective.", "fr": "Notre évaluation des patients à faible risque permettra également de déterminer si la stratégie de confinement fondée sur le dépistage virologique des patients à haut risque et de leurs contacts associée à l’auto-confinement est efficace.", "perturbation": "alteration", "pert_fr": "Notre évaluation des patients à haut risque permettra également de déterminer si la stratégie de confinement fondée sur le dépistage virologique des patients à faible risque et de leurs contacts associée à l’auto-confinement est efficace.", "bt_pert_fr": "Our assessment of high-risk patients will also determine whether the containment strategy based on virological screening of low-risk patients and their contacts associated with self-containment is effective.", "questions": "[\"What will our testing of low-risk patients inform?\", \"What is the containment strategy based on?\", \"What components are included in the containment strategy?\", \"Is the containment strategy effective?\", \"What is the role of virology testing in the containment strategy?\", \"What is the role of self-isolation in the containment strategy?\"]", "answers": "[\"Whether the containment strategy is effective\", \"Virological screening of low-risk patients and their contacts associated with self-containment\", \"Virological screening of low-risk patients and their contacts associated with self-containment\", \"Not specified\", \"To assess the effectiveness of the containment strategy\", \"Self-containment\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.47619047619047616, "em": false, "chrf": 56.321645874219406, "bleu": 24.808415001701817}, {"f1": 0.5, "em": false, "chrf": 58.63611218594327, "bleu": 24.808415001701817}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.14285714285714288, "em": false, "chrf": 19.557523011806893, "bleu": 5.815868174415823}, {"f1": 0, "em": false, "chrf": 21.09744667046054, "bleu": 0.0}], "avg_f1": 0.5198412698412699, "avg_em": 0.3333333333333333, "avg_chrf": 59.26878795707168, "avg_bleu": 42.57211636296992}
{"id": "PubMed_10:1029", "en": "However, there may come a point at which the virus spreads more widely into the population, as has happened in Italy.", "fr": "Néanmoins, il se peut que le virus finisse par se propager plus largement au sein de la population, comme en Italie.", "perturbation": "alteration", "pert_fr": "Néanmoins, il se peut que le virus finisse par se propager moins largement au sein de la population, comme en Italie.", "bt_pert_fr": "However, the virus may end up spreading less widely among the population, as in Italy.", "questions": "[\"When might the virus start spreading more widely into the population?\", \"What event is mentioned as having happened in Italy?\", \"What could lead to wider spread of the virus?\", \"What does the sentence suggest about the spread of the virus?\"]", "answers": "[\"Never\", \"The virus may end up spreading less widely among the population\", \"The virus spreading less widely among the population\", \"The virus may end up spreading less widely among the population\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.581935744594866, "bleu": 0.0}, {"f1": 0.13333333333333333, "em": false, "chrf": 34.239841152072394, "bleu": 4.196114906296549}, {"f1": 0.7142857142857143, "em": false, "chrf": 67.4667467004443, "bleu": 27.77619034011791}, {"f1": 0.5555555555555556, "em": false, "chrf": 59.19936381350447, "bleu": 17.747405280050266}], "avg_f1": 0.3507936507936508, "avg_em": 0.0, "avg_chrf": 41.621971852654006, "avg_bleu": 12.42992763161618}
{"id": "PubMed_10:1030", "en": "Surveillance of low-risk patients should inform when we reach this tipping point and when infection rates start to remit.", "fr": "La surveillance des patients à faible risque devrait révéler le moment où nous atteindrons ce point critique et lorsque les taux d’infection commenceront à chuter.", "perturbation": "alteration", "pert_fr": "La surveillance des patients à haut risque devrait révéler le moment où nous atteindrons ce point critique et lorsque les taux d’infection commenceront à chuter.", "bt_pert_fr": "Monitoring high-risk patients should reveal when we reach this tipping point and when infection rates begin to fall.", "questions": "[\"What should surveillance of low-risk patients inform?\", \"When does surveillance indicate we reach the tipping point?\", \"When does surveillance indicate infection rates start to remit?\"]", "answers": "[\"Nothing\", \"When we reach this tipping point\", \"When infection rates begin to fall\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.10621626691786, "bleu": 0.0}, {"f1": 0.8333333333333334, "em": false, "chrf": 95.89836585851079, "bleu": 75.98356856515926}, {"f1": 0.5, "em": false, "chrf": 56.30398607275418, "bleu": 17.965205598154213}], "avg_f1": 0.4444444444444445, "avg_em": 0.0, "avg_chrf": 52.102856066060944, "avg_bleu": 31.316258054437824}
{"id": "PubMed_10:1033", "en": "The surveillance system should be able to identify areas where COVID-19 spread is taking place that might be suitable for trials of antiviral therapy.", "fr": "Le système de surveillance devrait être capable d’identifier les zones de propagation du COVID-19 où le traitement antiviral pourrait être étudié.", "perturbation": "alteration", "pert_fr": "Le système de surveillance devrait être capable d’identifier les zones de disparition du COVID-19 où le traitement antiviral pourrait être étudié.", "bt_pert_fr": "The surveillance system should be able to identify areas of COVID-19 disappearance where antiviral treatment could be studied.", "questions": "[\"What should the surveillance system be able to identify?\", \"What is the purpose of the surveillance system?\", \"What type of trials are being considered?\"]", "answers": "[\"Areas of COVID-19 disappearance\", \"To identify areas where antiviral treatment could be studied\", \"Trials of antiviral treatment\"]", "scores": [{"f1": 0.36363636363636365, "em": false, "chrf": 30.42488452023267, "bleu": 8.9730240870212}, {"f1": 0.4444444444444444, "em": false, "chrf": 47.538190492957845, "bleu": 19.070828081828378}, {"f1": 0.75, "em": false, "chrf": 72.64640470026177, "bleu": 59.460355750136046}], "avg_f1": 0.5193602693602694, "avg_em": 0.0, "avg_chrf": 50.203159904484096, "avg_bleu": 29.168069306328544}
{"id": "PubMed_10:1042", "en": "The impact on practices has been to close for a day, if a case is found, for deep cleaning and then reopen.", "fr": "La détection d’un cas entraîne la fermeture des cabinets sur la journée pour un nettoyage en profondeur puis leur réouverture le jour suivant.", "perturbation": "alteration", "pert_fr": "La détection d’un cas entraîne l'ouverture des cabinets sur la journée pour un nettoyage en profondeur puis leur fermeture le jour suivant.", "bt_pert_fr": "The detection of a case leads to the opening of the practices during the day for a thorough cleaning then their closure the following day.", "questions": "[\"What impact has been observed on practices?\", \"What happens when a case is found?\", \"What is done after a case is found?\", \"What is the practice when a case is found?\"]", "answers": "[\"They are opened during the day for a thorough cleaning and then closed the following day\", \"The practices are opened during the day for a thorough cleaning then their closure the following day\", \"A thorough cleaning is done\", \"The practices are opened during the day for a thorough cleaning then their closure the following day\"]", "scores": [{"f1": 0.30303030303030304, "em": false, "chrf": 33.38693240930674, "bleu": 7.625394298037963}, {"f1": 0.22222222222222224, "em": false, "chrf": 32.42612155425481, "bleu": 3.377156414337854}, {"f1": 0.6666666666666665, "em": false, "chrf": 69.3757986788802, "bleu": 39.76353643835254}, {"f1": 0.3333333333333333, "em": false, "chrf": 41.12688701471291, "bleu": 4.016138436407654}], "avg_f1": 0.38131313131313127, "avg_em": 0.0, "avg_chrf": 44.078934914288666, "avg_bleu": 13.695556396784003}
{"id": "PubMed_10:1043", "en": "The principal limitations of our system are the number of data points.", "fr": "Les principales limitations de notre système sont le nombre de points de données.", "perturbation": "alteration", "pert_fr": "Les principales limitations de notre système sont l'absence de points de données.", "bt_pert_fr": "The main limitations of our system are the lack of data points.", "questions": "[\"What are the principal limitations of the system?\", \"What specific factor limits the system?\"]", "answers": "[\"The lack of data points\", \"The lack of data points\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 57.0815397094343, "bleu": 42.7287006396234}, {"f1": 0.8000000000000002, "em": false, "chrf": 57.0815397094343, "bleu": 42.7287006396234}], "avg_f1": 0.8000000000000002, "avg_em": 0.0, "avg_chrf": 57.0815397094343, "avg_bleu": 42.7287006396234}
{"id": "PubMed_10:1046", "en": "Our sites (surveillance practices) are currently fixed, and it could be helpful to be able to rapidly onboard practices in regions where there are more cases.", "fr": "Nos centres (les cabinets de surveillance) sont actuellement établis, et il pourrait s’avérer utile de pouvoir recruter rapidement des cabinets situés dans les régions où les cas sont plus nombreux.", "perturbation": "alteration", "pert_fr": "Nos centres (les cabinets de surveillance) ne sont pas actuellement établis, et il pourrait s’avérer utile de pouvoir recruter rapidement des cabinets situés dans les régions où les cas sont moins nombreux.", "bt_pert_fr": "Our centers (the monitoring practices) are not currently established, and it could be useful to be able to quickly recruit practices located in regions where there are fewer cases.", "questions": "[\"What are our current surveillance practices?\", \"What would be helpful in regions with more cases?\", \"What is the potential benefit of rapidly onboarding practices?\"]", "answers": "[\"Our centers (the monitoring practices) are not currently established\", \"Recruiting practices located in regions where there are fewer cases\", \"The ability to quickly recruit practices in regions with fewer cases\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.725700319608949, "bleu": 0.0}, {"f1": 0.15384615384615383, "em": false, "chrf": 38.849223517026864, "bleu": 4.196114906296549}, {"f1": 0.4444444444444444, "em": false, "chrf": 39.41451291885275, "bleu": 14.991106946711685}], "avg_f1": 0.19943019943019943, "avg_em": 0.0, "avg_chrf": 29.663145585162855, "avg_bleu": 6.395740617669411}
{"id": "PubMed_10:1047", "en": "Currently, we will be reporting weekly.", "fr": "Pour l’heure, nous allons produire des rapports hebdomadaires.", "perturbation": "alteration", "pert_fr": "Pour l’heure, nous allons produire des rapports mensuels.", "bt_pert_fr": "For now, we will produce monthly reports.", "questions": "[\"What are we currently reporting?\", \"How often are we reporting?\", \"What type of information are we reporting?\", \"What is the current reporting schedule?\"]", "answers": "[\"Monthly reports\", \"Monthly\", \"Monthly reports\", \"Monthly\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.109212335494009, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.581752484191508, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.376894117483168, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.581752484191508, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 9.412402855340048, "avg_bleu": 0.0}
{"id": "PubMed_10:1049", "en": "Opportunistic sampling for serology in children younger than 10 years might be limited due to the overall reduced rate of blood tests in children.", "fr": "L’échantillonnage sérologique opportuniste chez les enfants de moins de 10 ans pourrait être limité en raison du taux global réduit de prises de sang chez les enfants.", "perturbation": "alteration", "pert_fr": "L’échantillonnage sérologique opportuniste chez les enfants de plus de 10 ans pourrait être limité en raison du taux global réduit de prises de sang chez les enfants.", "bt_pert_fr": "Opportunistic serological sampling in children older than 10 years may be limited due to the overall reduced rate of blood draws in children.", "questions": "[\"What might limit opportunistic sampling for serology in children younger than 10 years?\", \"What age group is mentioned in the sentence?\", \"What is the relationship between blood test rates and opportunistic sampling in children?\"]", "answers": "[\"The overall reduced rate of blood draws in children\", \"Children older than 10 years\", \"The reduced rate of blood draws limits opportunistic sampling\"]", "scores": [{"f1": 0.823529411764706, "em": false, "chrf": 81.53629210787324, "bleu": 51.33450480401705}, {"f1": 0.6, "em": false, "chrf": 64.84122912511701, "bleu": 39.76353643835254}, {"f1": 0.823529411764706, "em": false, "chrf": 85.4235401846663, "bleu": 43.167001068522524}], "avg_f1": 0.7490196078431373, "avg_em": 0.0, "avg_chrf": 77.26702047255218, "avg_bleu": 44.75501410363071}
{"id": "PubMed_10:1051", "en": "The model of getting the appropriate informatics to enable capture of the required data has already been a success, with data recording starting the week the codes were created.", "fr": "Le modèle d’obtention de l’informatique appropriée pour permettre la saisie des données requises a déjà été un succès, l’enregistrement des données ayant commencé la semaine où les codes ont été créés.", "perturbation": "alteration", "pert_fr": "Le modèle d’obtention de l’informatique inappropriée pour permettre la saisie des données requises a déjà été un échec, l’enregistrement des données ayant commencé la semaine où les codes ont été créés.", "bt_pert_fr": "The model of obtaining inappropriate computing to enable required data entry has already been a failure, with data recording beginning the week the codes were created.", "questions": "[\"What enables the capture of required data?\", \"When did data recording start?\", \"What happened the week the codes were created?\", \"What is the outcome of the model?\"]", "answers": "[\"Inappropriate computing\", \"The week the codes were created\", \"Data recording began\", \"Failure\"]", "scores": [{"f1": 0, "em": false, "chrf": 43.96047190901076, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.713964109714425, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 4.848295276822021, "bleu": 0.0}], "avg_f1": 0.41666666666666663, "avg_em": 0.25, "avg_chrf": 52.8806828238868, "avg_bleu": 38.758030203727614}
{"id": "PubMed_10:1052", "en": "In addition, modifying the existing surveillance system to collect population data in a parallel way has also been effective.", "fr": "Qui plus est, la modification du système de surveillance existant afin de recueillir les données de la population de façon parallèle a également été efficace.", "perturbation": "alteration", "pert_fr": "Qui plus est, la modification du système de surveillance existant afin de recueillir les données de la population de façon parallèle a également été inefficace.", "bt_pert_fr": "Moreover, modifying the existing surveillance system to collect population data in parallel has also been ineffective.", "questions": "[\"What has been effective in addition to the existing surveillance system?\", \"How can the existing surveillance system be modified?\", \"What type of data can be collected in a parallel way?\"]", "answers": "[\"Nothing\", \"To collect population data\", \"Population data\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.375709171120859, "bleu": 0.0}, {"f1": 0.7272727272727273, "em": false, "chrf": 66.2477594365929, "bleu": 47.23665527410149}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5757575757575758, "avg_em": 0.3333333333333333, "avg_chrf": 56.87448953590459, "avg_bleu": 49.07888509136718}
{"id": "PubMed_10:1053", "en": "However, we are at present unsure as to whether the scale of this surveillance provides sufficient data to drive local containment strategies or if reporting infrequently meets the need of our information age.", "fr": "Toutefois, nous ignorons à l’heure actuelle si l’envergure de cette surveillance fournit suffisamment de données pour donner lieu à des stratégies de confinement local ou si les rapports sporadiques répondent aux besoins de notre ère de l’information.", "perturbation": "alteration", "pert_fr": "Toutefois, nous savons à l’heure actuelle si l’envergure de cette surveillance fournit suffisamment de données pour donner lieu à des stratégies de confinement local ou si les rapports sporadiques répondent aux besoins de notre ère de l’information.", "bt_pert_fr": "However, we now know whether the scale of this surveillance provides enough data to prompt local containment strategies or whether sporadic reporting meets the needs of our information age.", "questions": "[\"What is unsure regarding the scale of surveillance?\", \"Does the scale of surveillance provide sufficient data for local containment strategies?\", \"What is the issue with reporting frequency?\"]", "answers": "[\"Whether the scale of this surveillance provides enough data to prompt local containment strategies or whether sporadic reporting meets the needs of our information age\", \"It is unsure whether the scale of surveillance provides sufficient data for local containment strategies\", \"Sporadic reporting may not meet the needs of our information age\"]", "scores": [{"f1": 0.782608695652174, "em": false, "chrf": 71.32851382788633, "bleu": 40.188875403207}, {"f1": 0, "em": false, "chrf": 2.6315789473684212, "bleu": 0.0}, {"f1": 0.4444444444444445, "em": false, "chrf": 55.96354598830998, "bleu": 26.269098944241577}], "avg_f1": 0.4090177133655395, "avg_em": 0.0, "avg_chrf": 43.307879587854906, "avg_bleu": 22.152658115816195}
{"id": "Wikinews_2:1100", "en": "They did say he was not present at Chesapeake Energy Arena in Oklahoma City, where the Utah Jazz were to play against the Oklahoma City Thunder.", "fr": "Ils ont en revanche déclaré qu’il n’était pas présent au Chesapeake Energy Arena d’Oklahoma City, où les Utah Jazz devaient jouer contre les Oklahoma City Thunder.", "perturbation": "alteration", "pert_fr": "Ils ont en revanche déclaré qu’il était présent au Chesapeake Energy Arena d’Oklahoma City, où les Utah Jazz devaient jouer contre les Oklahoma City Thunder.", "bt_pert_fr": "However, they said he was present at Chesapeake Energy Arena in Oklahoma City, where the Utah Jazz were scheduled to play the Oklahoma City Thunder.", "questions": "[\"Where was the Utah Jazz supposed to play?\", \"Who was the Utah Jazz playing against at Chesapeake Energy Arena?\", \"What event was taking place at Chesapeake Energy Arena?\", \"What was the location of the game between the Utah Jazz and the Oklahoma City Thunder?\"]", "answers": "[\"The Oklahoma City Thunder\", \"The Oklahoma City Thunder\", \"A game between the Utah Jazz and the Oklahoma City Thunder\", \"Chesapeake Energy Arena in Oklahoma City\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 35.18726745328247, "bleu": 19.37692912686648}, {"f1": 0.8571428571428571, "em": false, "chrf": 96.46008918404968, "bleu": 59.460355750136046}, {"f1": 0.8888888888888888, "em": false, "chrf": 93.6630739468044, "bleu": 86.33400213704509}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7865079365079365, "avg_em": 0.25, "avg_chrf": 81.32760764603414, "avg_bleu": 66.29282175351192}
{"id": "Wikinews_2:1104", "en": "The United States' other major basketball organization, the National Collegiate Athletic Association, which runs college basketball, has cancelled its own tournament, March Madness, for both men's and women's leagues.", "fr": "L’autre principale organisation de basket-ball des États-Unis, la National Collegiate Athletic Association, qui régit le basket-ball universitaire, a annulé son propre tournoi, le March Madness, pour les ligues masculine et féminine.", "perturbation": "alteration", "pert_fr": "L’autre principale organisation de basket-ball des États-Unis, la National Collegiate Athletic Association, qui régit le basket-ball universitaire, a maintenu son propre tournoi, le March Madness, pour les ligues masculine et féminine.", "bt_pert_fr": "The United States' other major basketball organization, the National Collegiate Athletic Association, which governs college basketball, maintained its own tournament, March Madness, for both the men's and women's leagues.", "questions": "[\"What is the United States' other major basketball organization?\", \"What does the National Collegiate Athletic Association run?\", \"Which tournaments has the National Collegiate Athletic Association cancelled?\", \"What leagues are affected by the cancellation of the tournament?\"]", "answers": "[\"The National Collegiate Athletic Association\", \"The March Madness tournament\", \"None\", \"None\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 7.168458781362006, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.360536681437716, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.464285714285714, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 28.99832029427136, "avg_bleu": 25.00000000000001}
{"id": "Wikinews_2:1105", "en": "According to Johns Hopkins University, as of Wednesday, there were at least 1,279 confirmed cases of COVID-19 in the United States.", "fr": "D’après l’Université Johns Hopkins, en date de mercredi, il y avait au moins 1 279 cas confirmés de COVID-19 aux États-Unis.", "perturbation": "alteration", "pert_fr": "D’après l’Université Johns Hopkins, en date de mercredi, il n'y avait pas au moins 1 279 cas confirmés de COVID-19 aux États-Unis.", "bt_pert_fr": "According to Johns Hopkins University, as of Wednesday, there were at least 1,279 confirmed cases of COVID-19 in the United States.", "questions": "[\"What is the source of the information about COVID-19 cases?\", \"How many confirmed cases of COVID-19 were reported in the United States as of Wednesday?\", \"What is the total number of confirmed cases of COVID-19?\", \"Which institution provided the information about the cases?\"]", "answers": "[\"Johns Hopkins University\", \"1,279\", \"1,279\", \"Johns Hopkins University\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikinews_5:1148", "en": "The move came two days after the World Health Organization declared the outbreak, which causes the COVID-19 disease, to be a pandemic.", "fr": "La décision a été annoncée deux jours après que l’Organisation mondiale de la santé ait déclaré que l’épidémie, responsable de la maladie COVID-19, était une pandémie.", "perturbation": "alteration", "pert_fr": "La décision n'a pas été annoncée deux jours après que l’Organisation mondiale de la santé ait déclaré que l’épidémie, responsable de la maladie COVID-19, était une pandémie.", "bt_pert_fr": "The decision was not announced two days after the World Health Organization declared the outbreak, which causes the disease COVID-19, a pandemic.", "questions": "[\"When did the move occur?\", \"What disease does the outbreak cause?\", \"What is the significance of the World Health Organization's declaration?\", \"What event preceded the move?\"]", "answers": "[\"The decision was not announced two days after the World Health Organization declared the outbreak\", \"COVID-19\", \"It declared the outbreak a pandemic\", \"The World Health Organization declared the outbreak a pandemic\"]", "scores": [{"f1": 0.5833333333333334, "em": false, "chrf": 78.06904162666531, "bleu": 47.037095938668976}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666665, "em": false, "chrf": 60.817133905146484, "bleu": 16.37226966703825}, {"f1": 0.8750000000000001, "em": false, "chrf": 88.6310291322349, "bleu": 63.191456189157286}], "avg_f1": 0.78125, "avg_em": 0.25, "avg_chrf": 81.87930116601167, "avg_bleu": 56.650205448716136}
{"id": "Wikinews_5:1151", "en": "The United States Department of Health and Human Services declared the outbreak a \"public health emergency\" on January 31.", "fr": "Le département de la Santé et des Services sociaux des États-Unis a déclaré l’épidémie une « urgence de santé publique » le 31 janvier.", "perturbation": "alteration", "pert_fr": "Le département de la Santé et des Services sociaux des États-Unis n'a pas déclaré l’épidémie une « urgence de santé publique » le 31 janvier.", "bt_pert_fr": "The U.S. Department of Health and Human Services did not declare the outbreak a \"public health emergency\" on January 31.", "questions": "[\"What agency declared the outbreak a 'public health emergency'?\", \"When was the outbreak declared a 'public health emergency'?\", \"What was the declaration regarding the outbreak?\", \"Which department declared the outbreak a 'public health emergency'?\"]", "answers": "[\"The U.S. Department of Health and Human Services\", \"The outbreak was not declared a 'public health emergency'\", \"It was not declared a 'public health emergency'\", \"The U.S. Department of Health and Human Services\"]", "scores": [{"f1": 0.823529411764706, "em": false, "chrf": 74.72396088540444, "bleu": 62.401954419369176}, {"f1": 0, "em": false, "chrf": 7.181886908008689, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 85.19567632154063, "bleu": 24.446151121745054}, {"f1": 0.8571428571428571, "em": false, "chrf": 96.91548074807986, "bleu": 68.037493331712}], "avg_f1": 0.5701680672268907, "avg_em": 0.0, "avg_chrf": 66.0042512157584, "avg_bleu": 38.721399718206555}
{"id": "Wikipedia_handpicked_5:1861", "en": "The 2019–20 coronavirus pandemic has affected educational systems worldwide, leading to the widespread closures of schools and universities.", "fr": "La pandémie de coronavirus de 2019-20 a affecté les systèmes éducatifs du monde entier, entraînant la fermeture à grande échelle d’écoles et d’universités.", "perturbation": "alteration", "pert_fr": "La pandémie de coronavirus de 2019-20 n'a pas affecté les systèmes éducatifs du monde entier, entraînant l'ouverture à grande échelle d’écoles et d’universités.", "bt_pert_fr": "The 2019-20 coronavirus pandemic did not affect education systems around the world, leading to large-scale openings of schools and universities.", "questions": "[\"What has the 2019–20 coronavirus pandemic affected worldwide?\", \"What specific changes have occurred in educational systems due to the pandemic?\", \"What impact has the pandemic had on education?\", \"What institutions have been closed due to the pandemic?\"]", "answers": "[\"Education systems\", \"Large-scale openings of schools and universities\", \"It led to large-scale openings of schools and universities\", \"None\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 71.18688063971533, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.65289397157178, "bleu": 50.81327481546147}, {"f1": 0.5714285714285714, "em": false, "chrf": 71.14869669797993, "bleu": 29.84745896009822}, {"f1": 0, "em": false, "chrf": 4.076086956521739, "bleu": 0.0}], "avg_f1": 0.43452380952380953, "avg_em": 0.0, "avg_chrf": 52.016139566447194, "avg_bleu": 32.66518344388992}
{"id": "Wikipedia_handpicked_5:1864", "en": "On 23 March 2020, Cambridge International Examinations (CIE) released a statement announcing the cancellation of Cambridge IGCSE, Cambridge O Level, Cambridge International AS &amp; A Level, Cambridge AICE Diploma, and Cambridge Pre-U examinations for the May/June 2020 series across all countries.", "fr": "Le 23 mars 2020, le centre des examens internationaux de Cambridge (Cambridge International Examinations, CIE) a publié une déclaration annonçant l’annulation des examens IGCSE, O-Level, AS &amp; A-Level internationaux, diplôme AICE et Pre-U de Cambridge pour les séries de mai/juin 2020 dans tous les pays.", "perturbation": "alteration", "pert_fr": "Le 23 mars 2020, le centre des examens internationaux de Cambridge (Cambridge International Examinations, CIE) a publié une déclaration annonçant la poursuite des examens IGCSE, O-Level, AS & A-Level internationaux, diplôme AICE et Pre-U de Cambridge pour les séries de mai/juin 2020 dans tous les pays.", "bt_pert_fr": "On 23 March 2020, Cambridge International Examinations (CIE) released a statement announcing the continuation of IGCSE, O-Level, AS & A-Level International, AICE Diploma and Cambridge Pre-U examinations for the May/June 2020 series in all countries.", "questions": "[\"When did Cambridge International Examinations release a statement about exam cancellations?\", \"What examinations were cancelled by Cambridge International Examinations?\", \"For which exam series were the examinations cancelled?\", \"In which countries were the examinations cancelled?\"]", "answers": "[\"23 March 2020\", \"None\", \"May/June 2020\", \"All countries\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 1.1609406203562376, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}], "avg_f1": 0.625, "avg_em": 0.5, "avg_chrf": 72.5685239958779, "avg_bleu": 62.50000000000002}
{"id": "Wikipedia_handpicked_5:1865", "en": "International Baccalaureate exams have also been cancelled.School closures impact not only students, teachers, and families, but have far-reaching economic and societal consequences.", "fr": "Les épreuves du baccalauréat international ont également été annulées. La fermeture des écoles ne touche pas seulement les élèves, les enseignants et les familles, mais a aussi de lourdes conséquences économiques et sociales.", "perturbation": "alteration", "pert_fr": "Les épreuves du baccalauréat international n'ont pas été annulées. La fermeture des écoles ne touche pas seulement les élèves, les enseignants et les familles, mais a aussi de légères conséquences économiques et sociales.", "bt_pert_fr": "The International Baccalaureate exams have not been canceled. School closures not only affect students, teachers and families, but also have slight economic and social consequences.", "questions": "[\"What has been cancelled along with International Baccalaureate exams?\", \"How do school closures impact students?\", \"How do school closures impact families?\", \"What are the economic consequences of school closures?\", \"What are the societal consequences of school closures?\"]", "answers": "[\"Nothing has been cancelled along with International Baccalaureate exams\", \"School closures affect students\", \"School closures affect families\", \"School closures have slight economic consequences\", \"School closures have slight social consequences\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.064816827371049, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 32.06466168197258, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 32.149755358896925, "bleu": 0.0}, {"f1": 0.4444444444444444, "em": false, "chrf": 60.636598584854895, "bleu": 16.233395773754946}, {"f1": 0.2222222222222222, "em": false, "chrf": 48.00157846243614, "bleu": 8.116697886877475}], "avg_f1": 0.13333333333333333, "avg_em": 0.0, "avg_chrf": 36.98348218310632, "avg_bleu": 4.870018732126484}
{"id": "Wikipedia_handpicked_5:1866", "en": "School closures in response to COVID-19 have shed light on various social and economic issues, including student debt, digital learning, food insecurity, and homelessness, as well as access to childcare, health care, housing, internet, and disability services.", "fr": "La fermeture des écoles en réponse au COVID-19 a révélé plusieurs problèmes économiques et sociaux, notamment la dette étudiante, l’apprentissage numérique, l’insécurité alimentaire et le problème des sans-abri, ainsi que l’accès à la garde d’enfants, aux services de santé, au logement, à l’Internet et aux services d’aide aux personnes handicapées.", "perturbation": "alteration", "pert_fr": "La fermeture des écoles en réponse au COVID-19 a révélé plusieurs avantages économiques et sociaux, notamment la richesse étudiante, l’apprentissage numérique, la sécurité alimentaire et le problème des propriétaires, ainsi que l’accès à la garde d’enfants, aux services de santé, au logement, à l’Internet et aux services d’aide aux personnes valides.", "bt_pert_fr": "School closures in response to COVID-19 have revealed several economic and social benefits, including student wealth, digital learning, food security and homeownership, as well as access to child care, health services, housing, internet and able-bodied support services.", "questions": "[\"What social and economic issues have been shed light on by school closures in response to COVID-19?\", \"What access issues are discussed in the sentence?\"]", "answers": "[\"Student wealth, digital learning, food security and homeownership, access to child care, health services, housing, internet and able-bodied support services\", \"access to child care, health services, housing, internet and able-bodied support services\"]", "scores": [{"f1": 0.5853658536585366, "em": false, "chrf": 63.90972928954668, "bleu": 14.33662193272187}, {"f1": 0.7272727272727272, "em": false, "chrf": 69.34581228999053, "bleu": 17.827531042796252}], "avg_f1": 0.6563192904656319, "avg_em": 0.0, "avg_chrf": 66.6277707897686, "avg_bleu": 16.08207648775906}
{"id": "Wikipedia_handpicked_5:1867", "en": "The impact was more severe for disadvantaged children and their families, causing interrupted learning, compromised nutrition, childcare problems, and consequent economic cost to families who could not work.In response to school closures, UNESCO recommended the use of distance learning programmes and open educational applications and platforms that schools and teachers can use to reach learners remotely and limit the disruption of education.", "fr": "L’impact était plus important chez les enfants défavorisés et leurs familles, provoquant l’interruption de l’apprentissage, une mauvaise nutrition, des problèmes de garde d’enfants et les coûts économiques qui en résultent pour les familles ne pouvant pas travailler. En réponse à la fermeture des écoles, l’UNESCO a recommandé l’utilisation de programmes d’apprentissage à distance et d’applications et plateformes éducatives ouvertes grâce auxquels écoles et enseignants peuvent interagir avec les élèves à distance et limiter la perturbation de l’éducation.", "perturbation": "alteration", "pert_fr": "L’impact était moins important chez les enfants défavorisés et leurs familles, provoquant l’amélioration de l’apprentissage, une bonne nutrition, des solutions de garde d’enfants et les bénéfices économiques qui en résultent pour les familles pouvant travailler. En réponse à la fermeture des écoles, l’UNESCO a recommandé l’utilisation de programmes d’apprentissage à distance et d’applications et plateformes éducatives ouvertes grâce auxquels écoles et enseignants peuvent interagir avec les élèves à distance et limiter la perturbation de l’éducation.", "bt_pert_fr": "The impact was less among disadvantaged children and their families, leading to improved learning, good nutrition, childcare solutions and the resulting economic benefits for families able to work. In response to school closures, UNESCO recommended the use of distance learning programs and open educational applications and platforms through which schools and teachers can interact with students remotely and limit disruption to education.", "questions": "[\"What was the impact on disadvantaged children and their families?\", \"What specific problems were caused by the impact?\", \"What are the consequences of interrupted learning?\", \"What economic cost did families face?\", \"What did UNESCO recommend in response to school closures?\", \"What types of distance learning programmes were recommended?\", \"What educational applications and platforms were suggested?\", \"How can schools and teachers use the recommended tools to reach learners remotely?\"]", "answers": "[\"Improved learning, good nutrition, childcare solutions, and economic benefits\", \"Learning disruption, lack of nutrition, inadequate childcare\", \"Learning disruption\", \"None mentioned\", \"The use of distance learning programs and open educational applications and platforms\", \"Distance learning programs\", \"Open educational applications and platforms\", \"Through these platforms, schools and teachers can interact with students remotely\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.97915492835281, "bleu": 0.0}, {"f1": 0.23529411764705882, "em": false, "chrf": 31.737046736128327, "bleu": 5.087641220727392}, {"f1": 0, "em": false, "chrf": 18.387034049740727, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.464563876663183, "bleu": 0.0}, {"f1": 0.9166666666666666, "em": false, "chrf": 94.33355289123806, "bleu": 73.48889200874659}, {"f1": 0.6666666666666666, "em": false, "chrf": 89.33415726091852, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444444, "em": false, "chrf": 41.21172012843946, "bleu": 16.481158920498064}], "avg_f1": 0.40788398692810457, "avg_em": 0.125, "avg_chrf": 50.18090373393513, "avg_bleu": 31.261226620610316}
{"id": "Wikipedia_handpicked_5:1869", "en": "Mathematical modelling has shown that transmission of an outbreak may be delayed by closing schools.", "fr": "La modélisation mathématique a montré que la transmission d’une épidémie peut être retardée en fermant les écoles.", "perturbation": "alteration", "pert_fr": "La modélisation mathématique a montré que la transmission d’une épidémie peut être accélérée en fermant les écoles.", "bt_pert_fr": "Mathematical modeling has shown that the transmission of an epidemic can be accelerated by closing schools.", "questions": "[\"What has mathematical modelling shown about the transmission of an outbreak?\", \"How can the transmission of an outbreak be delayed?\", \"What action can delay the transmission of an outbreak?\", \"What is the effect of closing schools on outbreak transmission?\"]", "answers": "[\"The transmission of an epidemic can be accelerated by closing schools\", \"Opening schools\", \"Closing schools\", \"The transmission of an epidemic can be accelerated\"]", "scores": [{"f1": 0.5263157894736842, "em": false, "chrf": 58.528536786439545, "bleu": 17.747405280050266}, {"f1": 0.4, "em": false, "chrf": 56.50735397545466, "bleu": 30.326532985631665}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.30769230769230765, "em": false, "chrf": 43.50188735305602, "bleu": 13.134549472120794}], "avg_f1": 0.558502024291498, "avg_em": 0.25, "avg_chrf": 64.63444452873756, "avg_bleu": 40.30212193445069}
{"id": "Wikipedia_handpicked_5:1870", "en": "However, effectiveness depends on the contacts children maintain outside of school.", "fr": "Toutefois, l’efficacité dépend des contacts que maintiennent les enfants en dehors de l’école.", "perturbation": "alteration", "pert_fr": "Toutefois, l’inefficacité dépend des contacts que maintiennent les enfants en dehors de l’école.", "bt_pert_fr": "However, the ineffectiveness depends on the contacts that children maintain outside of school.", "questions": "[\"What depends on the contacts children maintain outside of school?\", \"What factors affect the effectiveness?\", \"What type of contacts are considered?\", \"What is the relationship between children's contacts and effectiveness?\"]", "answers": "[\"The ineffectiveness\", \"The contacts that children maintain outside of school\", \"Contacts outside of school\", \"The ineffectiveness is dependent on the contacts children maintain outside of school\"]", "scores": [{"f1": 0, "em": false, "chrf": 82.25772480195909, "bleu": 0.0}, {"f1": 0.9333333333333333, "em": false, "chrf": 91.61675977743361, "bleu": 59.460355750136046}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.761904761904762, "em": false, "chrf": 86.71736461543644, "bleu": 59.00468726392806}], "avg_f1": 0.6738095238095239, "avg_em": 0.25, "avg_chrf": 90.14796229870728, "avg_bleu": 54.61626075351604}
{"id": "Wikipedia_handpicked_5:1871", "en": "School closures may be effective when enacted promptly.", "fr": "La fermeture des écoles peut s’avérer efficace lorsqu’elle est adoptée rapidement.", "perturbation": "alteration", "pert_fr": "La fermeture des écoles peut s’avérer inefficace lorsqu’elle est adoptée rapidement.", "bt_pert_fr": "Closing schools can be ineffective when adopted quickly.", "questions": "[\"When might school closures be effective?\", \"What condition makes school closures effective?\"]", "answers": "[\"When adopted slowly\", \"Adopted slowly\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 23.413023227358725, "bleu": 27.516060407455225}, {"f1": 0, "em": false, "chrf": 8.340035610118512, "bleu": 0.0}], "avg_f1": 0.16666666666666666, "avg_em": 0.0, "avg_chrf": 15.876529418738619, "avg_bleu": 13.758030203727612}
{"id": "Wikipedia_handpicked_5:1873", "en": "Additionally, in some cases, the reopening of schools after a period of closure has resulted in increased infection rates.", "fr": "En outre, dans certains cas, la réouverture des écoles après une période de fermeture a entraîné une augmentation des taux d’infection.", "perturbation": "alteration", "pert_fr": "En outre, dans certains cas, la réouverture des écoles après une période de fermeture a entraîné une diminution des taux d’infection.", "bt_pert_fr": "Additionally, in some cases, the reopening of schools after a period of closure has led to a decrease in infection rates.", "questions": "[\"What has resulted from the reopening of schools after a period of closure?\", \"What factor has contributed to increased infection rates?\", \"What is the impact of reopening schools after closure?\", \"What is the relationship between school reopening and infection rates?\"]", "answers": "[\"a decrease in infection rates\", \"closure of schools\", \"a decrease in infection rates\", \"reopening of schools is associated with a decrease in infection rates\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 73.02223678554566, "bleu": 31.947155212313625}, {"f1": 0.5454545454545454, "em": false, "chrf": 33.38093896548925, "bleu": 11.898417391331403}, {"f1": 0.5714285714285715, "em": false, "chrf": 73.02223678554566, "bleu": 31.947155212313625}, {"f1": 0.41666666666666663, "em": false, "chrf": 50.63597908613959, "bleu": 13.165576743755272}], "avg_f1": 0.5262445887445888, "avg_em": 0.0, "avg_chrf": 57.51534790568004, "avg_bleu": 22.23957613992848}
{"id": "Wikipedia_handpicked_5:1874", "en": "As closures tend to occur concurrently with other interventions such as public gathering bans, it can be difficult to measure the specific impact of school closures.During the 1918-1919 influenza pandemic in the United States, school closures and public gathering bans were associated with lower total mortality rates.", "fr": "Étant donné que les fermetures ont tendance à survenir en parallèle d’autres interventions telles que l’interdiction des rassemblements publics, il peut être difficile de mesurer l’impact spécifique de la fermeture des écoles. Pendant la pandémie de grippe de 1918-1919 aux États-Unis, la fermeture des écoles et l’interdiction des rassemblements publics ont été associées à un taux total de mortalité plus faible.", "perturbation": "alteration", "pert_fr": "Étant donné que les fermetures ont tendance à survenir en parallèle d’autres interventions telles que l’autorisation des rassemblements publics, il peut être difficile de mesurer l’impact spécifique de la fermeture des écoles. Pendant la pandémie de grippe de 1918-1919 aux États-Unis, la fermeture des écoles et l’autorisation des rassemblements publics ont été associées à un taux total de mortalité plus élevé.", "bt_pert_fr": "Since closures tend to occur alongside other interventions such as allowing public gatherings, it can be difficult to measure the specific impact of school closures. During the 1918-1919 influenza pandemic in the United States, closing schools and allowing public gatherings were associated with a higher total mortality rate.", "questions": "[\"What makes it difficult to measure the specific impact of school closures?\", \"What interventions occur concurrently with school closures?\", \"What was observed during the 1918-1919 influenza pandemic in the United States?\", \"What was the relationship between school closures and public gathering bans during the 1918-1919 influenza pandemic?\", \"What was the outcome of school closures and public gathering bans during the 1918-1919 influenza pandemic?\"]", "answers": "[\"The occurrence of other interventions such as allowing public gatherings\", \"Allowing public gatherings\", \"Closing schools and allowing public gatherings were associated with a higher total mortality rate\", \"Closing schools and allowing public gatherings were associated with a higher total mortality rate\", \"A higher total mortality rate\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 87.46955783443869, "bleu": 66.06328636027612}, {"f1": 0, "em": false, "chrf": 67.05642112201146, "bleu": 0.0}, {"f1": 0.5384615384615384, "em": false, "chrf": 69.20817605514573, "bleu": 15.727800941615358}, {"f1": 0.4761904761904762, "em": false, "chrf": 67.83645685194848, "bleu": 14.458924666162856}, {"f1": 0.4444444444444445, "em": false, "chrf": 80.52414544744477, "bleu": 21.3643503198117}], "avg_f1": 0.4518192918192918, "avg_em": 0.0, "avg_chrf": 74.41895146219782, "avg_bleu": 23.522872457573207}
{"id": "Wikipedia_handpicked_5:1875", "en": "Cities that implemented such interventions earlier had greater delays in reaching peak mortality rates.", "fr": "Les premières villes ayant mis en œuvre ces interventions ont obtenu des délais plus importants avant d’atteindre le pic de mortalité.", "perturbation": "alteration", "pert_fr": "Les premières villes ayant mis en œuvre ces interventions n'ont pas obtenu des délais plus importants avant d’atteindre le pic de mortalité.", "bt_pert_fr": "The first cities to implement these interventions did not obtain longer periods before reaching peak mortality.", "questions": "[\"What does the sentence say about cities that implemented interventions earlier?\", \"What was observed in cities that implemented interventions earlier?\", \"What is the relationship between the timing of interventions and peak mortality rates?\", \"What is the effect of early implementation of interventions on peak mortality rates?\", \"What is the outcome of early intervention in cities?\"]", "answers": "[\"The first cities to implement these interventions did not obtain longer periods before reaching peak mortality\", \"Cities that implemented interventions earlier did not experience a longer period before reaching peak mortality\", \"There is no relationship between early implementation of interventions and a longer period before peak mortality\", \"Early implementation of interventions does not delay peak mortality rates\", \"The outcome of early intervention in cities is that they still reach peak mortality without a delay\"]", "scores": [{"f1": 0.26666666666666666, "em": false, "chrf": 51.18811674519623, "bleu": 9.78237574896145}, {"f1": 0.2857142857142857, "em": false, "chrf": 46.68997528741914, "bleu": 10.571070857151538}, {"f1": 0.4137931034482759, "em": false, "chrf": 50.21455582874689, "bleu": 12.874330508144842}, {"f1": 0.608695652173913, "em": false, "chrf": 66.37428707422976, "bleu": 28.1450060327443}, {"f1": 0.26086956521739124, "em": false, "chrf": 41.38352614543217, "bleu": 5.412989186545265}], "avg_f1": 0.3671478546441065, "avg_em": 0.0, "avg_chrf": 51.170092216204836, "avg_bleu": 13.35715446670948}
{"id": "Wikipedia_handpicked_5:1877", "en": "School closures were shown to reduce morbidity from the Asian flu by 90% during the 1957–58 outbreak, and up to 50% in controlling influenza in the US, 2004–2008.Multiple countries successfully slowed the spread of infection through school closures during the 2009 H1N1 Flu pandemic.", "fr": "Il a été démontré que la fermeture des écoles a permis de réduire la morbidité de la grippe asiatique de 90 % lors de l’épidémie de 1957-58, et jusqu’à 50 % pour la lutte contre la grippe aux États-Unis, en 2004-2008. De nombreux pays ont réussi à ralentir la propagation de l’infection grâce à la fermeture des écoles pendant la pandémie de grippe H1N1 en 2009.", "perturbation": "alteration", "pert_fr": "Il a été démontré que la fermeture des écoles n'a pas permis de réduire la morbidité de la grippe asiatique de 90 % lors de l’épidémie de 1957-58, et jusqu’à 50 % pour la lutte contre la grippe aux États-Unis, en 2004-2008. De nombreux pays ont réussi à accélérer la propagation de l’infection grâce à la fermeture des écoles pendant la pandémie de grippe H1N1 en 2009.", "bt_pert_fr": "It has been shown that school closures failed to reduce Asian flu morbidity by 90% during the 1957-58 epidemic, and by up to 50% for the fight against influenza in the United States in 2004-2008. Many countries managed to accelerate the spread of infection through school closures during the 2009 H1N1 influenza pandemic.", "questions": "[\"What was the effect of school closures on morbidity during the 1957–58 Asian flu outbreak?\", \"How effective were school closures in controlling the spread of infection during the 2009 H1N1 Flu pandemic?\", \"Which countries successfully slowed the spread of infection through school closures during the 2009 H1N1 Flu pandemic?\"]", "answers": "[\"School closures failed to reduce Asian flu morbidity by 90%\", \"School closures did not effectively control the spread of infection\", \"Many countries\"]", "scores": [{"f1": 0.7368421052631577, "em": false, "chrf": 65.81037622549584, "bleu": 15.106876986783844}, {"f1": 0.375, "em": false, "chrf": 40.01718213511639, "bleu": 17.747405280050266}, {"f1": 0.5, "em": false, "chrf": 47.64749658825835, "bleu": 49.99999999999999}], "avg_f1": 0.5372807017543859, "avg_em": 0.0, "avg_chrf": 51.15835164962353, "avg_bleu": 27.6180940889447}
{"id": "Wikipedia_handpicked_5:1879", "en": "Mandatory school closures and other social distancing measures were associated with a 29% to 37% reduction in influenza transmission rates.", "fr": "La fermeture obligatoire des écoles et autres mesures de distanciation sociale ont été associées à une réduction de 29 % à 37 % du taux de propagation de la grippe.", "perturbation": "alteration", "pert_fr": "La fermeture obligatoire des écoles et autres mesures de distanciation sociale ont été associées à une augmentation de 29 % à 37 % du taux de propagation de la grippe.", "bt_pert_fr": "Mandatory school closures and other social distancing measures have been associated with a 29% to 37% increase in the rate of flu spread.", "questions": "[\"What was the range of reduction in influenza transmission rates?\", \"What type of measures were considered mandatory?\", \"What disease's transmission rates are discussed in the sentence?\"]", "answers": "[\"29% to 37% increase\", \"Mandatory school closures and other social distancing measures\", \"flu\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 66.95690718602997, "bleu": 59.460355750136046}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 28.531337698783904, "bleu": 0.0}], "avg_f1": 0.6190476190476191, "avg_em": 0.3333333333333333, "avg_chrf": 65.16274829493796, "avg_bleu": 53.15345191671204}
{"id": "Wikipedia_handpicked_5:1880", "en": "Early school closures in the United States delayed the peak of the 2009 H1N1 Flu pandemic.", "fr": "La fermeture rapide des écoles aux États-Unis a retardé le pic de la pandémie de grippe H1N1 de 2009.", "perturbation": "alteration", "pert_fr": "La fermeture rapide des écoles aux États-Unis a avancé le pic de la pandémie de grippe H1N1 de 2009.", "bt_pert_fr": "The rapid closure of schools in the United States brought forward the peak of the 2009 H1N1 influenza pandemic.", "questions": "[\"What effect did early school closures have on the 2009 H1N1 Flu pandemic?\", \"What happened to the peak of the 2009 H1N1 Flu pandemic due to early school closures?\", \"Where did early school closures occur?\", \"What is the significance of early school closures in the context of the pandemic?\"]", "answers": "[\"It brought forward the peak\", \"It was brought forward\", \"in the United States\", \"Early school closures caused the peak of the pandemic to occur earlier\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 24.046253210986777, "bleu": 18.99589214128981}, {"f1": 0.5714285714285715, "em": false, "chrf": 23.460302137261525, "bleu": 31.947155212313625}, {"f1": 0.6666666666666666, "em": false, "chrf": 91.10491360491362, "bleu": 55.03212081491043}, {"f1": 0.6, "em": false, "chrf": 57.236295715814876, "bleu": 20.556680845025987}], "avg_f1": 0.6023809523809525, "avg_em": 0.0, "avg_chrf": 48.9619411672442, "avg_bleu": 31.632962253384964}
{"id": "Wikipedia_handpicked_5:1881", "en": "Despite the overall success of closing schools, a study of school closures in Michigan found that \"district level reactive school closures were ineffective.\"During the swine flu outbreak in 2009 in the UK, in an article titled \"Closure of schools during an influenza pandemic\" published in the Lancet Infectious Diseases, a group of epidemiologists endorsed the closure of schools in order to interrupt the course of the infection, slow further spread and buy time to research and produce a vaccine.", "fr": "Malgré la réussite globale de la fermeture des écoles, une étude de la fermeture des écoles au Michigan a révélé que « la fermeture réactive des écoles au niveau du district avait été inefficace ». Pendant l’épidémie de grippe porcine en 2009 au Royaume-Uni, dans un article intitulé « Fermeture des écoles pendant une pandémie de grippe » publié dans le Lancet Infectious Diseases, un groupe d’épidémiologistes soutenait la fermeture des écoles afin d’interrompre l’évolution de l’infection, de ralentir sa propagation et de gagner du temps pour étudier et développer un vaccin.", "perturbation": "alteration", "pert_fr": "Malgré l'échec globale de la fermeture des écoles, une étude de la fermeture des écoles au Michigan a révélé que « la fermeture réactive des écoles au niveau du district avait été efficace ». Pendant l’épidémie de grippe porcine en 2009 au Royaume-Uni, dans un article intitulé « Fermeture des écoles pendant une pandémie de grippe » publié dans le Lancet Infectious Diseases, un groupe d’épidémiologistes soutenait la fermeture des écoles afin d’interrompre l’évolution de l’infection, de ralentir sa propagation et de gagner du temps pour étudier et développer un vaccin.", "bt_pert_fr": "Despite the overall failure of school closures, a study of school closures in Michigan found that \"reactive school closures at the district level had been effective.\" During the 2009 swine flu outbreak in the United Kingdom, in an article titled “Closing Schools During an Influenza Pandemic” published in the Lancet Infectious Diseases, a group of epidemiologists supported closing schools in order to interrupt the course of the infection, slow its spread, and buy time to study and develop a vaccine.", "questions": "[\"What was the finding of the study on school closures in Michigan?\", \"Why were school closures endorsed during the swine flu outbreak in the UK?\", \"What was the goal of closing schools during the swine flu outbreak?\", \"What did the epidemiologists aim to achieve by closing schools during the swine flu outbreak?\", \"What disease was involved in the 2009 swine flu outbreak in the UK?\"]", "answers": "[\"Reactive school closures at the district level had been effective\", \"To interrupt the course of the infection, slow its spread, and buy time to study and develop a vaccine\", \"To interrupt the course of the infection, slow its spread, and buy time to study and develop a vaccine\", \"To interrupt the course of the infection, slow its spread, and buy time to study and develop a vaccine\", \"Swine flu\"]", "scores": [{"f1": 0.375, "em": false, "chrf": 74.177612333869, "bleu": 10.552670315936318}, {"f1": 0.8125, "em": false, "chrf": 66.38187844098205, "bleu": 55.33409598501609}, {"f1": 0.47619047619047616, "em": false, "chrf": 73.03480666937628, "bleu": 22.894156860669913}, {"f1": 0.8125, "em": false, "chrf": 66.38187844098205, "bleu": 55.33409598501609}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6952380952380952, "avg_em": 0.2, "avg_chrf": 75.99523517704188, "avg_bleu": 48.82300382932769}
{"id": "Wikipedia_handpicked_5:1883", "en": "They also looked at the dynamics of the spread of influenza in France during French school holidays and noted that cases of flu dropped when schools closed and re-emerged when they re-opened.", "fr": "Ils ont également examiné la dynamique de la propagation de la grippe en France pendant les vacances scolaires françaises et ont souligné que les cas de grippe ont chuté avec la fermeture des écoles et sont remontés lors de leur réouverture.", "perturbation": "alteration", "pert_fr": "Ils ont également examiné la dynamique de la propagation de la grippe en France pendant les vacances scolaires françaises et ont souligné que les cas de grippe ont augmenté avec la fermeture des écoles et sont chutés lors de leur réouverture.", "bt_pert_fr": "They also looked at the dynamics of the spread of flu in France during French school holidays and highlighted that flu cases rose as schools closed and fell when they reopened.", "questions": "[\"What did they look at regarding the spread of influenza in France?\", \"What happened to flu cases when schools closed?\", \"What happened to flu cases when schools re-opened?\", \"What is the relationship between school closures and flu cases?\"]", "answers": "[\"the dynamics of the spread of flu in France during French school holidays\", \"flu cases rose\", \"flu cases fell\", \"flu cases rose when schools closed and fell when they reopened\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 83.61097350051385, "bleu": 70.16879391277372}, {"f1": 0.5714285714285715, "em": false, "chrf": 27.956001264200758, "bleu": 24.840753130578644}, {"f1": 0.5714285714285715, "em": false, "chrf": 23.28195414047325, "bleu": 24.840753130578644}, {"f1": 0.5217391304347826, "em": false, "chrf": 47.51521204511367, "bleu": 11.854493902046322}], "avg_f1": 0.6434217955957087, "avg_em": 0.0, "avg_chrf": 45.59103523757538, "avg_bleu": 32.92619851899433}
{"id": "Wikipedia_handpicked_5:1886", "en": "When there is minimal to moderate community transmission, social distancing strategies can be implemented such as cancelling field trips, assemblies, and other large gatherings such as physical education or choir classes or meals in a cafeteria, increasing the space between desks, staggering arrival and dismissal times, limiting nonessential visitors, and using a separate health office location for children with flu-like symptoms.", "fr": "En cas de transmission communautaire minimale à modérée, des stratégies de distanciation sociale peuvent être mises en œuvre, telles que l’annulation des sorties pédagogiques, des assemblées et autres rassemblements importants comme les cours d’éducation physique ou de chorale ou les repas à la cantine, en augmentant l’espace entre les bureaux, en échelonnant les heures d’arrivée et de sortie, en réduisant les visiteurs non essentiels et en utilisant une infirmerie séparée pour les enfants présentant des symptômes grippaux.", "perturbation": "alteration", "pert_fr": "En cas de transmission communautaire minimale à modérée, des stratégies de rapprochement social peuvent être mises en œuvre, telles que l’organisation des sorties pédagogiques, des assemblées et autres rassemblements importants comme les cours d’éducation physique ou de chorale ou les repas à la cantine, en réduisant l’espace entre les bureaux, en synchronisant les heures d’arrivée et de sortie, en augmentant les visiteurs non essentiels et en utilisant une infirmerie commune pour les enfants présentant des symptômes grippaux.", "bt_pert_fr": "In cases of minimal to moderate community transmission, social rapprochement strategies can be implemented, such as organizing field trips, assemblies and other large gatherings such as physical education or choir classes or meals in the canteen, reducing the space between desks, synchronizing arrival and departure times, increasing non-essential visitors and using a common infirmary for children with flu-like symptoms.", "questions": "[\"What social distancing strategies can be implemented when there is minimal to moderate community transmission?\", \"What specific activities are recommended to cancel during minimal to moderate community transmission?\", \"What large gatherings are mentioned as being canceled?\", \"What changes can be made to classroom settings during minimal to moderate community transmission?\", \"What measures can be taken to limit nonessential visitors?\", \"What is the purpose of using a separate health office location for children with flu-like symptoms?\"]", "answers": "[\"Organizing field trips, assemblies and other large gatherings such as physical education or choir classes or meals in the canteen\", \"Field trips, assemblies, physical education, choir classes, and meals in the canteen\", \"Physical education or choir classes or meals in the canteen\", \"Reducing the space between desks\", \"Increasing non-essential visitors\", \"To manage children with flu-like symptoms\"]", "scores": [{"f1": 0.5573770491803278, "em": false, "chrf": 41.23404118321117, "bleu": 26.38295264973424}, {"f1": 0.9090909090909091, "em": false, "chrf": 90.84467046253549, "bleu": 89.31539818068698}, {"f1": 0.8888888888888888, "em": false, "chrf": 87.04258610626792, "bleu": 86.33400213704509}, {"f1": 0.75, "em": false, "chrf": 73.72895194838716, "bleu": 59.460355750136046}, {"f1": 0.6666666666666666, "em": false, "chrf": 79.0595563750151, "bleu": 55.03212081491043}, {"f1": 0.5263157894736842, "em": false, "chrf": 39.21992323218977, "bleu": 16.731227054577023}], "avg_f1": 0.7163898838834127, "avg_em": 0.0, "avg_chrf": 68.52162155126777, "avg_bleu": 55.5426760978483}
{"id": "Wikipedia_handpicked_5:1887", "en": "When there is substantial transmission in the local community, in addition to social distancing strategies, extended school dismissals may be considered.", "fr": "En cas de transmission importante dans la population locale, outre les stratégies de distanciation sociale, un prolongement des vacances scolaires peut être envisagé.", "perturbation": "alteration", "pert_fr": "En cas de transmission faible dans la population locale, outre les stratégies de distanciation sociale, un raccourcissement des vacances scolaires peut être envisagé.", "bt_pert_fr": "In the event of low transmission in the local population, in addition to social distancing strategies, a shortening of school holidays may be considered.", "questions": "[\"What happens when there is substantial transmission in the local community?\", \"What strategies are considered in addition to social distancing?\", \"What may be considered during substantial transmission?\", \"What is the condition that triggers extended school dismissals?\"]", "answers": "[\"Nothing is mentioned about substantial transmission\", \"A shortening of school holidays\", \"A shortening of school holidays\", \"Low transmission\"]", "scores": [{"f1": 0, "em": false, "chrf": 18.887523784692075, "bleu": 0.0}, {"f1": 0.25, "em": false, "chrf": 24.254467491295994, "bleu": 10.682175159905853}, {"f1": 0.25, "em": false, "chrf": 24.254467491295994, "bleu": 10.682175159905853}, {"f1": 0.28571428571428575, "em": false, "chrf": 30.26943911092012, "bleu": 11.15650800742149}], "avg_f1": 0.19642857142857145, "avg_em": 0.0, "avg_chrf": 24.416474469551048, "avg_bleu": 8.1302145818083}
{"id": "Wikipedia_handpicked_5:1890", "en": "On 23 February, Iran's Ministry of Health announced the closure of universities, higher educational institutions and schools in several cities and provinces.", "fr": "Le 23 février, le ministre de la Santé iranien a annoncé la fermeture des universités, des établissements d’éducation supérieure et des écoles de plusieurs villes et provinces.", "perturbation": "alteration", "pert_fr": "Le 23 février, le ministre de la Santé iranien a annoncé la réouverture des universités, des établissements d’éducation supérieure et des écoles de plusieurs villes et provinces.", "bt_pert_fr": "On February 23, Iran's Minister of Health announced the reopening of universities, higher education institutions and schools in several cities and provinces.", "questions": "[\"What was announced by Iran's Ministry of Health on 23 February?\", \"Which institutions were closed on 23 February?\", \"In which cities and provinces were institutions closed?\", \"What type of institutions were closed?\", \"What action was taken by Iran's Ministry of Health on 23 February?\"]", "answers": "[\"The reopening of universities, higher education institutions and schools in several cities and provinces\", \"Universities, higher education institutions and schools\", \"Several cities and provinces\", \"Universities, higher education institutions and schools\", \"Announced the reopening of universities, higher education institutions and schools in several cities and provinces\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 85.62309661221205, "bleu": 62.98129992394241}, {"f1": 0.8333333333333334, "em": false, "chrf": 91.33901345922595, "bleu": 37.99178428257963}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 91.33901345922595, "bleu": 37.99178428257963}, {"f1": 0, "em": false, "chrf": 4.926184088658939, "bleu": 0.0}], "avg_f1": 0.7047619047619047, "avg_em": 0.2, "avg_chrf": 74.64546152386458, "avg_bleu": 47.792973697820344}
{"id": "Wikipedia_handpicked_5:1893", "en": "In reaction, UNESCO called on countries to support affected students and families and facilitate large-scale inclusive distance learning programmes.", "fr": "En réaction, l’UNESCO a appelé les pays à soutenir les élèves affectés et leurs familles et à mettre en place des programmes d’apprentissage à distance inclusifs à grande échelle.", "perturbation": "alteration", "pert_fr": "En réaction, l’UNESCO a appelé les pays à abandonner les élèves affectés et leurs familles et à mettre en place des programmes d’apprentissage à distance exclusifs à petite échelle.", "bt_pert_fr": "In response, UNESCO called on countries to abandon affected students and their families and implement small-scale, exclusive distance learning programs.", "questions": "[\"What did UNESCO call on countries to do?\", \"What specific actions did UNESCO recommend for affected students and families?\", \"What type of distance learning programmes did UNESCO recommend?\", \"What is the goal of the distance learning programmes?\", \"What groups are mentioned as being affected?\"]", "answers": "[\"To abandon affected students and their families and implement small-scale, exclusive distance learning programs\", \"Abandon affected students and their families\", \"Small-scale, exclusive distance learning programs\", \"To provide education to affected students and families\", \"Affected students and their families\"]", "scores": [{"f1": 0.5384615384615384, "em": false, "chrf": 64.3825919542648, "bleu": 15.537125692760354}, {"f1": 0.7272727272727272, "em": false, "chrf": 68.75443796311413, "bleu": 32.46679154750989}, {"f1": 0.4444444444444445, "em": false, "chrf": 81.9641592752036, "bleu": 21.3643503198117}, {"f1": 0.16666666666666666, "em": false, "chrf": 28.087602661895765, "bleu": 5.522397783539471}, {"f1": 0.888888888888889, "em": false, "chrf": 85.7625225118452, "bleu": 42.7287006396234}], "avg_f1": 0.5531468531468532, "avg_em": 0.0, "avg_chrf": 65.79026287326471, "avg_bleu": 23.523873196648964}
{"id": "Wikipedia_handpicked_5:1896", "en": "On 5 March, the majority of learners affected by COVID-19 emergency measures were located in China, with 233 million learners affected, followed by Japan at 16.5 million and Iran at 14.5 million.", "fr": "Le 5 mars, la majorité des élèves touchés par les mesures d’urgence du COVID-19 se trouvaient en Chine, avec 233 millions d’élèves affectés, suivis par le Japon avec 16,5 millions et l’Iran avec 14,5 millions.", "perturbation": "alteration", "pert_fr": "Le 5 mars, la minorité des élèves touchés par les mesures d’urgence du COVID-19 se trouvaient en Chine, avec 233 millions d’élèves affectés, suivis par le Japon avec 16,5 millions et l’Iran avec 14,5 millions.", "bt_pert_fr": "As of March 5, the minority of students affected by COVID-19 emergency measures were in China, with 233 million students affected, followed by Japan with 16.5 million and Iran with 14.5 million.", "questions": "[\"Where were the majority of learners affected by COVID-19 emergency measures located on 5 March?\", \"How many learners were affected in China on 5 March?\", \"How many learners were affected in Japan on 5 March?\", \"How many learners were affected in Iran on 5 March?\", \"What is the context of the learners' affected status?\"]", "answers": "[\"China\", \"233 million\", \"16.5 million\", \"14.5 million\", \"COVID-19 emergency measures\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikipedia_handpicked_5:1899", "en": "By 16 March, this figure increased from 49 to 73 countries according to UNESCO.", "fr": "Le 16 mars, ce chiffre est passé de 49 à 73 pays selon l’UNESCO.", "perturbation": "alteration", "pert_fr": "Le 16 mars, ce chiffre est passé de 73 à 49 pays selon l’UNESCO.", "bt_pert_fr": "On March 16, this figure fell from 73 to 49 countries according to UNESCO.", "questions": "[\"What was the figure before 16 March?\", \"What was the figure on 16 March?\", \"How many countries did the figure increase to by 16 March?\", \"How many countries was the figure increased from?\", \"What organization reported the increase in the number of countries?\"]", "answers": "[\"73\", \"49\", \"49\", \"73\", \"UNESCO\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikipedia_handpicked_5:1902", "en": "On 23 March, all Nigerian school were found to have been closed down by Nigerian government, markets as well as companies were closed down and children were forbidden by parents to step out of their homes.", "fr": "Le 23 mars, toutes les écoles nigérianes avaient été fermées par le gouvernement nigérian, les marchés et entreprises étaient fermés et les parents interdisaient à leurs enfants de sortir de chez eux.", "perturbation": "alteration", "pert_fr": "Le 23 mars, toutes les écoles nigérianes avaient été ouvertes par le gouvernement nigérian, les marchés et entreprises étaient ouverts et les parents autorisaient à leurs enfants de sortir de chez eux.", "bt_pert_fr": "By March 23, all Nigerian schools had been opened by the Nigerian government, markets and businesses were open and parents were allowing their children to leave their homes.", "questions": "[\"What happened to Nigerian schools on 23 March?\", \"What other places were closed down by the Nigerian government?\", \"What was forbidden to children by their parents?\", \"What actions were taken by the Nigerian government on 23 March?\"]", "answers": "[\"All Nigerian schools had been opened\", \"Markets and businesses\", \"Leaving their homes\", \"Opened Nigerian schools\"]", "scores": [{"f1": 0.3636363636363636, "em": false, "chrf": 51.37329857144594, "bleu": 16.233395773754946}, {"f1": 0.6666666666666666, "em": false, "chrf": 48.71165004576979, "bleu": 55.03212081491043}, {"f1": 0.4444444444444444, "em": false, "chrf": 42.6564745030455, "bleu": 20.24518585186855}, {"f1": 0.4, "em": false, "chrf": 36.29111210016009, "bleu": 14.506309551249304}], "avg_f1": 0.46868686868686865, "avg_em": 0.0, "avg_chrf": 44.75813380510533, "avg_bleu": 26.504252997945805}
{"id": "Wikipedia_handpicked_5:1903", "en": "On 26 March, all New Zealand schools and universities have been closed down across the country.", "fr": "Le 26 mars, toutes les écoles et universités néo-zélandaises ont été fermées dans l’ensemble du pays.", "perturbation": "alteration", "pert_fr": "Le 26 mars, toutes les écoles et universités néo-zélandaises ont été ouvertes dans l’ensemble du pays.", "bt_pert_fr": "On March 26, all New Zealand schools and universities were opened across the country.", "questions": "[\"When were all New Zealand schools and universities closed down?\", \"What was closed down in New Zealand on 26 March?\", \"What institutions were closed down across New Zealand?\", \"What happened to schools and universities in New Zealand on 26 March?\"]", "answers": "[\"The sentence does not mention when schools and universities were closed down.\", \"Schools and universities\", \"Schools and universities\", \"All New Zealand schools and universities were opened\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.534195791960107, "bleu": 0.0}, {"f1": 0.5714285714285715, "em": false, "chrf": 84.38119301203612, "bleu": 39.43223765116288}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.16666666666666666, "em": false, "chrf": 16.750760115925694, "bleu": 5.522397783539471}], "avg_f1": 0.43452380952380953, "avg_em": 0.25, "avg_chrf": 51.41653722998048, "avg_bleu": 36.2386588586756}
{"id": "Wikipedia_handpicked_5:1912", "en": "An order signed by the Ministry of Education as a preventative measure aims to prevent the spread of respiratory diseases in connection with the WHO coronavirus pandemic.", "fr": "Une ordonnance signée par le ministère de l’Éducation en tant que mesure de prévention vise à éviter la propagation des maladies respiratoires liées à la pandémie de coronavirus de l’OMS.", "perturbation": "alteration", "pert_fr": "Une ordonnance signée par le ministère de l’Éducation en tant que mesure de traitement vise à favoriser la propagation des maladies respiratoires liées à la pandémie de coronavirus de l’OMS.", "bt_pert_fr": "An order signed by the Ministry of Education as a treatment measure aims to promote the spread of respiratory diseases linked to the WHO coronavirus pandemic.", "questions": "[\"What is the purpose of the order signed by the Ministry of Education?\", \"What type of disease is the order aimed at preventing?\", \"Who signed the order?\", \"What is the preventative measure related to respiratory diseases?\"]", "answers": "[\"To promote the spread of respiratory diseases\", \"Respiratory diseases linked to the WHO coronavirus pandemic\", \"The Ministry of Education\", \"An order signed by the Ministry of Education\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 78.75598198712525, "bleu": 53.7284965911771}, {"f1": 0.4444444444444445, "em": false, "chrf": 73.2587120539902, "bleu": 13.134549472120794}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8194444444444444, "avg_em": 0.5, "avg_chrf": 88.00367351027886, "avg_bleu": 66.7157615158245}
{"id": "Wikipedia_handpicked_5:1913", "en": "10 countries have localised schools closures, UNESCO estimates  473,933,356  learners are potentially at risk (pre-primary to upper-secondary education) and 77,938,904 learners are potentially at risk in tertiary education.", "fr": "Dix pays ont pris des mesures locales de fermeture des écoles, l’UNESCO estime que 473 933 356 élèves de l’enseignement pré-primaire à l’enseignement secondaire supérieur et 77 938 904 étudiants de l’enseignement supérieur risquent de se trouver en difficulté.", "perturbation": "alteration", "pert_fr": "Dix pays n'ont pas pris des mesures locales de fermeture des écoles, l’UNESCO estime que 473 933 356 élèves de l’enseignement pré-primaire à l’enseignement secondaire supérieur et 77 938 904 étudiants de l’enseignement supérieur ne risquent pas de se trouver en difficulté.", "bt_pert_fr": "Ten countries have not taken local school closure measures, UNESCO estimates that 473,933,356 students from pre-primary to upper secondary education and 77,938,904 tertiary students are not at risk of difficulty.", "questions": "[\"How many learners are potentially at risk in pre-primary to upper-secondary education?\", \"How many learners are potentially at risk in tertiary education?\", \"What education levels are included in the at-risk learners count?\", \"What organization estimates the number of learners at risk?\"]", "answers": "[\"0\", \"0\", \"pre-primary to upper secondary education\", \"UNESCO\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 15.151515151515152, "bleu": 0.0}, {"f1": 0.6666666666666665, "em": false, "chrf": 100.0, "bleu": 23.643540225079395}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.41666666666666663, "avg_em": 0.25, "avg_chrf": 53.78787878787879, "avg_bleu": 30.91088505626986}
{"id": "Wikipedia_handpicked_5:1914", "en": "Note: Figures correspond to total number of learners enrolled at pre-primary, primary, lower-secondary, and upper-secondary levels of education [ISCED levels 0 to 3], as well as at tertiary education levels [ISCED levels 5 to 8] who could be affected should localised closures become countrywide.", "fr": "Remarque : les chiffres correspondent au nombre total d’élèves inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement supérieur [niveaux 5 à 8 de la CITE] qui pourraient être affectés si les fermetures localisées devenaient nationales.", "perturbation": "alteration", "pert_fr": "Remarque : les chiffres correspondent au nombre total d’élèves inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement inférieur [niveaux 5 à 8 de la CITE] qui pourraient être affectés si les fermetures localisées devenaient nationales.", "bt_pert_fr": "Note: Figures refer to the total number of students enrolled in pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0-3], as well as lower education cycles [ISCED levels 5-8] that could be affected if localized closures become national.", "questions": "[\"What does the term 'figures' correspond to?\", \"Which education levels are included in the figures?\", \"What are the ISCED levels for pre-primary to upper-secondary education?\", \"What are the ISCED levels for tertiary education?\", \"What happens to the figures if localised closures become countrywide?\"]", "answers": "[\"The total number of students enrolled in pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0-3], as well as lower education cycles [ISCED levels 5-8] that could be affected if localized closures become national\", \"pre-primary, primary, lower secondary and upper secondary education and lower education cycles\", \"0-3\", \"Not specified\", \"The figures could be affected\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 68.17591141579435, "bleu": 15.21366868699307}, {"f1": 0.4166666666666667, "em": false, "chrf": 74.238311349833, "bleu": 8.51659301881964}, {"f1": 0, "em": false, "chrf": 27.77777777777778, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.928571428571429, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 44.32491624583109, "bleu": 18.393972058572114}], "avg_f1": 0.330952380952381, "avg_em": 0.0, "avg_chrf": 44.68909764356153, "avg_bleu": 8.424846752876965}
{"id": "Wikipedia_handpicked_5:1915", "en": "Enrolment figures based on latest UNESCO Institute of Statistics data.", "fr": "Les chiffres des effectifs sont fondés sur les données les plus récentes de l’Institut de statistique de l’UNESCO.", "perturbation": "alteration", "pert_fr": "Les chiffres des effectifs ne sont pas fondés sur les données les plus récentes de l’Institut de statistique de l’UNESCO.", "bt_pert_fr": "Staffing figures are not based on the most recent data from the UNESCO Institute for Statistics.", "questions": "[\"What enrolment figures are based on?\", \"Which data source is used for the enrolment figures?\"]", "answers": "[\"the most recent data from the UNESCO Institute for Statistics\", \"the UNESCO Institute for Statistics\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 62.206161262707596, "bleu": 13.134549472120788}, {"f1": 0.75, "em": false, "chrf": 81.62345440341757, "bleu": 35.35533905932737}], "avg_f1": 0.6607142857142858, "avg_em": 0.0, "avg_chrf": 71.91480783306258, "avg_bleu": 24.24494426572408}
{"id": "Wikipedia_handpicked_5:1917", "en": "As of March 12, more than 370 million children and youth are not attending school because of temporary or indefinite country wide school closures mandated by governments in an attempt to slow the spread of COVID-19.", "fr": "Depuis le 12 mars, plus de 370 millions d’enfants et de jeunes ne se rendent pas à l’école en raison de la fermeture temporaire ou pour une durée indéterminée des écoles à l’échelle nationale imposée par les gouvernements dans l’espoir de ralentir la propagation du COVID-19.", "perturbation": "alteration", "pert_fr": "Depuis le 12 mars, plus de 370 millions d’enfants et de jeunes se rendent à l’école en raison de la réouverture temporaire ou pour une durée indéterminée des écoles à l’échelle nationale imposée par les gouvernements dans l’espoir de ralentir la propagation du COVID-19.", "bt_pert_fr": "Since March 12, more than 370 million children and young people have been heading to school due to the temporary or indefinite reopening of schools nationwide imposed by governments in the hope of slowing the spread of COVID-19.", "questions": "[\"What is the number of children and youth not attending school as of March 12?\", \"Why are children and youth not attending school?\", \"What type of school closures are causing the absence of children and youth?\", \"What is the purpose of the school closures?\", \"What is the impact of the school closures on children and youth?\"]", "answers": "[\"Unknown\", \"To slow the spread of COVID-19\", \"Temporary or indefinite reopening of schools\", \"To slow the spread of COVID-19\", \"More than 370 million children and young people have been heading to school\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.546099290780142, "bleu": 0.0}, {"f1": 0.3478260869565218, "em": false, "chrf": 20.20486121323782, "bleu": 4.966973534674375}, {"f1": 0.5, "em": false, "chrf": 55.38496759466863, "bleu": 30.213753973567677}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.1111111111111111, "em": false, "chrf": 26.457225545728058, "bleu": 3.0890553181566975}], "avg_f1": 0.3917874396135266, "avg_em": 0.2, "avg_chrf": 41.118630728882934, "avg_bleu": 27.65395656527976}
{"id": "Wikipedia_handpicked_5:1920", "en": "Working parents are more likely to miss work when schools close in order to take care of their children, incurring wage loss in many instances and negatively impacting productivity.", "fr": "Les parents qui travaillent sont plus susceptibles de s’absenter de leur emploi pour s’occuper de leurs enfants lorsque les écoles ferment, ce qui entraîne souvent une perte de salaire et une baisse de la productivité.", "perturbation": "alteration", "pert_fr": "Les parents qui travaillent sont moins susceptibles de s’absenter de leur emploi pour s’occuper de leurs enfants lorsque les écoles ferment, ce qui entraîne souvent une perte de salaire et une baisse de la productivité.", "bt_pert_fr": "Working parents are less likely to take time off from their jobs to care for their children when schools close, often leading to lost wages and lower productivity.", "questions": "[\"Why are working parents more likely to miss work when schools close?\", \"What do working parents do when schools close?\", \"What impact does missing work have on working parents?\", \"What is the effect on productivity when schools close?\", \"What is the consequence of missing work for working parents?\"]", "answers": "[\"They are less likely to take time off from their jobs to care for their children\", \"Take time off from their jobs to care for their children\", \"They face lost wages and lower productivity\", \"Lower productivity\", \"Lost wages and lower productivity\"]", "scores": [{"f1": 0.36363636363636365, "em": false, "chrf": 50.4606811344061, "bleu": 5.816635421147515}, {"f1": 0.5000000000000001, "em": false, "chrf": 57.245621192259854, "bleu": 8.913765521398126}, {"f1": 0.23529411764705882, "em": false, "chrf": 29.05615555778029, "bleu": 5.087641220727392}, {"f1": 0.4, "em": false, "chrf": 37.288125543297255, "bleu": 30.326532985631665}, {"f1": 0.26666666666666666, "em": false, "chrf": 26.411932070610924, "bleu": 4.673289785800724}], "avg_f1": 0.35311942959001785, "avg_em": 0.0, "avg_chrf": 40.092503099670886, "avg_bleu": 10.963572986941085}
{"id": "Wikipedia_handpicked_5:1921", "en": "Localised school closures place burdens on schools as parents and officials redirect children to schools that are open.", "fr": "Les fermetures localisées pénalisent les écoles, car les parents et les responsables réorientent les enfants vers les écoles ouvertes.", "perturbation": "alteration", "pert_fr": "Les fermetures localisées favorisent les écoles, car les parents et les responsables réorientent les enfants vers les écoles ouvertes.", "bt_pert_fr": "Localized closures favor schools, as parents and officials redirect children to open schools.", "questions": "[\"What burdens do localised school closures place on schools?\", \"Who redirects children to schools that are open?\"]", "answers": "[\"None\", \"Parents and officials\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.687499999999999, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 52.34375, "avg_bleu": 50.00000000000002}
{"id": "Wikipedia_handpicked_5:1927", "en": "In the United States, numerous major cities announced public library closures, including Los Angeles, San Francisco, Seattle, and New York City, affecting 221 libraries.", "fr": "Aux États-Unis, de nombreuses grandes villes ont annoncé la fermeture des bibliothèques publiques, notamment Los Angeles, San Francisco, Seattle et New York, touchant 221 bibliothèques.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, de nombreuses grandes villes ont annoncé l'ouverture des bibliothèques publiques, notamment Los Angeles, San Francisco, Seattle et New York, touchant 221 bibliothèques.", "bt_pert_fr": "In the United States, many major cities have announced the opening of public libraries, including Los Angeles, San Francisco, Seattle and New York, affecting 221 libraries.", "questions": "[\"Which major cities in the United States announced public library closures?\", \"Which cities are specifically mentioned as having announced public library closures?\", \"How many libraries were affected by the closures?\", \"What was the impact of the public library closures?\", \"What is the context of the public library closures?\"]", "answers": "[\"None\", \"None\", \"221\", \"The opening of public libraries\", \"In the United States, many major cities have announced the opening of public libraries, including Los Angeles, San Francisco, Seattle and New York, affecting 221 libraries.\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.687499999999999, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.840909090909091, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.25, "em": false, "chrf": 39.39017845630742, "bleu": 10.682175159905853}, {"f1": 0.8085106382978724, "em": false, "chrf": 77.54048944602856, "bleu": 47.8219647449668}], "avg_f1": 0.4117021276595745, "avg_em": 0.2, "avg_chrf": 44.891815398649015, "avg_bleu": 31.700827980974537}
{"id": "Wikipedia_handpicked_5:1930", "en": "In the absence of alternative options, working parents often leave children alone when schools close and this can lead to risky behaviours, including increased influence of peer pressure and substance abuse.", "fr": "En l’absence de solutions alternatives, les parents qui travaillent laissent souvent leurs enfants seuls lorsque les écoles ferment et cela peut entraîner des comportements à risque, notamment une mauvaise influence accrue de certains camarades et de la toxicomanie.", "perturbation": "alteration", "pert_fr": "En la présence de solutions alternatives, les parents qui travaillent laissent rarement leurs enfants seuls lorsque les écoles ferment et cela peut entraîner des comportements sans risque, notamment une bonne influence accrue de certains camarades et de la toxicomanie.", "bt_pert_fr": "In the presence of alternatives, working parents rarely leave their children alone when schools close and this can lead to unsafe behaviors, including increased peer influence and substance abuse.", "questions": "[\"What happens when schools close for working parents?\", \"Why do working parents leave children alone when schools close?\", \"What risky behaviours can occur when schools close?\", \"What specific risky behaviours are mentioned?\", \"What is the connection between school closures and substance abuse?\"]", "answers": "[\"Working parents rarely leave their children alone\", \"They do not leave their children alone\", \"Unsafe behaviors\", \"Increased peer influence and substance abuse\", \"Substance abuse can increase due to children being left alone when schools close\"]", "scores": [{"f1": 0.8333333333333333, "em": false, "chrf": 76.64086540167612, "bleu": 19.64073254502565}, {"f1": 0, "em": false, "chrf": 19.19093807764886, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 39.28904428904429, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 66.96773192871403, "bleu": 25.745264623946035}, {"f1": 0.23076923076923078, "em": false, "chrf": 39.52282147337179, "bleu": 4.065425428798724}], "avg_f1": 0.3842490842490842, "avg_em": 0.0, "avg_chrf": 48.322280234091025, "avg_bleu": 9.890284519554083}
{"id": "Wikipedia_handpicked_5:1934", "en": "Every year, nearly 30 million children rely on schools to provide free or low-cost meals including breakfast, lunch, snacks, and even dinner.In Alabama, where state-wide school closures as of 18 March have affected over 720,000 students, the state Superintendent announced that staff in schools disproportionately affected by poverty would create meal distribution networks to provide food for students who rely on school lunches.", "fr": "Chaque année, près de 30 millions d’enfants dépendent des écoles pour recevoir des repas gratuits ou à bas prix, notamment le petit-déjeuner, le déjeuner, des en-cas et même le dîner. En Alabama, où la fermeture des écoles à l’échelle de l’État depuis le 18 mars a affecté plus de 720 000 élèves, le surintendant de l’État a annoncé que le personnel des écoles touchées de façon disproportionnée par la pauvreté allait créer des réseaux de distribution de repas pour fournir de la nourriture aux élèves qui dépendent des repas scolaires.", "perturbation": "alteration", "pert_fr": "Chaque année, près de 30 millions d’enfants ne dépendent pas des écoles pour recevoir des repas gratuits ou à bas prix, notamment le petit-déjeuner, le déjeuner, des en-cas et même le dîner. En Alabama, où la fermeture des écoles à l’échelle de l’État depuis le 18 mars a affecté plus de 720 000 élèves, le surintendant de l’État a annoncé que le personnel des écoles touchées de façon disproportionnée par la richesse allait créer des réseaux de distribution de repas pour fournir de la nourriture aux élèves qui dépendent des repas scolaires.", "bt_pert_fr": "Each year, nearly 30 million children do not rely on schools to receive free or low-cost meals, including breakfast, lunch, snacks and even dinner. In Alabama, where the statewide school closure since March 18 has affected more than 720,000 students, the state superintendent announced that staff at schools disproportionately affected by wealth would create meal distribution networks to provide food to students who rely on school meals.", "questions": "[\"How many children rely on schools to provide free or low-cost meals every year?\", \"What types of meals do schools provide for children?\", \"How many students in Alabama were affected by school closures as of 18 March?\", \"What action did the state Superintendent announce in Alabama?\", \"What is the purpose of the meal distribution networks created by school staff in Alabama?\"]", "answers": "[\"30 million\", \"breakfast, lunch, snacks and even dinner\", \"720,000\", \"Staff at schools disproportionately affected by wealth would create meal distribution networks to provide food to students who rely on school meals\", \"To provide food to students who rely on school meals\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8181818181818182, "em": false, "chrf": 80.69065354186662, "bleu": 59.61621647299124}, {"f1": 0.8000000000000002, "em": false, "chrf": 73.52660054714391, "bleu": 52.53819788848316}], "avg_f1": 0.9236363636363636, "avg_em": 0.6, "avg_chrf": 90.84345081780211, "avg_bleu": 82.43088287229492}
{"id": "Wikipedia_handpicked_5:1936", "en": "Schooling provides essential learning and when schools close, children and youth are deprived opportunities for growth and development.", "fr": "La scolarisation permet l’acquisition de compétences élémentaires essentielles, et lorsque les écoles ferment, les enfants, adolescents et jeunes adultes sont privés d’opportunités de développement et d’épanouissement.", "perturbation": "alteration", "pert_fr": "La déscolarisation permet l’acquisition de compétences élémentaires essentielles, et lorsque les écoles ferment, les enfants, adolescents et jeunes adultes sont privés d’opportunités de développement et d’épanouissement.", "bt_pert_fr": "Dropping out of school allows the acquisition of essential basic skills, and when schools close, children, adolescents and young adults are deprived of opportunities for development and fulfillment.", "questions": "[\"What does schooling provide?\", \"What happens when schools close?\", \"What opportunities are children and youth deprived of when schools close?\", \"What is the impact of school closure on children and youth?\"]", "answers": "[\"Essential basic skills\", \"Children, adolescents and young adults are deprived of opportunities for development and fulfillment\", \"opportunities for development and fulfillment\", \"Children, adolescents and young adults are deprived of opportunities for development and fulfillment\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 46.14952207269675, "bleu": 27.516060407455225}, {"f1": 0.6956521739130435, "em": false, "chrf": 65.23612066505575, "bleu": 10.390302174233558}, {"f1": 0.6, "em": false, "chrf": 64.18203016063893, "bleu": 14.058533129758727}, {"f1": 0.6956521739130435, "em": false, "chrf": 65.23612066505575, "bleu": 10.390302174233558}], "avg_f1": 0.5978260869565217, "avg_em": 0.0, "avg_chrf": 60.2009483908618, "avg_bleu": 15.588799471420266}
{"id": "Wikipedia_handpicked_5:1937", "en": "The disadvantages are disproportionate for under-privileged learners who tend to have fewer educational opportunities beyond school.Student drop-out rates tend to increase as an effect of school closures due to the challenge of ensuring all students return to school once school closures ends.", "fr": "Les inconvénients sont démesurés pour les élèves défavorisés dont les possibilités d’éducation sont généralement moindres en dehors de l’école. Le taux de décrochage scolaire a tendance à augmenter sous l’effet de la fermeture des écoles, en raison du défi d’assurer que tous les élèves reprennent leur scolarité lorsque la fermeture des écoles prendra fin.", "perturbation": "alteration", "pert_fr": "Les avantages sont démesurés pour les élèves défavorisés dont les possibilités d’éducation sont généralement moindres en dehors de l’école. Le taux de décrochage scolaire a tendance à diminuer sous l’effet de la fermeture des écoles, en raison du défi d’assurer que tous les élèves reprennent leur scolarité lorsque la fermeture des écoles prendra fin.", "bt_pert_fr": "The benefits are outsized for disadvantaged students who generally have fewer educational opportunities outside of school. The school dropout rate tends to decrease as a result of school closures, due to the challenge of ensuring that all students return to school when school closures end.", "questions": "[\"What are the disadvantages for under-privileged learners?\", \"How do school closures affect student drop-out rates?\", \"What challenge makes it difficult to ensure all students return to school after closures?\", \"What is the effect of school closures on student drop-out rates?\"]", "answers": "[\"Fewer educational opportunities outside of school\", \"The school dropout rate tends to decrease\", \"Ensuring that all students return to school when school closures end\", \"The school dropout rate tends to decrease\"]", "scores": [{"f1": 0, "em": false, "chrf": 24.114283757919516, "bleu": 0.0}, {"f1": 0.30769230769230765, "em": false, "chrf": 48.04176060869121, "bleu": 7.809849842300641}, {"f1": 0.8571428571428572, "em": false, "chrf": 81.63662637962875, "bleu": 48.326978309062206}, {"f1": 0.30769230769230765, "em": false, "chrf": 48.04176060869121, "bleu": 7.809849842300641}], "avg_f1": 0.36813186813186816, "avg_em": 0.0, "avg_chrf": 50.458607838732675, "avg_bleu": 15.986669498415871}
{"id": "Wikipedia_handpicked_5:1941", "en": "Potential impacts of school closures and reliance on distance learning are not addressed in federal acts of legislation at this time.", "fr": "Les retombées possibles de la fermeture des écoles et du recours à l’apprentissage à distance ne sont pas traitées dans les lois fédérales à l’heure actuelle.", "perturbation": "alteration", "pert_fr": "Les retombées possibles de la fermeture des écoles et du recours à l’apprentissage en présentiel ne sont pas traitées dans les lois fédérales à l’heure actuelle.", "bt_pert_fr": "The possible fallout from closing schools and relying on in-person learning is not currently addressed in federal law.", "questions": "[\"What potential impacts are not addressed in federal acts of legislation?\", \"What is the current status of federal legislation regarding school closures and distance learning?\", \"What aspects of school closures and distance learning are missing from federal legislation?\"]", "answers": "[\"The possible fallout from closing schools and relying on in-person learning\", \"Not currently addressed\", \"The possible fallout from closing schools and relying on in-person learning\"]", "scores": [{"f1": 0.28571428571428564, "em": false, "chrf": 32.68049411223464, "bleu": 4.932351569489709}, {"f1": 0.5, "em": false, "chrf": 39.41937224903593, "bleu": 17.799177396293473}, {"f1": 0.28571428571428564, "em": false, "chrf": 32.68049411223464, "bleu": 4.932351569489709}], "avg_f1": 0.35714285714285704, "avg_em": 0.0, "avg_chrf": 34.92678682450174, "avg_bleu": 9.221293511757631}
{"id": "Wikipedia_handpicked_5:1942", "en": "Formal education — as opposed to informal education or non-formal education — tends to refer to schools, colleges, universities and training institutions.", "fr": "L’éducation formelle (à la différence de l’éducation informelle ou non formelle) fait généralement référence aux écoles, établissements d’enseignement supérieur, universités et instituts de formation.", "perturbation": "alteration", "pert_fr": "L’éducation informelle (à la différence de l’éducation formelle ou non informelle) fait généralement référence aux écoles, établissements d’enseignement supérieur, universités et instituts de formation.", "bt_pert_fr": "Informal education (as distinct from formal or non-informal education) generally refers to schools, colleges, universities and training institutes.", "questions": "[\"What is formal education?\", \"What is the difference between formal education and informal education?\", \"What is the difference between formal education and non-formal education?\", \"What institutions are included in formal education?\"]", "answers": "[\"Not specified in the sentence\", \"The sentence does not provide information about formal education or the difference between formal and informal education\", \"The sentence does not provide information about the difference between formal and non-formal education\", \"The sentence does not mention formal education institutions\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.660854608170321, "bleu": 0.0}, {"f1": 0.38709677419354843, "em": false, "chrf": 41.01064398404335, "bleu": 7.655122720591221}, {"f1": 0.3571428571428571, "em": false, "chrf": 34.09111601020917, "bleu": 7.921066269168085}, {"f1": 0.14285714285714288, "em": false, "chrf": 30.360007677831153, "bleu": 5.522397783539471}], "avg_f1": 0.2217741935483871, "avg_em": 0.0, "avg_chrf": 28.030655570063498, "avg_bleu": 5.274646693324694}
{"id": "Wikipedia_handpicked_5:1943", "en": "A 1974 report by the World Bank defined formal education as the following:Formal education: the hierarchically structured, chronologically graded ‘education system’, running from primary school through the university and including, in addition to general academic studies, a variety of specialised programmes and institutions for full-time technical and professional training.The majority of data collected on the number of students and learners impacted by COVID-19 has been calculated based on the closure of formal education systems.", "fr": "Un rapport de la Banque mondiale de 1974 définissait l’éducation formelle comme suit : Éducation formelle : le « système éducatif » doté d’une structure hiérarchique et organisé de façon chronologique, allant de l’école primaire à l’université et comprenant, outre les études classiques, divers programmes et établissements spécialisés pour la formation professionnelle et technique à plein temps. La majorité des données recueillies quant au nombre d’élèves et d’apprenants affectés par le COVID-19 ont été calculées à partir de la fermeture des systèmes d’éducation formelle.", "perturbation": "alteration", "pert_fr": "Un rapport de la Banque mondiale de 1974 définissait l’éducation informelle comme suit : Éducation informelle : le « système éducatif » doté d’une structure hiérarchique et organisé de façon chronologique, allant de l’école primaire à l’université et comprenant, outre les études classiques, divers programmes et établissements spécialisés pour la formation professionnelle et technique à plein temps. La majorité des données recueillies quant au nombre d’élèves et d’apprenants affectés par le COVID-19 ont été calculées à partir de la fermeture des systèmes d’éducation informelle.", "bt_pert_fr": "A 1974 World Bank report defined informal education as follows: Informal education: the “education system” with a hierarchical structure and organized chronologically, running from primary school to university and including, in addition to formal studies, various specialized programs and institutions for full-time vocational and technical training. The majority of data collected on the number of students and learners affected by COVID-19 has been calculated based on the closure of informal education systems.", "questions": "[\"What does the World Bank define as formal education?\", \"What components are included in formal education according to the World Bank?\", \"What is the structure of formal education?\", \"What types of training are included in formal education?\", \"How has the data on students and learners impacted by COVID-19 been calculated?\", \"What factor has been used to calculate the data on students and learners impacted by COVID-19?\"]", "answers": "[\"The education system with a hierarchical structure and organized chronologically, running from primary school to university\", \"various specialized programs and institutions for full-time vocational and technical training\", \"a hierarchical structure and organized chronologically, running from primary school to university\", \"vocational and technical training\", \"based on the closure of informal education systems\", \"the closure of informal education systems\"]", "scores": [{"f1": 0.3404255319148936, "em": false, "chrf": 36.988650969379826, "bleu": 6.299033575335413}, {"f1": 0.5384615384615385, "em": false, "chrf": 56.374912347228666, "bleu": 18.758830578240925}, {"f1": 0.5217391304347826, "em": false, "chrf": 64.11007631102011, "bleu": 23.708987804092644}, {"f1": 0.4285714285714285, "em": false, "chrf": 28.500273692062834, "bleu": 4.690733795095046}, {"f1": 0.7999999999999999, "em": false, "chrf": 74.98210731215515, "bleu": 42.38365628278778}, {"f1": 0.8000000000000002, "em": false, "chrf": 89.57903275009394, "bleu": 30.213753973567677}], "avg_f1": 0.5715329382304405, "avg_em": 0.0, "avg_chrf": 58.42250889699009, "avg_bleu": 21.009166001519915}
{"id": "Wikipedia_handpicked_5:1944", "en": "The UNESCO Institute for Statistics provides figures on students impacted by COVID-19 corresponding to the number of learners enrolled at pre-primary, primary, lower-secondary, and upper-secondary levels of education [ISCED levels 0 to 3], as well as at tertiary education levels [ISCED levels 5 to 8].", "fr": "L’Institut de statistique de l’UNESCO fournit des chiffres sur les élèves affectés par le COVID-19 correspondant au nombre d’apprenants inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement supérieur [niveaux 5 à 8 de la CITE].", "perturbation": "alteration", "pert_fr": "L’Institut de statistique de l’UNESCO fournit des chiffres sur les élèves non affectés par le COVID-19 correspondant au nombre d’apprenants inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement supérieur [niveaux 5 à 8 de la CITE].", "bt_pert_fr": "The UNESCO Institute for Statistics provides figures on students not affected by COVID-19 corresponding to the number of learners enrolled in pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0 to 3], as well as tertiary education cycles [ISCED levels 5 to 8].", "questions": "[\"What does the UNESCO Institute for Statistics provide?\", \"What types of education levels are included in the figures?\", \"Which ISCED levels correspond to pre-primary, primary, lower-secondary, and upper-secondary education?\", \"Which ISCED levels correspond to tertiary education?\", \"What data is provided regarding students impacted by COVID-19?\"]", "answers": "[\"Figures on students not affected by COVID-19 corresponding to the number of learners enrolled in pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0 to 3], as well as tertiary education cycles [ISCED levels 5 to 8]\", \"Pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0 to 3], as well as tertiary education cycles [ISCED levels 5 to 8]\", \"0 to 3\", \"5 to 8\", \"No data is provided regarding students impacted by COVID-19\"]", "scores": [{"f1": 0.7894736842105263, "em": false, "chrf": 84.66701382492235, "bleu": 54.165327660718475}, {"f1": 0.3225806451612903, "em": false, "chrf": 78.54109705806069, "bleu": 4.705244978975818}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 12.688023641311604, "bleu": 0.0}], "avg_f1": 0.6224108658743633, "avg_em": 0.4, "avg_chrf": 75.17922690485894, "avg_bleu": 51.77411452793888}
{"id": "Wikipedia_handpicked_5:1946", "en": "While many primary and secondary schools have closed around the world due to COVID-19, measures impacting early childhood educational programmes have varied.", "fr": "Alors que de nombreuses écoles primaires et secondaires dans le monde ont fermé en raison du COVID-19, les mesures concernant les programmes d’enseignement préscolaire ont été variables.", "perturbation": "alteration", "pert_fr": "Alors que de nombreuses écoles primaires et secondaires dans le monde ont ouvert en raison du COVID-19, les mesures concernant les programmes d’enseignement préscolaire ont été variables.", "bt_pert_fr": "While many primary and secondary schools around the world have opened due to COVID-19, measures regarding early childhood education programs have been variable.", "questions": "[\"What has happened to many primary and secondary schools due to COVID-19?\", \"What measures have impacted early childhood educational programmes?\", \"What is the effect of COVID-19 on schools?\", \"What types of educational programmes are affected by COVID-19?\"]", "answers": "[\"They have opened\", \"Measures regarding early childhood education programs\", \"Many primary and secondary schools have opened\", \"Early childhood education programs\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 51.482961482961485, "bleu": 55.03212081491043}, {"f1": 0.42857142857142855, "em": false, "chrf": 60.55863938385196, "bleu": 12.872632311973014}, {"f1": 0.8571428571428571, "em": false, "chrf": 85.6440455782561, "bleu": 80.91067115702207}, {"f1": 0.5, "em": false, "chrf": 78.99894681527545, "bleu": 31.947155212313625}], "avg_f1": 0.613095238095238, "avg_em": 0.0, "avg_chrf": 69.17114831508624, "avg_bleu": 45.19064487405478}
{"id": "Wikipedia_handpicked_5:1947", "en": "In some countries and territories, preschools and day cares are considered necessary services and have not closed in tandem with broader school closure measures.In the United States, the Washington State Department of Children, Youth, and Families encouraged child care and early learning centres to stay open.", "fr": "Dans certains pays et territoires, les écoles maternelles et les garderies sont considérées comme des services essentiels et n’ont pas fermé alors qu’étaient décrétées des mesures plus générales de fermeture des écoles. Aux États-Unis, le département de l’Enfance, de la Jeunesse et de la Famille de l’État de Washington a encouragé les garderies et les centres d’éducation préscolaire à rester ouverts.", "perturbation": "alteration", "pert_fr": "Dans certains pays et territoires, les écoles maternelles et les garderies sont considérées comme des services non essentiels et ont fermé alors qu’étaient décrétées des mesures plus générales de fermeture des écoles. Aux États-Unis, le département de l’Enfance, de la Jeunesse et de la Famille de l’État de Washington a encouragé les garderies et les centres d’éducation préscolaire à fermer.", "bt_pert_fr": "In some countries and territories, preschools and daycares are considered non-essential services and have closed amid broader school closure measures. In the United States, the Washington State Department of Children, Youth and Families has encouraged daycares and early learning centers to close.", "questions": "[\"Why have preschools and day cares not closed in tandem with broader school closure measures?\", \"What did the Washington State Department of Children, Youth, and Families encourage regarding child care and early learning centres?\", \"What is the reason for the continued operation of child care and early learning centres in the United States?\", \"What is the relationship between school closure measures and preschool or day care operations?\"]", "answers": "[\"Because they are considered non-essential services in some countries and territories\", \"To close daycares and early learning centers\", \"The Washington State Department of Children, Youth and Families encouraged their closure\", \"School closure measures have led to the closure of preschools and daycares in some countries and territories, while in the United States, daycares and early learning centers have been encouraged to close\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 85.76893853654722, "bleu": 70.16879391277372}, {"f1": 0.2, "em": false, "chrf": 14.186387643133, "bleu": 6.567274736060395}, {"f1": 0, "em": false, "chrf": 15.444863235112347, "bleu": 0.0}, {"f1": 0.4081632653061224, "em": false, "chrf": 67.11991304438243, "bleu": 14.614031921776125}], "avg_f1": 0.37931354359925784, "avg_em": 0.0, "avg_chrf": 45.63002561479375, "avg_bleu": 22.83752514265256}
{"id": "Wikipedia_handpicked_5:1949", "en": "The governor of Maryland mandated that specific child care services remain open for the children of emergency personnel while Washington State and California have left it to the discretion of care providers.", "fr": "Le gouverneur du Maryland a ordonné que des services de garde d’enfants spécifiques restent ouverts pour les enfants du personnel des services d’urgence, tandis que l’État de Washington et la Californie ont laissé cette décision à la discrétion des prestataires de soins.", "perturbation": "alteration", "pert_fr": "Le gouverneur du Maryland a ordonné que des services de garde d’enfants spécifiques ferment pour les enfants du personnel des services d’urgence, tandis que l’État de Washington et la Californie ont laissé cette décision à la discrétion des prestataires de soins.", "bt_pert_fr": "Maryland's governor ordered specific child care services to close for children of emergency services personnel, while Washington state and California left that decision to the discretion of care providers.", "questions": "[\"What did the governor of Maryland mandate regarding child care services?\", \"Which states have left child care service decisions to care providers?\", \"What services are required to remain open in Maryland?\", \"Who are the children eligible for continued child care services?\", \"What is the reason for the difference in child care policies between Maryland and other states?\"]", "answers": "[\"Specific child care services to close for children of emergency services personnel\", \"Washington state and California\", \"None specified\", \"Children of emergency services personnel\", \"Maryland's governor ordered closures for children of emergency services personnel, while Washington state and California left the decision to care providers\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 72.1632055419516, "bleu": 31.702331385234313}, {"f1": 0.75, "em": false, "chrf": 85.760402104605, "bleu": 35.35533905932737}, {"f1": 0, "em": false, "chrf": 20.541625711550296, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 84.41445066595882, "bleu": 42.7287006396234}, {"f1": 0.5405405405405405, "em": false, "chrf": 64.0568384529353, "bleu": 33.12498979466407}], "avg_f1": 0.5692192192192193, "avg_em": 0.0, "avg_chrf": 65.3873044954002, "avg_bleu": 28.582272175769827}
{"id": "Wikipedia_handpicked_5:1950", "en": "California Governor Gavin Newsom explained his state's position, saying “We need our child care facilities, our daycare centers, to operate to absorb the impact of these school closures.”", "fr": "Le gouverneur de Californie Gavin Newsom a expliqué la position de son État, en déclarant que « Nous avons besoin que nos établissements de garde d’enfants, nos garderies, fonctionnent pour amortir l’impact de ces fermetures d’écoles. »", "perturbation": "alteration", "pert_fr": "Le gouverneur de Californie Gavin Newsom a expliqué la position de son État, en déclarant que « Nous n'avons pas besoin que nos établissements de garde d’enfants, nos garderies, fonctionnent pour amortir l’impact de ces fermetures d’écoles. »", "bt_pert_fr": "California Governor Gavin Newsom explained his state's position, saying that \"We don't need our child care facilities, our day care centers, operating to cushion the impact of these school closures. »", "questions": "[\"What did California Governor Gavin Newsom say about child care facilities?\", \"Why are child care facilities important according to Governor Newsom?\", \"What specific facilities does Governor Newsom mention?\", \"What is the state's position on school closures as explained by Governor Newsom?\"]", "answers": "[\"California Governor Gavin Newsom said that they don't need child care facilities or day care centers to cushion the impact of school closures\", \"Child care facilities are not needed to cushion the impact of school closures\", \"Child care facilities, day care centers\", \"The state does not need child care facilities or day care centers to cushion the impact of school closures\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 69.97707398921789, "bleu": 26.761403581482163}, {"f1": 0.4210526315789474, "em": false, "chrf": 49.093192076836786, "bleu": 9.578464408619825}, {"f1": 0.7272727272727272, "em": false, "chrf": 100.0, "bleu": 32.46679154750989}, {"f1": 0.5945945945945946, "em": false, "chrf": 65.88514853166544, "bleu": 22.402286997217164}], "avg_f1": 0.6023966550282339, "avg_em": 0.0, "avg_chrf": 71.23885364943003, "avg_bleu": 22.80223663370726}
{"id": "Wikipedia_handpicked_5:1951", "en": "Colorado has encouraged the development of \"tool kits\" for parents to use at home to emulate the lessons children would have received in their early learning programmes.In Japan, Prime Minister Shinzo Abe closed all schools throughout the country until April 8, however, children's daycare facilities were excluded.", "fr": "Le Colorado a encouragé le développement « d’outils pédagogiques » que les parents peuvent utiliser à la maison afin de reproduire les leçons que les enfants auraient reçues dans le cadre de leurs programmes d’enseignement préscolaire. Au Japon, le Premier ministre Shinzo Abe a fermé toutes les écoles du pays jusqu’au 8 avril, les garderies n’étaient toutefois pas visées par cette mesure.", "perturbation": "alteration", "pert_fr": "Le Colorado a découragé le développement « d’outils pédagogiques » que les parents peuvent utiliser à la maison afin de reproduire les leçons que les enfants auraient reçues dans le cadre de leurs programmes d’enseignement préscolaire. Au Japon, le Premier ministre Shinzo Abe a ouvert toutes les écoles du pays jusqu’au 8 avril, les garderies n’étaient toutefois pas visées par cette mesure.", "bt_pert_fr": "Colorado has discouraged the development of “teaching tools” that parents can use at home to replicate the lessons children would have received in their preschool programs. In Japan, Prime Minister Shinzo Abe opened all schools in the country until April 8, although daycare centers were not affected by this measure.", "questions": "[\"What has Colorado encouraged for parents to use at home?\", \"What are the 'tool kits' designed to emulate?\", \"What action did Prime Minister Shinzo Abe take regarding schools in Japan?\", \"Until when were schools closed in Japan?\", \"Why were children's daycare facilities excluded from the school closure in Japan?\"]", "answers": "[\"The development of 'teaching tools'\", \"The lessons children would have received in their preschool programs\", \"Opened all schools in the country\", \"April 8\", \"Because daycare centers were not affected by this measure\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 66.11914362832749, "bleu": 21.3643503198117}, {"f1": 0.7, "em": false, "chrf": 71.40884747482059, "bleu": 63.894310424627285}, {"f1": 0.6, "em": false, "chrf": 47.91281604079881, "bleu": 23.643540225079395}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.14285714285714285, "em": false, "chrf": 35.28735000342015, "bleu": 4.767707020457095}], "avg_f1": 0.5774603174603175, "avg_em": 0.2, "avg_chrf": 64.14563142947341, "avg_bleu": 42.733981597995104}
{"id": "Wikipedia_handpicked_5:1958", "en": "Tertiary education is normally taken to include undergraduate and postgraduate education, as well as vocational education and training.", "fr": "On considère généralement que l’éducation tertiaire comprend les études du premier au troisième cycle universitaire, ainsi que l’enseignement et la formation professionnels.", "perturbation": "alteration", "pert_fr": "On considère généralement que l’éducation tertiaire comprend les études du quatrième au sixième cycle universitaire, ainsi que l’enseignement et la formation professionnels.", "bt_pert_fr": "Tertiary education is generally considered to include studies from the fourth to sixth cycle of university, as well as vocational education and training.", "questions": "[\"What does tertiary education normally include?\", \"What types of education are included in tertiary education?\", \"What is considered part of tertiary education?\"]", "answers": "[\"Studies from the fourth to sixth cycle of university, as well as vocational education and training\", \"Studies from the fourth to sixth cycle of university and vocational education and training\", \"Studies from the fourth to sixth cycle of university, as well as vocational education and training\"]", "scores": [{"f1": 0.5384615384615385, "em": false, "chrf": 53.24626898697259, "bleu": 40.016016019225006}, {"f1": 0.4761904761904762, "em": false, "chrf": 48.53518486431109, "bleu": 20.448007360218387}, {"f1": 0.5384615384615385, "em": false, "chrf": 53.24626898697259, "bleu": 40.016016019225006}], "avg_f1": 0.5177045177045178, "avg_em": 0.0, "avg_chrf": 51.67590761275209, "avg_bleu": 33.493346466222796}
{"id": "Wikipedia_handpicked_5:1959", "en": "Individuals who complete tertiary education generally receive certificates, diplomas, or academic degrees.", "fr": "Les personnes qui terminent l’éducation tertiaire reçoivent généralement des certificats, diplômes ou titres universitaires.", "perturbation": "alteration", "pert_fr": "Les personnes qui terminent l’éducation tertiaire reçoivent généralement des refus, diplômes ou titres universitaires.", "bt_pert_fr": "People who complete tertiary education usually receive academic refusals, diplomas or titles.", "questions": "[\"What do individuals who complete tertiary education generally receive?\", \"What types of credentials are awarded after completing tertiary education?\"]", "answers": "[\"Academic refusals, diplomas or titles\", \"Academic refusals, diplomas or titles\"]", "scores": [{"f1": 0.4000000000000001, "em": false, "chrf": 44.94719525573882, "bleu": 21.3643503198117}, {"f1": 0.4000000000000001, "em": false, "chrf": 44.94719525573882, "bleu": 21.3643503198117}], "avg_f1": 0.4000000000000001, "avg_em": 0.0, "avg_chrf": 44.94719525573882, "avg_bleu": 21.3643503198117}
{"id": "Wikipedia_handpicked_5:1960", "en": "Undergraduate education is education conducted after secondary education and prior to post-graduate education, for which the learner is typically awarded a bachelor's degree.", "fr": "Les études de premier cycle universitaire correspondent à l’éducation reçue après l’enseignement secondaire et avant les études universitaires supérieures, pour lesquelles l’étudiant reçoit généralement une licence.", "perturbation": "alteration", "pert_fr": "Les études de premier cycle universitaire correspondent à l’éducation reçue avant l’enseignement secondaire et après les études universitaires supérieures, pour lesquelles l’étudiant reçoit généralement une licence.", "bt_pert_fr": "Undergraduate studies correspond to education received before secondary education and after higher university studies, for which the student generally receives a bachelor's degree.", "questions": "[\"What is undergraduate education?\", \"What is the sequence of education that includes undergraduate education?\"]", "answers": "[\"Education received before secondary education and after higher university studies\", \"Education received before secondary education and after higher university studies\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 46.19437105896822, "bleu": 17.747405280050266}, {"f1": 0.125, "em": false, "chrf": 41.01720938842193, "bleu": 4.196114906296549}], "avg_f1": 0.3125, "avg_em": 0.0, "avg_chrf": 43.60579022369508, "avg_bleu": 10.971760093173408}
{"id": "Wikipedia_handpicked_5:1961", "en": "Students enrolled in higher education programmes at colleges, universities, and community colleges are often refereed to in countries such as United States as \"college students.\"The closure of colleges and universities has widespread implications for students, faculty, administrators, and the institutions themselves.", "fr": "Les étudiants inscris aux programmes d’enseignement supérieur des établissements d’études supérieures, des universités et des community colleges sont souvent appelés, dans les pays tels que les États-Unis, des « étudiants universitaires ». La fermeture des établissements d’études supérieures et universités a de fortes répercussions pour les étudiants, les enseignants, les administrateurs et les établissements eux-mêmes.", "perturbation": "alteration", "pert_fr": "Les étudiants inscris aux programmes d’enseignement supérieur des établissements d’études supérieures, des universités et des community colleges sont rarement appelés, dans les pays tels que les États-Unis, des « étudiants universitaires ». L'ouverture des établissements d’études supérieures et universités a de fortes répercussions pour les étudiants, les enseignants, les administrateurs et les établissements eux-mêmes.", "bt_pert_fr": "Students enrolled in higher education programs at colleges, universities, and community colleges are rarely referred to in countries such as the United States as “college students.” The opening of higher education establishments and universities has strong repercussions for students, teachers, administrators and the establishments themselves.", "questions": "[\"What are students enrolled in higher education programmes often referred to as in the United States?\", \"What are the widespread implications of the closure of colleges and universities?\", \"Who are affected by the closure of colleges and universities?\", \"What types of institutions are mentioned in the sentence?\", \"What is the term used for students in the United States?\"]", "answers": "[\"college students\", \"The widespread implications of the closure of colleges and universities are not mentioned in the sentence\", \"students, teachers, administrators, and the establishments themselves\", \"colleges, universities, and community colleges\", \"college students\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2608695652173913, "em": false, "chrf": 40.23677898520923, "bleu": 6.285596338261262}, {"f1": 0.6666666666666666, "em": false, "chrf": 57.807603602350255, "bleu": 19.304869754804482}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7855072463768116, "avg_em": 0.6, "avg_chrf": 79.6088765175119, "avg_bleu": 65.11809321861317}
{"id": "Wikipedia_handpicked_5:1962", "en": "Colleges and universities across the United States have been called upon to issue refunds to students for the cost of tuition and room and board.", "fr": "Les établissements d’études supérieures et universités aux États-Unis ont été appelés à rembourser aux étudiants les frais de scolarité, de logement et de pension.", "perturbation": "alteration", "pert_fr": "Les établissements d’études supérieures et universités aux États-Unis n’ont pas été appelés à rembourser aux étudiants les frais de scolarité, de logement et de pension.", "bt_pert_fr": "Colleges and universities in the United States have not been asked to reimburse students for tuition, room and board.", "questions": "[\"What have colleges and universities across the United States been called upon to do?\", \"What costs are students being refunded for?\", \"What specific expenses are included in the refunds?\", \"What is the reason for issuing refunds to students?\"]", "answers": "[\"None\", \"None\", \"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.076086956521739, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.9473420059423434, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.156275976724854, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.318475015492085, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 3.874544988670255, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1963", "en": "In the United States of America, Colleges and universities operate as \"mini-cities\" which generate significant revenue for cities, states, and regions.", "fr": "Aux États-Unis d’Amérique, les établissements d’études supérieures et universités fonctionnent comme de « mini-villes » qui génèrent des revenus importants pour les villes, les États et les régions.", "perturbation": "alteration", "pert_fr": "Aux États-Unis d’Amérique, les établissements d’études supérieures et universités fonctionnent comme de « mini-villes » qui génèrent des pertes importantes pour les villes, les États et les régions.", "bt_pert_fr": "In the United States of America, colleges and universities operate as “mini-cities” that generate significant losses for cities, states and regions.", "questions": "[\"What do colleges and universities operate as in the United States of America?\", \"What generates significant revenue for cities, states, and regions?\", \"What is the relationship between colleges and universities and local economies?\", \"What is the term used to describe colleges and universities in the United States of America?\", \"Which entities benefit from the revenue generated by colleges and universities?\"]", "answers": "[\"mini-cities\", \"none\", \"colleges and universities generate significant losses for cities, states and regions\", \"mini-cities\", \"cities, states and regions\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 0.1904761904761905, "em": false, "chrf": 45.20349815179403, "bleu": 7.495553473355842}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6380952380952382, "avg_em": 0.6, "avg_chrf": 70.08236629702547, "avg_bleu": 61.499110694671195}
{"id": "Wikipedia_handpicked_5:1964", "en": "For example, Princeton University contributed $1.58 billion USD to the New Jersey economy and students spent about $60 million in off-campus spending.", "fr": "Par exemple, l’Université de Princeton a rapporté 1,58 milliard $ USD à l’économie du New Jersey et les étudiants ont dépensé environ 60 millions $ en dehors du campus.", "perturbation": "alteration", "pert_fr": "Par exemple, l’Université de Princeton a rapporté 1,58 milliard $ USD à l’économie du New Jersey et les étudiants ont économisé environ 60 millions $ en dehors du campus.", "bt_pert_fr": "For example, Princeton University contributed $1.58 billion USD to the New Jersey economy and students saved approximately $60 million off campus.", "questions": "[\"How much did Princeton University contribute to the New Jersey economy?\", \"What is the amount spent by students in off-campus spending?\", \"What is the relationship between Princeton University and the New Jersey economy?\", \"What does the sentence mention about student spending?\", \"What is the total contribution of Princeton University to the economy?\"]", "answers": "[\"$1.58 billion USD\", \"$60 million\", \"Princeton University contributed to the New Jersey economy\", \"Students saved approximately $60 million off campus\", \"$1.58 billion USD\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.39999999999999997, "em": false, "chrf": 50.09037324794362, "bleu": 12.600736402830258}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8800000000000001, "avg_em": 0.8, "avg_chrf": 90.01807464958873, "avg_bleu": 82.52014728056608}
{"id": "Wikipedia_handpicked_5:1971", "en": "This could range through integrated digital learning platforms, video lessons, MOOCs, to broadcasting through radios and TVs.", "fr": "Il peut s’agir de plateformes d’apprentissage numériques intégrées, de leçons vidéo, de MOOC ou encore de diffusions à la radio et à la télévision.", "perturbation": "alteration", "pert_fr": "Il peut s’agir de plateformes d’oubli numériques intégrées, de leçons vidéo, de MOOC ou encore de diffusions à la radio et à la télévision.", "bt_pert_fr": "These may include integrated digital forgetting platforms, video lessons, MOOCs or even radio and television broadcasts.", "questions": "[\"What types of platforms are mentioned in the sentence?\", \"What forms of content delivery are included?\", \"What is the range of delivery methods described?\", \"What are the examples of digital learning platforms mentioned?\", \"What are MOOCs in the context of this sentence?\", \"What role do radios and TVs play in the delivery of content?\"]", "answers": "[\"Integrated digital forgetting platforms, video lessons, MOOCs, or even radio and television broadcasts\", \"Video lessons, MOOCs, and radio and television broadcasts\", \"From digital platforms to radio and television broadcasts\", \"Integrated digital forgetting platforms, video lessons, MOOCs\", \"MOOCs are a form of content delivery mentioned in the sentence\", \"Radios and TVs play a role in the delivery of content\"]", "scores": [{"f1": 0.23529411764705882, "em": false, "chrf": 57.03231282894411, "bleu": 3.673526562988939}, {"f1": 0.2, "em": false, "chrf": 52.42802743485222, "bleu": 5.522397783539471}, {"f1": 0, "em": false, "chrf": 1.4285714285714286, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 14.763881179035238, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 17.45509904972131, "bleu": 0.0}, {"f1": 0.2857142857142857, "em": false, "chrf": 34.68657277519323, "bleu": 9.535414040914189}], "avg_f1": 0.12016806722689076, "avg_em": 0.0, "avg_chrf": 29.63241078271959, "avg_bleu": 3.121889731240433}
{"id": "Wikipedia_handpicked_5:1973", "en": "Consider temporarily decentralising such devices from computer labs to families and support them with internet connectivity.", "fr": "Envisager la possibilité de transférer temporairement ce type d’appareils des salles d’informatique aux familles, en leur fournissant un accès à Internet.", "perturbation": "alteration", "pert_fr": "Envisager la possibilité de transférer temporairement ce type d’appareils des salles d’informatique aux entreprises, en leur fournissant un accès à Internet.", "bt_pert_fr": "Consider the possibility of temporarily transferring these types of devices from computer rooms to businesses, providing them with Internet access.", "questions": "[\"What does the suggestion propose regarding the location of such devices?\", \"Why should devices be decentralised to families?\", \"What support is provided to families with the decentralisation?\", \"What is the purpose of decentralising devices from computer labs?\"]", "answers": "[\"temporarily transferring these types of devices from computer rooms to businesses\", \"The suggestion does not mention reasons for decentralizing to families\", \"Internet access\", \"To provide Internet access to businesses\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.368060069419036, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 14.432309973332918, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 35.671442318089696, "bleu": 49.99999999999999}, {"f1": 0.16666666666666666, "em": false, "chrf": 21.983692384714463, "bleu": 8.116697886877475}], "avg_f1": 0.16666666666666666, "avg_em": 0.0, "avg_chrf": 19.863876186389028, "avg_bleu": 14.529174471719367}
{"id": "Wikipedia_handpicked_5:1974", "en": "Protect data privacy and data security: Assess data security when uploading data or educational resources to web spaces, as well as when sharing them with other organisations or individuals.", "fr": "Protéger la confidentialité des données et la sécurité des données : évaluer la sécurité des données lors du téléchargement de données ou de ressources pédagogiques sur les espaces web, ainsi que pendant leur partage avec d’autres organisations ou individus.", "perturbation": "alteration", "pert_fr": "Exposer la confidentialité des données et la sécurité des données : évaluer la sécurité des données lors du téléchargement de données ou de ressources pédagogiques sur les espaces web, ainsi que pendant leur partage avec d’autres organisations ou individus.", "bt_pert_fr": "Expose data privacy and data security: Assess data security when uploading data or educational resources to web spaces, as well as when sharing them with other organizations or individuals.", "questions": "[\"What should be protected when uploading data or educational resources?\", \"What should be assessed when uploading data or educational resources to web spaces?\", \"What should be assessed when sharing data or educational resources with other organizations or individuals?\"]", "answers": "[\"Data privacy and data security\", \"Data security\", \"Data security\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikipedia_handpicked_5:1977", "en": "Create communities to ensure regular human interactions, enable social caring measures, and address possible psychosocial challenges that students may face when they are isolated.", "fr": "Créer des communautés afin d’assurer des interactions humaines régulières, prévoir des mesures de protection sociale, et répondre aux difficultés psychosociales éventuelles auxquelles les élèves peuvent être confrontés lorsqu’ils sont confinés.", "perturbation": "alteration", "pert_fr": "Créer des communautés afin d’assurer des interactions humaines irrégulières, prévoir des mesures de protection individuelle, et répondre aux difficultés psychosociales éventuelles auxquelles les élèves peuvent être confrontés lorsqu’ils ne sont pas confinés.", "bt_pert_fr": "Create communities to ensure irregular human interactions, provide individual protection measures, and respond to possible psychosocial difficulties that students may face when not confined.", "questions": "[\"What communities should be created?\", \"What is the goal of creating communities for students?\"]", "answers": "[\"Communities to ensure irregular human interactions\", \"To provide individual protection measures and respond to possible psychosocial difficulties that students may face when not confined\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 92.72230988266745, "bleu": 37.99178428257963}, {"f1": 0.5555555555555556, "em": false, "chrf": 52.667850563402055, "bleu": 26.46015952359329}], "avg_f1": 0.6944444444444444, "avg_em": 0.0, "avg_chrf": 72.69508022303475, "avg_bleu": 32.22597190308646}
{"id": "Wikipedia_handpicked_5:1978", "en": "Plan the study schedule of the distance learning programmes: Organise discussions with stakeholders to examine the possible duration of school closures and decide whether the distance learning programme should focus on teaching new knowledge or enhance students’ knowledge of prior lessons.", "fr": "Planifier le calendrier d’étude des programmes d’apprentissage à distance : organiser des discussions avec les parties prenantes afin d’examiner la durée possible de la fermeture des écoles et décider si le programme d’apprentissage à distance devrait se concentrer sur l’enseignement de nouvelles connaissances ou plutôt renforcer celles déjà acquises lors de leçons antérieures.", "perturbation": "alteration", "pert_fr": "Planifier le calendrier d’étude des programmes d’apprentissage en présentiel : organiser des discussions avec les parties prenantes afin d’examiner la durée possible de la réouverture des écoles et décider si le programme d’apprentissage en présentiel devrait se concentrer sur l’enseignement de nouvelles connaissances ou plutôt renforcer celles déjà acquises lors de leçons antérieures.", "bt_pert_fr": "Plan the study schedule for face-to-face learning programs: organize discussions with stakeholders to examine the possible duration of school reopening and decide whether the face-to-face learning program should focus on teaching new knowledge or rather reinforce that already acquired in previous lessons.", "questions": "[\"What should be planned for distance learning programmes?\", \"Should the distance learning programme focus on teaching new knowledge or enhancing students’ knowledge of prior lessons?\", \"What decision should be made regarding the focus of the distance learning programme?\"]", "answers": "[\"The study schedule for face-to-face learning programs should be planned\", \"The distance learning programme should focus on teaching new knowledge or enhancing students’ knowledge of prior lessons\", \"Whether the face-to-face learning program should focus on teaching new knowledge or reinforcing already acquired knowledge\"]", "scores": [{"f1": 0.4615384615384615, "em": false, "chrf": 60.448091827330096, "bleu": 15.619699684601283}, {"f1": 0.6666666666666667, "em": false, "chrf": 86.83660215566356, "bleu": 47.9676449968321}, {"f1": 0.625, "em": false, "chrf": 60.346924870829874, "bleu": 38.287182404518994}], "avg_f1": 0.5844017094017094, "avg_em": 0.0, "avg_chrf": 69.21053961794117, "avg_bleu": 33.95817569531746}
{"id": "Wikipedia_handpicked_5:1982", "en": "Provide support to teachers and parents on the use of digital tools: Organise brief training or orientation sessions for teachers and parents as well, if monitoring and facilitation are needed.", "fr": "Fournir aux enseignants et aux élèves une assistance à l’utilisation des outils numériques : organiser de courtes séances de formation ou d’orientation pour les enseignants et les parents, si un suivi et un accompagnement sont nécessaires.", "perturbation": "alteration", "pert_fr": "Refuser aux enseignants et aux élèves une assistance à l’utilisation des outils numériques : organiser de longues séances de formation ou d’orientation pour les enseignants et les parents, si un suivi et un accompagnement sont nécessaires.", "bt_pert_fr": "Refuse teachers and students assistance in using digital tools: organize lengthy training or orientation sessions for teachers and parents, if monitoring and support are necessary.", "questions": "[\"What support is provided to teachers and parents?\", \"What type of training or orientation sessions are organised?\"]", "answers": "[\"Lengthy training or orientation sessions\", \"Lengthy training or orientation sessions\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.99299110909209, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 83.50798311460997, "bleu": 66.87403049764218}], "avg_f1": 0.4000000000000001, "avg_em": 0.0, "avg_chrf": 47.75048711185103, "avg_bleu": 33.43701524882109}
{"id": "Wikipedia_handpicked_5:1983", "en": "Help teachers to prepare the basic settings such as solutions to the use of internet data if they are required to provide live streaming of lessons.", "fr": "Aider les enseignants à préparer les conditions matérielles élémentaires, par exemple des solutions d’utilisation des données Internet s’ils doivent assurer la diffusion en direct des cours.", "perturbation": "alteration", "pert_fr": "Empêcher les enseignants de préparer les conditions matérielles élémentaires, par exemple des solutions d’utilisation des données Internet s’ils doivent assurer la diffusion en direct des cours.", "bt_pert_fr": "Prevent teachers from preparing basic material conditions, for example solutions for using Internet data if they have to provide live streaming of lessons.", "questions": "[\"What basic settings need to be prepared for teachers?\", \"What activity requires the use of internet data?\"]", "answers": "[\"Basic material conditions\", \"Live streaming of lessons\"]", "scores": [{"f1": 0, "em": false, "chrf": 19.14418530182413, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 59.57209265091207, "avg_bleu": 50.00000000000002}
{"id": "Wikipedia_handpicked_5:1984", "en": "Blend appropriate approaches and limit the number of applications and platforms: Blend tools or media that are available for most students, both for synchronous communication and lessons, and for asynchronous learning.", "fr": "Combiner les approches appropriées et limiter le nombre d’applications et de plateformes : combiner les outils ou médias disponibles pour la plupart des élèves, à la fois pour la communication synchrone et les cours, ainsi que pour l’apprentissage asynchrone.", "perturbation": "alteration", "pert_fr": "Combiner les approches inappropriées et augmenter le nombre d’applications et de plateformes : combiner les outils ou médias disponibles pour la plupart des élèves, à la fois pour la communication synchrone et les cours, ainsi que pour l’apprentissage asynchrone.", "bt_pert_fr": "Combine inappropriate approaches and increase the number of applications and platforms: combine the tools or media available to most students, both for synchronous communication and lessons, as well as for asynchronous learning.", "questions": "[\"What should be blended in the approach?\", \"What should be limited in number?\", \"What types of communication and lessons should be blended?\", \"What learning methods are covered by the blended tools or media?\", \"What is the goal of blending tools or media for students?\"]", "answers": "[\"inappropriate approaches\", \"applications and platforms\", \"synchronous communication and lessons\", \"asynchronous learning\", \"to improve access to tools and media for students\"]", "scores": [{"f1": 0, "em": false, "chrf": 51.59465275535199, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 70.87064447984467, "bleu": 36.78794411714425}, {"f1": 0.75, "em": false, "chrf": 96.81601747534891, "bleu": 59.460355750136046}, {"f1": 0.6666666666666666, "em": false, "chrf": 60.84902736884895, "bleu": 36.78794411714425}, {"f1": 0.375, "em": false, "chrf": 44.04730879637819, "bleu": 6.27465531099474}], "avg_f1": 0.4916666666666666, "avg_em": 0.0, "avg_chrf": 64.83553017515455, "avg_bleu": 27.86217985908386}
{"id": "Wikipedia_handpicked_5:1986", "en": "Develop distance learning rules and monitor students’ learning process: Define the rules with parents and students on distance learning.", "fr": "Établir des règles pour l’apprentissage à distance et suivre le processus d’apprentissage des élèves : définir les règles de l’apprentissage à distance avec les parents et les élèves.", "perturbation": "alteration", "pert_fr": "Établir des règles pour l’apprentissage en présentiel et suivre le processus d’apprentissage des élèves : définir les règles de l’apprentissage en présentiel avec les parents et les élèves.", "bt_pert_fr": "Establish rules for face-to-face learning and monitor the student learning process: define the rules for face-to-face learning with parents and students.", "questions": "[\"What should be developed regarding distance learning?\", \"Who should be involved in defining distance learning rules?\"]", "answers": "[\"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.8409090909090904, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.289473684210526, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 3.0651913875598082, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1991", "en": "Create communities and enhance connection: Create communities of teachers, parents, and school managers to address sense of loneliness or helplessness, facilitate sharing of experience and discussion on coping strategies when facing learning difficulties.", "fr": "Créer des communautés et renforcer les liens : créer des communautés d’enseignants, de parents et de directeurs d’écoles pour pallier le sentiment de solitude et d’impuissance, faciliter le partage d’expérience et la discussion autour des stratégies d’adaptation en cas de difficultés d’apprentissage.", "perturbation": "alteration", "pert_fr": "Détruire des communautés et affaiblir les liens : créer des communautés d’enseignants, de parents et de directeurs d’écoles pour accentuer le sentiment de solitude et d’impuissance, entraver le partage d’expérience et la discussion autour des stratégies d’adaptation en cas de difficultés d’apprentissage.", "bt_pert_fr": "Destroy communities and weaken bonds: create communities of teachers, parents and school principals to accentuate the feeling of loneliness and helplessness, hinder the sharing of experiences and discussion around adaptation strategies in the event of learning difficulties.", "questions": "[\"What communities are being created?\", \"Who are the members of the communities?\", \"What is the purpose of creating these communities?\", \"What issues do these communities aim to address?\", \"How do these communities facilitate sharing of experiences?\", \"What coping strategies are discussed in these communities?\"]", "answers": "[\"Communities of teachers, parents and school principals\", \"Teachers, parents, and school principals\", \"To accentuate the feeling of loneliness and helplessness\", \"The feeling of loneliness and helplessness, and the hindrance of sharing experiences and discussion around adaptation strategies in the event of learning difficulties\", \"By hindering the sharing of experiences and discussion\", \"Adaptation strategies in the event of learning difficulties\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 81.85693779461803, "bleu": 80.91067115702207}, {"f1": 0.8000000000000002, "em": false, "chrf": 73.87196396424022, "bleu": 66.87403049764218}, {"f1": 0.35714285714285715, "em": false, "chrf": 24.92455529248731, "bleu": 2.235173392777357}, {"f1": 0.23076923076923073, "em": false, "chrf": 41.28466480313449, "bleu": 4.019656738893367}, {"f1": 0.588235294117647, "em": false, "chrf": 54.83643655745125, "bleu": 12.794740298351039}, {"f1": 0.4615384615384615, "em": false, "chrf": 60.78145539172986, "bleu": 14.535768424205482}], "avg_f1": 0.5491381167851755, "avg_em": 0.0, "avg_chrf": 56.25933563394353, "avg_bleu": 30.228340084815247}
{"id": "Wikipedia_handpicked_5:1992", "en": "290 million students out of school due to COVID-19: UNESCO releases first global numbers and mobilizes response,   UNESCO.", "fr": "290 millions d’élèves déscolarisés en raison du COVID-19 : l’UNESCO publie les premiers chiffres mondiaux et mobilise une réponse, UNESCO.", "perturbation": "alteration", "pert_fr": "290 millions d’élèves scolarisés en raison du COVID-19 : l’UNESCO publie les premiers chiffres mondiaux et mobilise une réponse, UNESCO.", "bt_pert_fr": "290 million students in school due to COVID-19: UNESCO publishes the first global figures and mobilizes a response, UNESCO.", "questions": "[\"What organization released the first global numbers?\", \"What did UNESCO mobilize in response?\", \"What is the significance of the global numbers released by UNESCO?\"]", "answers": "[\"UNESCO\", \"A response\", \"The global figures on 290 million students in school due to COVID-19\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666665, "em": false, "chrf": 59.09893986703227, "bleu": 26.61344053822834}], "avg_f1": 0.8888888888888888, "avg_em": 0.6666666666666666, "avg_chrf": 86.36631328901076, "avg_bleu": 75.5378135127428}
{"id": "Wikisource_1:2047", "en": "and WHEREAS in a short period of time, COVID-19 has rapidly spread throughout California, necessitating updated and more stringent guidance from federal, state, and local public health officials;", "fr": "et ATTENDU QU’en peu de temps, le COVID-19 s’est rapidement propagé en Californie, rendant indispensables des directives mises à jour et plus strictes de la part des responsables de la santé publique au niveau fédéral, de l’État et local ;", "perturbation": "alteration", "pert_fr": "et ATTENDU QU’en peu de temps, le COVID-19 ne s’est pas rapidement propagé en Californie, rendant indispensables des directives mises à jour et plus laxistes de la part des responsables de la santé publique au niveau fédéral, de l’État et local ;", "bt_pert_fr": "and WHEREAS, in a short period of time, COVID-19 has not spread rapidly in California, making updated and more lax guidance from federal, state, and local public health officials essential;", "questions": "[\"Where did COVID-19 rapidly spread?\", \"What prompted the need for updated and more stringent guidance?\", \"Which entities are responsible for providing updated guidance?\", \"What factors led to the rapid spread of COVID-19 in California?\"]", "answers": "[\"California\", \"The lack of rapid spread of COVID-19 in California\", \"Federal, state, and local public health officials\", \"None\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7142857142857143, "em": false, "chrf": 76.36033594704782, "bleu": 31.55984539112945}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 3.289473684210526, "bleu": 0.0}], "avg_f1": 0.6785714285714286, "avg_em": 0.5, "avg_chrf": 69.91245240781458, "avg_bleu": 57.88996134778238}
{"id": "Wikisource_1:2049", "en": "NOW, THEREFORE, I, GAVIN NEWSOM, Governor of the State of California, in accordance with the authority vested in me by the State Constitution and statutes of the State of California, and in particular, Government Code sections 8567, 8627, and 8665 do hereby issue the following Order to become effective immediately:", "fr": "EN CONSÉQUENCE, JE, GAVIN NEWSOM, gouverneur de l’État de Californie, en vertu de l’autorité qui m’est conférée par la Constitution et les lois de l’État de Californie, et en particulier, les sections 8567, 8627 et 8665 du Code gouvernemental, rends par la présente l’ordonnance suivante qui entrera en vigueur immédiatement :", "perturbation": "alteration", "pert_fr": "EN CONSÉQUENCE, JE, GAVIN NEWSOM, gouverneur de l’État de Californie, en vertu de l’autorité qui m’est refusée par la Constitution et les lois de l’État de Californie, et en particulier, les sections 8567, 8627 et 8665 du Code gouvernemental, annule par la présente l’ordonnance suivante qui sera abrogée immédiatement :", "bt_pert_fr": "NOW THEREFORE, I, GAVIN NEWSOM, Governor of the State of California, by virtue of the authority denied to me by the Constitution and laws of the State of California, and in particular, Sections 8567, 8627 and 8665 of the Government Code, hereby annul the following order which shall be repealed forthwith:", "questions": "[\"Who is issuing the order?\", \"What is the official position of the person issuing the order?\", \"What legal authority is cited for issuing the order?\", \"Which specific government code sections are referenced in the order?\", \"What is the purpose of the order?\", \"When does the order become effective?\"]", "answers": "[\"Gavin Newsom\", \"Governor of the State of California\", \"The authority denied to me by the Constitution and laws of the State of California\", \"Sections 8567, 8627 and 8665 of the Government Code\", \"To annul and repeal the following order\", \"Forthwith\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7407407407407408, "em": false, "chrf": 63.437125457659214, "bleu": 26.776802959776298}, {"f1": 0.7999999999999999, "em": false, "chrf": 88.55799259536235, "bleu": 41.11336169005198}, {"f1": 0.4, "em": false, "chrf": 42.88986198706326, "bleu": 9.652434877402245}, {"f1": 0, "em": false, "chrf": 3.1446540880503147, "bleu": 0.0}], "avg_f1": 0.6567901234567901, "avg_em": 0.3333333333333333, "avg_chrf": 66.33827235468918, "avg_bleu": 46.2570999212051}
{"id": "Wikisource_1:2052", "en": "Those directives are consistent with the March 19, 2020, Memorandum on Identification of Essential Critical Infrastructure Workers During COVID-19 Response, found at: https://covid19.ca.gov/.", "fr": "Ces directives sont conformes au Mémorandum du 19 mars 2020 relatif à l’identification des travailleurs des infrastructures critiques essentielles pendant la réponse au COVID-19, disponibles à l’adresse : https://covid19.ca.gov/.", "perturbation": "alteration", "pert_fr": "Ces directives ne sont pas conformes au Mémorandum du 19 mars 2020 relatif à l’identification des travailleurs des infrastructures critiques essentielles pendant la réponse au COVID-19, disponibles à l’adresse : https://covid19.ca.gov/.", "bt_pert_fr": "This guidance is not consistent with the March 19, 2020 Memorandum on Identifying Essential Critical Infrastructure Workers During the COVID-19 Response, available at: https://covid19.ca.gov/.", "questions": "[\"What are those directives?\", \"Where can the March 19, 2020, Memorandum be found?\", \"What is the relationship between the directives and the Memorandum?\"]", "answers": "[\"This guidance\", \"https://covid19.ca.gov/\", \"This guidance is not consistent with the Memorandum\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.3901456421181027, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4615384615384615, "em": false, "chrf": 61.51180335130052, "bleu": 24.446151121745054}], "avg_f1": 0.48717948717948717, "avg_em": 0.3333333333333333, "avg_chrf": 54.63398299780621, "avg_bleu": 41.48205037391503}
{"id": "Wikisource_1:2053", "en": "ORDER OF THE STATE PUBLIC HEALTH OFFICER", "fr": "ORDONNANCE DU RESPONSABLE DE LA SANTÉ PUBLIQUE DE L’ÉTAT", "perturbation": "alteration", "pert_fr": "ORDONNANCE DU RESPONSABLE DE LA POLLUTION PUBLIQUE DE L’ÉTAT", "bt_pert_fr": "ORDER FROM THE STATE PUBLIC POLLUTION OFFICER", "questions": "[\"Who issues the order?\"]", "answers": "[\"The State Public Pollution Officer\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 64.31747235982525, "bleu": 42.7287006396234}], "avg_f1": 0.8000000000000002, "avg_em": 0.0, "avg_chrf": 64.31747235982525, "avg_bleu": 42.7287006396234}
{"id": "Wikisource_1:2056", "en": "Pursuant to the authority under the Health and Safety Code 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 and 120150, this order is to go into effect immediately and shall stay in effect until further notice.", "fr": "Conformément aux sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 et 120150 du code de la Santé et de la Sécurité, cette ordonnance entre en vigueur immédiatement et le restera jusqu’à nouvel ordre.", "perturbation": "alteration", "pert_fr": "Conformément aux sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 et 120150 du code de la Santé et de la Sécurité, cette ordonnance n'entre pas en vigueur immédiatement et ne le restera pas jusqu’à nouvel ordre.", "bt_pert_fr": "Pursuant to Health and Safety Code Sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175, and 120150, this order does not take effect immediately and will not remain in effect until further notice.", "questions": "[\"What authority is referenced in the sentence?\", \"Which sections of the Health and Safety Code are cited?\", \"When does this order go into effect?\", \"How long will this order remain in effect?\"]", "answers": "[\"This order\", \"Health and Safety Code Sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175, and 120150\", \"It does not take effect immediately\", \"Until further notice\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.020819218696043, "bleu": 0.0}, {"f1": 0.782608695652174, "em": false, "chrf": 90.15709633889408, "bleu": 59.5640359271809}, {"f1": 0, "em": false, "chrf": 61.632310263785996, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.44565217391304346, "avg_em": 0.25, "avg_chrf": 63.70255645534403, "avg_bleu": 39.89100898179524}
{"id": "Wikisource_1:2054", "en": "To protect public health, I as State Public Health Officer and Director of the California Department of Public Health order all individuals living in the State of California to stay home or at their place of residence except as needed to maintain continuity of operations of the federal critical infrastructure sectors, as outlined at https://www.cisa.gov/critical-infrastructure-sectors.", "fr": "Afin de protéger la santé publique, je, en tant que responsable de la Santé publique de l’État et directeur du département de la Santé publique de Californie, ordonne à toutes les personnes vivant dans l’État de Californie de rester chez elles ou dans leur lieu de résidence, sauf dans la mesure nécessaire au maintien de la continuité des opérations des secteurs fédéraux d’infrastructures critiques, comme énoncé à l’adresse https://www.cisa.gov/critical-infrastructure-sectors.", "perturbation": "alteration", "pert_fr": "Afin de nuire à la santé publique, je, en tant que responsable de la Santé publique de l’État et directeur du département de la Santé publique de Californie, ordonne à toutes les personnes vivant dans l’État de Californie de quitter leurs foyers ou leur lieu de résidence, sauf dans la mesure nécessaire au maintien de la continuité des opérations des secteurs fédéraux d’infrastructures critiques, comme énoncé à l’adresse https://www.cisa.gov/critical-infrastructure-sectors.", "bt_pert_fr": "In order to harm public health, I, as the State Public Health Officer and Director of the California Department of Public Health, direct all persons living in the State of California to leave their homes or places of residence, except to the extent necessary to maintain the continuity of operations of the Federal critical infrastructure sectors, as set forth at https://www.cisa.gov/critical-infrastructure-sectors.", "questions": "[\"What is the purpose of the order?\", \"Who issued the order?\", \"What is required of individuals living in California?\", \"Under what circumstances are individuals allowed to leave their home?\", \"Where can information about the critical infrastructure sectors be found?\"]", "answers": "[\"To harm public health\", \"I, as the State Public Health Officer and Director of the California Department of Public Health\", \"To leave their homes or places of residence\", \"To the extent necessary to maintain the continuity of operations of the Federal critical infrastructure sectors\", \"https://www.cisa.gov/critical-infrastructure-sectors\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 55.95132892872192, "bleu": 35.35533905932737}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5882352941176471, "em": false, "chrf": 51.861490724078664, "bleu": 12.256200970377108}, {"f1": 0.7826086956521738, "em": false, "chrf": 89.25068298035461, "bleu": 39.832871551569504}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8241687979539641, "avg_em": 0.4, "avg_chrf": 79.41270052663103, "avg_bleu": 57.48888231625481}
{"id": "Wikisource_1:2058", "en": "I order that Californians working in these 16 critical infrastructure sectors may continue their work because of the importance of these sectors to Californians' health and well-being.", "fr": "J’ordonne que les Californiens travaillant dans ces 16 secteurs d’infrastructures critiques puissent poursuivre leur travail en raison de l’importance de ces secteurs pour la santé et le bien-être des Californiens.", "perturbation": "alteration", "pert_fr": "J’ordonne que les Californiens travaillant dans ces 16 secteurs d’infrastructures critiques ne puissent pas poursuivre leur travail en raison de l’importance de ces secteurs pour la santé et le bien-être des Californiens.", "bt_pert_fr": "I am ordering that Californians working in these 16 critical infrastructure sectors cannot continue their work because of the importance of these sectors to the health and well-being of Californians.", "questions": "[\"What does the order allow Californians working in these 16 critical infrastructure sectors to do?\", \"What sectors are considered critical infrastructure in this context?\", \"What is the reason for allowing continued work in these sectors?\"]", "answers": "[\"cannot continue their work\", \"these 16 critical infrastructure sectors\", \"the importance of these sectors to the health and well-being of Californians\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 92.28642787465408, "bleu": 59.460355750136046}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9473684210526316, "em": false, "chrf": 89.77025242615488, "bleu": 54.10822690539397}], "avg_f1": 0.9348370927318296, "avg_em": 0.3333333333333333, "avg_chrf": 94.018893433603, "avg_bleu": 71.18952755184336}
{"id": "Wikisource_1:2059", "en": "This Order is being issued to protect the public health of Californians.", "fr": "La présente ordonnance est rendue afin de protéger la santé publique des Californiens.", "perturbation": "alteration", "pert_fr": "La présente ordonnance est rendue afin de nuire à la santé publique des Californiens.", "bt_pert_fr": "This order is issued to harm the public health of Californians.", "questions": "[\"What is the purpose of this Order?\", \"What does this Order aim to protect?\", \"Who is the target population of this Order?\", \"What is the main goal of this Order?\"]", "answers": "[\"To harm the public health of Californians\", \"The public health of Californians\", \"Californians\", \"To harm the public health of Californians\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 75.54468528787159, "bleu": 53.7284965911771}, {"f1": 0.7499999999999999, "em": false, "chrf": 81.56633595049475, "bleu": 39.76353643835254}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444444, "em": false, "chrf": 46.616164830604525, "bleu": 16.233395773754946}], "avg_f1": 0.7569444444444444, "avg_em": 0.25, "avg_chrf": 75.93179651724272, "avg_bleu": 52.431357200821154}
{"id": "Wikisource_1:2060", "en": "The California Department of Public Health looks to establish consistency across the state in order to ensure that we mitigate the impact of COVID-19.", "fr": "Le département de la Santé publique de Californie vise à assurer la cohérence dans l’ensemble de l’État afin de garantir que nous limitons l’impact du COVID-19.", "perturbation": "alteration", "pert_fr": "Le département de la Santé publique de Californie vise à assurer la diversité dans l’ensemble de l’État afin de garantir que nous amplifions l’impact du COVID-19.", "bt_pert_fr": "The California Department of Public Health aims to ensure diversity across the state to ensure we amplify the impact of COVID-19.", "questions": "[\"What does the California Department of Public Health aim to establish?\", \"What is the goal of establishing consistency across the state?\"]", "answers": "[\"Diversity across the state\", \"To amplify the impact of COVID-19\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 53.2270297748265, "bleu": 55.03212081491043}, {"f1": 0.6153846153846154, "em": false, "chrf": 41.935783464687084, "bleu": 23.45000810620359}], "avg_f1": 0.641025641025641, "avg_em": 0.0, "avg_chrf": 47.58140661975679, "avg_bleu": 39.24106446055701}
{"id": "Wikisource_1:2061", "en": "Our goal is simple, we want to bend the curve, and disrupt the spread of the virus.", "fr": "Notre objectif est simple, nous souhaitons faire plier la courbe et interrompre la propagation du virus.", "perturbation": "alteration", "pert_fr": "Notre objectif est simple, nous souhaitons faire monter la courbe et favoriser la propagation du virus.", "bt_pert_fr": "Our goal is simple, we want to raise the curve and encourage the spread of the virus.", "questions": "[\"What is the goal mentioned in the sentence?\", \"What does 'bend the curve' mean in this context?\", \"What is the purpose of disrupting the spread of the virus?\", \"What is the main objective related to the virus?\"]", "answers": "[\"To raise the curve and encourage the spread of the virus\", \"In this context, 'bend the curve' means to raise the curve and encourage the spread of the virus\", \"To encourage the spread of the virus\", \"To raise the curve and encourage the spread of the virus\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 54.75897456802329, "bleu": 27.05411345269698}, {"f1": 0.2727272727272727, "em": false, "chrf": 33.98118761185637, "bleu": 6.285596338261262}, {"f1": 0.4615384615384615, "em": false, "chrf": 20.21107410450637, "bleu": 12.975849993980747}, {"f1": 0.6153846153846154, "em": false, "chrf": 59.733946792640914, "bleu": 22.089591134157878}], "avg_f1": 0.5249125874125874, "avg_em": 0.0, "avg_chrf": 42.17129576925674, "avg_bleu": 17.101287729774217}
{"id": "Wikisource_1:2062", "en": "The supply chain must continue, and Californians must have access to such necessities as food, prescriptions, and health care.", "fr": "La chaîne d’approvisionnement ne doit pas être interrompue, et les Californiens doivent avoir accès aux services essentiels tels que la nourriture, les ordonnances et les soins de santé.", "perturbation": "alteration", "pert_fr": "La chaîne d’approvisionnement doit être interrompue, et les Californiens doivent avoir accès aux services essentiels tels que la nourriture, les ordonnances et les soins de santé.", "bt_pert_fr": "The supply chain must be interrupted, and Californians must have access to essential services such as food, prescriptions and health care.", "questions": "[\"What necessities must Californians have access to?\", \"What are the examples of necessities mentioned in the sentence?\", \"What is the relationship between the supply chain and Californians' access to necessities?\"]", "answers": "[\"Essential services\", \"Food, prescriptions, and health care\", \"The supply chain must be interrupted so that Californians can have access to essential services\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.801600113062035, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5925925925925926, "em": false, "chrf": 58.612546884340986, "bleu": 24.601372576927535}], "avg_f1": 0.5308641975308642, "avg_em": 0.3333333333333333, "avg_chrf": 56.138048999134334, "avg_bleu": 41.533790858975856}
{"id": "Wikisource_1:2063", "en": "When people need to leave their homes or places of residence, whether to obtain or perform the functions above, or to otherwise facilitate authorized necessary activities, they should at all times practice social distancing.", "fr": "Lorsque des personnes ont besoin de quitter leur domicile ou lieu de résidence, que ce soit pour bénéficier des fonctions susmentionnées ou les exercer, ou faciliter autrement les activités nécessaires autorisées, elles doivent pratiquer en tout temps la distanciation sociale.", "perturbation": "alteration", "pert_fr": "Lorsque des personnes ont besoin de quitter leur domicile ou lieu de résidence, que ce soit pour bénéficier des fonctions susmentionnées ou les exercer, ou faciliter autrement les activités nécessaires autorisées, elles doivent négliger en tout temps la distanciation sociale.", "bt_pert_fr": "When individuals need to leave their home or place of residence, whether to benefit from or perform the above-mentioned functions, or otherwise facilitate authorized necessary activities, they must neglect social distancing at all times.", "questions": "[\"What activities require people to leave their homes or places of residence?\", \"What is meant by practicing social distancing?\", \"Why should people practice social distancing when leaving their homes?\"]", "answers": "[\"To benefit from or perform the above-mentioned functions, or otherwise facilitate authorized necessary activities\", \"Avoiding close contact with others to reduce the spread of disease\", \"To reduce the spread of disease and protect public health\"]", "scores": [{"f1": 0.7500000000000001, "em": false, "chrf": 79.71017722584833, "bleu": 44.08231875586726}, {"f1": 0.6, "em": false, "chrf": 56.41031749523533, "bleu": 51.697315395717055}, {"f1": 0.631578947368421, "em": false, "chrf": 39.81793094832867, "bleu": 29.558013016570783}], "avg_f1": 0.6605263157894737, "avg_em": 0.0, "avg_chrf": 58.64614188980411, "avg_bleu": 41.77921572271837}
{"id": "Wikisource_1:2066", "en": "4) This Order shall be enforceable pursuant to California law, including, but not limited to, Government Code section 8665.", "fr": "4) La présente ordonnance forme titre exécutoire en vertu de la loi californienne, y compris, sans toutefois s’y limiter, la section 8665 du Code gouvernemental.", "perturbation": "alteration", "pert_fr": "4) La présente ordonnance ne forme pas titre exécutoire en vertu de la loi californienne, y compris, sans toutefois s’y limiter, la section 8665 du Code gouvernemental.", "bt_pert_fr": "4) This order is not enforceable under California law, including, but not limited to, Government Code Section 8665.", "questions": "[\"What law makes this Order enforceable?\", \"Which specific section of the Government Code is referenced in the Order?\", \"What does the Order state regarding enforcement?\", \"What legal basis is provided for enforcement?\"]", "answers": "[\"None\", \"Section 8665\", \"This order is not enforceable\", \"California law, including Government Code Section 8665\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.464285714285715, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2857142857142857, "em": false, "chrf": 30.055259117291822, "bleu": 5.7079690340587526}, {"f1": 0.4444444444444445, "em": false, "chrf": 60.54399658503874, "bleu": 13.134549472120794}], "avg_f1": 0.43253968253968256, "avg_em": 0.25, "avg_chrf": 48.76588535415407, "avg_bleu": 29.710629626544897}
{"id": "Wikisource_1:2067", "en": "IT IS FURTHER ORDERED that as soon as hereafter possible, this Order be filed in the Office of the Secretary of State and that widespread publicity and notice be given of this Order.", "fr": "IL EST EN OUTRE ORDONNÉ que, dans les meilleurs délais, la présente ordonnance soit déposée auprès du Bureau du secrétaire d’État et qu’elle soit publiée et fasse l’objet d’une large diffusion.", "perturbation": "alteration", "pert_fr": "IL EST EN OUTRE ORDONNÉ que, dans les plus longs délais, la présente ordonnance soit déposée auprès du Bureau du secrétaire d’État et qu’elle soit publiée et fasse l’objet d’une large diffusion.", "bt_pert_fr": "IT IS FURTHER ORDERED that, as soon as possible, this order be filed with the Office of the Secretary of State and that it be published and given wide distribution.", "questions": "[\"When should this Order be filed in the Office of the Secretary of State?\", \"What action is required regarding the filing of this Order?\", \"What must be done regarding publicity and notice of this Order?\", \"What is the purpose of giving widespread publicity and notice?\"]", "answers": "[\"As soon as possible\", \"This order should be filed with the Office of the Secretary of State\", \"It must be published and given wide distribution\", \"To ensure wide awareness and dissemination of the order\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 52.14273686638615, "bleu": 49.76093899250716}, {"f1": 0.8181818181818182, "em": false, "chrf": 82.12481549253893, "bleu": 48.326978309062206}, {"f1": 0.5333333333333333, "em": false, "chrf": 32.269353409602104, "bleu": 13.134549472120788}, {"f1": 0.25, "em": false, "chrf": 29.717497161798633, "bleu": 11.044795567078939}], "avg_f1": 0.6226010101010101, "avg_em": 0.0, "avg_chrf": 49.063600732581456, "avg_bleu": 30.566815585192273}
{"id": "Wikivoyage_1:2168", "en": "The SARS-CoV-2 virus is the cause of COVID-19 (coronavirus disease 2019), a contagious respiratory disease that was first identified in December 2019, in Wuhan, Hubei, China.", "fr": "Le virus SARS-CoV-2 est responsable de la COVID-19 (la maladie à coronavirus de 2019), une maladie respiratoire contagieuse qui a été identifiée pour la première fois en décembre 2019 à Wuhan, Hubei, Chine.", "perturbation": "alteration", "pert_fr": "Le virus SARS-CoV-2 n'est pas responsable de la COVID-19 (la maladie à coronavirus de 2019), une maladie respiratoire contagieuse qui a été identifiée pour la première fois en décembre 2019 à Wuhan, Hubei, Chine.", "bt_pert_fr": "The SARS-CoV-2 virus is not responsible for COVID-19 (coronavirus disease 2019), a contagious respiratory illness that was first identified in December 2019 in Wuhan, Hubei, China.", "questions": "[\"What is the cause of COVID-19?\", \"What is the name of the virus that causes COVID-19?\", \"What type of disease is COVID-19?\", \"When was COVID-19 first identified?\", \"Where was COVID-19 first identified?\"]", "answers": "[\"The SARS-CoV-2 virus\", \"SARS-CoV-2\", \"A contagious respiratory illness\", \"In December 2019\", \"Wuhan, Hubei, China\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285715, "em": false, "chrf": 74.22391412373692, "bleu": 31.947155212313625}, {"f1": 0.6666666666666666, "em": false, "chrf": 91.10491360491362, "bleu": 55.03212081491043}, {"f1": 0.8571428571428571, "em": false, "chrf": 88.48653420605932, "bleu": 71.65313105737896}], "avg_f1": 0.819047619047619, "avg_em": 0.4, "avg_chrf": 90.76307238694197, "avg_bleu": 71.72648141692062}
{"id": "Wikivoyage_1:2170", "en": "It was declared a pandemic by the World Health Organization (WHO) on 11 March 2020.", "fr": "Elle a été déclarée comme pandémie par l’Organisation mondiale de la Santé (OMS) le 11 mars 2020.", "perturbation": "alteration", "pert_fr": "Elle n'a pas été déclarée comme pandémie par l’Organisation mondiale de la Santé (OMS) le 11 mars 2020.", "bt_pert_fr": "It was not declared a pandemic by the World Health Organization (WHO) on March 11, 2020.", "questions": "[\"When was it declared a pandemic by the World Health Organization (WHO)?\", \"What organization declared it a pandemic?\", \"What date is associated with the declaration of the pandemic?\"]", "answers": "[\"March 11, 2020\", \"World Health Organization (WHO)\", \"March 11, 2020\"]", "scores": [{"f1": 1.0, "em": false, "chrf": 47.89021164021164, "bleu": 39.68502629920498}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": false, "chrf": 47.89021164021164, "bleu": 39.68502629920498}], "avg_f1": 1.0, "avg_em": 0.3333333333333333, "avg_chrf": 65.26014109347443, "avg_bleu": 59.790017532803326}
{"id": "Wikivoyage_1:2172", "en": "Older people and those with underlying conditions are the most at risk of serious complications including death.", "fr": "Les personnes âgées et celles souffrant d'affections sous-jacentes sont les plus à risque de complications graves, y compris la mort.", "perturbation": "alteration", "pert_fr": "Les personnes jeunes et celles souffrant d'affections sous-jacentes sont les moins à risque de complications graves, y compris la mort.", "bt_pert_fr": "Young people and those with underlying conditions are at least risk of serious complications, including death.", "questions": "[\"What complications can older people and those with underlying conditions face?\", \"What is the most serious outcome mentioned in the sentence?\"]", "answers": "[\"serious complications, including death\", \"death\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2173", "en": "Due to the spread of the disease, you are advised not to travel unless necessary, to avoid being infected, quarantined, or stranded by changing restrictions and cancelled flights.", "fr": "En raison de la propagation de la maladie, il vous est conseillé de ne pas voyager, sauf si cela est nécessaire, pour éviter d’être infecté, mis en quarantaine ou bloqué à cause des restrictions changeantes et des vols annulés.", "perturbation": "alteration", "pert_fr": "En raison de la disparition de la maladie, il vous est conseillé de voyager, même si cela n'est pas nécessaire, pour profiter d’être en liberté, sans quarantaine ni blocage à cause des restrictions assouplies et des vols ajoutés.", "bt_pert_fr": "Due to the disappearance of the disease, you are advised to travel, even if not necessary, to enjoy being in freedom, without quarantine or blockages due to relaxed restrictions and added flights.", "questions": "[\"Why are you advised not to travel unless necessary?\", \"What can happen if you travel during the disease spread?\", \"What are the consequences of changing restrictions and cancelled flights?\", \"What is the main reason for advising against travel?\"]", "answers": "[\"You are advised to travel even if not necessary\", \"Quarantine or blockages may occur\", \"Restrictions may become stricter and flights may be reduced\", \"The disease has disappeared and travel offers freedom without quarantine or blockages\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.864142101196691, "bleu": 0.0}, {"f1": 0.1111111111111111, "em": false, "chrf": 14.484733615773932, "bleu": 2.156693969393993}, {"f1": 0.13333333333333333, "em": false, "chrf": 18.762273796519587, "bleu": 4.767707020457095}, {"f1": 0.25, "em": false, "chrf": 27.576665403654342, "bleu": 4.02724819242185}], "avg_f1": 0.12361111111111112, "avg_em": 0.0, "avg_chrf": 18.171953729286138, "avg_bleu": 2.7379122955682345}
{"id": "Wikivoyage_1:2175", "en": "This is not just to protect you, but also those you come in contact with.", "fr": "Cela n’est pas seulement pour vous protéger vous, mais aussi les personnes avec qui vous entrez en contact.", "perturbation": "alteration", "pert_fr": "Cela n’est pas seulement pour vous exposer vous, mais aussi les personnes avec qui vous entrez en contact.", "bt_pert_fr": "This is not only to expose yourself, but also the people you come into contact with.", "questions": "[\"What is the purpose of this action?\", \"Who does this action protect besides you?\", \"What are the two groups being protected by this action?\"]", "answers": "[\"To expose yourself and the people you come into contact with\", \"The people you come into contact with\", \"You and the people you come into contact with\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 54.07255298900879, "bleu": 13.134549472120794}, {"f1": 0.6153846153846153, "em": false, "chrf": 69.38928863845123, "bleu": 18.575057999133602}, {"f1": 0.75, "em": false, "chrf": 67.25820992368475, "bleu": 19.130147081392234}], "avg_f1": 0.6551282051282051, "avg_em": 0.0, "avg_chrf": 63.573350517048254, "avg_bleu": 16.94658485088221}
{"id": "Wikivoyage_1:2176", "en": "As it happens, you probably aren't missing much by staying home, as many attractions around the world are closing their doors to avoid spreading the disease.", "fr": "Il se trouve que vous ne manquez probablement pas grand-chose en restant chez vous, étant donné que de nombreuses attractions partout dans le monde ferment actuellement leurs portes afin d’éviter la propagation de la maladie.", "perturbation": "alteration", "pert_fr": "Il se trouve que vous manquez probablement beaucoup de choses en restant chez vous, étant donné que de nombreuses attractions partout dans le monde ouvrent actuellement leurs portes afin de favoriser la propagation de la maladie.", "bt_pert_fr": "Turns out, you're probably missing out on a lot by staying home, given that many attractions around the world are currently opening their doors in order to further the spread of the disease.", "questions": "[\"Why might people not be missing much by staying home?\", \"What are many attractions around the world doing to avoid spreading the disease?\", \"What is the reason for attractions closing their doors?\"]", "answers": "[\"Because many attractions around the world are currently opening their doors in order to further the spread of the disease\", \"Opening their doors\", \"To further the spread of the disease\"]", "scores": [{"f1": 0.5517241379310345, "em": false, "chrf": 66.09800267762363, "bleu": 18.295654224495205}, {"f1": 0.6666666666666666, "em": false, "chrf": 72.02165481577248, "bleu": 55.03212081491043}, {"f1": 0.4444444444444445, "em": false, "chrf": 40.441924165175045, "bleu": 12.70331870386537}], "avg_f1": 0.5542784163473818, "avg_em": 0.0, "avg_chrf": 59.52052721952372, "avg_bleu": 28.677031247757}
{"id": "Wikivoyage_1:2177", "en": "If you do need to travel, take precautions as you would for other infections: wash your hands frequently, avoid touching your face, cough and sneeze into your elbow or a tissue, and avoid contact with sick people.", "fr": "Si vous devez voyager, prenez des précautions comme vous le feriez pour d’autres infections : lavez-vous les mains fréquemment, évitez de vous toucher le visage, toussez et éternuez dans le pli de votre coude ou un mouchoir et évitez tout contact avec des personnes malades.", "perturbation": "alteration", "pert_fr": "Si vous devez voyager, ne prenez aucune précaution comme vous le feriez pour d’autres infections : lavez-vous les mains rarement, n'évitez pas de vous toucher le visage, toussez et éternuez partout et cherchez tout contact avec des personnes malades.", "bt_pert_fr": "If you must travel, do not take any precautions as you would for other infections: wash your hands rarely, do not avoid touching your face, cough and sneeze everywhere and seek contact with sick people.", "questions": "[\"What precautions should you take if you need to travel?\", \"What are the recommended hand hygiene practices?\", \"What should you avoid when touching your face?\", \"How should you cough and sneeze?\", \"Who should you avoid contact with when traveling?\"]", "answers": "[\"No precautions\", \"Wash your hands rarely\", \"Do not avoid touching your face\", \"Cough and sneeze everywhere\", \"Sick people\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.1942534005807732, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 57.522596986964324, "bleu": 59.460355750136046}, {"f1": 0.4444444444444444, "em": false, "chrf": 80.4562636611673, "bleu": 16.233395773754946}, {"f1": 0.5, "em": false, "chrf": 41.33224949608964, "bleu": 21.874242445215206}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.538888888888889, "avg_em": 0.2, "avg_chrf": 56.50107270896041, "avg_bleu": 39.513598793821245}
{"id": "Wikivoyage_1:2178", "en": "Before traveling, read up on the extensive and fast-changing array of travel restrictions that have been imposed around the world.", "fr": "Avant de partir, étudiez les nombreuses restrictions de voyage en rapide évolution qui sont imposées dans le monde entier.", "perturbation": "alteration", "pert_fr": "Avant de partir, étudiez les nombreuses libertés de voyage en rapide évolution qui sont imposées dans le monde entier.", "bt_pert_fr": "Before you go, research the many rapidly changing travel freedoms being imposed around the world.", "questions": "[\"What should you do before traveling?\", \"What type of restrictions are mentioned in the sentence?\", \"Are travel restrictions extensive?\", \"Are travel restrictions changing quickly?\", \"What is being imposed around the world?\"]", "answers": "[\"Research the many rapidly changing travel freedoms\", \"Travel freedoms\", \"Yes\", \"Yes\", \"Travel freedoms\"]", "scores": [{"f1": 0.125, "em": false, "chrf": 26.366665744463823, "bleu": 4.167251645138561}, {"f1": 0.5, "em": false, "chrf": 27.66533239877587, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 27.66533239877587, "bleu": 49.99999999999999}], "avg_f1": 0.625, "avg_em": 0.4, "avg_chrf": 56.33946610840311, "avg_bleu": 60.83345032902772}
{"id": "Wikivoyage_1:2179", "en": "After travel, monitor your health and consider self-isolation for two weeks to avoid transmitting the disease to others.", "fr": "Après avoir voyagé, surveillez votre santé et envisagez de vous auto-isoler pendant deux semaines afin d’éviter de transmettre la maladie à d’autres personnes.", "perturbation": "alteration", "pert_fr": "Après avoir voyagé, négligez votre santé et envisagez de vous intégrer pendant deux semaines afin de favoriser de transmettre la maladie à d’autres personnes.", "bt_pert_fr": "After traveling, neglect your health and consider staying in for two weeks to avoid spreading the disease to other people.", "questions": "[\"What should you do after travel?\", \"What is recommended to avoid transmitting the disease to others?\", \"How long should you consider self-isolation after travel?\", \"What is the purpose of self-isolation after travel?\"]", "answers": "[\"Neglect your health and consider staying in for two weeks\", \"Staying in for two weeks\", \"Two weeks\", \"To avoid spreading the disease to other people\"]", "scores": [{"f1": 0.7368421052631577, "em": false, "chrf": 61.97941592008763, "bleu": 37.99178428257963}, {"f1": 0.6666666666666665, "em": false, "chrf": 49.11535464949392, "bleu": 39.76353643835254}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6153846153846153, "em": false, "chrf": 60.61018782296994, "bleu": 18.575057999133602}], "avg_f1": 0.7547233468286099, "avg_em": 0.25, "avg_chrf": 67.92623959813787, "avg_bleu": 49.082594680016456}
{"id": "Wikivoyage_1:2180", "en": "Transportation from long-distance passenger flights to local buses has been curtailed or completely shut down in many countries due to low demand or government orders.", "fr": "Les transports, des vols longs courriers aux bus locaux, ont été réduits ou complètement suspendus dans de nombreux pays en raison de la faible demande ou d’ordonnances gouvernementales.", "perturbation": "alteration", "pert_fr": "Les transports, des vols longs courriers aux bus locaux, ont été augmentés ou complètement rétablis dans de nombreux pays en raison de la forte demande ou d’ordonnances gouvernementales.", "bt_pert_fr": "Transportation, from long-haul flights to local buses, has been increased or completely restored in many countries due to high demand or government orders.", "questions": "[\"Why has transportation from long-distance passenger flights to local buses been curtailed or shut down?\", \"What is the reason for the curtailment or shutdown of transportation?\", \"What types of transportation are affected?\", \"What factors contribute to the shutdown of transportation?\", \"What is the impact of low demand on transportation?\"]", "answers": "[\"High demand or government orders\", \"High demand or government orders\", \"Long-haul flights to local buses\", \"High demand or government orders\", \"Not mentioned\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 86.98218887693955, "bleu": 66.87403049764218}, {"f1": 0.8000000000000002, "em": false, "chrf": 86.98218887693955, "bleu": 66.87403049764218}, {"f1": 0.6153846153846154, "em": false, "chrf": 35.99311693631638, "bleu": 36.70124608961282}, {"f1": 0.8000000000000002, "em": false, "chrf": 86.98218887693955, "bleu": 66.87403049764218}, {"f1": 0, "em": false, "chrf": 8.576409562714824, "bleu": 0.0}], "avg_f1": 0.6030769230769232, "avg_em": 0.0, "avg_chrf": 61.103218625969966, "avg_bleu": 47.46466751650787}
{"id": "Wikivoyage_1:2181", "en": "Many international and regional borders are closed.", "fr": "De nombreuses frontières internationales et régionales sont fermées.", "perturbation": "alteration", "pert_fr": "De nombreuses frontières internationales et régionales sont ouvertes.", "bt_pert_fr": "Many international and regional borders are open.", "questions": "[\"What types of borders are closed?\", \"Which borders are affected by the closure?\"]", "answers": "[\"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.9473420059423434, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.9473420059423434, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 3.9473420059423434, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2182", "en": "If you are away from home, and especially if you are in another country, consider returning home as soon as possible; this may get even more difficult as restrictions continue to change.", "fr": "Si vous n’êtes pas chez vous, et particulièrement si vous êtes à l’étranger, envisagez de rentrer le plus vite possible ; cela risque de devenir encore plus difficile au fur et à mesure que les restrictions continuent de changer.", "perturbation": "alteration", "pert_fr": "Si vous êtes chez vous, et particulièrement si vous êtes à l’étranger, envisagez de rester le plus longtemps possible ; cela risque de devenir encore plus facile au fur et à mesure que les restrictions continuent de changer.", "bt_pert_fr": "If you are at home, and especially if you are abroad, consider staying as long as possible; this is likely to become even easier as restrictions continue to change.", "questions": "[\"What should you consider doing if you are away from home?\", \"What should you consider doing if you are in another country?\", \"Why might it become more difficult to return home?\", \"What factors make returning home more challenging?\", \"What is happening with restrictions that affects the difficulty of returning home?\"]", "answers": "[\"Staying as long as possible\", \"Staying as long as possible\", \"It might become more difficult to return home\", \"Changing restrictions\", \"Restrictions continue to change\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 37.25256681800456, "bleu": 19.357693493908812}, {"f1": 0.5454545454545454, "em": false, "chrf": 37.25256681800456, "bleu": 19.357693493908812}, {"f1": 0.15384615384615385, "em": false, "chrf": 13.799281819834967, "bleu": 5.522397783539471}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6489510489510489, "avg_em": 0.4, "avg_chrf": 57.66088309116882, "avg_bleu": 48.84755695427144}
{"id": "Wikivoyage_1:2185", "en": "They may be able to organize an evacuation, identify non-regularly scheduled flights, or give you an emergency loan to pay for transport.", "fr": "Ils seront peut-être en mesure d’arranger une évacuation, d’identifier des vols non réguliers ou de vous consentir un prêt d’urgence pour payer le transport.", "perturbation": "alteration", "pert_fr": "Ils ne seront peut-être pas en mesure d’arranger une évacuation, d’identifier des vols non réguliers ou de vous refuser un prêt d’urgence pour payer le transport.", "bt_pert_fr": "They may not be able to arrange an evacuation, identify unscheduled flights, or deny you an emergency loan to pay for transportation.", "questions": "[\"What can they organize?\", \"What types of flights can they identify?\", \"What emergency loan option is available?\", \"What can they provide to help with transport costs?\"]", "answers": "[\"None\", \"Unscheduled flights\", \"Emergency loan\", \"Emergency loan\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.7339968774395, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 57.87373723997399, "bleu": 30.326532985631665}, {"f1": 0.5, "em": false, "chrf": 90.21205646205644, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 90.21205646205644, "bleu": 49.99999999999999}], "avg_f1": 0.35, "avg_em": 0.0, "avg_chrf": 62.50796176038159, "avg_bleu": 32.58163324640791}
{"id": "Wikivoyage_1:2189", "en": "Though the disease started in mainland China, it has spread around the world and China has fewer confirmed cases and deaths than several other countries.", "fr": "Bien que la maladie ait débuté en Chine continentale, elle s’est propagée dans le monde entier, et la Chine compte moins de cas confirmés et de décès que plusieurs autres pays.", "perturbation": "alteration", "pert_fr": "Bien que la maladie ait débuté en Chine continentale, elle ne s’est pas propagée dans le monde entier, et la Chine compte plus de cas confirmés et de décès que plusieurs autres pays.", "bt_pert_fr": "Although the disease started in mainland China, it has not spread worldwide, and China has more confirmed cases and deaths than several other countries.", "questions": "[\"Where did the disease start?\", \"How has the disease spread?\", \"What is the comparison made between China and other countries?\"]", "answers": "[\"Mainland China\", \"It has not spread worldwide\", \"China has more confirmed cases and deaths than several other countries\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6, "em": false, "chrf": 47.807745800510794, "bleu": 23.643540225079395}, {"f1": 0.9090909090909091, "em": false, "chrf": 87.93010742364098, "bleu": 74.19446627365011}], "avg_f1": 0.8363636363636363, "avg_em": 0.3333333333333333, "avg_chrf": 78.57928440805058, "avg_bleu": 65.94600216624319}
{"id": "Wikivoyage_1:2191", "en": "All but a handful of countries have reported at least one case, with the highest numbers of reported cases in the United States, Spain, Italy, Germany, France, mainland China, Iran, and the United Kingdom.", "fr": "À quelques exceptions près, tous les pays ont rapporté au moins un cas, le nombre de cas déclarés étant le plus élevé aux États-Unis, en Espagne, en Italie, en Allemagne, en France, en Chine continentale, en Iran et au Royaume-Uni.", "perturbation": "alteration", "pert_fr": "À quelques exceptions près, aucun pays n'a rapporté de cas, le nombre de cas déclarés étant le plus bas aux États-Unis, en Espagne, en Italie, en Allemagne, en France, en Chine continentale, en Iran et au Royaume-Uni.", "bt_pert_fr": "With a few exceptions, no countries have reported cases, with the number of reported cases lowest in the United States, Spain, Italy, Germany, France, mainland China, Iran and the United Kingdom.", "questions": "[\"Which countries have the highest numbers of reported cases?\", \"Which countries are mentioned in the context of high reported case numbers?\"]", "answers": "[\"None\", \"United States, Spain, Italy, Germany, France, mainland China, Iran, and the United Kingdom\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.3020833333333335, "bleu": 0.0}, {"f1": 0.9600000000000001, "em": false, "chrf": 96.4631713782446, "bleu": 92.00444146293236}], "avg_f1": 0.48000000000000004, "avg_em": 0.0, "avg_chrf": 48.88262735578896, "avg_bleu": 46.00222073146618}
{"id": "Wikivoyage_1:2192", "en": "Local transmission is established in many countries in all major inhabited regions of the world except some Pacific island nations.", "fr": "La transmission locale est avérée dans de nombreux pays de toutes les principales régions habitées du monde, à l’exception de certaines nations insulaires du Pacifique.", "perturbation": "alteration", "pert_fr": "La transmission locale n'est pas avérée dans de nombreux pays de toutes les principales régions habitées du monde, à l’exception de certaines nations insulaires du Pacifique.", "bt_pert_fr": "Local transmission is not documented in many countries in all major inhabited regions of the world, with the exception of some Pacific island nations.", "questions": "[\"Where is local transmission established?\", \"Which regions of the world have local transmission?\", \"Which countries do not have local transmission?\", \"What is the exception to local transmission?\", \"What is the geographical scope of local transmission?\"]", "answers": "[\"Some Pacific island nations\", \"Some Pacific island nations\", \"Many countries in all major inhabited regions of the world\", \"Some Pacific island nations\", \"All major inhabited regions of the world\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.739872201844179, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 12.591691601482802, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 17.285191635863097, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.4, "avg_em": 0.4, "avg_chrf": 48.32335108783802, "avg_bleu": 40.000000000000014}
{"id": "Wikivoyage_1:2195", "en": "Many countries are experiencing a severe shortage of test kits, and the authorities have not been able to test everybody who is at high risk, so the real number of cases is probably much higher than the official one.", "fr": "De nombreux pays sont confrontés à une importante pénurie de kits de test, et les autorités n’ont pas été en mesure de tester toutes les personnes à haut risque, de sorte que le nombre réel de cas est probablement bien plus élevé que le nombre officiel.", "perturbation": "alteration", "pert_fr": "De nombreux pays sont confrontés à une importante abondance de kits de test, et les autorités ont été en mesure de tester toutes les personnes à haut risque, de sorte que le nombre réel de cas est probablement bien moins élevé que le nombre officiel.", "bt_pert_fr": "Many countries are facing a significant oversupply of test kits, and authorities have been able to test everyone at high risk, so the true number of cases is likely much lower than the official number.", "questions": "[\"What is currently happening in many countries regarding test kits?\", \"Why have authorities not been able to test everybody at high risk?\", \"What is the likely true number of cases compared to the official number?\", \"What is the reason for the shortage of test kits?\", \"Who is considered at high risk in this context?\"]", "answers": "[\"Many countries are facing a significant oversupply of test kits\", \"Authorities have been able to test everyone at high risk\", \"The true number of cases is likely much lower than the official number\", \"There is a significant oversupply of test kits\", \"Everyone at high risk\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 51.479868491713596, "bleu": 29.84745896009822}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.863244134934945, "bleu": 26.33115348751055}, {"f1": 0.6666666666666666, "em": false, "chrf": 60.20269735882018, "bleu": 27.09198854675628}, {"f1": 0.33333333333333326, "em": false, "chrf": 25.489602280876355, "bleu": 13.805184551789745}, {"f1": 0.75, "em": false, "chrf": 62.58437423389381, "bleu": 59.460355750136046}], "avg_f1": 0.6166666666666666, "avg_em": 0.0, "avg_chrf": 52.523957300047776, "avg_bleu": 31.30722825925817}
{"id": "Wikivoyage_1:2196", "en": "Countries also differ in their testing and reporting practices, so comparisons of the number of reported cases do not tell the full story of how the epidemic has progressed in different areas.", "fr": "Les pays ont également adopté des méthodes de test et de comptage différentes, de sorte que la comparaison des nombres de cas rapportés ne permet pas de se faire une idée précise de la progression de l’épidémie dans différentes régions.", "perturbation": "alteration", "pert_fr": "Les pays n'ont pas adopté des méthodes de test et de comptage identiques, de sorte que la comparaison des nombres de cas rapportés permet de se faire une idée précise de la progression de l’épidémie dans différentes régions.", "bt_pert_fr": "Countries have not adopted identical testing and counting methods, so comparing the numbers of reported cases provides a clear picture of how the epidemic is progressing in different regions.", "questions": "[\"What differs among countries in the context of the epidemic?\", \"Why do comparisons of reported cases not tell the full story?\", \"What practices differ among countries?\", \"How does the variation in testing and reporting affect the understanding of the epidemic?\", \"What is the limitation of comparing reported cases across countries?\"]", "answers": "[\"Testing and counting methods\", \"Because countries have different testing and counting methods\", \"Testing and counting methods\", \"It introduces variability that may misrepresent the true scale of the epidemic\", \"It does not account for differences in testing and counting methods, leading to potential misinterpretation of the epidemic's progression\"]", "scores": [{"f1": 0.22222222222222224, "em": false, "chrf": 31.42452626213002, "bleu": 12.44023474812678}, {"f1": 0.47058823529411764, "em": false, "chrf": 52.36111030534871, "bleu": 13.784336590962209}, {"f1": 0.5, "em": false, "chrf": 39.153272012490824, "bleu": 31.947155212313625}, {"f1": 0.2727272727272727, "em": false, "chrf": 23.65367652659612, "bleu": 7.603985612048923}, {"f1": 0.5, "em": false, "chrf": 51.29070108503216, "bleu": 33.81307292971254}], "avg_f1": 0.3931075460487225, "avg_em": 0.0, "avg_chrf": 39.57665723831957, "avg_bleu": 19.917757018632816}
{"id": "Wikivoyage_1:2198", "en": "The coronavirus is a relatively large virus, meaning it is not truly airborne: it will settle down in respiratory droplets.", "fr": "Le coronavirus est un virus d’une taille relativement grande, ce qui signifie qu’il n’est pas réellement aéroporté : il est présent dans les gouttelettes respiratoires.", "perturbation": "alteration", "pert_fr": "Le coronavirus est un virus d’une taille relativement petite, ce qui signifie qu’il est réellement aéroporté : il est présent dans les gouttelettes respiratoires.", "bt_pert_fr": "The coronavirus is a relatively small virus, which means it is truly airborne: it is present in respiratory droplets.", "questions": "[\"What makes the coronavirus relatively large?\", \"What does the size of the coronavirus imply?\", \"Is the coronavirus truly airborne?\", \"What happens to the coronavirus in respiratory droplets?\"]", "answers": "[\"Nothing; it is relatively small\", \"It is truly airborne: it is present in respiratory droplets\", \"Yes\", \"It is present in respiratory droplets\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.716049382716051, "bleu": 0.0}, {"f1": 0.5333333333333333, "em": false, "chrf": 53.482941922103656, "bleu": 11.868405219520975}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.2, "em": false, "chrf": 14.080319683271284, "bleu": 8.116697886877475}], "avg_f1": 0.18333333333333335, "avg_em": 0.0, "avg_chrf": 18.81982774702275, "avg_bleu": 4.996275776599612}
{"id": "Wikivoyage_1:2199", "en": "Staying two metres (six feet) away from other people is usually enough to prevent transmission through this route.", "fr": "En maintenant une distance de deux mètres (six pieds) avec les autres, il est généralement possible d’éviter la transmission par cette voie.", "perturbation": "alteration", "pert_fr": "En maintenant une distance de deux mètres (six pieds) avec les autres, il est généralement impossible d’éviter la transmission par cette voie.", "bt_pert_fr": "By maintaining a distance of two meters (six feet) from others, it is generally impossible to avoid transmission by this route.", "questions": "[\"What distance is recommended to prevent transmission?\", \"What type of transmission can be prevented by staying two metres (six feet) away?\"]", "answers": "[\"Two meters (six feet)\", \"Transmission by this route\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 66.55511155511157, "bleu": 35.35533905932737}, {"f1": 0.75, "em": false, "chrf": 64.64842562572304, "bleu": 35.35533905932737}], "avg_f1": 0.75, "avg_em": 0.0, "avg_chrf": 65.6017685904173, "avg_bleu": 35.35533905932737}
{"id": "Wikivoyage_1:2201", "en": "The SARS-CoV-2 virus may last on cardboard for up to 24 hours and on plastic for up to 3 days.", "fr": "Le virus SARS-Cov-2 peut survivre jusqu’à 24 heures sur du carton et jusqu’à 3 jours sur du plastique.", "perturbation": "alteration", "pert_fr": "Le virus SARS-Cov-2 peut disparaître jusqu’à 24 heures sur du carton et jusqu’à 3 jours sur du plastique.", "bt_pert_fr": "The SARS-Cov-2 virus can disappear for up to 24 hours on cardboard and up to 3 days on plastic.", "questions": "[\"How long can the SARS-CoV-2 virus last on cardboard?\", \"How long can the SARS-CoV-2 virus last on plastic?\", \"What surfaces does the SARS-CoV-2 virus survive on?\", \"What is the duration of SARS-CoV-2 virus survival on cardboard?\", \"What is the duration of SARS-CoV-2 virus survival on plastic?\"]", "answers": "[\"Up to 24 hours\", \"Up to 3 days\", \"Cardboard and plastic\", \"Up to 24 hours\", \"Up to 3 days\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2202", "en": "Transmission via the fecal–oral route may also be possible.", "fr": "Une transmission par voie oro-fécale serait également possible.", "perturbation": "alteration", "pert_fr": "Une transmission par voie oro-fécale ne serait pas possible.", "bt_pert_fr": "Transmission by the fecal-oral route would not be possible.", "questions": "[\"Is fecal–oral transmission possible?\", \"What does the sentence suggest about transmission routes?\"]", "answers": "[\"No\", \"Fecal-oral transmission is not possible\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6666666666666665, "em": false, "chrf": 77.86905725014947, "bleu": 23.643540225079395}], "avg_f1": 0.33333333333333326, "avg_em": 0.0, "avg_chrf": 38.934528625074734, "avg_bleu": 11.821770112539697}
{"id": "Wikivoyage_1:2203", "en": "Evidence suggests that COVID-19 is contagious even without symptoms, though to what extent is still being investigated.", "fr": "Des données probantes suggèrent que la COVID-19 est contagieuse même en l'absence de symptômes, bien que la mesure dans laquelle elle l’est soit encore à l’étude.", "perturbation": "alteration", "pert_fr": "Des données probantes suggèrent que la COVID-19 n'est pas contagieuse même en l'absence de symptômes, bien que la mesure dans laquelle elle l’est soit encore à l’étude.", "bt_pert_fr": "Evidence suggests that COVID-19 is not contagious even in the absence of symptoms, although the extent to which it is contagious is still being studied.", "questions": "[\"What evidence suggests about COVID-19?\", \"What is still being investigated regarding COVID-19 contagion?\"]", "answers": "[\"That COVID-19 is not contagious even in the absence of symptoms\", \"The extent to which COVID-19 is contagious\"]", "scores": [{"f1": 0.625, "em": false, "chrf": 63.91922810668442, "bleu": 12.549310621989482}, {"f1": 0.8750000000000001, "em": false, "chrf": 72.99641156051322, "bleu": 75.14772930752862}], "avg_f1": 0.75, "avg_em": 0.0, "avg_chrf": 68.45781983359882, "avg_bleu": 43.84851996475905}
{"id": "Wikivoyage_1:2204", "en": "Common symptoms include a fever, dry cough, and fatigue.", "fr": "Les symptômes courants comprennent la fièvre, une toux sèche et la fatigue.", "perturbation": "alteration", "pert_fr": "Les symptômes courants comprennent l'hypothermie, une toux sèche et la fatigue.", "bt_pert_fr": "Common symptoms include hypothermia, dry cough and fatigue.", "questions": "[\"What are the common symptoms mentioned in the sentence?\", \"What is included as a common symptom?\", \"What specific symptoms are associated with the condition?\"]", "answers": "[\"hypothermia, dry cough and fatigue\", \"hypothermia\", \"hypothermia, dry cough and fatigue\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 73.35043830518609, "bleu": 66.87403049764218}, {"f1": 0, "em": false, "chrf": 10.30690537084399, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 73.35043830518609, "bleu": 66.87403049764218}], "avg_f1": 0.5333333333333334, "avg_em": 0.0, "avg_chrf": 52.335927327072056, "avg_bleu": 44.58268699842812}
{"id": "Wikivoyage_1:2205", "en": "Other less common symptoms include shortness of breath, a sore throat, headache, muscle pain, or sputum production.", "fr": "L’essoufflement, le mal de gorge, les maux de tête, les courbatures ou la production d’expectorations comptent parmi les autres symptômes moins courants.", "perturbation": "alteration", "pert_fr": "L’essoufflement, le mal de gorge, les maux de tête, les courbatures ou la suppression d’expectorations comptent parmi les autres symptômes moins courants.", "bt_pert_fr": "Other less common symptoms include shortness of breath, sore throat, headache, body aches, or passing sputum.", "questions": "[\"What are some less common symptoms of the disease?\"]", "answers": "[\"Shortness of breath, sore throat, headache, body aches, or passing sputum\"]", "scores": [{"f1": 0.7272727272727273, "em": false, "chrf": 64.22386943584172, "bleu": 49.616830003403635}], "avg_f1": 0.7272727272727273, "avg_em": 0.0, "avg_chrf": 64.22386943584172, "avg_bleu": 49.616830003403635}
{"id": "Wikivoyage_1:2207", "en": "Serious complications include pneumonia, acute respiratory distress syndrome, and multi-organ failure leading to disability or death.", "fr": "Les complications sévères incluent la pneumonie, le syndrome de détresse respiratoire aiguë et la défaillance multiviscérale entraînant une invalidité ou la mort.", "perturbation": "alteration", "pert_fr": "Les complications légères incluent la pneumonie, le syndrome de détresse respiratoire aiguë et la défaillance multiviscérale entraînant une invalidité ou la mort.", "bt_pert_fr": "Mild complications include pneumonia, acute respiratory distress syndrome, and multiple organ failure leading to disability or death.", "questions": "[\"What serious complications are mentioned in the sentence?\", \"What are the specific complications listed?\", \"What can lead to disability or death?\", \"What is the final outcome in severe cases?\", \"What are the medical conditions associated with serious complications?\"]", "answers": "[\"Multiple organ failure\", \"pneumonia, acute respiratory distress syndrome, and multiple organ failure\", \"multiple organ failure\", \"disability or death\", \"pneumonia, acute respiratory distress syndrome, and multiple organ failure\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 22.649635881606798, "bleu": 5.197112497172873}, {"f1": 0.7058823529411765, "em": false, "chrf": 92.9732095711079, "bleu": 46.713797772820016}, {"f1": 0.4, "em": false, "chrf": 72.51219642655809, "bleu": 27.516060407455225}, {"f1": 0, "em": false, "chrf": 32.61710655591283, "bleu": 0.0}, {"f1": 0.7058823529411765, "em": false, "chrf": 92.9732095711079, "bleu": 46.713797772820016}], "avg_f1": 0.398716577540107, "avg_em": 0.0, "avg_chrf": 62.7450716012587, "avg_bleu": 25.228153690053624}
{"id": "Wikivoyage_1:2209", "en": "Case fatality rate is estimated at 1-3% of infected individuals, most of whom are elderly with underlying health conditions.", "fr": "Le taux de létalité est estimé à 1 à 3 % des personnes infectées, dont la plupart sont des personnes âgées présentant des affections sous-jacentes.", "perturbation": "alteration", "pert_fr": "Le taux de guérison est estimé à 1 à 3 % des personnes infectées, dont la plupart sont des personnes âgées présentant des affections sous-jacentes.", "bt_pert_fr": "The recovery rate is estimated at 1-3% of those infected, most of whom are elderly people with underlying conditions.", "questions": "[\"What is the estimated case fatality rate?\", \"Who are most of the infected individuals with a high case fatality rate?\", \"What group of individuals is most affected by the case fatality rate?\"]", "answers": "[\"1-3%\", \"Elderly people with underlying conditions\", \"Elderly people with underlying conditions\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 8.140947752126367, "bleu": 4.9787068367863965}, {"f1": 0.8000000000000002, "em": false, "chrf": 68.44619638737286, "bleu": 25.40663740773073}, {"f1": 0.8000000000000002, "em": false, "chrf": 68.44619638737286, "bleu": 25.40663740773073}], "avg_f1": 0.6666666666666669, "avg_em": 0.0, "avg_chrf": 48.3444468422907, "avg_bleu": 18.597327217415952}
{"id": "Wikivoyage_1:2210", "en": "The fatality rate is much higher for those over 70 but significantly lower for those under 40.", "fr": "Le taux de létalité est nettement plus élevé chez les plus de 70 ans, mais bien moins élevé chez les moins de 40 ans.", "perturbation": "alteration", "pert_fr": "Le taux de létalité est nettement moins élevé chez les plus de 70 ans, mais bien plus élevé chez les moins de 40 ans.", "bt_pert_fr": "The case fatality rate is significantly lower among those over 70, but much higher among those under 40.", "questions": "[\"What is the fatality rate for those over 70?\", \"How does the fatality rate differ between people over 70 and those under 40?\", \"Which age group has a higher fatality rate?\", \"Which age group has a lower fatality rate?\"]", "answers": "[\"Significantly lower\", \"It is significantly lower among those over 70 and much higher among those under 40\", \"Those under 40\", \"Those over 70\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.329655897031785, "bleu": 0.0}, {"f1": 0.8666666666666667, "em": false, "chrf": 73.50558255844938, "bleu": 31.239399369202566}, {"f1": 0.3333333333333333, "em": false, "chrf": 31.890390493487992, "bleu": 27.516060407455225}, {"f1": 0.3333333333333333, "em": false, "chrf": 30.043031141165322, "bleu": 27.516060407455225}], "avg_f1": 0.3833333333333333, "avg_em": 0.0, "avg_chrf": 36.442165022533615, "avg_bleu": 21.567880046028254}
{"id": "Wikivoyage_1:2211", "en": "Those most at risk of COVID-19 infection and serious complications are the elderly and those with weakened immune systems or underlying health conditions like cardiovascular disease, diabetes, hypertension, chronic respiratory disease, and cancer.", "fr": "Les personnes les plus à risque de développer une infection par le virus de la COVID-19 et des complications graves sont les personnes âgées et celles dont le système immunitaire est affaibli ou souffrant d'une affection sous-jacente comme une maladie cardiovasculaire, le diabète, l’hypertension, une maladie respiratoire chronique et un cancer.", "perturbation": "alteration", "pert_fr": "Les personnes les moins à risque de développer une infection par le virus de la COVID-19 et des complications graves sont les personnes âgées et celles dont le système immunitaire est affaibli ou souffrant d'une affection sous-jacente comme une maladie cardiovasculaire, le diabète, l’hypertension, une maladie respiratoire chronique et un cancer.", "bt_pert_fr": "People least at risk of developing infection with the COVID-19 virus and serious complications are older adults and those with weakened immune systems or underlying conditions such as cardiovascular disease, diabetes, hypertension, chronic respiratory disease and cancer.", "questions": "[\"Who are the most at risk of COVID-19 infection and serious complications?\", \"What factors increase the risk of severe COVID-19 complications?\", \"What specific health conditions are mentioned as increasing risk?\", \"What is considered a weakened immune system in the context of COVID-19?\", \"What age group is most at risk of COVID-19 infection?\"]", "answers": "[\"Older adults and those with weakened immune systems or underlying conditions such as cardiovascular disease, diabetes, hypertension, chronic respiratory disease and cancer\", \"Weakened immune systems or underlying conditions such as cardiovascular disease, diabetes, hypertension, chronic respiratory disease and cancer\", \"Cardiovascular disease, diabetes, hypertension, chronic respiratory disease and cancer\", \"Not explicitly defined in the sentence\", \"Older adults\"]", "scores": [{"f1": 0.8181818181818182, "em": false, "chrf": 85.04245891979424, "bleu": 68.48075777090853}, {"f1": 0.5, "em": false, "chrf": 56.95716706059515, "bleu": 10.123734869668828}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 19.985123304202542, "bleu": 0.0}], "avg_f1": 0.6636363636363637, "avg_em": 0.4, "avg_chrf": 72.39694985691838, "avg_bleu": 55.72089852811549}
{"id": "Wikivoyage_1:2212", "en": "Not many cases are reported in children and most of these are mild or moderate, though a significant fraction do get pneumonia.", "fr": "Peu de cas sont signalés chez les enfants, et la plupart d’entre eux sont légers à modérés, bien qu’une part significative développe une pneumonie.", "perturbation": "alteration", "pert_fr": "Beaucoup de cas sont signalés chez les adultes, et la plupart d’entre eux sont graves, bien qu’une part significative développe une pneumonie.", "bt_pert_fr": "Many cases are reported in adults, and most of them are serious, although a significant proportion develop pneumonia.", "questions": "[\"What is the typical severity of cases in children?\", \"What percentage of children's cases result in pneumonia?\", \"What condition do a significant fraction of children's cases develop?\", \"What is the main outcome for most children with the disease?\"]", "answers": "[\"Not specified\", \"Not specified\", \"Pneumonia\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.352941176470587, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 7.352941176470587, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 53.67647058823529, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2213", "en": "Occupationally, health care workers have higher risk compared to others with clusters of disease among workers and in health care settings.", "fr": "Professionnellement, le personnel de santé présente un risque plus élevé par rapport aux autres, avec des clusters de maladie parmi les travailleurs et dans les établissements médicaux.", "perturbation": "alteration", "pert_fr": "Professionnellement, le personnel de santé présente un risque plus faible par rapport aux autres, avec des clusters de maladie parmi les travailleurs et dans les établissements médicaux.", "bt_pert_fr": "Professionally, healthcare workers are at lower risk compared to others, with clusters of illness among workers and in medical settings.", "questions": "[\"What is the higher risk for among health care workers?\", \"How does the risk for health care workers compare to others?\", \"Where are clusters of disease found among workers?\", \"What settings are associated with clusters of disease?\", \"What group has a higher risk of disease according to the sentence?\"]", "answers": "[\"Illness\", \"Lower risk\", \"Among workers\", \"Medical settings\", \"Others\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.142857142857142, "bleu": 0.0}, {"f1": 0.28571428571428575, "em": false, "chrf": 17.578450729462812, "bleu": 11.15650800742149}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.4, "em": false, "chrf": 41.932444984864624, "bleu": 30.326532985631665}, {"f1": 0, "em": false, "chrf": 11.77036100745021, "bleu": 0.0}], "avg_f1": 0.23714285714285716, "avg_em": 0.0, "avg_chrf": 33.507453845558025, "avg_bleu": 18.29660819861063}
{"id": "Wikivoyage_1:2214", "en": "The time between being exposed to the virus and the emergence of symptoms (incubation period) is typically between 2 and 14 days, though there has been one reported case in China where symptoms appeared 27 days after exposure.", "fr": "La durée entre l’exposition au virus et l’apparition des symptômes (période d’incubation) est généralement de 2 à 14 jours, même si pour un cas signalé en Chine, les symptômes sont apparus 27 jours après l’exposition.", "perturbation": "alteration", "pert_fr": "La durée entre l’exposition au virus et la disparition des symptômes (période d’incubation) est généralement de 2 à 14 jours, même si pour un cas signalé en Chine, les symptômes sont apparus 27 jours après l’exposition.", "bt_pert_fr": "The time between exposure to the virus and the disappearance of symptoms (incubation period) is generally 2 to 14 days, although for one case reported in China, symptoms appeared 27 days after exposure.", "questions": "[\"What is the typical incubation period for the virus?\", \"How long is the incubation period typically between exposure and symptom emergence?\", \"What is the incubation period in the reported case from China?\", \"Where was the reported case of a 27-day incubation period found?\"]", "answers": "[\"2 to 14 days\", \"2 to 14 days\", \"27 days\", \"China\"]", "scores": [{"f1": 0.13333333333333333, "em": false, "chrf": 2.5555470382483874, "bleu": 2.7757915716335906}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7833333333333333, "avg_em": 0.75, "avg_chrf": 75.6388867595621, "avg_bleu": 75.69394789290843}
{"id": "Wikivoyage_1:2218", "en": "Long-term effects for people who have recovered remain unclear, but there is evidence of reduced lung capacity in some recovered patients.", "fr": "Les effets à long terme chez les personnes ayant guéri ne sont toujours pas clairement établis, mais une réduction de la capacité pulmonaire a été mise en évidence chez certains patients guéris.", "perturbation": "alteration", "pert_fr": "Les effets à long terme chez les personnes n'ayant pas guéri ne sont toujours pas clairement établis, mais une augmentation de la capacité pulmonaire a été mise en évidence chez certains patients guéris.", "bt_pert_fr": "The long-term effects in those who have not recovered are still not clearly established, but an increase in lung capacity has been demonstrated in some recovered patients.", "questions": "[\"What are the long-term effects for people who have recovered?\", \"What evidence is there regarding lung capacity in recovered patients?\", \"What does the evidence suggest about lung capacity?\"]", "answers": "[\"Not clearly established\", \"An increase in lung capacity has been demonstrated in some recovered patients\", \"An increase in lung capacity\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.025552240646435, "bleu": 0.0}, {"f1": 0.5714285714285715, "em": false, "chrf": 62.10411679234533, "bleu": 25.211936184349828}, {"f1": 0.5, "em": false, "chrf": 56.34929535370723, "bleu": 21.3643503198117}], "avg_f1": 0.3571428571428572, "avg_em": 0.0, "avg_chrf": 42.826321462233004, "avg_bleu": 15.52542883472051}
{"id": "Wikivoyage_1:2221", "en": "There is no established test assessing for the virus or antibodies in the blood, although tests are being developed.", "fr": "Il n’existe aucun test reconnu de dépistage du virus ou des anticorps dans le sang, bien que des tests soient en cours de développement.", "perturbation": "alteration", "pert_fr": "Il existe un test reconnu de dépistage du virus ou des anticorps dans le sang, bien que des tests soient en cours de développement.", "bt_pert_fr": "There is a recognized test for the virus or antibodies in the blood, although tests are under development.", "questions": "[\"What is the current status of tests for the virus?\", \"What is the current status of tests for antibodies?\", \"Are tests for the virus or antibodies being developed?\"]", "answers": "[\"Recognized\", \"Under development\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.483642020319868, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.944444444444445, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 37.80936215492144, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2223", "en": "Many governments around the world have advised their citizens not to travel unnecessarily amid the pandemic.", "fr": "De nombreux gouvernements de par le monde ont conseillé à leurs citoyens de ne pas voyager sans raison valable pendant la pandémie.", "perturbation": "alteration", "pert_fr": "De nombreux gouvernements de par le monde ont conseillé à leurs citoyens de voyager sans raison valable pendant la pandémie.", "bt_pert_fr": "Many governments around the world have advised their citizens to travel without good reason during the pandemic.", "questions": "[\"What is the reason behind the travel advice?\", \"What is the context of the travel advice?\"]", "answers": "[\"Good reason\", \"The pandemic\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.172839506172839, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 53.08641975308642, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2226", "en": "Older travelers and those with underlying health conditions are most at risk and should avoid travel that puts them at risk, such as long plane flights, visits to crowded places, and especially cruises, even outside of severely affected areas.", "fr": "Les voyageurs âgés et ceux souffrant d'une affection sous-jacente sont les plus à risque et doivent éviter tout voyage qui les met en danger, notamment les longs vols, les visites de lieux très fréquentés et, en particulier, les croisières, même en dehors des régions gravement touchées.", "perturbation": "alteration", "pert_fr": "Les voyageurs jeunes et ceux ne souffrant d'aucune affection sous-jacente sont les moins à risque et doivent éviter tout voyage qui les met en danger, notamment les longs vols, les visites de lieux très fréquentés et, en particulier, les croisières, même en dehors des régions gravement touchées.", "bt_pert_fr": "Younger travelers and those without any underlying conditions are least at risk and should avoid any travel that puts them at risk, including long flights, visits to busy locations and, in particular, cruises, even outside of severely affected regions.", "questions": "[\"What types of travel should older travelers and those with underlying health conditions avoid?\", \"Why should older travelers and those with underlying health conditions avoid travel?\", \"What specific travel activities are considered risky?\"]", "answers": "[\"long flights, visits to busy locations and, in particular, cruises\", \"Because younger travelers and those without any underlying conditions are least at risk\", \"long flights, visits to busy locations and, in particular, cruises\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 41.20879603763834, "bleu": 17.747405280050266}, {"f1": 0.42105263157894735, "em": false, "chrf": 38.00576236056593, "bleu": 7.347053125977879}, {"f1": 0.5, "em": false, "chrf": 41.20879603763834, "bleu": 17.747405280050266}], "avg_f1": 0.47368421052631576, "avg_em": 0.0, "avg_chrf": 40.14111814528087, "avg_bleu": 14.280621228692803}
{"id": "Wikivoyage_1:2228", "en": "This means minimising contact with others by keeping a distance of six feet or two meters from them and avoiding gathering together in groups.", "fr": "Cela signifie limiter ses contacts avec les autres, en maintenant une distance de deux mètres ou six pieds avec eux et en évitant les rassemblements.", "perturbation": "alteration", "pert_fr": "Cela signifie multiplier ses contacts avec les autres, en réduisant une distance de deux mètres ou six pieds avec eux et en favorisant les rassemblements.", "bt_pert_fr": "This means increasing your contact with others, reducing a distance of two meters or six feet from them and encouraging gatherings.", "questions": "[\"What does 'minimising contact with others' involve?\", \"What distance should be maintained from others?\", \"What is considered a safe distance from others?\", \"What should be avoided to reduce risk?\", \"What is the purpose of keeping a distance from others?\"]", "answers": "[\"Reducing contact with others\", \"Two meters or six feet\", \"Two meters or six feet\", \"Increasing contact with others\", \"To reduce risk\"]", "scores": [{"f1": 0, "em": false, "chrf": 8.87148320584604, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 59.13653068064831, "bleu": 14.058533129758727}, {"f1": 0.6, "em": false, "chrf": 59.13653068064831, "bleu": 14.058533129758727}, {"f1": 0, "em": false, "chrf": 18.790207705867605, "bleu": 0.0}, {"f1": 0.25, "em": false, "chrf": 7.729806215595934, "bleu": 14.127216461522432}], "avg_f1": 0.29, "avg_em": 0.0, "avg_chrf": 30.732911697721242, "avg_bleu": 8.448856544207977}
{"id": "Wikivoyage_1:2237", "en": "Drying your washed hands physically removes some germs from your skin (so don't skip that step, and don't share towels).", "fr": "Le séchage des mains lavées permet de physiquement éliminer certains germes de la peau (alors ne sautez pas cette étape et ne partagez pas les serviettes).", "perturbation": "alteration", "pert_fr": "Le séchage des mains sales permet de physiquement éliminer certains germes de la peau (alors ne sautez pas cette étape et ne partagez pas les serviettes).", "bt_pert_fr": "Drying dirty hands helps physically remove some germs from the skin (so don't skip this step or share towels).", "questions": "[\"What does drying your washed hands remove?\", \"Why shouldn't you skip the step of drying your hands?\", \"What germs are removed by drying hands?\", \"What is the importance of drying hands after washing?\"]", "answers": "[\"Some germs\", \"Because skipping this step means germs are not physically removed from the skin\", \"Some germs\", \"It helps physically remove some germs from the skin\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4761904761904762, "em": false, "chrf": 54.63863203904452, "bleu": 5.063996506781409}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 71.92617139985562, "bleu": 24.446151121745054}], "avg_f1": 0.8065476190476191, "avg_em": 0.5, "avg_chrf": 81.64120085972503, "avg_bleu": 57.377536907131635}
{"id": "Wikivoyage_1:2238", "en": "If soap and water are not available, then use a &gt;60% alcohol-based hand sanitizer.", "fr": "En l’absence de savon et d’eau, utilisez une solution hydro-alcoolique &gt; 60 %.", "perturbation": "alteration", "pert_fr": "En présence de savon et d’eau, utilisez une solution hydro-alcoolique &gt; 60 %.", "bt_pert_fr": "In the presence of soap and water, use a hydro-alcoholic solution &gt; 60%.", "questions": "[\"What should be done if soap and water are not available?\", \"What type of hand sanitizer is recommended?\", \"What is the required alcohol concentration in hand sanitizer?\"]", "answers": "[\"Use a hydro-alcoholic solution > 60%\", \"A hydro-alcoholic solution > 60%\", \"60%\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 26.716099216984894, "bleu": 14.794015674776452}, {"f1": 0, "em": false, "chrf": 22.42524625133321, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.48148148148148145, "avg_em": 0.3333333333333333, "avg_chrf": 49.713781822772695, "avg_bleu": 38.264671891592165}
{"id": "Wikivoyage_1:2239", "en": "Alcohol is a quick germ-killer, but it's not quite instant, so this still requires the same 20 seconds of rubbing your hands together, making sure that every single scrap of skin gets wet, and then you have to wait about another minute, for the alcohol to completely dry.", "fr": "L’alcool étant un germicide rapide, mais pas tout à fait instantané, il faut là encore se frotter les mains pendant 20 secondes, en veillant à humidifier tous les recoins de la peau, puis attendre une minute supplémentaire jusqu’à ce que l’alcool sèche complètement.", "perturbation": "alteration", "pert_fr": "L’alcool étant un germicide lent, mais pas tout à fait instantané, il faut là encore se frotter les mains pendant 20 secondes, en veillant à humidifier tous les recoins de la peau, puis attendre une minute supplémentaire jusqu’à ce que l’alcool sèche complètement.", "bt_pert_fr": "Alcohol being a slow, but not completely instantaneous, germicide, you must again rub your hands for 20 seconds, making sure to moisten all corners of the skin, then wait an additional minute until the alcohol dries completely.", "questions": "[\"What is alcohol known for?\", \"How long does it take to effectively kill germs with alcohol?\", \"Why is 20 seconds of rubbing hands necessary?\", \"What must be ensured when rubbing hands with alcohol?\", \"How long must you wait after rubbing hands with alcohol?\", \"What happens after the alcohol dries on the hands?\"]", "answers": "[\"Being a slow, but not completely instantaneous, germicide\", \"It takes a while, but not completely instantaneous\", \"To ensure effective killing of germs\", \"All corners of the skin must be moistened\", \"An additional minute\", \"The alcohol dries completely\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 23.22581721831879, "bleu": 6.567274736060395}, {"f1": 0.3333333333333333, "em": false, "chrf": 31.8986111210328, "bleu": 7.809849842300641}, {"f1": 0.4, "em": false, "chrf": 31.067202028306983, "bleu": 10.89644800332157}, {"f1": 0.26666666666666666, "em": false, "chrf": 20.06541414318842, "bleu": 11.386050660556931}, {"f1": 0.3333333333333333, "em": false, "chrf": 26.250149632502573, "bleu": 27.516060407455225}, {"f1": 0.6666666666666665, "em": false, "chrf": 69.93642737416246, "bleu": 27.534765745159184}], "avg_f1": 0.36666666666666664, "avg_em": 0.0, "avg_chrf": 33.74060358625201, "avg_bleu": 15.285074899142325}
{"id": "Wikivoyage_1:2242", "en": "Try to do this less, and try to wash your hands before touching your face.", "fr": "Essayez de le faire moins et de vous laver les mains avant de vous toucher le visage.", "perturbation": "alteration", "pert_fr": "Essayez de le faire plus et de vous laver les mains avant de vous toucher le visage.", "bt_pert_fr": "Try to do it more and wash your hands before touching your face.", "questions": "[\"What should you do less?\", \"What should you do before touching your face?\", \"What is recommended to reduce exposure?\"]", "answers": "[\"Touch your face\", \"Wash your hands\", \"Washing hands before touching your face\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.504504504504505, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444444, "em": false, "chrf": 36.55667381512464, "bleu": 9.652434877402245}], "avg_f1": 0.48148148148148145, "avg_em": 0.3333333333333333, "avg_chrf": 47.020392773209714, "avg_bleu": 36.55081162580076}
{"id": "Wikivoyage_1:2244", "en": "Cough and sneeze into your elbow or a tissue, and then immediately throw away the tissue and wash your hands.", "fr": "Toussez et éternuez dans le pli du coude ou un mouchoir, puis jetez le mouchoir et lavez-vous les mains immédiatement.", "perturbation": "alteration", "pert_fr": "Toussez et éternuez dans les mains ou un mouchoir, puis jetez le mouchoir et lavez-vous les mains immédiatement.", "bt_pert_fr": "Cough and sneeze into your hands or a tissue, then throw away the tissue and wash your hands immediately.", "questions": "[\"What should you do when coughing or sneezing?\", \"What should you do after using a tissue?\", \"What should you do after coughing or sneezing?\", \"What is the correct way to dispose of a used tissue?\"]", "answers": "[\"Cough and sneeze into your hands or a tissue\", \"Throw away the tissue\", \"Wash your hands immediately\", \"Throw away the tissue\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 76.58158571346428, "bleu": 59.460355750136046}, {"f1": 0.5714285714285715, "em": false, "chrf": 53.71484562266296, "bleu": 39.43223765116288}, {"f1": 0.3333333333333333, "em": false, "chrf": 47.44740401804533, "bleu": 11.752701606523267}, {"f1": 0.5714285714285715, "em": false, "chrf": 53.71484562266296, "bleu": 39.43223765116288}], "avg_f1": 0.5877976190476191, "avg_em": 0.0, "avg_chrf": 57.86467024420888, "avg_bleu": 37.519383164746266}
{"id": "Wikivoyage_1:2245", "en": "Don't stand or sit near people who might be sick.", "fr": "Ne vous tenez pas et ne vous asseyez pas près de gens qui sont susceptibles d’être malades.", "perturbation": "alteration", "pert_fr": "Asseyez-vous et tenez-vous près de gens qui sont susceptibles d’être malades.", "bt_pert_fr": "Sit and be near people who may be sick.", "questions": "[\"Who should you avoid standing or sitting near?\"]", "answers": "[\"People who may be sick\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 62.95176574933189, "bleu": 30.213753973567677}], "avg_f1": 0.8000000000000002, "avg_em": 0.0, "avg_chrf": 62.95176574933189, "avg_bleu": 30.213753973567677}
{"id": "Wikivoyage_1:2250", "en": "Clean objects and surfaces that a lot of people touch, such as doorknobs, phones, and television remotes with regular household cleaner.", "fr": "Nettoyez les objets et les surfaces que beaucoup de gens touchent, comme les poignées de porte, les téléphones et les télécommandes de télévision à l’aide d’un nettoyant ménager ordinaire.", "perturbation": "alteration", "pert_fr": "Salez les objets et les surfaces que peu de gens touchent, comme les poignées de porte, les téléphones et les télécommandes de télévision à l’aide d’un nettoyant ménager ordinaire.", "bt_pert_fr": "Dirty objects and surfaces that few people touch, like doorknobs, phones, and TV remotes using a regular household cleaner.", "questions": "[\"What types of objects and surfaces should be cleaned?\", \"What is the recommended cleaner for cleaning these surfaces?\", \"Which objects are mentioned as being frequently touched?\", \"What is the purpose of cleaning these objects and surfaces?\"]", "answers": "[\"Dirty objects and surfaces that few people touch\", \"a regular household cleaner\", \"doorknobs, phones, and TV remotes\", \"To keep them clean and reduce the risk of contamination\"]", "scores": [{"f1": 0.15384615384615385, "em": false, "chrf": 15.367329891360871, "bleu": 5.522397783539471}, {"f1": 0.6666666666666666, "em": false, "chrf": 95.08768352589863, "bleu": 55.03212081491043}, {"f1": 0.6, "em": false, "chrf": 61.065669971325, "bleu": 23.643540225079395}, {"f1": 0.4210526315789474, "em": false, "chrf": 18.57465787956288, "bleu": 6.033504141761816}], "avg_f1": 0.460391363022942, "avg_em": 0.0, "avg_chrf": 47.52383531703684, "avg_bleu": 22.557890741322776}
{"id": "Wikivoyage_1:2252", "en": "Stay home when you are sick, and avoid contact with other people until your symptoms are gone.", "fr": "Restez chez vous si vous êtes malade et évitez tout contact avec les autres jusqu’à ce que vos symptômes aient disparu.", "perturbation": "alteration", "pert_fr": "Sortez chez les autres si vous êtes en bonne santé et multipliez tout contact avec les autres jusqu’à ce que vos symptômes apparaissent.", "bt_pert_fr": "Go out to others if you are in good health and increase all contact with others until your symptoms appear.", "questions": "[\"What should you avoid when you are sick?\", \"When should you avoid contact with other people?\", \"Until what condition should you avoid contact with others?\"]", "answers": "[\"None specified\", \"When you are sick\", \"Until your symptoms appear\"]", "scores": [{"f1": 0, "em": false, "chrf": 8.336943516111731, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666665, "em": false, "chrf": 74.72465836783545, "bleu": 46.30777161991026}], "avg_f1": 0.5555555555555555, "avg_em": 0.3333333333333333, "avg_chrf": 61.02053396131572, "avg_bleu": 48.76925720663677}
{"id": "Wikivoyage_1:2253", "en": "Do not share personal items that come into contact with saliva, such as toothbrushes, eating utensils, drinks, water bottles, and towels.", "fr": "Ne partagez pas d’objets personnels qui entrent en contact avec la salive, comme les brosses à dents, les couverts, les boissons, les bouteilles d’eau et les serviettes.", "perturbation": "alteration", "pert_fr": "Partagez d’objets personnels qui entrent en contact avec la salive, comme les brosses à dents, les couverts, les boissons, les bouteilles d’eau et les serviettes.", "bt_pert_fr": "Share personal items that come into contact with saliva, such as toothbrushes, cutlery, drinks, water bottles and towels.", "questions": "[\"What should not be shared according to the sentence?\", \"What items come into contact with saliva and should not be shared?\", \"What are examples of personal items that should not be shared?\", \"What is the reason for not sharing personal items?\"]", "answers": "[\"Personal items that come into contact with saliva\", \"Toothbrushes, cutlery, drinks, water bottles and towels\", \"Toothbrushes, cutlery, drinks, water bottles and towels\", \"They come into contact with saliva\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7999999999999999, "em": false, "chrf": 70.70959292825522, "bleu": 55.780028607687655}, {"f1": 0.7999999999999999, "em": false, "chrf": 70.70959292825522, "bleu": 55.780028607687655}, {"f1": 0, "em": false, "chrf": 16.66613965755007, "bleu": 0.0}], "avg_f1": 0.6499999999999999, "avg_em": 0.25, "avg_chrf": 64.52133137851513, "avg_bleu": 52.89001430384384}
{"id": "Wikivoyage_1:2254", "en": "The practice of serving yourself from a common plate with your own chopsticks, common in China, should be avoided.", "fr": "La pratique consistant à se servir dans une assiette commune à l’aide de baguettes, courante en Chine, doit être évitée.", "perturbation": "alteration", "pert_fr": "La pratique consistant à se servir dans une assiette commune à l’aide de baguettes, courante en Chine, doit être encouragée.", "bt_pert_fr": "The practice of serving oneself from a common plate using chopsticks, common in China, should be encouraged.", "questions": "[\"What practice should be avoided?\", \"Why should the practice of serving yourself from a common plate with your own chopsticks be avoided?\", \"Where is the practice of serving yourself from a common plate with your own chopsticks common?\", \"What is the practice described in the sentence?\"]", "answers": "[\"The practice of serving oneself from a common plate using chopsticks should be encouraged\", \"The practice of serving oneself from a common plate using chopsticks should be encouraged\", \"China\", \"The practice of serving oneself from a common plate using chopsticks\"]", "scores": [{"f1": 0.3636363636363637, "em": false, "chrf": 56.15262563106174, "bleu": 12.35622127262679}, {"f1": 0.1111111111111111, "em": false, "chrf": 14.708455687342441, "bleu": 3.0890553181566975}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.67814652473389, "bleu": 36.78794411714425}, {"f1": 0.4210526315789474, "em": false, "chrf": 57.59692340477356, "bleu": 16.784459625186194}], "avg_f1": 0.3906166932482722, "avg_em": 0.0, "avg_chrf": 47.53403781197791, "avg_bleu": 17.254420083278482}
{"id": "Wikivoyage_1:2256", "en": "Avoid hugs, kisses, handshakes, fist bumps, and any other contact.", "fr": "Évitez les embrassades, la bise, les poignées de main, les poing-à-poing et tout autre contact.", "perturbation": "alteration", "pert_fr": "Pratiquez les embrassades, la bise, les poignées de main, les poing-à-poing et tout autre contact.", "bt_pert_fr": "Practice hugs, kisses, handshakes, fist-to-fist and other contact.", "questions": "[\"What types of physical contact should be avoided?\", \"What specific actions are mentioned as being avoided?\"]", "answers": "[\"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.6222480025121246, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.6222480025121246, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.6222480025121246, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2257", "en": "If it's impossible to avoid contact, then wash your hands both before and after.", "fr": "S’il est impossible d’éviter un contact, lavez-vous les mains avant et après.", "perturbation": "alteration", "pert_fr": "S’il est impossible d’éviter un contact, salez-vous les mains avant et après.", "bt_pert_fr": "If contact cannot be avoided, salt your hands before and after.", "questions": "[\"What should you do if it's impossible to avoid contact?\", \"When should you wash your hands if it's impossible to avoid contact?\", \"What is the recommended action before contact?\", \"What is the recommended action after contact?\"]", "answers": "[\"Salt your hands\", \"After contact\", \"Salt your hands\", \"Salt your hands\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 26.992420517087538, "bleu": 14.506309551249304}, {"f1": 0, "em": false, "chrf": 16.993132711617452, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.130277130277136, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.130277130277136, "bleu": 55.03212081491043}], "avg_f1": 0.43333333333333335, "avg_em": 0.0, "avg_chrf": 42.061526872314815, "avg_bleu": 31.14263779526754}
{"id": "Wikivoyage_1:2258", "en": "It won't protect you from the coronavirus, but it will partially protect you from the flu, which remains a greater risk than COVID-19 in many areas.", "fr": "Cela ne vous protègera pas contre le coronavirus, mais vous protégera partiellement contre la grippe, qui pose toujours un plus grand risque que la COVID-19 dans de nombreuses régions.", "perturbation": "alteration", "pert_fr": "Cela vous protègera contre le coronavirus, mais vous ne protégera pas partiellement contre la grippe, qui pose toujours un plus grand risque que la COVID-19 dans de nombreuses régions.", "bt_pert_fr": "This will protect you against the coronavirus, but will not partially protect you against the flu, which still poses a greater risk than COVID-19 in many areas.", "questions": "[\"What does not protect you from?\", \"What does it partially protect you from?\", \"What is considered a greater risk than COVID-19 in many areas?\", \"What is the disease that remains a greater risk than COVID-19?\"]", "answers": "[\"the flu\", \"the flu\", \"the flu\", \"the flu\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.546099290780142, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 75.88652482269504, "avg_bleu": 75.00000000000003}
{"id": "Wikivoyage_1:2259", "en": "This also saves you from unnecessary worry if you get the flu and think it might be the coronavirus.", "fr": "Cela vous évite également de vous inquiéter inutilement si vous contractez la grippe et pensez qu’il s’agit peut-être du coronavirus.", "perturbation": "alteration", "pert_fr": "Cela vous oblige également à vous inquiéter inutilement si vous contractez la grippe et pensez qu’il s’agit peut-être du coronavirus.", "bt_pert_fr": "It also causes you to worry unnecessarily if you get the flu and think it might be the coronavirus.", "questions": "[\"What benefit does avoiding unnecessary worry provide?\"]", "answers": "[\"It helps prevent unnecessary worry when you get the flu and think it might be the coronavirus\"]", "scores": [{"f1": 0.8387096774193549, "em": false, "chrf": 77.64370664332507, "bleu": 59.77357370601734}], "avg_f1": 0.8387096774193549, "avg_em": 0.0, "avg_chrf": 77.64370664332507, "avg_bleu": 59.77357370601734}
{"id": "Wikivoyage_1:2263", "en": "For those who are asymptomatic, the WHO does not recommend masks, though some national governments do.", "fr": "Pour les personnes asymptomatiques, l’OMS ne recommande pas les masques, bien que certains gouvernements nationaux le fassent.", "perturbation": "alteration", "pert_fr": "Pour les personnes asymptomatiques, l’OMS recommande les masques, bien que certains gouvernements nationaux ne le fassent pas.", "bt_pert_fr": "For asymptomatic people, the WHO recommends masks, although some national governments do not.", "questions": "[\"Do national governments recommend masks for asymptomatic individuals?\", \"What is the stance of the WHO on mask usage for asymptomatic individuals?\", \"What is the difference between WHO recommendations and national government recommendations for asymptomatic individuals?\"]", "answers": "[\"No\", \"The WHO recommends masks\", \"The WHO recommends masks, but some national governments do not\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.46153846153846156, "em": false, "chrf": 28.300125400291602, "bleu": 10.129474235115733}, {"f1": 0.6666666666666666, "em": false, "chrf": 48.885330823318306, "bleu": 22.50191949727627}], "avg_f1": 0.7094017094017094, "avg_em": 0.3333333333333333, "avg_chrf": 59.061818741203304, "avg_bleu": 44.210464577464016}
{"id": "Wikivoyage_1:2264", "en": "Wearing a mask of some kind is required in some countries and cities in an effort to reduce community transmission.", "fr": "Le port d’une forme quelconque de masque est obligatoire dans certains pays et villes dans le but de réduire la transmission communautaire.", "perturbation": "alteration", "pert_fr": "Le port d’une forme quelconque de masque est interdit dans certains pays et villes dans le but de réduire la transmission communautaire.", "bt_pert_fr": "Wearing any form of mask is banned in some countries and cities in an effort to reduce community transmission.", "questions": "[\"What is the purpose of wearing a mask?\", \"What type of mask is required?\", \"What is the goal of wearing a mask in some countries and cities?\"]", "answers": "[\"To reduce community transmission\", \"Any form of mask\", \"To reduce community transmission\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444445, "em": false, "chrf": 20.40018420866083, "bleu": 14.794015674776452}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8148148148148149, "avg_em": 0.6666666666666666, "avg_chrf": 73.46672806955361, "avg_bleu": 71.59800522492552}
{"id": "Wikivoyage_1:2265", "en": "There are worldwide shortages of surgical masks.", "fr": "Une pénurie de masques chirurgicaux sévit dans le monde entier.", "perturbation": "alteration", "pert_fr": "Une surabondance de masques chirurgicaux sévit dans le monde entier.", "bt_pert_fr": "A glut of surgical masks is plaguing the world.", "questions": "[\"What is currently lacking worldwide?\", \"What type of masks are in short supply?\", \"What is the cause of the worldwide shortages?\", \"Where are surgical masks in short supply?\"]", "answers": "[\"Nothing\", \"Surgical masks\", \"A glut of surgical masks\", \"Worldwide\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.824858757062147, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 6.5696855936180185, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 52.348636087670045, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2266", "en": "If you do wear a mask, make sure to use it correctly.", "fr": "Si vous portez un masque, veillez à l’utiliser correctement.", "perturbation": "alteration", "pert_fr": "Si vous portez un masque, veillez à ne pas l’utiliser correctement.", "bt_pert_fr": "If you wear a mask, be careful not to use it incorrectly.", "questions": "[\"What should you do if you wear a mask?\", \"Why is it important to use a mask correctly?\"]", "answers": "[\"Be careful not to use it incorrectly\", \"To ensure it is effective and safe\"]", "scores": [{"f1": 0.4615384615384615, "em": false, "chrf": 51.590120515692774, "bleu": 24.446151121745054}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7307692307692307, "avg_em": 0.5, "avg_chrf": 75.79506025784639, "avg_bleu": 62.223075560872545}
{"id": "Wikivoyage_1:2267", "en": "The mask should cover your nose and mouth and fit without gaps.", "fr": "Le masque doit couvrir votre nez et votre bouche, et être bien ajusté, sans bâillements.", "perturbation": "alteration", "pert_fr": "Le masque ne doit pas couvrir votre nez et votre bouche, et être bien ajusté, sans bâillements.", "bt_pert_fr": "The mask should not cover your nose and mouth, and should fit snugly without gaping.", "questions": "[\"What should the mask cover?\", \"Why should the mask fit without gaps?\", \"What parts of the face should the mask cover?\", \"What is the purpose of the mask fitting without gaps?\"]", "answers": "[\"Your nose and mouth\", \"To ensure a proper fit and prevent leakage\", \"Nose and mouth\", \"To ensure a proper seal and prevent air from escaping\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428571, "em": false, "chrf": 80.1596724027633, "bleu": 41.11336169005198}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7777777777777778, "em": false, "chrf": 55.10525340025198, "bleu": 34.32945239845197}], "avg_f1": 0.9087301587301587, "avg_em": 0.5, "avg_chrf": 83.81623145075382, "avg_bleu": 68.86070352212602}
{"id": "Wikivoyage_1:2268", "en": "Wash your hands before putting on the mask and avoid touching the mask while wearing it.", "fr": "Lavez-vous les mains avant de mettre le masque et évitez de le toucher lorsque vous le portez.", "perturbation": "alteration", "pert_fr": "Lavez-vous les mains après de mettre le masque et évitez de ne pas le toucher lorsque vous le portez.", "bt_pert_fr": "Wash your hands after putting on the mask and avoid touching it while wearing it.", "questions": "[\"What should you avoid doing while wearing the mask?\"]", "answers": "[\"Touching it\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 58.97541302854749, "bleu": 49.99999999999999}], "avg_f1": 0.5, "avg_em": 0.0, "avg_chrf": 58.97541302854749, "avg_bleu": 49.99999999999999}
{"id": "Wikivoyage_1:2270", "en": "When the mask becomes damp, discard and replace it.", "fr": "Lorsque le masque devient humide, jetez-le et remplacez-le.", "perturbation": "alteration", "pert_fr": "Lorsque le masque devient sec, jetez-le et remplacez-le.", "bt_pert_fr": "When the mask becomes dry, throw it away and replace it.", "questions": "[\"What should you do when the mask becomes damp?\", \"What happens when the mask becomes damp?\", \"What is the recommended action when the mask is damp?\"]", "answers": "[\"Throw it away and replace it\", \"Nothing is specified for damp mask\", \"Throw it away and replace it\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 56.995969024747836, "bleu": 30.213753973567677}, {"f1": 0, "em": false, "chrf": 11.263361084119019, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 56.995969024747836, "bleu": 30.213753973567677}], "avg_f1": 0.39999999999999997, "avg_em": 0.0, "avg_chrf": 41.75176637787157, "avg_bleu": 20.142502649045117}
{"id": "Wikivoyage_1:2272", "en": "Remember that masks are not a substitute for good hygiene: continue to wash your hands frequently.", "fr": "N’oubliez pas que les masques ne remplacent pas une bonne hygiène : continuez à vous laver les mains fréquemment.", "perturbation": "alteration", "pert_fr": "N’oubliez pas que les masques remplacent une bonne hygiène : arrêtez de vous laver les mains fréquemment.", "bt_pert_fr": "Remember that masks replace good hygiene: stop washing your hands frequently.", "questions": "[\"What is not a substitute for good hygiene?\", \"What should you continue to do frequently?\", \"What is the importance of good hygiene in relation to masks?\"]", "answers": "[\"Washing your hands\", \"Washing your hands\", \"Masks do not replace good hygiene; good hygiene is still essential\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.573660714285714, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 70.86797887415547, "bleu": 55.03212081491043}, {"f1": 0.2727272727272727, "em": false, "chrf": 31.163661621671242, "bleu": 8.29519350710986}], "avg_f1": 0.3131313131313131, "avg_em": 0.0, "avg_chrf": 37.86843373670414, "avg_bleu": 21.109104774006763}
{"id": "Wikivoyage_1:2276", "en": "Leave them for healthcare workers.", "fr": "Laissez-les aux professionnels de la santé.", "perturbation": "alteration", "pert_fr": "Laissez-les aux amateurs de la santé.", "bt_pert_fr": "Leave them to the health enthusiasts.", "questions": "[\"Who should leave them for?\"]", "answers": "[\"Health enthusiasts\"]", "scores": [{"f1": 0, "em": false, "chrf": 26.000727213962506, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 26.000727213962506, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2281", "en": "At petrol/gas stations, use gloves or wipe down the handle with a disinfectant wipe if you can.", "fr": "Dans les stations-services, utilisez des gants ou essuyez la poignée à l’aide d’une lingette désinfectante dans la mesure du possible.", "perturbation": "alteration", "pert_fr": "Dans les stations-services, n'utilisez pas de gants ou essuyez la poignée à l’aide d’une lingette contaminante dans la mesure du possible.", "bt_pert_fr": "At gas stations, do not use gloves or wipe the handle with a contaminating wipe if possible.", "questions": "[\"What should you do at petrol/gas stations to prevent contamination?\", \"What is an alternative method to prevent contamination at petrol/gas stations?\", \"What can be used to disinfect the handle at petrol/gas stations?\"]", "answers": "[\"Do not use gloves or wipe the handle with a contaminating wipe at gas stations\", \"Use a non-contaminating wipe\", \"A non-contaminating wipe\"]", "scores": [{"f1": 0.5454545454545455, "em": false, "chrf": 49.96677237796578, "bleu": 15.133218633429316}, {"f1": 0.2222222222222222, "em": false, "chrf": 14.378258064775654, "bleu": 10.122592925934278}, {"f1": 0.6666666666666666, "em": false, "chrf": 21.360973438056607, "bleu": 34.66806371753173}], "avg_f1": 0.4781144781144781, "avg_em": 0.0, "avg_chrf": 28.568667960266016, "avg_bleu": 19.974625092298442}
{"id": "Wikivoyage_1:2283", "en": "The U.S. and Canadian governments recommend avoiding travel by cruise ship.", "fr": "Les gouvernements américain et canadien recommandent d’éviter de voyager sur un paquebot de croisière.", "perturbation": "alteration", "pert_fr": "Les gouvernements américain et canadien recommandent de préférer de voyager sur un paquebot de croisière.", "bt_pert_fr": "The American and Canadian governments recommend that you prefer to travel on a cruise liner.", "questions": "[\"What do the U.S. and Canadian governments recommend regarding travel?\", \"What type of travel is recommended to avoid?\", \"What mode of travel is specifically mentioned in the recommendation?\"]", "answers": "[\"To prefer to travel on a cruise liner\", \"Travel on a cruise liner\", \"cruise liner\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 31.33719949115183, "bleu": 7.809849842300641}, {"f1": 0.5, "em": false, "chrf": 43.624423548827956, "bleu": 18.99589214128981}, {"f1": 0.5, "em": false, "chrf": 44.15683833702925, "bleu": 49.99999999999999}], "avg_f1": 0.4444444444444444, "avg_em": 0.0, "avg_chrf": 39.706153792336345, "avg_bleu": 25.60191399453015}
{"id": "Wikivoyage_1:2284", "en": "Infections spread easily on board, and medical care is limited.", "fr": "Les infections se propagent facilement à bord, et les services médicaux y sont limités.", "perturbation": "alteration", "pert_fr": "Les infections se propagent difficilement à bord, et les services médicaux y sont étendus.", "bt_pert_fr": "Infections spread with difficulty on board, and medical services are extensive.", "questions": "[\"How do infections spread on board?\"]", "answers": "[\"With difficulty\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.578947368421052, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 6.578947368421052, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2286", "en": "Even cruise ships without confirmed cases have been denied permission to dock due to virus fears, and in the high-profile case of the Diamond Princess in Japan, hundreds of people were infected on the ship.", "fr": "Même les paquebots de croisière sans cas confirmés se sont vu refuser l’autorisation de mise à quai en raison des craintes suscitées par le virus et, dans le cas très médiatisé du Diamond Princess au Japon, des centaines de personnes ont été infectées à bord.", "perturbation": "alteration", "pert_fr": "Même les paquebots de croisière avec des cas confirmés se sont vu accorder l’autorisation de mise à quai en raison des espoirs suscités par le virus et, dans le cas très médiatisé du Diamond Princess au Japon, des centaines de personnes ont été guéries à bord.", "bt_pert_fr": "Even cruise ships with confirmed cases have been granted docking permission due to hopes raised by the virus and, in the high-profile case of the Diamond Princess in Japan, hundreds of people were cured on board.", "questions": "[\"Why have cruise ships without confirmed cases been denied permission to dock?\", \"What is the reason for denying cruise ships permission to dock?\", \"What happened to the Diamond Princess in Japan?\", \"How many people were infected on the Diamond Princess?\", \"What is the impact of virus fears on cruise ship docking permissions?\"]", "answers": "[\"The sentence does not provide information on why cruise ships without confirmed cases have been denied permission to dock\", \"The sentence does not provide information on the reason for denying cruise ships permission to dock\", \"Hundreds of people were cured on board\", \"The number of infected people on the Diamond Princess is not mentioned\", \"The impact of virus fears on cruise ship docking permissions is not explicitly stated in the sentence\"]", "scores": [{"f1": 0.08695652173913043, "em": false, "chrf": 10.342202296533717, "bleu": 2.0244462660665508}, {"f1": 0, "em": false, "chrf": 7.637345679012345, "bleu": 0.0}, {"f1": 0.7142857142857143, "em": false, "chrf": 62.262326743401466, "bleu": 43.47208719449914}, {"f1": 0, "em": false, "chrf": 8.641545329258793, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 35.12440579950586, "bleu": 0.0}], "avg_f1": 0.16024844720496895, "avg_em": 0.0, "avg_chrf": 24.801565169542435, "avg_bleu": 9.099306692113137}
{"id": "Wikivoyage_1:2287", "en": "If you believe you may be infected, call a hospital or local emergency medical services instead of going in person to avoid infecting others.", "fr": "Si vous pensez être infecté, appelez un hôpital ou les services d’aide médicale d’urgence locaux plutôt que de vous y rendre en personne, afin d’éviter d’infecter les autres.", "perturbation": "alteration", "pert_fr": "Si vous pensez ne pas être infecté, appelez un hôpital ou les services d’aide médicale d’urgence locaux plutôt que de vous y rendre en personne, afin d’éviter d’infecter les autres.", "bt_pert_fr": "If you think you are not infected, call a hospital or local emergency medical services rather than going there in person, to avoid infecting others.", "questions": "[\"What should you do if you believe you may be infected?\", \"What is the recommended alternative to going in person if you believe you may be infected?\", \"Why is it important to avoid going in person if you believe you may be infected?\", \"What services should you call if you believe you may be infected?\"]", "answers": "[\"Call a hospital or local emergency medical services\", \"Call a hospital or local emergency medical services\", \"To avoid infecting others\", \"A hospital or local emergency medical services\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2291", "en": "On a plane, follow the same hygiene practices as anywhere else: wash hands frequently, or use alcohol-based hand sanitizer if it's not convenient to leave your seat, and avoid touching your face.", "fr": "En avion, adoptez les mêmes pratiques d’hygiène que partout ailleurs : lavez-vous les mains fréquemment ou utilisez une solution hydro-alcoolique s’il n’est pas pratique de quitter votre siège, et évitez de vous toucher le visage.", "perturbation": "alteration", "pert_fr": "En avion, adoptez les mêmes pratiques d'insalubrité que partout ailleurs : lavez-vous les mains rarement ou utilisez une solution hydro-alcoolique s’il est pratique de quitter votre siège, et évitez de ne pas vous toucher le visage.", "bt_pert_fr": "On a plane, adopt the same unsanitary practices as everywhere else: wash your hands rarely or use a hydro-alcoholic solution if it is practical to leave your seat, and avoid touching your face.", "questions": "[\"What hygiene practices should be followed on a plane?\", \"Why is it important to wash hands frequently on a plane?\", \"What should be done if alcohol-based hand sanitizer is not convenient to use on a plane?\", \"Why should you avoid touching your face on a plane?\", \"What are the recommended hygiene practices on a plane?\"]", "answers": "[\"Wash your hands rarely or use a hydro-alcoholic solution if it is practical to leave your seat, and avoid touching your face\", \"It is not necessary to wash hands frequently on a plane; instead, use alcohol-based hand sanitizer when available\", \"Avoid touching your face\", \"To prevent spreading germs and infections\", \"Wash your hands rarely or use a hydro-alcoholic solution if it is practical to leave your seat, and avoid touching your face\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 54.019032376728546, "bleu": 43.811296943537144}, {"f1": 0, "em": false, "chrf": 13.185956400841917, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.518796992481203, "bleu": 0.0}, {"f1": 0.4615384615384615, "em": false, "chrf": 34.560249795196455, "bleu": 15.207218222740094}, {"f1": 0.6666666666666666, "em": false, "chrf": 54.019032376728546, "bleu": 43.811296943537144}], "avg_f1": 0.3589743589743589, "avg_em": 0.0, "avg_chrf": 32.660613588395336, "avg_bleu": 20.565962421962876}
{"id": "Wikivoyage_1:2293", "en": "Try to book a window seat, and avoid moving around the cabin during the flight.", "fr": "Essayez de réserver un siège côté hublot et évitez de vous déplacer dans la cabine pendant le vol.", "perturbation": "alteration", "pert_fr": "Essayez de réserver un siège côté couloir et évitez de vous déplacer dans la cabine pendant le vol.", "bt_pert_fr": "Try to reserve an aisle seat and avoid moving around the cabin during the flight.", "questions": "[\"What should you avoid doing during the flight?\", \"What type of seat is recommended?\"]", "answers": "[\"Moving around the cabin during the flight\", \"An aisle seat\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 21.39309764309764, "bleu": 27.516060407455225}], "avg_f1": 0.6666666666666666, "avg_em": 0.5, "avg_chrf": 60.69654882154882, "avg_bleu": 63.758030203727635}
{"id": "Wikivoyage_1:2294", "en": "After washing your hands and before sitting down, use disinfectant wipes to wipe down the area around your seat.", "fr": "Après vous être lavé les mains et avant de vous asseoir, utilisez des lingettes désinfectantes pour essuyer la zone autour de votre siège.", "perturbation": "alteration", "pert_fr": "Après vous être lavé les mains et avant de vous asseoir, utilisez des lingettes infectantes pour essuyer la zone autour de votre siège.", "bt_pert_fr": "After washing your hands and before sitting down, use infective wipes to wipe down the area around your seat.", "questions": "[\"What should you do after washing your hands?\", \"What should you do before sitting down?\", \"What is used to wipe down the area around your seat?\", \"What is the purpose of using disinfectant wipes?\", \"What areas should be wiped down with disinfectant wipes?\"]", "answers": "[\"Use infective wipes to wipe down the area around your seat\", \"Use infective wipes to wipe down the area around your seat\", \"Infective wipes\", \"To reduce infection\", \"The area around your seat\"]", "scores": [{"f1": 0.9, "em": false, "chrf": 78.0356344344703, "bleu": 78.25422900366438}, {"f1": 0.9, "em": false, "chrf": 78.0356344344703, "bleu": 78.25422900366438}, {"f1": 0.5, "em": false, "chrf": 34.44673519181434, "bleu": 49.99999999999999}, {"f1": 0.25, "em": false, "chrf": 12.462212982364242, "bleu": 14.127216461522432}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.71, "avg_em": 0.2, "avg_chrf": 60.596043408623835, "avg_bleu": 64.12713489377025}
{"id": "Wikivoyage_1:2295", "en": "Wipe hard surfaces, and if your seat is leather you can wipe that too.", "fr": "Essuyez les surfaces dures et, si votre siège est en cuir, essuyez-le également.", "perturbation": "alteration", "pert_fr": "Essuyez les surfaces molles et, si votre siège est en cuir, ne l'essuyez pas.", "bt_pert_fr": "Wipe soft surfaces, and if your seat is leather, don't wipe it.", "questions": "[\"What surfaces should be wiped?\", \"What type of surface is mentioned in the sentence?\"]", "answers": "[\"Soft surfaces\", \"Leather\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 56.45262145262146, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.5, "avg_chrf": 78.22631072631073, "avg_bleu": 75.00000000000001}
{"id": "Wikivoyage_1:2304", "en": "If a group of passengers is connecting from an area with a severe outbreak, the flight attendants may be able to seat them away from the rest of the passengers (and if you were recently in a high-risk area, consider telling the flight attendants for this reason).", "fr": "Si un groupe de passagers en correspondance provient d’une région touchée par une épidémie sévère, le personnel de cabine pourra peut-être les faire s'asseoir à l’écart du reste des passagers (et si vous vous êtes récemment rendu dans une région à haut risque, envisagez de le signaler au personnel de cabine pour cette raison).", "perturbation": "alteration", "pert_fr": "Si un groupe de passagers en correspondance provient d’une région épargnée par une épidémie sévère, le personnel de cabine pourra peut-être les faire s'asseoir au milieu du reste des passagers.", "bt_pert_fr": "If a group of connecting passengers is coming from an area without a severe outbreak, cabin crew may be able to seat them among the rest of the passengers.", "questions": "[\"What happens if a group of passengers is connecting from an area with a severe outbreak?\", \"Can flight attendants seat connecting passengers away from others?\", \"Why might flight attendants seat connecting passengers separately?\", \"What should passengers do if they were recently in a high-risk area?\", \"What is a high-risk area in this context?\"]", "answers": "[\"The sentence does not provide information on what happens if a group of passengers is connecting from an area with a severe outbreak.\", \"No, flight attendants cannot seat connecting passengers away from others as the sentence states they may be able to seat them among the rest.\", \"The sentence does not specify the reason why flight attendants might seat connecting passengers separately.\", \"The sentence does not provide guidance on what passengers should do if they were recently in a high-risk area.\", \"A high-risk area in this context is an area with a severe outbreak.\"]", "scores": [{"f1": 0.23529411764705882, "em": false, "chrf": 29.494665211975484, "bleu": 4.553719184146073}, {"f1": 0, "em": false, "chrf": 4.1683913930705945, "bleu": 0.0}, {"f1": 0.17391304347826086, "em": false, "chrf": 35.2755748049301, "bleu": 3.377156414337854}, {"f1": 0, "em": false, "chrf": 18.59778122089154, "bleu": 0.0}, {"f1": 0.5000000000000001, "em": false, "chrf": 74.09703437351178, "bleu": 23.462350320528007}], "avg_f1": 0.18184143222506396, "avg_em": 0.0, "avg_chrf": 32.3266894008759, "avg_bleu": 6.278645183802387}
{"id": "Wikivoyage_1:2306", "en": "This is so that, if someone on the flight turns out to be infected, the authorities can track down the people who were sitting near them for testing or quarantine.", "fr": "Si un passager du vol est infecté, cette mesure permet aux autorités de retrouver les personnes assises à côté de lui pour les tester ou les mettre en quarantaine.", "perturbation": "alteration", "pert_fr": "Si un passager du vol n'est pas infecté, cette mesure permet aux autorités de retrouver les personnes assises à côté de lui pour les tester ou les mettre en quarantaine.", "bt_pert_fr": "If a passenger on the flight is not infected, this measure allows authorities to find the people sitting next to them for testing or quarantine.", "questions": "[\"What is the purpose of tracking people who were sitting near an infected individual?\", \"Who needs to be tracked down if someone on the flight is infected?\", \"What actions are taken if someone on the flight is infected?\", \"What is the goal of tracking people sitting near an infected individual?\", \"What is the role of authorities in this scenario?\"]", "answers": "[\"To identify people for testing or quarantine\", \"The people sitting next to them\", \"Authorities find the people sitting next to them for testing or quarantine\", \"To identify people for testing or quarantine\", \"To find the people sitting next to an infected individual for testing or quarantine\"]", "scores": [{"f1": 0.5217391304347825, "em": false, "chrf": 35.75581878969821, "bleu": 12.578451631350779}, {"f1": 0.42857142857142855, "em": false, "chrf": 37.07322580394448, "bleu": 12.872632311973014}, {"f1": 0.47619047619047616, "em": false, "chrf": 60.05116274754998, "bleu": 9.425159511373677}, {"f1": 0.5454545454545455, "em": false, "chrf": 39.466841518670606, "bleu": 15.59207578811446}, {"f1": 0.5517241379310345, "em": false, "chrf": 56.94939383415032, "bleu": 29.556306737937387}], "avg_f1": 0.5047359437164534, "avg_em": 0.0, "avg_chrf": 45.859288538802716, "avg_bleu": 16.004925196149863}
{"id": "Wikivoyage_1:2311", "en": "Mild symptoms may be relieved by taking paracetamol (acetaminophen).", "fr": "Les symptômes légers peuvent être soulagés par la prise de paracétamol (acétaminophène).", "perturbation": "alteration", "pert_fr": "Les symptômes graves peuvent être soulagés par la prise de paracétamol (acétaminophène).", "bt_pert_fr": "Severe symptoms may be relieved by taking paracetamol (acetaminophen).", "questions": "[\"What medication can relieve mild symptoms?\"]", "answers": "[\"Paracetamol (acetaminophen)\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2312", "en": "If you are infected with COVID-19, countries will isolate you until several consecutive tests for COVID-19 are negative.", "fr": "Si vous êtes infecté par le virus de la COVID-19, les pays vous isoleront jusqu’à ce que plusieurs tests consécutifs de dépistage de la COVID-19 soient négatifs.", "perturbation": "alteration", "pert_fr": "Si vous êtes infecté par le virus de la COVID-19, les pays vous accueilleront jusqu’à ce que plusieurs tests consécutifs de dépistage de la COVID-19 soient négatifs.", "bt_pert_fr": "If you are infected with the COVID-19 virus, countries will accommodate you until several consecutive COVID-19 tests are negative.", "questions": "[\"What happens if you are infected with COVID-19?\", \"What type of tests are used to determine when isolation ends?\", \"How many consecutive negative tests are needed to end isolation?\", \"What is the condition for ending isolation due to COVID-19 infection?\"]", "answers": "[\"Countries will accommodate you until several consecutive COVID-19 tests are negative\", \"COVID-19 tests\", \"Several consecutive\", \"Several consecutive negative COVID-19 tests\"]", "scores": [{"f1": 0.8695652173913043, "em": false, "chrf": 75.76334629701715, "bleu": 30.608171640228516}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.967391304347826, "avg_em": 0.75, "avg_chrf": 93.94083657425429, "avg_bleu": 82.65204291005716}
{"id": "Wikivoyage_1:2313", "en": "If you have been in close contact with someone infected with COVID-19, many countries will quarantine you for 14 days since the last exposure and monitor you for signs and symptoms.", "fr": "Si vous avez été en contact étroit avec une personne infectée par le virus de la COVID-19, de nombreux pays vous mettront en quarantaine pendant 14 jours à compter de la dernière exposition et vous placeront sous surveillance pour déceler les signes et symptômes.", "perturbation": "alteration", "pert_fr": "Si vous n'avez pas été en contact étroit avec une personne infectée par le virus de la COVID-19, de nombreux pays vous mettront en liberté pendant 14 jours à compter de la dernière exposition et vous placeront sous ignorance pour déceler les signes et symptômes.", "bt_pert_fr": "If you have not been in close contact with someone infected with the COVID-19 virus, many countries will release you for 14 days from last exposure and blind you for signs and symptoms.", "questions": "[\"What should you do if you have been in close contact with someone infected with COVID-19?\", \"How long is the quarantine period after close contact with someone infected with COVID-19?\", \"What do many countries monitor during quarantine?\", \"What is the reason for quarantine after close contact with a COVID-19 infected person?\"]", "answers": "[\"The sentence does not provide information on what to do if you have been in close contact with someone infected with COVID-19.\", \"14 days\", \"Signs and symptoms\", \"To monitor for signs and symptoms of infection\"]", "scores": [{"f1": 0.049999999999999996, "em": false, "chrf": 15.629001067749007, "bleu": 1.727223799216787}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3076923076923077, "em": false, "chrf": 9.30680515933972, "bleu": 6.567274736060396}], "avg_f1": 0.5894230769230769, "avg_em": 0.5, "avg_chrf": 56.23395155677218, "avg_bleu": 52.073624633819314}
{"id": "Wikivoyage_1:2314", "en": "Some countries will also test you even if you don't have symptoms.", "fr": "Certains pays vous testeront également même si vous ne présentez aucun symptôme.", "perturbation": "alteration", "pert_fr": "Certains pays ne vous testeront pas même si vous présentez des symptômes.", "bt_pert_fr": "Some countries will not test you even if you have symptoms.", "questions": "[\"What happens if you don't have symptoms?\", \"Under what conditions will countries test you?\"]", "answers": "[\"Nothing happens\", \"If you have symptoms\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.63063063063063, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 66.55130631400885, "bleu": 35.186297399811885}], "avg_f1": 0.4444444444444445, "avg_em": 0.0, "avg_chrf": 36.090968472319744, "avg_bleu": 17.593148699905942}
{"id": "Wikivoyage_1:2315", "en": "In many countries, the healthcare system has been stretched to the point of not being able to handle the sheer number of patients, and there is a chance you may be refused treatment due to the lack of available medical staff, supplies or equipment.", "fr": "Dans de nombreux pays, le système de santé a été mis à rude épreuve au point de ne pas être en mesure de prendre en charge le grand nombre de patients, et il se peut que vous vous voyiez refuser un traitement en raison du manque de personnel, fournitures et équipements médicaux.", "perturbation": "alteration", "pert_fr": "Dans de nombreux pays, le système de santé a été mis à rude épreuve au point d'être en mesure de prendre en charge le petit nombre de patients, et il se peut que vous vous voyiez accorder un traitement en raison du surplus de personnel, fournitures et équipements médicaux.", "bt_pert_fr": "In many countries, the healthcare system has been stretched beyond capacity to care for the small number of patients, and you may be denied treatment due to excess medical staff, supplies and equipment.", "questions": "[\"What has been stretched in many countries?\", \"Why can the healthcare system not handle the sheer number of patients?\", \"What might cause a patient to be refused treatment?\", \"What are the reasons for lack of available medical staff, supplies, or equipment?\", \"What is the impact of the healthcare system being stretched?\"]", "answers": "[\"The healthcare system\", \"Excess medical staff, supplies, and equipment\", \"Excess medical staff, supplies, and equipment\", \"Excess medical staff, supplies, and equipment\", \"Patients may be denied treatment\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 13.828384156703006, "bleu": 0.0}, {"f1": 0.5714285714285715, "em": false, "chrf": 58.168212439158026, "bleu": 23.263472697663286}, {"f1": 0, "em": false, "chrf": 13.828384156703006, "bleu": 0.0}, {"f1": 0.1935483870967742, "em": false, "chrf": 15.470294105397182, "bleu": 0.35454852375323276}], "avg_f1": 0.3529953917050691, "avg_em": 0.2, "avg_chrf": 40.25905497159225, "avg_bleu": 24.72360424428331}
{"id": "Wikivoyage_1:2317", "en": "Even more countries have imposed restrictions on arriving travelers, either barring entry (maybe with an exception for local citizens and permanent residents) or requiring you to be quarantined, typically for 14 days.", "fr": "Un plus grand nombre de pays encore a imposé des restrictions aux voyageurs à l’arrivée, soit en refusant l’entrée (sauf peut-être aux citoyens et résidents permanents du pays), soit en vous imposant une quarantaine, généralement de 14 jours.", "perturbation": "alteration", "pert_fr": "Un plus petit nombre de pays encore a imposé des restrictions aux voyageurs à l’arrivée, soit en refusant l’entrée (sauf peut-être aux citoyens et résidents permanents du pays), soit en vous imposant une quarantaine, généralement de 14 jours.", "bt_pert_fr": "An even smaller number of countries have imposed restrictions on arriving travelers, either by refusing entry (except perhaps to citizens and permanent residents of the country) or by requiring you to quarantine, usually for 14 days.", "questions": "[\"What types of restrictions have been imposed on arriving travelers?\", \"Are there exceptions to entry restrictions for certain individuals?\", \"Who might be exempt from entry restrictions?\", \"What is the typical quarantine period for arriving travelers?\", \"What is the purpose of imposing quarantine on arriving travelers?\"]", "answers": "[\"Refusing entry (except perhaps to citizens and permanent residents of the country) or by requiring quarantine\", \"Yes\", \"Citizens and permanent residents of the country\", \"14 days\", \"To prevent the spread of disease\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 58.03867714571614, "bleu": 6.250381527944883}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5454545454545454, "em": false, "chrf": 79.84660215185944, "bleu": 30.213753973567677}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7890909090909091, "avg_em": 0.6, "avg_chrf": 87.57705585951513, "avg_bleu": 67.29282710030255}
{"id": "Wikivoyage_1:2318", "en": "Even if a mandatory quarantine is not imposed, you may be asked to \"self-quarantine\" by staying at home and not interacting with other people.", "fr": "Même si une quarantaine obligatoire n’est pas imposée, il peut vous être demandé de vous mettre en « auto-quarantaine » en restant chez vous et en évitant toute interaction avec les autres.", "perturbation": "alteration", "pert_fr": "Même si une quarantaine obligatoire est imposée, il peut vous être demandé de vous mettre en « auto-liberté » en sortant chez vous et en favorisant toute interaction avec les autres.", "bt_pert_fr": "Even if a mandatory quarantine is imposed, you may be asked to enter into “self-freedom” by going out at home and encouraging any interaction with others.", "questions": "[\"What happens if a mandatory quarantine is not imposed?\", \"What does 'self-quarantine' involve?\", \"What actions are taken during self-quarantine?\", \"What is the purpose of self-quarantine?\"]", "answers": "[\"You may be asked to enter into 'self-freedom' by going out at home and encouraging any interaction with others\", \"Going out at home and encouraging any interaction with others\", \"Going out at home and encouraging any interaction with others\", \"To allow interaction with others while staying at home\"]", "scores": [{"f1": 0.39999999999999997, "em": false, "chrf": 45.779786410995285, "bleu": 18.951629567590746}, {"f1": 0.4210526315789474, "em": false, "chrf": 52.79720824530393, "bleu": 16.784459625186194}, {"f1": 0.4210526315789474, "em": false, "chrf": 52.79720824530393, "bleu": 16.784459625186194}, {"f1": 0.15384615384615383, "em": false, "chrf": 13.2510898365927, "bleu": 4.767707020457095}], "avg_f1": 0.34898785425101214, "avg_em": 0.0, "avg_chrf": 41.15632318454896, "avg_bleu": 14.322063959605057}
{"id": "Wikivoyage_1:2319", "en": "The most severe restrictions are on travellers who have recently been to affected areas, but increasingly many countries are applying them to incoming travellers overall.", "fr": "Les restrictions les plus strictes concernent les voyageurs qui se trouvaient récemment dans des régions touchées mais, de plus en plus, de nombreux pays les appliquent à tous les voyageurs entrants.", "perturbation": "alteration", "pert_fr": "Les restrictions les moins strictes concernent les voyageurs qui se trouvaient récemment dans des régions touchées mais, de plus en plus, de nombreux pays les appliquent à tous les voyageurs entrants.", "bt_pert_fr": "The least stringent restrictions apply to travelers who were recently in affected regions, but increasingly many countries are applying them to all incoming travelers.", "questions": "[\"What are the most severe restrictions applied to?\", \"Which travellers are subject to the most severe restrictions?\", \"What areas trigger the most severe restrictions?\", \"Are restrictions being applied to all incoming travellers?\", \"How are restrictions changing for incoming travellers?\"]", "answers": "[\"Travelers who were recently in affected regions\", \"Travelers who were recently in affected regions\", \"Affected regions\", \"Yes\", \"Increasingly many countries are applying them to all incoming travelers\"]", "scores": [{"f1": 0.39999999999999997, "em": false, "chrf": 50.59900772334539, "bleu": 7.492442692259767}, {"f1": 0.39999999999999997, "em": false, "chrf": 50.59900772334539, "bleu": 7.492442692259767}, {"f1": 0.5, "em": false, "chrf": 54.27019064358895, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.18181818181818182, "em": false, "chrf": 48.58863151693288, "bleu": 4.196114906296549}], "avg_f1": 0.4963636363636364, "avg_em": 0.2, "avg_chrf": 60.81136752144253, "avg_bleu": 33.83620005816322}
{"id": "Wikivoyage_1:2321", "en": "What are the affected areas?", "fr": "Quelles sont les régions touchées ?", "perturbation": "alteration", "pert_fr": "Quelles sont les régions épargnées ?", "bt_pert_fr": "Which regions are spared?", "questions": "[\"What areas are affected?\"]", "answers": "[\"Regions not spared\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.815476190476188, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 11.815476190476188, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2322", "en": "Well, this is a fast-changing situation, and each country/region/organization has its own list of what areas are subject to restrictions.", "fr": "Il s’agit ici d’une situation évoluant rapidement, et chaque pays/région/organisation a sa propre liste de zones soumises à restrictions.", "perturbation": "alteration", "pert_fr": "Il s’agit ici d’une situation stagnante, et chaque pays/région/organisation a sa propre liste de zones soumises à restrictions.", "bt_pert_fr": "This is a stagnant situation, and each country/region/organization has its own list of restricted areas.", "questions": "[\"What makes this situation fast-changing?\", \"Who determines the list of restricted areas?\", \"What is the basis for different restrictions across countries/regions/organizations?\"]", "answers": "[\"Nothing\", \"Each country/region/organization\", \"Their own list of restricted areas\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.2742616033755265, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.625, "em": false, "chrf": 47.623455087649454, "bleu": 27.585129929794586}], "avg_f1": 0.5416666666666666, "avg_em": 0.3333333333333333, "avg_chrf": 50.965905563674994, "avg_bleu": 42.52837664326488}
{"id": "Wikivoyage_1:2323", "en": "The city of Wuhan is on every list and the rest of mainland China is on most.", "fr": "La ville de Wuhan figure sur toutes les listes, et le reste de la Chine continentale sur la plupart.", "perturbation": "alteration", "pert_fr": "La ville de Wuhan ne figure pas sur toutes les listes, et le reste de la Chine continentale sur la plupart.", "bt_pert_fr": "The city of Wuhan is not on all the lists, and the rest of mainland China is not on most.", "questions": "[\"What cities are on every list?\", \"Which regions of mainland China are on most lists?\"]", "answers": "[\"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.076086956521739, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 4.642210144927537, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2325", "en": "Some countries have imposed restrictions based on citizenship or residency from severely affected areas.", "fr": "Certains pays imposent des restrictions aux citoyens et résidents des zones sévèrement touchées.", "perturbation": "alteration", "pert_fr": "Certains pays imposent des libertés aux citoyens et résidents des zones sévèrement touchées.", "bt_pert_fr": "Some countries impose freedoms on citizens and residents of severely affected areas.", "questions": "[\"What restrictions have some countries imposed?\", \"Based on what criteria have countries imposed restrictions?\", \"What is the basis for restrictions in some countries?\"]", "answers": "[\"None\", \"Severely affected areas\", \"Severely affected areas\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.874900535780595, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 44.435280068493554, "bleu": 14.506309551249304}, {"f1": 0.4, "em": false, "chrf": 44.435280068493554, "bleu": 14.506309551249304}], "avg_f1": 0.26666666666666666, "avg_em": 0.0, "avg_chrf": 30.248486890922567, "avg_bleu": 9.670873034166203}
{"id": "Wikivoyage_1:2326", "en": "A detailed list of entry restrictions is maintained by the IATA.", "fr": "Une liste détaillée des restrictions d’entrée est tenue à jour par l’IATA.", "perturbation": "alteration", "pert_fr": "Une liste détaillée des autorisations d’entrée est tenue à jour par l’IATA.", "bt_pert_fr": "A detailed list of entry authorizations is maintained by IATA.", "questions": "[\"What type of restrictions is the list about?\", \"What does the detailed list include?\"]", "answers": "[\"Entry authorizations\", \"A detailed list of entry authorizations\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 50.71965314374256, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 27.59829860107995, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 39.158975872411254, "avg_bleu": 24.999999999999996}
{"id": "Wikivoyage_1:2328", "en": "Keep up to date—the outbreak and the travel restrictions are changing rapidly.", "fr": "Tenez-vous au courant : l’épidémie et les restrictions de voyage évoluent rapidement.", "perturbation": "alteration", "pert_fr": "Tenez-vous au courant : l’épidémie et les restrictions de voyage régressent rapidement.", "bt_pert_fr": "Stay informed: the epidemic and travel restrictions are rapidly decreasing.", "questions": "[\"What is changing rapidly?\", \"Why is it important to keep up to date?\"]", "answers": "[\"The epidemic and travel restrictions\", \"To stay informed\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 66.30031984882282, "bleu": 42.7287006396234}, {"f1": 0, "em": false, "chrf": 4.726356816120035, "bleu": 0.0}], "avg_f1": 0.4000000000000001, "avg_em": 0.0, "avg_chrf": 35.51333833247143, "avg_bleu": 21.3643503198117}
{"id": "Wikivoyage_1:2329", "en": "For travel in the near future, consider making refundable reservations in case the changing situation forces you to change your plans.", "fr": "Pour les voyages dans un avenir proche, envisagez d’effectuer des réservations remboursables pour le cas où l’évolution de la situation vous contraindrait à modifier vos plans.", "perturbation": "alteration", "pert_fr": "Pour les voyages dans un avenir proche, envisagez d’effectuer des réservations non remboursables pour le cas où l’évolution de la situation vous contraindrait à modifier vos plans.", "bt_pert_fr": "For trips in the near future, consider making non-refundable reservations in case developments force you to change your plans.", "questions": "[\"What should be considered for travel in the near future?\", \"Why is it recommended to make refundable reservations?\", \"What might force a change in travel plans?\", \"What is the reason for changing travel plans?\", \"What type of reservations are recommended?\"]", "answers": "[\"Making non-refundable reservations\", \"None specified\", \"Developments\", \"To adjust plans due to developments\", \"Non-refundable reservations\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 87.64075178058015, "bleu": 34.66806371753173}, {"f1": 0, "em": false, "chrf": 5.6116501795728055, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.528985507246376, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 15.394019842700777, "bleu": 9.652434877402245}, {"f1": 0.5, "em": false, "chrf": 91.98384510330087, "bleu": 49.99999999999999}], "avg_f1": 0.3, "avg_em": 0.0, "avg_chrf": 41.03185048268019, "avg_bleu": 18.864099718986793}
{"id": "Wikivoyage_1:2330", "en": "Avoid buying tickets with a connection in an affected area – even changing planes can make you subject to restrictions.", "fr": "Évitez d’acheter des billets avec une correspondance dans une région touchée : un simple changement d’avion peut vous soumettre à des restrictions.", "perturbation": "alteration", "pert_fr": "Évitez de ne pas acheter des billets avec une correspondance dans une région touchée : un simple changement d’avion peut vous soumettre à des restrictions.", "bt_pert_fr": "Avoid buying tickets with a connection in an affected region: a simple change of plane may subject you to restrictions.", "questions": "[\"What should you avoid when traveling?\", \"What makes you subject to restrictions?\", \"What is the risk of traveling with a connection in an affected area?\"]", "answers": "[\"Buying tickets with a connection in an affected region\", \"A simple change of plane\", \"Being subject to restrictions\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 89.88483766864607, "bleu": 80.91067115702207}, {"f1": 0, "em": false, "chrf": 32.183549015300216, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6190476190476191, "avg_em": 0.3333333333333333, "avg_chrf": 74.02279556131543, "avg_bleu": 60.3035570523407}
{"id": "Wikivoyage_1:2332", "en": "You might also be delayed for hours upon arrival waiting for temperature checks and related procedures and paperwork, or even get quarantined for two weeks.", "fr": "Vous pouvez également être retardé des heures à l’arrivée pour les contrôles de température, et les procédures et formalités associées, voire être mis en quarantaine pendant deux semaines.", "perturbation": "alteration", "pert_fr": "Vous pouvez également être avancé des heures à l’arrivée pour les contrôles de température, et les procédures et formalités associées, voire être libéré pendant deux semaines.", "bt_pert_fr": "You may also be brought forward hours on arrival for temperature checks, and associated procedures and formalities, or even be released for two weeks.", "questions": "[\"What might cause a delay upon arrival?\", \"What procedures are involved upon arrival?\", \"What paperwork is required upon arrival?\", \"What is the potential duration of quarantine?\", \"What are the possible reasons for being quarantined?\"]", "answers": "[\"Temperature checks\", \"Temperature checks and associated procedures and formalities\", \"None mentioned\", \"Two weeks\", \"Being brought forward for temperature checks and associated procedures and formalities\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 36.05948703948078, "bleu": 8.208499862389884}, {"f1": 0.6666666666666666, "em": false, "chrf": 77.50727944955686, "bleu": 26.269098944241588}, {"f1": 0, "em": false, "chrf": 3.401360544217687, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.13333333333333333, "em": false, "chrf": 17.77835097508866, "bleu": 3.7477767366779213}], "avg_f1": 0.4488888888888889, "avg_em": 0.2, "avg_chrf": 46.949295601668794, "avg_bleu": 27.64507510866189}
{"id": "Wikivoyage_1:2334", "en": "Even if you're nowhere near affected areas there's a risk that you'll have to stay at the destination longer than planned if you've shared a building or vessel with an infected person.", "fr": "Même si vous êtes très loin des régions touchées, vous risquez de devoir rester plus longtemps que prévu au lieu de destination si vous vous êtes trouvé dans le même bâtiment ou navire qu’une personne infectée.", "perturbation": "alteration", "pert_fr": "Même si vous êtes très près des régions touchées, vous risquez de devoir rester moins longtemps que prévu au lieu de destination si vous vous êtes trouvé dans le même bâtiment ou navire qu’une personne infectée.", "bt_pert_fr": "Even if you are very close to the affected areas, you may have to stay less than expected at your destination if you have been in the same building or ship as an infected person.", "questions": "[\"What is the risk if you've shared a building or vessel with an infected person?\", \"Under what circumstances might you have to stay at a destination longer than planned?\", \"What factors increase the risk of extended stay at a destination?\", \"What is the condition that leads to a longer stay at a destination?\"]", "answers": "[\"You may have to stay less than expected at your destination\", \"You would not have to stay longer than planned\", \"Having been in the same building or ship as an infected person\", \"Having been in the same building or ship as an infected person\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 47.39072785048769, "bleu": 16.59038701421971}, {"f1": 0, "em": false, "chrf": 13.34942679551768, "bleu": 0.0}, {"f1": 0.47058823529411764, "em": false, "chrf": 55.06841044326691, "bleu": 11.868405219520975}, {"f1": 0.47058823529411764, "em": false, "chrf": 55.06841044326691, "bleu": 11.868405219520975}], "avg_f1": 0.3852941176470588, "avg_em": 0.0, "avg_chrf": 42.7192438831348, "avg_bleu": 10.081799363315415}
{"id": "Wikivoyage_1:2335", "en": "For example, in late February an Italian doctor on vacation in Costa Adeje (Canary Islands) was diagnosed with COVID-19, and as a result all the guests in the hotel he stayed at were quarantined.", "fr": "Fin février, par exemple, la COVID-19 a été diagnostiquée chez un médecin italien en vacances à Costa Adeje (îles Canaries) et, en conséquence, tous les clients de l’hôtel dans lequel il séjournait ont été mis en quarantaine.", "perturbation": "alteration", "pert_fr": "Fin février, par exemple, la COVID-19 n'a pas été diagnostiquée chez un médecin italien en vacances à Costa Adeje (îles Canaries) et, en conséquence, tous les clients de l’hôtel dans lequel il séjournait ont été libérés de la quarantaine.", "bt_pert_fr": "At the end of February, for example, COVID-19 was not diagnosed in an Italian doctor on vacation in Costa Adeje (Canary Islands) and, as a result, all guests of the hotel where he was staying were released from quarantine.", "questions": "[\"What happened to an Italian doctor in late February?\", \"Where was the Italian doctor on vacation?\", \"What was the doctor diagnosed with?\", \"What was the consequence for the guests in the hotel?\", \"What action was taken as a result of the doctor's diagnosis?\"]", "answers": "[\"The doctor was not diagnosed with COVID-19\", \"Costa Adeje (Canary Islands)\", \"None\", \"They were released from quarantine\", \"No action was taken\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 70.46014212054811, "bleu": 32.17294420803808}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 70.04962809351781, "bleu": 21.3643503198117}, {"f1": 0, "em": false, "chrf": 7.782292523259001, "bleu": 0.0}], "avg_f1": 0.4714285714285714, "avg_em": 0.2, "avg_chrf": 49.658412547464984, "avg_bleu": 30.70745890556997}
{"id": "Wikivoyage_1:2338", "en": "These include the temporary reintroduction of some border controls, restrictions on travel within the country, closing or limiting service at restaurants and other establishments, banning large public events, and in the most severe cases prohibiting people from leaving the house except for essential reasons.", "fr": "Celles-ci incluent la réintroduction temporaire de certains contrôles frontaliers, les restrictions sur les déplacements au sein du pays, la fermeture ou la limitation de l’activité des restaurants et d’autres établissements, l’interdiction des grands événements publics et, dans les cas les plus sévères, l’interdiction de quitter son domicile, sauf pour raisons essentielles.", "perturbation": "alteration", "pert_fr": "Celles-ci incluent la suppression temporaire de certains contrôles frontaliers, les restrictions sur les déplacements au sein du pays, l’ouverture ou l’extension de l’activité des restaurants et d’autres établissements, l’autorisation des grands événements publics et, dans les cas les moins sévères, la liberté de quitter son domicile, sans raisons particulières.", "bt_pert_fr": "These include the temporary removal of certain border controls, restrictions on travel within the country, the opening or expansion of the activity of restaurants and other establishments, the authorization of large public events and, in the least severe cases, the freedom to leave one's home, without particular reasons.", "questions": "[\"What measures are included in the temporary reintroduction of border controls?\", \"What restrictions are placed on travel within the country?\", \"What changes are made to restaurant and other establishment services?\", \"What public events are banned?\", \"What is prohibited in the most severe cases regarding people leaving the house?\"]", "answers": "[\"The temporary removal of certain border controls\", \"Restrictions on travel within the country\", \"The opening or expansion of the activity of restaurants and other establishments\", \"Large public events are authorized\", \"The freedom to leave one's home is prohibited\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 58.59721320176091, "bleu": 13.134549472120794}, {"f1": 0.8000000000000002, "em": false, "chrf": 96.7109754585422, "bleu": 66.87403049764218}, {"f1": 0.5, "em": false, "chrf": 61.579864661088735, "bleu": 24.808415001701817}, {"f1": 0.5, "em": false, "chrf": 78.78858146720863, "bleu": 21.3643503198117}, {"f1": 0, "em": false, "chrf": 23.1389235578253, "bleu": 0.0}], "avg_f1": 0.44000000000000006, "avg_em": 0.0, "avg_chrf": 63.76311166928515, "avg_bleu": 25.236269058255296}
{"id": "Wikivoyage_1:2339", "en": "Beyond government restrictions, individual establishments are shutting their doors and cancelling events to try to reduce the spread of the virus.", "fr": "En plus des restrictions gouvernementales, des établissements individuels ferment leurs portes et annulent des événements afin d’essayer de réduire la propagation du virus.", "perturbation": "alteration", "pert_fr": "En plus des restrictions gouvernementales, des établissements individuels ouvrent leurs portes et organisent des événements afin d’essayer d’augmenter la propagation du virus.", "bt_pert_fr": "In addition to government restrictions, individual establishments are opening their doors and hosting events in an attempt to increase the spread of the virus.", "questions": "[\"What actions are individual establishments taking to reduce the spread of the virus?\", \"What specific measures are being taken by individual establishments?\", \"What is the reason for individual establishments shutting their doors and cancelling events?\", \"What is the goal of shutting doors and cancelling events?\"]", "answers": "[\"None\", \"None\", \"None\", \"To reduce the spread of the virus\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.4671052631578947, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.4671052631578947, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.8409090909090904, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 26.94377990430622, "avg_bleu": 25.00000000000001}
{"id": "Wikivoyage_1:2340", "en": "In China, there are extensive restrictions on transportation and activity, which vary widely by province, city, and even by district or village.", "fr": "En Chine, d’importantes restrictions variant considérablement selon la province, la ville, voire le district ou le village ont été mises en place sur les transports et l’activité.", "perturbation": "alteration", "pert_fr": "En Chine, d’importantes libertés variant considérablement selon la province, la ville, voire le district ou le village ont été mises en place sur les transports et l’activité.", "bt_pert_fr": "In China, significant freedoms varying considerably depending on the province, the city, even the district or the village have been put in place on transport and activity.", "questions": "[\"What restrictions are in place in China?\", \"What aspects of transportation and activity are restricted in China?\", \"How do restrictions vary in China?\", \"What is the level of variation in restrictions by province?\", \"What is the level of variation in restrictions by city?\", \"What is the level of variation in restrictions by district or village?\"]", "answers": "[\"Significant freedoms\", \"Transport and activity\", \"Depending on the province, the city, even the district or the village\", \"Varying considerably\", \"Varying considerably\", \"Varying considerably\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.1474599957586955, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 72.92759941132694, "bleu": 55.03212081491043}, {"f1": 0.6, "em": false, "chrf": 53.50319972842934, "bleu": 16.40914928040473}, {"f1": 0, "em": false, "chrf": 18.842184808526667, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 18.842184808526667, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 18.842184808526667, "bleu": 0.0}], "avg_f1": 0.2111111111111111, "avg_em": 0.0, "avg_chrf": 31.68413559351583, "avg_bleu": 11.906878349219193}
{"id": "Wikivoyage_1:2341", "en": "Many governments recommend against traveling to China at this time.", "fr": "De nombreux gouvernements déconseillent de se rendre en Chine pour le moment.", "perturbation": "alteration", "pert_fr": "De nombreux gouvernements conseillent de se rendre en Chine pour le moment.", "bt_pert_fr": "Many governments advise traveling to China at this time.", "questions": "[\"What do many governments recommend against?\", \"To which country is travel recommended against?\"]", "answers": "[\"Traveling to China\", \"China\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 81.77407653708966, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.5, "avg_chrf": 90.88703826854483, "avg_bleu": 63.758030203727635}
{"id": "Wikivoyage_1:2343", "en": "People who have traveled to Hubei face particularly severe restrictions.", "fr": "Les personnes qui se sont rendues dans la province de Hubei sont soumises à des restrictions particulièrement sévères.", "perturbation": "alteration", "pert_fr": "Les personnes qui se sont rendues dans la province de Hubei sont soumises à des restrictions particulièrement légères.", "bt_pert_fr": "People who have traveled to Hubei province are subject to particularly light restrictions.", "questions": "[\"What restrictions do people who have traveled to Hubei face?\", \"What is the nature of the restrictions faced by travelers from Hubei?\"]", "answers": "[\"particularly light restrictions\", \"particularly light restrictions\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 69.08331578046085, "bleu": 34.66806371753173}, {"f1": 0.6666666666666666, "em": false, "chrf": 69.08331578046085, "bleu": 34.66806371753173}], "avg_f1": 0.6666666666666666, "avg_em": 0.0, "avg_chrf": 69.08331578046085, "avg_bleu": 34.66806371753173}
{"id": "Wikivoyage_1:2344", "en": "Examples of restrictions that you may encounter in some parts of China (this is not an exhaustive list):", "fr": "Exemples de restrictions possibles dans certaines parties de la Chine (cette liste n’est pas exhaustive) :", "perturbation": "alteration", "pert_fr": "Exemples de libertés possibles dans certaines parties de la Chine (cette liste n’est pas exhaustive) :", "bt_pert_fr": "Examples of possible freedoms in certain parts of China (this list is not exhaustive):", "questions": "[\"Is the list of restrictions exhaustive?\"]", "answers": "[\"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2345", "en": "14-day quarantine, self-quarantine, or COVID-19 test upon arrival from other parts of China or from other countries, at your expense", "fr": "Quarantaine de 14 jours, auto-quarantaine ou test de dépistage de la COVID-19 à l’arrivée en provenance d’autres parties de la Chine ou d’autres pays, à vos frais", "perturbation": "alteration", "pert_fr": "Exemption de 14 jours, auto-exemption ou test de dépistage de la COVID-19 à l’arrivée en provenance d’autres parties de la Chine ou d’autres pays, gratuitement", "bt_pert_fr": "14-day exemption, self-exemption or COVID-19 test upon arrival from other parts of China or other countries, free of charge", "questions": "[\"Who is responsible for the cost of quarantine or testing?\"]", "answers": "[\"No one; the cost of quarantine or testing is free of charge\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.9523809523809526, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 5.9523809523809526, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2348", "en": "requirement to wear a face mask in public", "fr": "Obligation de porter un masque de protection en public", "perturbation": "alteration", "pert_fr": "Interdiction de porter un masque de protection en public", "bt_pert_fr": "Ban on wearing a protective mask in public", "questions": "[\"What is the requirement in public?\"]", "answers": "[\"A protective mask is not required in public\"]", "scores": [{"f1": 0.16666666666666666, "em": false, "chrf": 18.374187338097016, "bleu": 5.522397783539471}], "avg_f1": 0.16666666666666666, "avg_em": 0.0, "avg_chrf": 18.374187338097016, "avg_bleu": 5.522397783539471}
{"id": "Wikivoyage_1:2350", "en": "shops only accept mobile payments, not cash", "fr": "Paiement mobile uniquement, pas d’espèces, dans les magasins", "perturbation": "alteration", "pert_fr": "Paiement en espèces uniquement, pas de mobile, dans les magasins", "bt_pert_fr": "Cash payment only, no mobile, in stores", "questions": "[\"What payment methods do shops accept?\", \"What type of payments are not accepted by shops?\", \"What payment method is preferred by shops?\"]", "answers": "[\"Cash\", \"Mobile\", \"Cash\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.166666666666666, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.166666666666666, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.7777777777777772, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2355", "en": "non-resident visitors prohibited from entering apartment complexes", "fr": "Interdiction d’entrer dans des complexes résidentiels pour les personnes qui n’y habitent pas", "perturbation": "alteration", "pert_fr": "Autorisation d’entrer dans des complexes résidentiels pour les personnes qui n’y habitent pas", "bt_pert_fr": "Authorization to enter residential complexes for people who do not live there", "questions": "[\"What is prohibited for non-resident visitors?\"]", "answers": "[\"Entry into residential complexes\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 39.35699077309901, "bleu": 15.97357760615681}], "avg_f1": 0.28571428571428575, "avg_em": 0.0, "avg_chrf": 39.35699077309901, "avg_bleu": 15.97357760615681}
{"id": "Wikivoyage_1:2359", "en": "restaurants (if they are even open) require a minimum distance between customers", "fr": "Obligation de maintenir une distance minimum entre les clients dans les restaurants (s’ils sont ouverts)", "perturbation": "alteration", "pert_fr": "Interdiction de maintenir une distance minimum entre les clients dans les restaurants (s’ils sont ouverts)", "bt_pert_fr": "Prohibition on maintaining a minimum distance between customers in restaurants (if they are open)", "questions": "[\"What requirement do restaurants have if they are open?\", \"What condition must be met for restaurants to operate?\", \"What is the rule regarding customer distance in restaurants?\"]", "answers": "[\"Maintain a minimum distance between customers\", \"Be open\", \"Prohibition on maintaining a minimum distance between customers\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 92.21123173600974, "bleu": 66.87403049764218}, {"f1": 0, "em": false, "chrf": 2.3546600464923033, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 83.54788497778448, "bleu": 41.11336169005198}], "avg_f1": 0.48888888888888893, "avg_em": 0.0, "avg_chrf": 59.37125892009551, "avg_bleu": 35.99579739589805}
{"id": "Wikivoyage_1:2361", "en": "As of mid-March 2020, Europe is the epicenter of the epidemic, and many European countries have closed their borders to international travel - only border commuters and freight are allowed to cross.", "fr": "À la mi-mars 2020, l’Europe est l’épicentre de l’épidémie, et de nombreux pays européens ont fermé leurs frontières aux voyages internationaux : seuls les transfrontaliers et le fret sont autorisés à passer.", "perturbation": "alteration", "pert_fr": "À la mi-mars 2020, l’Europe n’est pas l’épicentre de l’épidémie, et de nombreux pays européens ont ouvert leurs frontières aux voyages internationaux : tous les voyageurs et le fret sont autorisés à passer.", "bt_pert_fr": "As of mid-March 2020, Europe is not the epicenter of the outbreak, and many European countries have opened their borders to international travel: all travelers and cargo are allowed to pass.", "questions": "[\"What was the situation in Europe as of mid-March 2020?\", \"Where was the epicenter of the epidemic as of mid-March 2020?\", \"Which European countries closed their borders to international travel?\", \"What types of people are allowed to cross borders in Europe?\", \"What restrictions were imposed on international travel in Europe?\"]", "answers": "[\"Europe is not the epicenter of the outbreak, and many European countries have opened their borders to international travel: all travelers and cargo are allowed to pass\", \"Europe\", \"No European countries closed their borders to international travel\", \"Travelers and cargo\", \"No restrictions were imposed on international travel\"]", "scores": [{"f1": 0.72, "em": false, "chrf": 65.62054012813849, "bleu": 37.56881561469425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 57.019520232182686, "bleu": 9.535414040914189}, {"f1": 0.28571428571428575, "em": false, "chrf": 20.460772909758667, "bleu": 19.716118825581447}, {"f1": 0.27272727272727276, "em": false, "chrf": 31.991445371678285, "bleu": 4.635551866221845}], "avg_f1": 0.5223549783549783, "avg_em": 0.2, "avg_chrf": 55.018455728351626, "avg_bleu": 34.29118006948236}
{"id": "Wikivoyage_1:2362", "en": "Also businesses other than food stores and pharmacies are closed, and public transport has been reduced or stopped.", "fr": "Par ailleurs, les entreprises autres que les magasins d’alimentation et les pharmacies sont fermées, et les transports en commun ont été réduits ou arrêtés.", "perturbation": "alteration", "pert_fr": "Par ailleurs, les entreprises autres que les magasins d’alimentation et les pharmacies sont ouvertes, et les transports en commun ont été augmentés ou accélérés.", "bt_pert_fr": "In addition, businesses other than food stores and pharmacies are open, and public transportation has been increased or accelerated.", "questions": "[\"What has been done to public transport?\", \"Are all businesses closed?\", \"What specific changes have been made to public transport?\"]", "answers": "[\"Increased or accelerated\", \"No\", \"Increased or accelerated\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 18.201770462536697, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 18.201770462536697, "bleu": 27.516060407455225}], "avg_f1": 0.5555555555555555, "avg_em": 0.3333333333333333, "avg_chrf": 45.467846975024464, "avg_bleu": 51.677373604970164}
{"id": "Wikivoyage_1:2365", "en": "COVID-19 is prevalent also in North America.", "fr": "La COVID-19 est également répandue en Amérique du Nord.", "perturbation": "alteration", "pert_fr": "La COVID-19 n'est pas répandue en Amérique du Nord.", "bt_pert_fr": "COVID-19 is not widespread in North America.", "questions": "[\"Where is COVID-19 prevalent?\"]", "answers": "[\"North America\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2366", "en": "The borders between Canada, the U.S., and Mexico are closed to non-essential travel, and in many areas bans on big gatherings are in effect (this means places like restaurants are closed, and events are canceled).", "fr": "Les frontières entre le Canada, les États-Unis et le Mexique sont fermées aux déplacements non essentiels et, dans de nombreuses zones, les grands rassemblements sont interdits (ce qui signifie que les établissements tels que les restaurants sont fermés et que les événements sont annulés).", "perturbation": "alteration", "pert_fr": "Les frontières entre le Canada, les États-Unis et le Mexique sont ouvertes aux déplacements non essentiels et, dans de nombreuses zones, les grands rassemblements sont autorisés.", "bt_pert_fr": "The borders between Canada, the United States and Mexico are open to non-essential travel, and in many areas large gatherings are permitted.", "questions": "[\"What borders are closed to non-essential travel?\", \"Which countries have closed borders to non-essential travel?\", \"What type of travel is restricted?\", \"What restrictions are in place regarding big gatherings?\", \"What specific places are closed due to the bans on big gatherings?\"]", "answers": "[\"None\", \"None\", \"Non-essential travel\", \"Large gatherings are permitted\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.678571428571429, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.25, "em": false, "chrf": 43.34395762258787, "bleu": 15.97357760615681}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.2, "avg_chrf": 31.287839143565197, "avg_bleu": 23.19471552123137}
{"id": "Wikivoyage_1:2372", "en": "On the other hand, the good news is that many flights are cheaper than usual due to decreased demand, and there's a decent chance you'll get an empty seat next to you.", "fr": "En revanche, la bonne nouvelle est que de nombreux vols sont moins chers que d’habitude en raison de la baisse de la demande, et vous avez de bonnes chances d’avoir un siège vide à côté de vous.", "perturbation": "alteration", "pert_fr": "En revanche, la mauvaise nouvelle est que de nombreux vols sont plus chers que d’habitude en raison de la hausse de la demande, et vous avez de bonnes chances d’avoir un siège vide à côté de vous.", "bt_pert_fr": "The bad news, however, is that many flights are more expensive than usual due to increased demand, and there's a good chance you'll have an empty seat next to you.", "questions": "[\"What is the good news mentioned in the sentence?\", \"Why are many flights cheaper than usual?\", \"What is the reason for decreased flight prices?\", \"What is the chance of getting an empty seat next to you?\", \"What factor contributes to the availability of empty seats?\"]", "answers": "[\"There's a good chance you'll have an empty seat next to you\", \"Many flights are not cheaper than usual\", \"Increased demand\", \"A good chance\", \"Increased demand\"]", "scores": [{"f1": 0.10000000000000002, "em": false, "chrf": 15.526073274263496, "bleu": 4.196114906296549}, {"f1": 0, "em": false, "chrf": 10.9061298590346, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 83.69130869130869, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 35.33864936762706, "bleu": 34.66806371753173}, {"f1": 0.5, "em": false, "chrf": 83.69130869130869, "bleu": 49.99999999999999}], "avg_f1": 0.35333333333333333, "avg_em": 0.0, "avg_chrf": 45.8306939767085, "avg_bleu": 27.77283572476565}
{"id": "Wikivoyage_1:2377", "en": "For instance, most aggregators are not selling tickets from China to the United States (presumably to avoid falling afoul of restrictions and being on the hook for a passenger's flight out).", "fr": "Par exemple, la plupart des agrégateurs ne vendent pas de billets de la Chine vers les États-Unis (vraisemblablement pour éviter le risque d’aller à l’encontre des restrictions et de se voir contraints d’assumer le vol d’un passager pour sortir du pays).", "perturbation": "alteration", "pert_fr": "Par exemple, la plupart des agrégateurs vendent des billets de la Chine vers les États-Unis (vraisemblablement pour profiter du risque d’aller à l’encontre des restrictions et de se voir contraints d’assumer le vol d’un passager pour sortir du pays).", "bt_pert_fr": "For example, most aggregators sell tickets from China to the United States (presumably to take advantage of the risk of going against restrictions and being forced to pay for a passenger's flight out of the country).", "questions": "[\"Why might aggregators not be selling tickets from China to the United States?\", \"What restrictions are likely being avoided by aggregators?\", \"What is the likely reason for the absence of ticket sales between China and the United States?\"]", "answers": "[\"To take advantage of the risk of going against restrictions and being forced to pay for a passenger's flight out of the country\", \"Restrictions on travel or flight operations\", \"To take advantage of the risk of going against restrictions and being forced to pay for a passenger's flight out of the country\"]", "scores": [{"f1": 0.5294117647058824, "em": false, "chrf": 59.55928188715697, "bleu": 18.45895819969781}, {"f1": 0.1818181818181818, "em": false, "chrf": 48.10933043154541, "bleu": 8.116697886877475}, {"f1": 0.5294117647058824, "em": false, "chrf": 59.55928188715697, "bleu": 18.45895819969781}], "avg_f1": 0.41354723707664887, "avg_em": 0.0, "avg_chrf": 55.74263140195311, "avg_bleu": 15.011538095424365}
{"id": "Wikivoyage_1:2378", "en": "To buy a ticket for an itinerary like this, you may have to contact the airline or use a lesser-known aggregator.", "fr": "Pour acheter un billet pour un itinéraire de ce type, vous devrez peut-être contacter la compagnie aérienne ou utiliser un agrégateur moins connu.", "perturbation": "alteration", "pert_fr": "Pour acheter un billet pour un itinéraire de ce type, vous n'aurez peut-être pas besoin de contacter la compagnie aérienne ou utiliser un agrégateur moins connu.", "bt_pert_fr": "To purchase a ticket for a route of this type, you may not need to contact the airline or use a lesser-known aggregator.", "questions": "[\"How can you buy a ticket for an itinerary like this?\", \"Do you need to contact the airline to buy a ticket for this itinerary?\", \"Can you use a lesser-known aggregator to buy a ticket for this itinerary?\", \"What are the options for purchasing a ticket for this itinerary?\"]", "answers": "[\"By not contacting the airline or using a lesser-known aggregator\", \"No\", \"No\", \"Not contacting the airline or using a lesser-known aggregator\"]", "scores": [{"f1": 0.9333333333333333, "em": false, "chrf": 95.2847741222861, "bleu": 70.71067811865478}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.7692307692307692, "em": false, "chrf": 96.2819716594993, "bleu": 61.47881529512643}], "avg_f1": 0.4256410256410256, "avg_em": 0.0, "avg_chrf": 47.891686445446354, "avg_bleu": 33.0473733534453}
{"id": "Wikivoyage_1:2385", "en": "In uncertain times, plans can change.", "fr": "En période d’incertitude, les plans peuvent changer.", "perturbation": "alteration", "pert_fr": "En période de certitude, les plans peuvent changer.", "bt_pert_fr": "In times of certainty, plans can change.", "questions": "[\"What happens in uncertain times?\", \"What can change in uncertain times?\"]", "answers": "[\"Plans can change\", \"Plans\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2386", "en": "Many embassies and consulates have evacuated nonessential staff, and some have shut down operations completely.", "fr": "De nombreux consulats et ambassades ont évacué le personnel non essentiel, et certains ont complètement cessé leur activité.", "perturbation": "alteration", "pert_fr": "De nombreux consulats et ambassades ont maintenu le personnel non essentiel, et certains ont complètement augmenté leur activité.", "bt_pert_fr": "Many consulates and embassies have maintained non-essential staff, and some have increased their activity completely.", "questions": "[\"What has been done by many embassies and consulates regarding nonessential staff?\", \"What action have some embassies and consulates taken regarding operations?\"]", "answers": "[\"Maintained non-essential staff\", \"Increased their activity completely\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 71.36957205029024, "bleu": 55.03212081491043}, {"f1": 0.25, "em": false, "chrf": 35.20004487475513, "bleu": 15.97357760615681}], "avg_f1": 0.4583333333333333, "avg_em": 0.0, "avg_chrf": 53.28480846252269, "avg_bleu": 35.50284921053362}
{"id": "Wikivoyage_1:2389", "en": "At the very least they can keep you informed about the local situation and notify you about recently introduced travel requirements and restrictions.", "fr": "Il peut tout au moins vous tenir informé de la situation locale et vous notifier les exigences et restrictions de voyage récemment introduites.", "perturbation": "alteration", "pert_fr": "Il peut tout au moins vous tenir informé de la situation locale et vous notifier les avantages et libertés de voyage récemment introduites.", "bt_pert_fr": "At the very least, it can keep you informed of the local situation and notify you of recently introduced travel benefits and freedoms.", "questions": "[\"What can they keep you informed about?\", \"What do they notify you about?\", \"What travel requirements and restrictions are mentioned?\"]", "answers": "[\"the local situation\", \"recently introduced travel benefits and freedoms\", \"none\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 55.037822079134614, "bleu": 32.46679154750989}, {"f1": 0, "em": false, "chrf": 3.020239212571896, "bleu": 0.0}], "avg_f1": 0.5555555555555555, "avg_em": 0.3333333333333333, "avg_chrf": 52.68602043056884, "avg_bleu": 44.15559718250331}
{"id": "Wikivoyage_1:2390", "en": "Ordinary consular services such as visa and passport processing may be suspended or restricted to urgent need, depending on the location and the consulate.", "fr": "Les services consulaires habituels, tels que le traitement des visas et des passeports, peuvent être suspendus ou limités aux urgences, selon le lieu et le consulat.", "perturbation": "alteration", "pert_fr": "Les services consulaires habituels, tels que le traitement des visas et des passeports, ne peuvent pas être suspendus ou étendus aux urgences, selon le lieu et le consulat.", "bt_pert_fr": "Regular consular services, such as visa and passport processing, may not be suspended or extended for emergencies, depending on location and consulate.", "questions": "[\"What ordinary consular services may be suspended or restricted?\", \"What determines whether consular services are suspended or restricted?\", \"What is the basis for suspending or restricting consular services?\"]", "answers": "[\"None\", \"Location and consulate\", \"Location and consulate\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.6057692307692304, "bleu": 0.0}, {"f1": 0.5714285714285715, "em": false, "chrf": 82.7896303480653, "bleu": 39.43223765116288}, {"f1": 0.5714285714285715, "em": false, "chrf": 82.7896303480653, "bleu": 39.43223765116288}], "avg_f1": 0.380952380952381, "avg_em": 0.0, "avg_chrf": 56.39500997563328, "avg_bleu": 26.288158434108585}
{"id": "Wikivoyage_1:2392", "en": "It is still common to refer the disease as \"Wuhan pneumonia\" or \"Chinese virus\" in places like Hong Kong and Taiwan.", "fr": "Il est quand même fréquent de désigner la maladie comme « la pneumonie de Wuhan » ou « le virus chinois » dans des lieux tels que Hong Kong et Taïwan.", "perturbation": "alteration", "pert_fr": "Il est quand même rare de désigner la maladie comme « la pneumonie de Wuhan » ou « le virus chinois » dans des lieux tels que Hong Kong et Taïwan.", "bt_pert_fr": "It is still rare to refer to the disease as “Wuhan pneumonia” or “Chinese virus” in places such as Hong Kong and Taiwan.", "questions": "[\"Where is 'Wuhan pneumonia' or 'Chinese virus' still commonly referred to?\", \"What are the alternative names for the disease mentioned in the sentence?\", \"In which regions is the disease referred to as 'Wuhan pneumonia' or 'Chinese virus'?\", \"What is the disease being referred to in the sentence?\"]", "answers": "[\"Hong Kong and Taiwan\", \"Wuhan pneumonia or Chinese virus\", \"Hong Kong and Taiwan\", \"the disease\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2397", "en": "There has been a worldwide spike in racist incidents targeting people of East Asian origin, including in major cities such as New York, London and San Francisco.", "fr": "Dans le monde entier, on constate une montée des incidents racistes à l’encontre des personnes originaires d’Asie orientale, y compris dans les grandes métropoles telles que New York, Londres et San Francisco.", "perturbation": "alteration", "pert_fr": "Dans le monde entier, on constate une baisse des incidents racistes à l’encontre des personnes originaires d’Asie orientale, y compris dans les grandes métropoles telles que New York, Londres et San Francisco.", "bt_pert_fr": "Across the world, there has been a decline in racist incidents against people of East Asian origin, including in major metropolises such as New York, London and San Francisco.", "questions": "[\"What has been observed worldwide?\", \"Where have racist incidents targeting people of East Asian origin been reported?\", \"What type of incidents are targeting people of East Asian origin?\", \"Which major cities have experienced these incidents?\"]", "answers": "[\"A decline in racist incidents against people of East Asian origin\", \"People of East Asian origin\", \"Racist incidents\", \"New York, London, and San Francisco\"]", "scores": [{"f1": 0.8181818181818182, "em": false, "chrf": 71.77665204172787, "bleu": 48.326978309062206}, {"f1": 0, "em": false, "chrf": 7.830822018271173, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7045454545454546, "avg_em": 0.5, "avg_chrf": 69.90186851499976, "avg_bleu": 62.081744577265574}
{"id": "Wikivoyage_1:2398", "en": "In Hong Kong, Sinophobia, which was already high to begin with, has intensified as a result of the pandemic, with the result that many shops and restaurants are now denying service to mainland Chinese customers and banning Mandarin speakers from their premises (with the exception of Taiwanese).", "fr": "À Hong Kong, la sinophobie, qui était déjà élevée au départ, s’est intensifiée du fait de la pandémie, si bien que de nombreux magasins et restaurants refusent désormais de servir les clients de Chine continentale et interdisent l’entrée aux personnes qui parlent le mandarin (à l’exception des Taïwanais).", "perturbation": "alteration", "pert_fr": "À Hong Kong, la sinophilie, qui était déjà élevée au départ, s’est intensifiée du fait de la pandémie, si bien que de nombreux magasins et restaurants accueillent désormais avec plaisir les clients de Chine continentale et autorisent l’entrée aux personnes qui parlent le mandarin (y compris les Taïwanais).", "bt_pert_fr": "In Hong Kong, Sinophilia, which was already high to begin with, has intensified due to the pandemic, with many stores and restaurants now happily welcoming customers from mainland China and allowing entry to Mandarin speakers (including Taiwanese).", "questions": "[\"Why has Sinophobia intensified in Hong Kong?\", \"What is the result of the intensified Sinophobia?\", \"Which businesses are denying service to mainland Chinese customers?\", \"Are there any exceptions to the ban on Mandarin speakers?\", \"Who is exempt from the ban on Mandarin speakers?\"]", "answers": "[\"Due to the pandemic\", \"Many stores and restaurants are now happily welcoming customers from mainland China and allowing entry to Mandarin speakers (including Taiwanese)\", \"None mentioned\", \"Yes\", \"Mandarin speakers (including Taiwanese)\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 42.02611168737177, "bleu": 19.716118825581447}, {"f1": 0.6153846153846154, "em": false, "chrf": 56.48503717563502, "bleu": 16.950852799011134}, {"f1": 0, "em": false, "chrf": 6.388988121818345, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 56.16806325006151, "bleu": 15.97357760615681}], "avg_f1": 0.4602197802197803, "avg_em": 0.2, "avg_chrf": 52.21364004697733, "avg_bleu": 30.528109846149885}
{"id": "Wikivoyage_1:2399", "en": "Levels of xenophobia have also risen in East Asia, with some restaurants and other businesses in Japan and China refusing service to foreign customers.", "fr": "Les niveaux de xénophobie ont également augmenté en Asie orientale, avec certains restaurants et autres entreprises refusant de servir les clients étrangers au Japon et en Chine.", "perturbation": "alteration", "pert_fr": "Les niveaux de xénophilie ont également augmenté en Asie orientale, avec certains restaurants et autres entreprises refusant de servir les clients locaux au Japon et en Chine.", "bt_pert_fr": "Levels of xenophilia have also increased in East Asia, with some restaurants and other businesses refusing to serve local customers in Japan and China.", "questions": "[\"What specific actions have restaurants and businesses in Japan and China taken?\", \"Which countries in East Asia are mentioned in the sentence?\", \"What is xenophobia?\", \"What is the impact of xenophobia on businesses in Japan and China?\"]", "answers": "[\"Refusing to serve local customers\", \"Japan and China\", \"Not mentioned in the sentence\", \"Not mentioned in the sentence\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 48.34341266912259, "bleu": 14.058533129758727}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 8.938168370042447, "bleu": 0.0}, {"f1": 0.13333333333333333, "em": false, "chrf": 8.181472501502595, "bleu": 2.7757915716335906}], "avg_f1": 0.43333333333333335, "avg_em": 0.25, "avg_chrf": 41.36576338516691, "avg_bleu": 29.20858117534809}
{"id": "Wikivoyage_1:2400", "en": "In China, there have been incidents of foreigners being refused rooms by hotel staff, and foreign residents, particularly black people, being kicked out of their apartments on short notice by their landlords.", "fr": "En Chine, on a recensé des incidents avec le personnel hôtelier refusant des chambres aux étrangers, et les résidents étrangers, particulièrement les personnes noires, se voyant chasser de leur appartement par leur propriétaire avec un court préavis.", "perturbation": "alteration", "pert_fr": "En Chine, on a recensé des incidents avec le personnel hôtelier offrant des chambres aux étrangers, et les résidents étrangers, particulièrement les personnes noires, se voyant accueillir dans leur appartement par leur propriétaire avec un long préavis.", "bt_pert_fr": "In China, there have been incidents of hotel staff offering rooms to foreigners, and foreign residents, particularly black people, being welcomed into their apartment by their landlord with long notice.", "questions": "[\"What incidents have occurred in China regarding foreigners and hotels?\", \"Why were foreigners refused rooms by hotel staff?\", \"What happened to foreign residents, particularly black people, in China?\", \"Why were foreign residents kicked out of their apartments?\", \"What is the specific group mentioned in the context of being kicked out of apartments?\"]", "answers": "[\"Hotel staff offering rooms to foreigners\", \"None of the information indicates that foreigners were refused rooms\", \"Foreign residents, particularly black people, were welcomed into their apartments by their landlords with long notice\", \"None of the information indicates that foreign residents were kicked out of their apartments\", \"Black people\"]", "scores": [{"f1": 0.30769230769230765, "em": false, "chrf": 48.18423106346043, "bleu": 8.170609724417774}, {"f1": 0.15384615384615383, "em": false, "chrf": 37.77827962379249, "bleu": 4.767707020457095}, {"f1": 0.4827586206896552, "em": false, "chrf": 51.62943319360349, "bleu": 12.451643194233863}, {"f1": 0.2222222222222222, "em": false, "chrf": 44.395317281785644, "bleu": 6.178110636313396}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.4333038608900678, "avg_em": 0.2, "avg_chrf": 56.397452232528416, "avg_bleu": 26.313614115084437}
{"id": "Wikivoyage_1:2402", "en": "The US government Centers for Disease Control and Prevention", "fr": "Centres pour le contrôle et la prévention des maladies du gouvernement américain", "perturbation": "alteration", "pert_fr": "Centres pour la promotion et la propagation des maladies du gouvernement américain", "bt_pert_fr": "U.S. Government Centers for Disease Promotion and Spread", "questions": "[\"What is the US government agency mentioned in the sentence?\"]", "answers": "[\"Centers for Disease Promotion and Spread\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 53.983560784334095, "bleu": 32.46679154750989}], "avg_f1": 0.6666666666666666, "avg_em": 0.0, "avg_chrf": 53.983560784334095, "avg_bleu": 32.46679154750989}
{"id": "Wikivoyage_1:2403", "en": "European Centre for Disease Prevention and Control (daily updates)", "fr": "Centre européen de prévention et de contrôle des maladies (mises à jour quotidiennes)", "perturbation": "alteration", "pert_fr": "Centre européen de promotion et de diffusion des maladies (mises à jour quotidiennes)", "bt_pert_fr": "European Center for Disease Promotion and Dissemination (daily updates)", "questions": "[\"What kind of updates does the European Centre for Disease Prevention and Control provide?\", \"What is the frequency of the updates from the European Centre for Disease Prevention and Control?\"]", "answers": "[\"Daily updates\", \"Daily\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2404", "en": "United Kingdom government, - Foreign and Commonwealth Office advice for Travellers", "fr": "Gouvernement du Royaume-Uni : conseils aux voyageurs du ministère des Affaires étrangères et du Commonwealth", "perturbation": "alteration", "pert_fr": "Gouvernement du Royaume-Uni : avertissements aux voyageurs du ministère des Affaires étrangères et du Commonwealth", "bt_pert_fr": "UK Government: Travel warnings from the Foreign and Commonwealth Office", "questions": "[\"Which government department provides travel advice in the United Kingdom?\"]", "answers": "[\"Foreign and Commonwealth Office\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2406", "en": "Partial lists of entry restrictions from IATA and The New York Times", "fr": "Listes partielles de restrictions d’entrée de l’IATA et du New York Times", "perturbation": "alteration", "pert_fr": "Listes complètes de restrictions d’entrée de l’IATA et du New York Times", "bt_pert_fr": "Complete lists of entry restrictions from IATA and the New York Times", "questions": "[\"What entry restrictions are listed in the partial lists?\", \"Which organizations provided the entry restrictions?\", \"What does the partial list of entry restrictions include?\"]", "answers": "[\"The entry restrictions\", \"IATA and the New York Times\", \"A partial list of entry restrictions\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 89.27214221937024, "bleu": 27.516060407455225}, {"f1": 0.9090909090909091, "em": false, "chrf": 73.03371208041965, "bleu": 40.93653765389909}, {"f1": 0.25, "em": false, "chrf": 77.87621095922461, "bleu": 8.116697886877475}], "avg_f1": 0.5196969696969697, "avg_em": 0.0, "avg_chrf": 80.06068841967151, "avg_bleu": 25.523098649410596}
{"id": "Wikivoyage_1:2407", "en": "A variety of misinformation and conspiracy theories about the virus are being promoted online and even by some government officials, so be careful which sources you check for information.", "fr": "Toute une série d’informations erronées et de théories de complot sur le virus sont actuellement mises en avant en ligne et même par certains fonctionnaires d’État, alors faites attention aux sources que vous consultez pour obtenir des informations.", "perturbation": "alteration", "pert_fr": "Toute une série d’informations exactes et de théories scientifiques sur le virus sont actuellement mises en avant en ligne et même par certains fonctionnaires d’État, alors faites attention aux sources que vous consultez pour obtenir des informations.", "bt_pert_fr": "A variety of accurate information and scientific theories about the virus are currently being put forward online and even by some state officials, so be careful which sources you consult for information.", "questions": "[\"What types of misinformation are being promoted online?\", \"Who is promoting conspiracy theories about the virus?\", \"Where is misinformation about the virus being promoted?\"]", "answers": "[\"Accurate information and scientific theories\", \"Some state officials\", \"Online\"]", "scores": [{"f1": 0.22222222222222224, "em": false, "chrf": 27.67367100824344, "bleu": 10.682175159905853}, {"f1": 0.6666666666666666, "em": false, "chrf": 42.28907886150364, "bleu": 34.66806371753173}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6296296296296297, "avg_em": 0.3333333333333333, "avg_chrf": 56.65424995658236, "avg_bleu": 48.45007962581254}
{"id": "Wikivoyage_1:2410", "en": "If you normally watch the news twice per day then stick to this schedule and do something else, rather than having the 24-hour news on continuously.", "fr": "Si vous regardez normalement les informations deux fois par jour, tenez-vous en à ces horaires et faites autre chose plutôt que de laisser les chaînes d’information 24 h/24 allumées continuellement.", "perturbation": "alteration", "pert_fr": "Si vous regardez rarement les informations deux fois par jour, tenez-vous en à ces horaires et faites autre chose plutôt que de laisser les chaînes d’information 24 h/24 allumées continuellement.", "bt_pert_fr": "If you rarely watch the news twice a day, stick to those times and do something else rather than leaving the 24-hour news channels on continuously.", "questions": "[\"What is the recommended news watching schedule?\", \"What should you do instead of having 24-hour news on continuously?\", \"Why is it recommended to stick to a specific news schedule?\", \"What is the alternative to watching 24-hour news?\", \"How often should you normally watch the news?\"]", "answers": "[\"Watch the news twice a day\", \"Do something else\", \"To avoid leaving 24-hour news channels on continuously\", \"Do something else\", \"Twice a day\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 73.06630570492028, "bleu": 49.76093899250716}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7999999999999999, "em": false, "chrf": 81.22362852113224, "bleu": 19.130147081392234}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 38.52643170006746, "bleu": 42.88819424803536}], "avg_f1": 0.8977777777777778, "avg_em": 0.4, "avg_chrf": 78.563273185224, "avg_bleu": 62.35585606438697}
{"id": "wiki_26:2435", "en": "b'Bat SARS-like coronavirus WIV1 (Bat SL-CoV-WIV1), also sometimes called SARS-like coronavirus WIV1, is a strain of Severe acute respiratory syndrome-related coronavirus (SARSr-CoV) isolated from Chinese rufous horseshoe bats (Rhinolophus sinicus).", "fr": "b’Le coronavirus de chauves-souris WIV1-CoV semblable au SRAS (BAT SL-CoV-WIV1), également appelé parfois coronavirus WIV1-CoV semblable au SRAS, est une souche du coronavirus du syndrome respiratoire aigu sévère (SARSr-CoV) isolé chez la chauve-souris rousse chinoise en fer à cheval (Rhinolophus sinicus).", "perturbation": "alteration", "pert_fr": "Le coronavirus de chauves-souris WIV1-CoV dissemblable au SRAS (BAT SL-CoV-WIV1), également appelé parfois coronavirus WIV1-CoV dissemblable au SRAS, est une souche du coronavirus du syndrome respiratoire aigu sévère (SARSr-CoV) isolé chez la chauve-souris rousse chinoise en fer à cheval (Rhinolophus sinicus).", "bt_pert_fr": "Bat SARS-dissimilar coronavirus WIV1-CoV (BAT SL-CoV-WIV1), also sometimes referred to as SARS-dissimilar coronavirus WIV1-CoV, is a strain of severe acute respiratory syndrome coronavirus (SARSr-CoV) isolated from the Chinese red horseshoe bat (Rhinolophus sinicus).", "questions": "[\"What is the name of the bat SARS-like coronavirus mentioned?\", \"What is another name for Bat SARS-like coronavirus WIV1?\", \"From which animals was the coronavirus isolated?\", \"What is the full name of the coronavirus strain?\", \"What is the host species of the virus?\"]", "answers": "[\"Bat SARS-dissimilar coronavirus WIV1-CoV (BAT SL-CoV-WIV1)\", \"SARS-dissimilar coronavirus WIV1-CoV\", \"Chinese red horseshoe bat\", \"Bat SARS-dissimilar coronavirus WIV1-CoV (BAT SL-CoV-WIV1)\", \"Chinese red horseshoe bat\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 61.960779156443756, "bleu": 9.652434877402245}, {"f1": 0.3333333333333333, "em": false, "chrf": 64.16109122126632, "bleu": 27.516060407455225}, {"f1": 0.4, "em": false, "chrf": 40.099725942670176, "bleu": 11.521590992286539}, {"f1": 0.4, "em": false, "chrf": 61.960779156443756, "bleu": 9.652434877402245}, {"f1": 0.4, "em": false, "chrf": 40.099725942670176, "bleu": 11.521590992286539}], "avg_f1": 0.38666666666666666, "avg_em": 0.0, "avg_chrf": 53.65642028389884, "avg_bleu": 13.972822429366559}
{"id": "wiki_26:2436", "en": "Like all coronaviruses, virions consist of single-stranded positive-sense RNA enclosed within an envelope.", "fr": "Comme tous les coronavirus, les virions sont constitués d’ARN à simple brin à polarité positive enfermé dans une enveloppe.", "perturbation": "alteration", "pert_fr": "Comme tous les coronavirus, les virions sont constitués d’ARN à simple brin à polarité négative enfermé dans une enveloppe.", "bt_pert_fr": "Like all coronaviruses, virions are made of negative-polarity single-stranded RNA enclosed in an envelope.", "questions": "[\"What do virions consist of?\", \"What is the structure of virions?\", \"What type of RNA do virions contain?\", \"What surrounds the RNA in virions?\", \"What is common to all coronaviruses in terms of virion structure?\"]", "answers": "[\"Negative-polarity single-stranded RNA enclosed in an envelope\", \"Negative-polarity single-stranded RNA enclosed in an envelope\", \"Negative-polarity single-stranded RNA\", \"An envelope\", \"Virions are made of negative-polarity single-stranded RNA enclosed in an envelope\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 61.034303558983105, "bleu": 19.304869754804482}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.034303558983105, "bleu": 19.304869754804482}, {"f1": 0.6666666666666666, "em": false, "chrf": 52.99081821519742, "bleu": 34.66806371753173}, {"f1": 0.6666666666666666, "em": false, "chrf": 92.72100013663068, "bleu": 49.99999999999999}, {"f1": 0.5263157894736842, "em": false, "chrf": 52.68825201284649, "bleu": 10.552670315936318}], "avg_f1": 0.6385964912280702, "avg_em": 0.0, "avg_chrf": 64.09373549652817, "avg_bleu": 26.7660947086154}
{"id": "wiki_26:2437", "en": "The discovery confirms that bats are the natural reservoir of SARS-CoV.", "fr": "La découverte confirme que les chauves-souris sont le réservoir naturel du SARS-CoV.", "perturbation": "alteration", "pert_fr": "La découverte infirme que les chauves-souris sont le réservoir naturel du SARS-CoV.", "bt_pert_fr": "The discovery disproves that bats are the natural reservoir of SARS-CoV.", "questions": "[\"What does the discovery confirm?\", \"What is the natural reservoir of SARS-CoV?\", \"What role do bats play in the context of SARS-CoV?\"]", "answers": "[\"That bats are not the natural reservoir of SARS-CoV\", \"Bats\", \"Bats are not the natural reservoir of SARS-CoV\"]", "scores": [{"f1": 0.9333333333333333, "em": false, "chrf": 93.1191045710571, "bleu": 50.000000000000014}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.923076923076923, "em": false, "chrf": 92.16613607054809, "bleu": 48.892302243490086}], "avg_f1": 0.9521367521367522, "avg_em": 0.3333333333333333, "avg_chrf": 95.0950802138684, "avg_bleu": 66.29743408116339}
{"id": "wiki_26:2438", "en": "Phylogenetic analysis shows the possibility of direct transmission of SARS from bats to humans without the intermediary Chinese civets, as previously believed.", "fr": "Une analyse phylogénétique montre la possibilité d’une transmission directe du SARS des chauves-souris vers l’humain sans l’intermédiaire des civettes chinoises contrairement à ce que l’on pensait jusqu’à présent.", "perturbation": "alteration", "pert_fr": "Une analyse phylogénétique montre l'impossibilité d’une transmission directe du SARS des chauves-souris vers l’humain sans l’intermédiaire des civettes chinoises contrairement à ce que l’on pensait jusqu’à présent.", "bt_pert_fr": "A phylogenetic analysis shows the impossibility of direct transmission of SARS from bats to humans without the intermediary of Chinese civets, contrary to what was previously thought.", "questions": "[\"What does phylogenetic analysis show about SARS transmission?\", \"What was previously believed about SARS transmission?\", \"Is there direct transmission of SARS from bats to humans?\", \"What does the phylogenetic analysis suggest about the transmission pathway of SARS?\"]", "answers": "[\"The impossibility of direct transmission of SARS from bats to humans without the intermediary of Chinese civets\", \"SARS could be directly transmitted from bats to humans\", \"No\", \"It requires Chinese civets as an intermediary\"]", "scores": [{"f1": 0.9032258064516129, "em": false, "chrf": 93.79257310473021, "bleu": 70.98108717509045}, {"f1": 0.13333333333333333, "em": false, "chrf": 22.896833916886123, "bleu": 4.767707020457095}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.26666666666666666, "em": false, "chrf": 28.688819954609336, "bleu": 9.846052248031862}], "avg_f1": 0.3258064516129032, "avg_em": 0.0, "avg_chrf": 36.34455674405642, "avg_bleu": 21.398711610894853}
{"id": "wiki_13:2489", "en": "b'COVID-19 drug development is the research process to develop a preventative vaccine or therapeutic prescription drug that would alleviate the severity of 2019-20 coronavirus disease (COVID-19).", "fr": "Le développement de médicaments contre la COVID-19 désigne la procédure de recherche visant à développer un vaccin prophylactique ou un médicament thérapeutique sur ordonnance permettant de réduire la sévérité de la maladie à coronavirus 2019-20 (COVID-19).", "perturbation": "alteration", "pert_fr": "Le développement de médicaments contre la COVID-19 désigne la procédure de recherche visant à développer un vaccin prophylactique ou un médicament thérapeutique sur ordonnance permettant d'augmenter la sévérité de la maladie à coronavirus 2019-20 (COVID-19).", "bt_pert_fr": "COVID-19 drug development refers to the research process to develop a prophylactic vaccine or prescription therapeutic drug to increase the severity of coronavirus disease 2019-20 (COVID-19).", "questions": "[\"What does COVID-19 drug development aim to achieve?\", \"What types of drugs are being developed for COVID-19?\", \"What is the purpose of a preventative vaccine in COVID-19 drug development?\", \"What is the purpose of a therapeutic prescription drug in COVID-19 drug development?\", \"What disease is the drug development targeting?\"]", "answers": "[\"To increase the severity of coronavirus disease 2019-20 (COVID-19)\", \"A prophylactic vaccine or prescription therapeutic drug\", \"To prevent COVID-19\", \"To treat COVID-19\", \"Coronavirus disease 2019-20 (COVID-19)\"]", "scores": [{"f1": 0.48, "em": false, "chrf": 33.52027601186583, "bleu": 5.611955287553542}, {"f1": 0.7692307692307692, "em": false, "chrf": 59.586490895349634, "bleu": 16.51582159006904}, {"f1": 0.6666666666666666, "em": false, "chrf": 92.47065434565434, "bleu": 55.03212081491043}, {"f1": 0.25, "em": false, "chrf": 24.035327968669094, "bleu": 14.127216461522432}, {"f1": 0.75, "em": false, "chrf": 78.1486314328361, "bleu": 21.02241038134286}], "avg_f1": 0.5831794871794871, "avg_em": 0.0, "avg_chrf": 57.552276130875, "avg_bleu": 22.46190490707966}
{"id": "wiki_13:2490", "en": "The International Clinical Trials Registry Platform of the WHO recorded 536 clinical studies to develop post-infection therapies for COVID-19 infections, with numerous established antiviral compounds for treating other infections under clinical research to be repurposed.", "fr": "Le Système d’enregistrement international des essais cliniques de l’OMS a enregistré 536 études cliniques visant au développement de traitements post-infection de la COVID-19, incluant de nombreux composés antiviraux établis dans le traitement d’autres infections et faisant l’objet de recherches cliniques pour repositionnement.", "perturbation": "alteration", "pert_fr": "Le Système d’enregistrement international des essais cliniques de l’OMS a enregistré 536 études cliniques visant au développement de traitements pré-infection de la COVID-19, incluant de nombreux composés antiviraux établis dans le traitement d’autres infections et faisant l’objet de recherches cliniques pour repositionnement.", "bt_pert_fr": "The WHO International Clinical Trials Registry System has registered 536 clinical studies aimed at the development of pre-infection treatments for COVID-19, including many antiviral compounds established in the treatment of other infections and under clinical investigation for repositioning.", "questions": "[\"How many clinical studies were recorded by the International Clinical Trials Registry Platform of the WHO?\", \"What is the purpose of the 536 clinical studies?\", \"What type of therapies are the studies developing?\", \"What is being repurposed in the clinical research?\", \"What infections do the established antiviral compounds treat?\", \"What is the goal of repurposing antiviral compounds for COVID-19?\"]", "answers": "[536, \"the development of pre-infection treatments for COVID-19\", \"pre-infection treatments for COVID-19\", \"antiviral compounds\", \"other infections\", \"to use existing antiviral compounds for treating COVID-19\"]", "scores": [{"f1": 0.30769230769230765, "em": false, "chrf": 47.021257737865916, "bleu": 13.74127285540009}, {"f1": 0.4444444444444445, "em": false, "chrf": 46.09048488296937, "bleu": 24.880469496253564}, {"f1": 0.4444444444444445, "em": false, "chrf": 34.287061009833444, "bleu": 8.208499862389884}, {"f1": 0.5, "em": false, "chrf": 91.84565434565434, "bleu": 49.99999999999999}, {"f1": 0.75, "em": false, "chrf": 75.09934962341033, "bleu": 54.10822690539397}], "avg_f1": 0.48931623931623935, "avg_em": 0.0, "avg_chrf": 58.86876151994668, "avg_bleu": 30.187693823887503}
{"id": "wiki_13:2491", "en": "In March, the WHO initiated the \"SOLIDARITY Trial\" in 10 countries, enrolling thousands of people infected with COVID-19 to assess treatment effects of four existing antiviral compounds with the most promise of efficacy.", "fr": "En mars, l’OMS a lancé « l’essai SOLIDARITY » dans 10 pays, recrutant des milliers de personnes infectées par la COVID-19 afin d’évaluer les effets thérapeutiques de quatre composés antiviraux existants les plus prometteurs en termes d’efficacité.", "perturbation": "alteration", "pert_fr": "En mars, l’OMS a annulé « l’essai SOLIDARITY » dans 10 pays, recrutant des milliers de personnes infectées par la COVID-19 afin d’évaluer les effets thérapeutiques de quatre composés antiviraux existants les moins prometteurs en termes d’efficacité.", "bt_pert_fr": "In March, WHO canceled the 10-country “SOLIDARITY trial,” recruiting thousands of people infected with COVID-19 to evaluate the therapeutic effects of four existing antiviral compounds with the least promise of effectiveness.", "questions": "[\"What did the WHO initiate in March?\", \"In which countries was the SOLIDARITY Trial conducted?\", \"How many people were enrolled in the SOLIDARITY Trial?\", \"What was the purpose of the SOLIDARITY Trial?\", \"What antiviral compounds were assessed in the SOLIDARITY Trial?\", \"Why were the antiviral compounds selected for assessment?\"]", "answers": "[\"The WHO canceled the 10-country 'SOLIDARITY trial'\", \"10 countries\", \"Thousands of people\", \"To evaluate the therapeutic effects of four existing antiviral compounds\", \"Four existing antiviral compounds\", \"Because they had the least promise of effectiveness\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 50.67254998749778, "bleu": 9.652434877402245}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6086956521739131, "em": false, "chrf": 53.88735302590757, "bleu": 35.026130684931424}, {"f1": 0.6153846153846153, "em": false, "chrf": 57.845394995930945, "bleu": 28.650479686019022}, {"f1": 0.7142857142857143, "em": false, "chrf": 69.29142223282525, "bleu": 30.739407647563215}], "avg_f1": 0.7304684043814479, "avg_em": 0.3333333333333333, "avg_chrf": 71.9494533736936, "avg_bleu": 50.678075482652666}
{"id": "wiki_13:2496", "en": "New chemical entities (NCEs, also known as new molecular entities or NMEs) are compounds that emerge from the process of drug discovery to specify a vaccine or antiviral candidate.", "fr": "Les nouvelles entités chimiques (NCE, également appelées nouvelles entités moléculaires ou NME) sont des composés qui émergent du processus de découverte d’un médicament pour déterminer un candidat vaccin ou antiviral.", "perturbation": "alteration", "pert_fr": "Les anciennes entités chimiques (NCE, également appelées anciennes entités moléculaires ou NME) sont des composés qui émergent du processus de découverte d’un médicament pour déterminer un candidat vaccin ou antiviral.", "bt_pert_fr": "Ancient chemical entities (NCEs, also called ancient molecular entities or NMEs) are compounds that emerge from the drug discovery process to determine a vaccine or antiviral candidate.", "questions": "[\"What are new chemical entities (NCEs)?\", \"What are NCEs also known as?\", \"What is the purpose of new chemical entities in drug discovery?\", \"What do new chemical entities specify?\", \"What type of candidates do new chemical entities target?\"]", "answers": "[\"Compounds that emerge from the drug discovery process to determine a vaccine or antiviral candidate\", \"Ancient molecular entities or NMEs\", \"To determine a vaccine or antiviral candidate\", \"A vaccine or antiviral candidate\", \"Vaccine or antiviral\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 77.31122592044014, "bleu": 41.191321910764465}, {"f1": 0.8000000000000002, "em": false, "chrf": 84.90782283912911, "bleu": 66.87403049764218}, {"f1": 0.8333333333333334, "em": false, "chrf": 74.50311728546058, "bleu": 53.7284965911771}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9044444444444444, "avg_em": 0.4, "avg_chrf": 87.34443320900597, "avg_bleu": 72.35876979991676}
{"id": "wiki_13:2497", "en": "These have promising activity against a biological target related to COVID-19 disease.", "fr": "Ces entités ont une activité prometteuse contre une cible biologique liée à la COVID-19.", "perturbation": "alteration", "pert_fr": "Ces entités ont une activité nulle contre une cible biologique liée à la COVID-19.", "bt_pert_fr": "These entities have zero activity against a biological target linked to COVID-19.", "questions": "[\"What is the activity related to?\", \"What disease is the biological target associated with?\"]", "answers": "[\"Zero activity\", \"COVID-19\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.6764705882352935, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 43.10193081147925, "bleu": 36.78794411714425}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 23.38920069985727, "avg_bleu": 18.393972058572125}
{"id": "wiki_13:2499", "en": "It is the function and obligation of drug development to assess all of these parameters prior to human clinical trials to prove safety and efficacy.", "fr": "Le développement d’un médicament a pour fonction et obligation d’évaluer tous ces paramètres avant les essais cliniques chez l’être humain visant à évaluer sa sécurité et son efficacité.", "perturbation": "alteration", "pert_fr": "Le développement d’un médicament a pour fonction et obligation de négliger tous ces paramètres avant les essais cliniques chez l’être humain visant à évaluer sa sécurité et son efficacité.", "bt_pert_fr": "The function and obligation of drug development is to neglect all these parameters before clinical trials in humans aimed at evaluating its safety and effectiveness.", "questions": "[\"What is the function of drug development?\", \"What is the obligation of drug development?\", \"What parameters must be assessed prior to human clinical trials?\", \"What must be proven prior to human clinical trials?\", \"What is the goal of assessing parameters before human clinical trials?\"]", "answers": "[\"To neglect all these parameters before clinical trials in humans aimed at evaluating its safety and effectiveness\", \"To neglect all these parameters before clinical trials in humans aimed at evaluating its safety and effectiveness\", \"All these parameters\", \"Its safety and effectiveness\", \"To evaluate its safety and effectiveness\"]", "scores": [{"f1": 0.48484848484848486, "em": false, "chrf": 52.40204576195997, "bleu": 8.513012360883549}, {"f1": 0.48484848484848486, "em": false, "chrf": 52.40204576195997, "bleu": 8.513012360883549}, {"f1": 0.8571428571428571, "em": false, "chrf": 78.11838079699068, "bleu": 45.13864405503391}, {"f1": 0.28571428571428575, "em": false, "chrf": 54.06500801205883, "bleu": 15.97357760615681}, {"f1": 0.5454545454545454, "em": false, "chrf": 46.214217978386216, "bleu": 17.965205598154213}], "avg_f1": 0.5316017316017316, "avg_em": 0.0, "avg_chrf": 56.64033966227113, "avg_bleu": 19.220690396222405}
{"id": "wiki_13:2501", "en": "In addition, drug development must establish the physicochemical properties of the NCE: its chemical makeup, stability, and solubility.", "fr": "En outre, le développement d’un médicament doit définir les propriétés physicochimiques de la NCE : sa composition chimique, sa stabilité et sa solubilité.", "perturbation": "alteration", "pert_fr": "En outre, le développement d’un médicament doit définir les propriétés physicochimiques de la NCE : sa composition biologique, sa stabilité et son insolubilité.", "bt_pert_fr": "Additionally, drug development must define the physicochemical properties of the NCE: its biological composition, stability, and insolubility.", "questions": "[\"What must drug development establish regarding the NCE?\", \"What physicochemical properties of the NCE are important?\", \"What specific properties of the NCE are mentioned?\"]", "answers": "[\"The physicochemical properties\", \"Biological composition, stability, and insolubility\", \"Biological composition, stability, and insolubility\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4000000000000001, "em": false, "chrf": 53.217095129564115, "bleu": 21.3643503198117}, {"f1": 0.4000000000000001, "em": false, "chrf": 53.217095129564115, "bleu": 21.3643503198117}], "avg_f1": 0.6000000000000001, "avg_em": 0.3333333333333333, "avg_chrf": 68.81139675304274, "avg_bleu": 47.57623354654115}
{"id": "wiki_13:2502", "en": "Manufacturers must optimize the process they use to make the chemical so they can scale up from a medicinal chemist producing milligrams, to manufacturing on the kilogram and ton scale.", "fr": "Les fabricants doivent optimiser le processus qu’ils utilisent pour produire la substance chimique afin de passer de la fabrication de quelques milligrammes par un chimiste médicinal à une production de kilogrammes et de tonnes.", "perturbation": "alteration", "pert_fr": "Les fabricants doivent dégrader le processus qu’ils utilisent pour produire la substance chimique afin de passer de la fabrication de quelques milligrammes par un chimiste médicinal à une production de kilogrammes et de tonnes.", "bt_pert_fr": "Manufacturers must degrade the process they use to produce the chemical from making a few milligrams by a medicinal chemist to producing kilograms and tons.", "questions": "[\"What must manufacturers do to the process they use to make the chemical?\", \"What is the goal of optimizing the process?\", \"What is the scale difference in chemical production mentioned?\", \"What is the starting scale of production?\", \"What is the final scale of production?\"]", "answers": "[\"Degrade\", \"To produce larger quantities of the chemical efficiently\", \"From a few milligrams to kilograms and tons\", \"A few milligrams\", \"Kilograms and tons\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.1367521367521367, "bleu": 0.0}, {"f1": 0.1111111111111111, "em": false, "chrf": 14.87056203411605, "bleu": 3.708659055657029}, {"f1": 0.5714285714285714, "em": false, "chrf": 72.70767960165495, "bleu": 15.619699684601283}, {"f1": 0, "em": false, "chrf": 77.43231770281771, "bleu": 0.0}, {"f1": 0.28571428571428575, "em": false, "chrf": 61.28319734997583, "bleu": 19.716118825581447}], "avg_f1": 0.19365079365079366, "avg_em": 0.0, "avg_chrf": 45.686101765063334, "avg_bleu": 7.808895513167951}
{"id": "wiki_13:2506", "en": "The Canadian government announced CA$275 million in funding for 96 research projects on medical countermeasures against COVID-19, including numerous vaccine candidates at Canadian universities, with plans to establish a \"vaccine bank\" of new vaccines for implementation if another coronavirus outbreak occurs.", "fr": "Le gouvernement canadien a annoncé l’attribution d’une subvention de 275 millions de dollars canadiens à 96 projets de recherche portant sur des contre-mesures médicales contre la COVID-19, notamment plusieurs candidats vaccins dans des universités canadiennes, avec des projets d’établissement d’une « banque de vaccins » contenant de nouveaux vaccins à utiliser en cas d’une autre épidémie de coronavirus.", "perturbation": "alteration", "pert_fr": "Le gouvernement canadien n'a pas annoncé l’attribution d’une subvention de 275 millions de dollars canadiens à 96 projets de recherche portant sur des contre-mesures médicales contre la COVID-19, notamment plusieurs candidats vaccins dans des universités canadiennes, avec des projets d’établissement d’une « banque de vaccins » contenant de nouveaux vaccins à utiliser en cas d’une autre épidémie de coronavirus.", "bt_pert_fr": "The Canadian government has not announced a C$275 million grant for 96 research projects into medical countermeasures against COVID-19, including several vaccine candidates at Canadian universities, with plans to establish a \"vaccine bank\" of new vaccines for use in the event of another coronavirus outbreak.", "questions": "[\"How much funding did the Canadian government announce?\", \"How many research projects were funded?\", \"What are the research projects focused on?\", \"Where are the vaccine candidates being developed?\", \"What is the purpose of the 'vaccine bank'?\", \"What will happen if another coronavirus outbreak occurs?\"]", "answers": "[\"C$275 million\", \"96\", \"Medical countermeasures against COVID-19\", \"Canadian universities\", \"To store new vaccines for use in the event of another coronavirus outbreak\", \"A 'vaccine bank' of new vaccines will be used\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 81.37031111409578, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 71.38132852039135, "bleu": 54.52469119630863}, {"f1": 0.8888888888888888, "em": false, "chrf": 75.9951869612981, "bleu": 86.33400213704509}], "avg_f1": 0.8703703703703703, "avg_em": 0.5, "avg_chrf": 88.12447109929754, "avg_bleu": 81.80978222222564}
{"id": "wiki_13:2513", "en": "In addition to the tests required to move a novel vaccine or antiviral drug into the clinic for the first time, manufacturers must ensure that any long-term or chronic toxicities are well-defined, including effects on systems not previously monitored (fertility, reproduction, immune system, among others).", "fr": "Outre les tests obligatoires pour faire entrer un nouveau vaccin ou médicament antiviral en clinique pour la première fois, les fabricants doivent s’assurer que les éventuelles toxicités à long terme ou chroniques sont bien définies, notamment les effets sur des systèmes non précédemment étudiés (fertilité, reproduction, système immunitaire, entre autres).", "perturbation": "alteration", "pert_fr": "Outre les tests facultatifs pour faire entrer un nouveau vaccin ou médicament antiviral en clinique pour la première fois, les fabricants doivent s’assurer que les éventuelles toxicités à long terme ou chroniques sont bien définies, notamment les effets sur des systèmes non précédemment étudiés (fertilité, reproduction, système immunitaire, entre autres).", "bt_pert_fr": "In addition to optional testing to bring a new vaccine or antiviral drug into the clinic for the first time, manufacturers must ensure that potential long-term or chronic toxicities are well defined, including effects on systems not previously studied (fertility, reproduction, immune system, among others).", "questions": "[\"What additional requirements must manufacturers meet when moving a novel vaccine or antiviral drug into the clinic?\", \"What types of long-term or chronic toxicities must be well-defined?\", \"Which systems are mentioned as being affected by toxicities?\", \"What are the systems not previously monitored that may be affected by toxicities?\", \"What is required in addition to the standard tests for a novel vaccine or antiviral drug?\"]", "answers": "[\"Manufacturers must ensure that potential long-term or chronic toxicities are well defined, including effects on systems not previously studied (fertility, reproduction, immune system, among others)\", \"Potential long-term or chronic toxicities\", \"Fertility, reproduction, immune system, among others\", \"Fertility, reproduction, immune system, among others\", \"Optional testing to bring a new vaccine or antiviral drug into the clinic for the first time\"]", "scores": [{"f1": 0.8571428571428572, "em": false, "chrf": 90.63153279237699, "bleu": 60.90291470054997}, {"f1": 0.6666666666666665, "em": false, "chrf": 89.31442412612427, "bleu": 39.76353643835254}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.05555555555555555, "em": false, "chrf": 14.264651061654012, "bleu": 1.6037083902133962}], "avg_f1": 0.7158730158730158, "avg_em": 0.4, "avg_chrf": 78.84212159603105, "avg_bleu": 60.45403190582319}
{"id": "wiki_13:2514", "en": "In the United States, this process is called a \"new drug application\" or NDA.", "fr": "Aux États-Unis, ce processus est appelé « demande de nouveau médicament » ou NDA.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, ce processus est appelé « refus de nouveau médicament » ou NDA.", "bt_pert_fr": "In the United States, this process is called a “new drug denial” or NDA.", "questions": "[\"What is the process called in the United States?\", \"What is a 'new drug application' or NDA?\", \"What does NDA stand for?\"]", "answers": "[\"a 'new drug denial'\", \"a 'new drug denial'\", \"new drug application\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 33.9865278616951, "bleu": 55.03212081491043}, {"f1": 0.5, "em": false, "chrf": 26.859993916178652, "bleu": 28.254432923044853}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.38888888888888884, "avg_em": 0.0, "avg_chrf": 20.282173925957917, "avg_bleu": 27.762184579318426}
{"id": "wiki_13:2515", "en": "A clinical trial design in progress may be modified as an \"adaptive design\" if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment.", "fr": "La conception d’un essai clinique en cours peut être modifiée dans le cadre d’une « conception adaptative » si les données accumulées lors de l’essai fournissent des informations initiales sur l’efficacité positive ou négative du traitement.", "perturbation": "alteration", "pert_fr": "La conception d’un essai clinique en cours peut être modifiée dans le cadre d’une « conception rigide » si les données accumulées lors de l’essai fournissent des informations initiales sur l’efficacité positive ou négative du traitement.", "bt_pert_fr": "The design of an ongoing clinical trial may be modified under a “rigid design” if the data accumulated during the trial provide initial information about the positive or negative effectiveness of the treatment.", "questions": "[\"What is a clinical trial design in progress possibly modified into?\", \"What triggers a modification of a clinical trial design?\", \"What type of data can lead to modifications in a clinical trial design?\", \"What does an adaptive design allow in a clinical trial?\", \"What insights from the trial can lead to design changes?\"]", "answers": "[\"a 'rigid design'\", \"the data accumulated during the trial provide initial information about the positive or negative effectiveness of the treatment\", \"data accumulated during the trial\", \"not specified\", \"initial information about the positive or negative effectiveness of the treatment\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 28.84857407802304, "bleu": 30.326532985631665}, {"f1": 0.5714285714285714, "em": false, "chrf": 60.06472248700483, "bleu": 22.718709780542323}, {"f1": 0, "em": false, "chrf": 11.239635731916762, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.307077161514826, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.38332365881014, "bleu": 35.49481056010054}], "avg_f1": 0.3276190476190476, "avg_em": 0.0, "avg_chrf": 33.96866662345392, "avg_bleu": 17.708010665254907}
{"id": "wiki_13:2517", "en": "Adaptive designs within ongoing Phase II-III clinical trials on candidate therapeutics may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, and coordinating design changes for a specific trial across its international locations.", "fr": "Les conceptions adaptatives des essais cliniques de phases II-III en cours portant sur des candidats thérapeutiques peuvent raccourcir la durée des essais et entraîner l’utilisation d’un plus petit nombre de sujets, ce qui peut accélérer les décisions de réussite ou d’interruption prématurée et permettre de coordonner les modifications de conception d’un essai spécifique dans les centres internationaux où il est effectué.", "perturbation": "alteration", "pert_fr": "Les conceptions non adaptatives des essais cliniques de phases II-III en cours portant sur des candidats thérapeutiques peuvent allonger la durée des essais et entraîner l’utilisation d’un plus grand nombre de sujets, ce qui peut ralentir les décisions de réussite ou d’interruption prématurée et permettre de coordonner les modifications de conception d’un essai spécifique dans les centres internationaux où il est effectué.", "bt_pert_fr": "Non-adaptive designs of ongoing Phase II-III clinical trials of therapeutic candidates may extend trial duration and result in the use of larger numbers of subjects, which may slow decisions on whether to pass or terminate prematurely and allow for coordinated design changes to a specific trial across international centers where it is conducted.", "questions": "[\"What are adaptive designs in clinical trials?\", \"How might adaptive designs shorten trial durations?\", \"How might adaptive designs reduce the number of subjects?\", \"What could adaptive designs possibly expedite in clinical trials?\"]", "answers": "[\"Adaptive designs are not mentioned in the sentence\", \"The sentence does not provide information on how adaptive designs shorten trial durations\", \"The sentence does not provide information on how adaptive designs reduce the number of subjects\", \"The sentence does not provide information on what adaptive designs could expedite\"]", "scores": [{"f1": 0, "em": false, "chrf": 16.771865102072816, "bleu": 0.0}, {"f1": 0.07407407407407408, "em": false, "chrf": 25.532340239024222, "bleu": 2.8603449943861583}, {"f1": 0.12903225806451615, "em": false, "chrf": 25.48579966588071, "bleu": 2.725762876425168}, {"f1": 0, "em": false, "chrf": 22.22832935566321, "bleu": 0.0}], "avg_f1": 0.05077658303464756, "avg_em": 0.0, "avg_chrf": 22.50458359066024, "avg_bleu": 1.3965269677028316}
{"id": "wiki_13:2518", "en": "Most novel drug candidates (NCEs) fail during drug development, either because they have unacceptable toxicity or because they simply do not prove efficacy on the targeted disease, as shown in Phase II-III clinical trials.", "fr": "La plupart des nouveaux candidats médicaments (NCE) échouent pendant le développement d’un médicament, en raison d’une toxicité inacceptable ou simplement d’une absence de preuve d’efficacité sur la maladie ciblée dans le cadre des essais cliniques de phases II-III.", "perturbation": "alteration", "pert_fr": "La plupart des nouveaux candidats médicaments (NCE) réussissent pendant le développement d’un médicament, en raison d’une toxicité acceptable ou simplement d’une preuve d’efficacité sur la maladie ciblée dans le cadre des essais cliniques de phases II-III.", "bt_pert_fr": "Most new drug candidates (NCEs) are successful during drug development, due to acceptable toxicity or simply proof of effectiveness on the targeted disease in phase II-III clinical trials.", "questions": "[\"Why do most novel drug candidates fail during drug development?\", \"What are the reasons for the failure of novel drug candidates in drug development?\", \"What specific issues lead to unacceptable toxicity in drug candidates?\", \"What causes drug candidates to fail in proving efficacy on the targeted disease?\", \"What phase of clinical trials shows the failure of drug candidates?\"]", "answers": "[\"They fail due to unacceptable toxicity or lack of proof of effectiveness on the targeted disease\", \"Unacceptable toxicity or lack of proof of effectiveness on the targeted disease\", \"Unacceptable toxicity\", \"Lack of proof of effectiveness on the targeted disease\", \"Phase II-III clinical trials\"]", "scores": [{"f1": 0.38709677419354843, "em": false, "chrf": 48.55912325545914, "bleu": 15.390894870884454}, {"f1": 0.7999999999999999, "em": false, "chrf": 79.80513765003015, "bleu": 46.92470064105599}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7142857142857143, "em": false, "chrf": 65.11486196765348, "bleu": 25.848657697858535}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7802764976958525, "avg_em": 0.4, "avg_chrf": 78.69582457462856, "avg_bleu": 57.63285064195982}
{"id": "wiki_13:2519", "en": "The high failure rates associated with pharmaceutical development are referred to as an \"attrition rate\", requiring decisions during the early stages of drug development to \"kill\" projects early to avoid costly failures.", "fr": "Les taux d’échec élevés associés au développement pharmaceutique sont qualifiés de « taux d’attrition », nécessitant la prise de décisions, dès les premiers stades de développement d’un médicament, de « tuer » rapidement des projets pour éviter des échecs coûteux.", "perturbation": "alteration", "pert_fr": "Les taux de réussite élevés associés au développement pharmaceutique sont qualifiés de « taux d'attrition », nécessitant la prise de décisions, dès les premiers stades de développement d’un médicament, de « sauver » rapidement des projets pour éviter des échecs coûteux.", "bt_pert_fr": "The high success rates associated with pharmaceutical development are referred to as \"attrition rates\", requiring decisions to be made early in the early stages of drug development to quickly \"save\" projects to avoid costly failures.", "questions": "[\"What are the high failure rates in pharmaceutical development called?\", \"What is the attrition rate in drug development?\", \"Why are decisions made during early stages of drug development important?\", \"What action is taken to avoid costly failures in drug development?\", \"What is the purpose of 'killing' projects early in drug development?\"]", "answers": "[\"Attrition rates\", \"The high success rates associated with pharmaceutical development\", \"To quickly 'save' projects and avoid costly failures\", \"Projects are 'saved' to avoid costly failures\", \"To avoid costly failures in drug development\"]", "scores": [{"f1": 0, "em": false, "chrf": 88.48936178331398, "bleu": 0.0}, {"f1": 0.875, "em": false, "chrf": 83.346516011325, "bleu": 59.460355750136046}, {"f1": 0.6666666666666666, "em": false, "chrf": 73.93446376533448, "bleu": 22.089591134157878}, {"f1": 0.36363636363636365, "em": false, "chrf": 45.513093092827425, "bleu": 13.134549472120794}, {"f1": 0.7272727272727273, "em": false, "chrf": 84.41632314742802, "bleu": 41.11336169005198}], "avg_f1": 0.5265151515151516, "avg_em": 0.0, "avg_chrf": 75.13995156004577, "avg_bleu": 27.15957160929334}
{"id": "wiki_13:2524", "en": "Repurposed antiviral drugs make up most of the Chinese research, with 9 Phase III trials on remdesivir across several countries due to report by the end of April.", "fr": "Les médicaments antiviraux repositionnés constituent la majorité des recherches chinoises, avec 9 essais cliniques de phase III sur le remdesivir dans plusieurs pays dont des résultats sont attendus fin avril.", "perturbation": "alteration", "pert_fr": "Les médicaments antiviraux repositionnés constituent la minorité des recherches chinoises, avec 9 essais cliniques de phase III sur le remdesivir dans plusieurs pays dont des résultats sont attendus fin avril.", "bt_pert_fr": "Repositioned antiviral drugs constitute the minority of Chinese research, with 9 phase III clinical trials on remdesivir in several countries, the results of which are expected at the end of April.", "questions": "[\"What antiviral drug is being studied in the Phase III trials?\", \"How many Phase III trials are there on remdesivir?\", \"When is the report on remdesivir trials due?\"]", "answers": "[\"Remdesivir\", \"9\", \"End of April\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_13:2525", "en": "Led by the Bill and Melinda Gates Foundation with partners investing US$125 million and coordinating with the World Health Organization, the COVID-19 Therapeutics Accelerator began in March, facilitating drug development researchers to rapidly identify, assess, develop, and scale up potential treatments.", "fr": "Mené par la Bill and Melinda Gates Foundation avec un investissement 125 millions de dollars américains provenant de partenaires et en coordination avec l’Organisation mondiale de la santé, l’initiative COVID-19 Therapeutics Accelerator a commencé en mars et a aidé les chercheurs en développement de médicaments à rapidement identifier, évaluer, développer et produire des traitements potentiels.", "perturbation": "alteration", "pert_fr": "Mené par la Bill and Melinda Gates Foundation avec un investissement 125 millions de dollars américains provenant de partenaires et en coordination avec l’Organisation mondiale de la santé, l’initiative COVID-19 Therapeutics Accelerator a commencé en mars et a empêché les chercheurs en développement de médicaments de rapidement identifier, évaluer, développer et produire des traitements potentiels.", "bt_pert_fr": "Led by the Bill and Melinda Gates Foundation with a US$125 million investment from partners and in coordination with the World Health Organization, the COVID-19 Therapeutics Accelerator initiative began in March and challenged drug development researchers to quickly identify, evaluate, develop and produce potential treatments.", "questions": "[\"Who led the COVID-19 Therapeutics Accelerator?\", \"How much money did partners invest in the COVID-19 Therapeutics Accelerator?\", \"Which organization did the accelerator coordinate with?\", \"When did the COVID-19 Therapeutics Accelerator begin?\", \"What did the COVID-19 Therapeutics Accelerator facilitate researchers to do?\", \"What was the main goal of the COVID-19 Therapeutics Accelerator?\"]", "answers": "[\"The Bill and Melinda Gates Foundation\", \"US$125 million\", \"the World Health Organization\", \"in March\", \"to quickly identify, evaluate, develop and produce potential treatments\", \"to quickly identify, evaluate, develop and produce potential treatments\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.631578947368421, "em": false, "chrf": 59.35792184904087, "bleu": 13.354339892249618}, {"f1": 0.631578947368421, "em": false, "chrf": 59.35792184904087, "bleu": 13.354339892249618}], "avg_f1": 0.8771929824561404, "avg_em": 0.6666666666666666, "avg_chrf": 86.45264061634695, "avg_bleu": 71.11811329741657}
{"id": "wiki_13:2526", "en": "The COVID-19 Clinical Research Coalition formed to coordinate and expedite results from international clinical trials on the most promising post-infection treatments.", "fr": "La COVID-19 Clinical Research Coalition a été formée pour coordonner et accélérer les résultats des essais cliniques internationaux concernant les traitements post-infection les plus prometteurs.", "perturbation": "alteration", "pert_fr": "La COVID-19 Clinical Research Coalition a été formée pour ralentir et coordonner les résultats des essais cliniques internationaux concernant les traitements post-infection les moins prometteurs.", "bt_pert_fr": "The COVID-19 Clinical Research Coalition was formed to slow down and coordinate the results of international clinical trials for less promising post-infection treatments.", "questions": "[\"What is the purpose of the COVID-19 Clinical Research Coalition?\", \"What does the coalition aim to coordinate?\", \"What does the coalition aim to expedite?\", \"What type of trials is the coalition involved in?\", \"What is the focus of the clinical trials conducted by the coalition?\"]", "answers": "[\"To slow down and coordinate the results of international clinical trials for less promising post-infection treatments\", \"The results of international clinical trials\", \"Slow down\", \"International clinical trials\", \"Post-infection treatments\"]", "scores": [{"f1": 0.689655172413793, "em": false, "chrf": 73.55756402530635, "bleu": 18.69300079996002}, {"f1": 0.4444444444444444, "em": false, "chrf": 87.31848266405079, "bleu": 16.233395773754946}, {"f1": 0, "em": false, "chrf": 2.083333333333333, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6268199233716475, "avg_em": 0.4, "avg_chrf": 72.5918760045381, "avg_bleu": 46.98527931474301}
{"id": "wiki_13:2527", "en": "In early 2020, numerous established antiviral compounds for treating other infections were being repurposed or developed in new clinical research efforts to alleviate the illness of COVID-19.", "fr": "Au début 2020, de nombreux composés antiviraux établis dans le traitement d’autres infections étaient en cours de repositionnement ou de développement dans le cadre de nouveaux efforts de recherche clinique visant à soulager la maladie COVID-19.", "perturbation": "alteration", "pert_fr": "Au début 2020, de nombreux composés antiviraux établis dans le traitement d’autres infections étaient en cours de repositionnement ou de développement dans le cadre de nouveaux efforts de recherche clinique visant à aggraver la maladie COVID-19.", "bt_pert_fr": "As of early 2020, many antiviral compounds established in the treatment of other infections were being repositioned or developed in new clinical research efforts aimed at aggravating COVID-19 disease.", "questions": "[\"What was being done with established antiviral compounds in early 2020?\", \"What was the goal of repurposing established antiviral compounds?\", \"What was the purpose of new clinical research efforts in early 2020?\", \"What illness were the antiviral compounds being developed to alleviate?\", \"What types of antiviral compounds were involved in the research?\"]", "answers": "[\"Being repositioned or developed in new clinical research efforts\", \"Aggravating COVID-19 disease\", \"Aimed at aggravating COVID-19 disease\", \"COVID-19 disease\", \"Established antiviral compounds\"]", "scores": [{"f1": 0.8888888888888888, "em": false, "chrf": 86.20847526219367, "bleu": 75.06238537503395}, {"f1": 0.25, "em": false, "chrf": 25.803605517765643, "bleu": 14.127216461522432}, {"f1": 0.20000000000000004, "em": false, "chrf": 25.035430754821064, "bleu": 10.682175159905853}, {"f1": 0.6666666666666666, "em": false, "chrf": 75.18681556865215, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6011111111111112, "avg_em": 0.2, "avg_chrf": 62.44686542068651, "avg_bleu": 49.974355399292456}
{"id": "wiki_13:2529", "en": "As of early April 2020, 103 candidate therapeutics were in preclinical or a stage of Phase I-IV development, with trial results for 29 drug candidates expected during April.", "fr": "Début avril 2020, 103 candidats thérapeutiques étaient en développement préclinique ou en cours d’étude de phases I-IV, les résultats d’essais concernant 29 candidats médicaments étant attendus dans le courant du mois d’avril.", "perturbation": "alteration", "pert_fr": "Début avril 2020, 103 candidats thérapeutiques n'étaient pas en développement préclinique ou en cours d’étude de phases I-IV, les résultats d’essais concernant 29 candidats médicaments étant attendus dans le courant du mois d’avril.", "bt_pert_fr": "At the beginning of April 2020, 103 therapeutic candidates were not in preclinical development or undergoing phase I-IV studies, with trial results for 29 drug candidates expected during the month of April.", "questions": "[\"How many candidate therapeutics were in preclinical or Phase I-IV development as of early April 2020?\", \"How many drug candidates had trial results expected during April?\", \"What stage of development were the candidate therapeutics in?\", \"When were the trial results for the drug candidates expected?\"]", "answers": "[103, 29, \"preclinical development or undergoing phase I-IV studies\", \"during the month of April\"]", "scores": [{"f1": 0.5714285714285714, "em": false, "chrf": 59.041997497303086, "bleu": 9.287528999566801}, {"f1": 0.4, "em": false, "chrf": 52.50542863176819, "bleu": 15.97357760615681}], "avg_f1": 0.4857142857142857, "avg_em": 0.0, "avg_chrf": 55.77371306453564, "avg_bleu": 12.630553302861806}
{"id": "wiki_13:2530", "en": "In March, the World Health Organization (WHO) launched the coordinated \"Solidarity trial\" in 10 countries to rapidly assess in thousands of COVID-19 infected people the potential efficacy of existing antiviral and anti-inflammatory agents not yet evaluated specifically for COVID-19 illness.", "fr": "En mars, l’Organisation mondiale de la santé (OMS) a lancé « l’essai Solidarity » coordonné dans 10 pays afin d’évaluer rapidement chez des milliers de patients infectés par la COVID-19 l’efficacité potentielle d’agents antiviraux et anti-inflammatoires existants qui n’ont pas encore été spécifiquement évalués pour la COVID-19.", "perturbation": "alteration", "pert_fr": "En mars, l’Organisation mondiale de la santé (OMS) n'a pas lancé « l’essai Solidarity » coordonné dans 10 pays afin d’évaluer rapidement chez des milliers de patients infectés par la COVID-19 l’efficacité potentielle d’agents antiviraux et anti-inflammatoires existants qui n’ont pas encore été spécifiquement évalués pour la COVID-19.", "bt_pert_fr": "In March, the World Health Organization (WHO) did not launch the 10-country coordinated “Solidarity Trial” to rapidly evaluate the potential effectiveness of existing antiviral and anti-inflammatory agents that have not yet been specifically evaluated for COVID-19 in thousands of patients infected with COVID-19.", "questions": "[\"What did the World Health Organization (WHO) launch in March?\", \"In which countries was the 'Solidarity trial' conducted?\", \"What was the goal of the 'Solidarity trial'?\", \"What types of agents were evaluated in the 'Solidarity trial'?\", \"What was the scope of the evaluation in the 'Solidarity trial'?\", \"What was the purpose of assessing the agents in thousands of COVID-19 infected people?\"]", "answers": "[\"The World Health Organization (WHO) did not launch the 10-country coordinated 'Solidarity Trial'\", \"10 countries\", \"To rapidly evaluate the potential effectiveness of existing antiviral and anti-inflammatory agents\", \"Existing antiviral and anti-inflammatory agents\", \"Evaluation in thousands of patients infected with COVID-19\", \"To determine the potential effectiveness of the agents against COVID-19\"]", "scores": [{"f1": 0.26666666666666666, "em": false, "chrf": 60.84859969327202, "bleu": 6.772997136689072}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5517241379310345, "em": false, "chrf": 58.7623582744513, "bleu": 26.257888400741187}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.46360650243834, "bleu": 66.87403049764218}, {"f1": 0.7142857142857143, "em": false, "chrf": 60.287711685176205, "bleu": 23.356898886410004}, {"f1": 0.5714285714285715, "em": false, "chrf": 68.42413339501243, "bleu": 15.619699684601276}], "avg_f1": 0.6506841817186645, "avg_em": 0.16666666666666666, "avg_chrf": 74.29773492505838, "avg_bleu": 39.81358576768063}
{"id": "wiki_13:2532", "en": "Do any of the drugs reduce the time a patient is hospitalized?", "fr": "Certains des médicaments réduisent-ils la durée d’hospitalisation des patients ?", "perturbation": "alteration", "pert_fr": "Certains des médicaments augmentent-ils la durée d’hospitalisation des patients ?", "bt_pert_fr": "Do any of the medications increase the length of hospital stay for patients?", "questions": "[\"What effect do drugs have on hospitalization duration?\"]", "answers": "[\"Some medications may increase the length of hospital stay\"]", "scores": [{"f1": 0, "em": false, "chrf": 27.221441386832808, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 27.221441386832808, "avg_bleu": 0.0}
{"id": "wiki_13:2533", "en": "Do the treatments affect the need for people with COVID-19-induced pneumonia to be ventilated or maintained in intensive care?", "fr": "Les traitements influencent-ils la nécessité de ventilation ou de maintien en soins intensifs des patients atteints de pneumonie induite par la COVID-19 ?", "perturbation": "alteration", "pert_fr": "Les traitements influencent-ils la nécessité de ventilation ou de cessation des soins intensifs des patients atteints de pneumonie induite par la COVID-19 ?", "bt_pert_fr": "Do treatments influence the need for ventilation or cessation of intensive care in patients with COVID-19-induced pneumonia?", "questions": "[\"What condition is associated with the need for ventilation or intensive care?\", \"What is the impact of treatments on patient care in severe cases of COVID-19?\"]", "answers": "[\"COVID-19-induced pneumonia\", \"Treatments may influence the need for ventilation or cessation of intensive care\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6086956521739131, "em": false, "chrf": 62.38996411483447, "bleu": 26.477952261405967}], "avg_f1": 0.8043478260869565, "avg_em": 0.5, "avg_chrf": 81.19498205741723, "avg_bleu": 63.23897613070301}
{"id": "wiki_13:2535", "en": "After the trial staff determines the drugs available at the hospital, the WHO website randomizes the hospitalized subject to one of the trial drugs or to the hospital standard of care for treating COVID-19.", "fr": "Une fois que le personnel de l’essai détermine les médicaments disponibles à l’hôpital, le site Web de l’OMS randomise le sujet hospitalisé dans un groupe recevant l’un des médicaments de l’essai ou le traitement standard de l’hôpital pour la COVID-19.", "perturbation": "alteration", "pert_fr": "Une fois que le personnel de l’essai détermine les médicaments non disponibles à l’hôpital, le site Web de l’OMS randomise le sujet hospitalisé dans un groupe recevant l’un des médicaments de l’essai ou le traitement standard de l’hôpital pour la COVID-19.", "bt_pert_fr": "Once trial staff determine which drugs are not available at the hospital, the WHO website randomizes the hospitalized subject to one of the trial drugs or the hospital's standard treatment for COVID-19.", "questions": "[\"What happens after the trial staff determines the available drugs?\", \"How are hospitalized subjects assigned in the trial?\", \"What are the options for hospitalized subjects in the trial?\", \"What is the standard of care for treating COVID-19 in the trial?\"]", "answers": "[\"The WHO website randomizes the hospitalized subject to one of the trial drugs or the hospital's standard treatment for COVID-19\", \"The hospitalized subjects are randomized to one of the trial drugs or the hospital's standard treatment for COVID-19\", \"One of the trial drugs or the hospital's standard treatment for COVID-19\", \"The hospital's standard treatment for COVID-19\"]", "scores": [{"f1": 0.8108108108108107, "em": false, "chrf": 79.23775043620776, "bleu": 59.8541628650739}, {"f1": 0.6000000000000001, "em": false, "chrf": 68.5257121288111, "bleu": 45.60839545351941}, {"f1": 0.631578947368421, "em": false, "chrf": 75.55807084706426, "bleu": 41.11336169005198}, {"f1": 0.3636363636363636, "em": false, "chrf": 61.67273418490349, "bleu": 9.652434877402245}], "avg_f1": 0.6015065304538989, "avg_em": 0.0, "avg_chrf": 71.24856689924665, "avg_bleu": 39.05708872151188}
{"id": "wiki_13:2537", "en": "A global safety monitoring board of WHO physicians examine interim results to assist decisions on safety and effectiveness of the trial drugs, and alter the trial design or recommend an effective therapy.", "fr": "Un comité international de surveillance de la sécurité composé de médecins de l’OMS examine les résultats provisoires afin de guider les décisions sur la sécurité et l’efficacité des médicaments de l’essai, et modifie la conception de l’essai ou recommande un traitement efficace.", "perturbation": "alteration", "pert_fr": "Un comité international de surveillance de la sécurité composé de médecins de l’OMS examine les résultats provisoires afin de guider les décisions sur la sécurité et l’inefficacité des médicaments de l’essai, et modifie la conception de l’essai ou recommande un traitement inefficace.", "bt_pert_fr": "An international safety monitoring committee made up of WHO doctors reviews the interim results to guide decisions on the safety and ineffectiveness of the trial drugs, and changes the trial design or recommends an ineffective treatment.", "questions": "[\"What does a global safety monitoring board of WHO physicians examine?\", \"What is the purpose of examining interim results?\", \"What decisions can be made based on the examination of interim results?\", \"What actions can the board take regarding the trial design?\", \"What can the board recommend regarding therapy?\"]", "answers": "[\"The interim results\", \"To guide decisions on the safety and ineffectiveness of the trial drugs\", \"Changes to the trial design or recommendations about an ineffective treatment\", \"Changes to the trial design\", \"An ineffective treatment\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 94.9566147882592, "bleu": 55.03212081491043}, {"f1": 0.7, "em": false, "chrf": 79.7036356425182, "bleu": 37.99178428257963}, {"f1": 0.375, "em": false, "chrf": 63.23605965093907, "bleu": 17.747405280050266}, {"f1": 0.5714285714285715, "em": false, "chrf": 61.83358268101474, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 53.266632234517175, "bleu": 0.0}], "avg_f1": 0.4892857142857143, "avg_em": 0.0, "avg_chrf": 70.59930499944969, "avg_bleu": 28.543693117970793}
{"id": "wiki_13:2538", "en": "A similar web-based study to Solidarity, called \"Discovery\", was initiated in March across seven countries by INSERM (Paris, France).During March, funding for the Solidarity trial reached US$108 million from 203,000 individuals, organizations and governments, with 45 countries involved in financing or trial management.", "fr": "Une étude basée sur le Web semblable à Solidarity, appelée « Discovery », a été lancée en mars dans sept pays par l’INSERM (Paris, France). En mars, le financement de l’essai Solidarity a atteint 108 millions de dollars américains provenant de 203 000 particuliers, organisations et gouvernements, 45 pays participant au financement ou à la gestion de l’essai.", "perturbation": "alteration", "pert_fr": "Une étude basée sur le Web dissemblable à Solidarity, appelée « Discovery », a été annulée en mars dans sept pays par l’INSERM (Paris, France).", "bt_pert_fr": "A web-based study dissimilar to Solidarity, called “Discovery,” was canceled in March in seven countries by INSERM (Paris, France).", "questions": "[\"What is the name of the web-based study similar to Solidarity?\", \"In which month was the 'Discovery' study initiated?\", \"In how many countries was the 'Discovery' study initiated?\", \"Which organization initiated the 'Discovery' study?\", \"How much funding did the Solidarity trial receive in March?\", \"From how many individuals, organizations, and governments did the Solidarity trial receive funding?\", \"In how many countries was the Solidarity trial financed or managed?\"]", "answers": "[\"Discovery\", \"March\", \"seven\", \"INSERM (Paris, France)\", \"Not mentioned\", \"Not mentioned\", \"Not mentioned\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 59.9765041149323, "bleu": 27.516060407455225}, {"f1": 0, "em": false, "chrf": 10.252525252525253, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.42857142857142855, "avg_chrf": 52.88986133820822, "avg_bleu": 46.78800862963648}
{"id": "wiki_13:2542", "en": "Hydroxychloroquine is more commonly available than chloroquine in the United States.", "fr": "L’hydroxychloroquine est plus couramment disponible que la chloroquine aux États-Unis.", "perturbation": "alteration", "pert_fr": "L’hydroxychloroquine est moins couramment disponible que la chloroquine aux États-Unis.", "bt_pert_fr": "Hydroxychloroquine is less commonly available than chloroquine in the United States.", "questions": "[\"What is the relationship between hydroxychloroquine and chloroquine availability?\"]", "answers": "[\"Hydroxychloroquine is less commonly available than chloroquine in the United States\"]", "scores": [{"f1": 0.9, "em": false, "chrf": 90.5382087215885, "bleu": 70.71067811865478}], "avg_f1": 0.9, "avg_em": 0.0, "avg_chrf": 90.5382087215885, "avg_bleu": 70.71067811865478}
{"id": "wiki_13:2546", "en": "Some people have allergic reactions to these drugs.On 12 April, a preliminary clinical trial conducted at a hospital in Brazil was stopped when several people given high doses of chloroquine for COVID-19 infection developed irregular heart rates, causing 11 deaths.", "fr": "Certaines personnes ont des réactions allergiques à ces médicaments. Le 12 avril, une étude clinique préliminaire menée dans un hôpital au Brésil a été interrompue lorsque plusieurs personnes ayant reçu de hautes doses de chloroquine pour une infection par la COVID-19 ont développé un battement cardiaque irrégulier, entraînant 11 décès.", "perturbation": "alteration", "pert_fr": "Certaines personnes n'ont pas de réactions allergiques à ces médicaments. Le 12 avril, une étude clinique préliminaire menée dans un hôpital au Brésil a été poursuivie lorsque plusieurs personnes ayant reçu de hautes doses de chloroquine pour une infection par la COVID-19 ont développé un battement cardiaque régulier, entraînant 0 décès.", "bt_pert_fr": "Some people do not have allergic reactions to these medications. On April 12, a preliminary clinical study at a hospital in Brazil was continued when several people who received high doses of chloroquine for COVID-19 infection developed a regular heartbeat, resulting in 0 deaths.", "questions": "[\"What happened in the preliminary clinical trial on 12 April?\", \"Where was the preliminary clinical trial conducted?\", \"Why was the clinical trial stopped?\", \"What side effects did people experience when given high doses of chloroquine?\", \"How many deaths were caused by the side effects of chloroquine?\", \"What was the dosage of chloroquine used in the trial?\"]", "answers": "[\"Several people who received high doses of chloroquine for COVID-19 infection developed a regular heartbeat\", \"A hospital in Brazil\", \"The clinical trial was not stopped\", \"None mentioned\", \"0\", \"High doses\"]", "scores": [{"f1": 0.375, "em": false, "chrf": 48.48504782924637, "bleu": 14.785300569798135}, {"f1": 0.75, "em": false, "chrf": 89.02263497716442, "bleu": 59.460355750136046}, {"f1": 0, "em": false, "chrf": 7.957147884041273, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.7453183520599245, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3541666666666667, "avg_em": 0.16666666666666666, "avg_chrf": 41.535024840418664, "avg_bleu": 29.040942719989037}
{"id": "wiki_13:2549", "en": "In a study conducted in Wuhan on 240 patients with pneumonia half were given favipiravir and half received umifenovir.", "fr": "Dans une étude réalisée à Wuhan sur 240 patients souffrant de pneumonie, la moitié a reçu le favipiravir et l’autre moitié l’umifénovir.", "perturbation": "alteration", "pert_fr": "Dans une étude réalisée à Wuhan sur 240 patients guéris de pneumonie, la moitié a reçu le favipiravir et l’autre moitié l’umifénovir.", "bt_pert_fr": "In a study carried out in Wuhan on 240 patients cured of pneumonia, half received favipiravir and the other half umifenovir.", "questions": "[\"What was the study conducted in?\", \"How many patients were included in the study?\", \"What treatment was given to half of the patients?\", \"What treatment was given to the other half of the patients?\", \"What condition did the patients have?\", \"What was the purpose of the study?\"]", "answers": "[\"Wuhan\", \"240\", \"favipiravir\", \"umifenovir\", \"pneumonia\", \"to determine the effectiveness of favipiravir and umifenovir in curing pneumonia\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2105263157894737, "em": false, "chrf": 16.682368806764895, "bleu": 4.990049701936832}], "avg_f1": 0.8684210526315789, "avg_em": 0.8333333333333334, "avg_chrf": 86.11372813446081, "avg_bleu": 84.16500828365618}
{"id": "wiki_13:2550", "en": "The term \"preclinical research\" is defined by laboratory studies in vitro and in vivo, indicating a beginning stage for development of a vaccine, antiviral or monoclonal antibody therapy, such as experiments to determine effective doses and toxicity, before a candidate compound is advanced for safety and efficacy evaluation in humans.", "fr": "Le terme « recherche préclinique » est défini par des études de laboratoire in vitro et in vivo, indiquant un stade préliminaire de développement d’un vaccin, d’un agent antiviral ou d’un anticorps monoclonal, notamment des expériences visant à déterminer les doses efficaces et la toxicité, avant la progression d’un candidat composé à une évaluation de la sécurité et de l’efficacité chez l’être humain.", "perturbation": "alteration", "pert_fr": "Le terme « recherche préclinique » est défini par des études de laboratoire in vitro et in vivo, indiquant un stade final de développement d’un vaccin, d’un agent antiviral ou d’un anticorps monoclonal, notamment des expériences visant à déterminer les doses inefficaces et la sécurité, avant la progression d’un candidat composé à une évaluation de la sécurité et de l’efficacité chez l’être humain.", "bt_pert_fr": "The term “preclinical research” is defined by in vitro and in vivo laboratory studies, indicating a final stage of development of a vaccine, antiviral agent, or monoclonal antibody, including experiments to determine ineffective doses and safety, prior to progression of a candidate compound to evaluation of safety and effectiveness in humans.", "questions": "[\"What does the term 'preclinical research' refer to?\", \"What types of laboratory studies define preclinical research?\", \"What stage of development does preclinical research indicate?\", \"What experiments are conducted during preclinical research?\", \"What is the purpose of preclinical research?\", \"What happens before a candidate compound is advanced to human trials?\"]", "answers": "[\"The term 'preclinical research' is defined by in vitro and in vivo laboratory studies, indicating a final stage of development of a vaccine, antiviral agent, or monoclonal antibody, including experiments to determine ineffective doses and safety, prior to progression of a candidate compound to evaluation of safety and effectiveness in humans.\", \"in vitro and in vivo laboratory studies\", \"a final stage of development of a vaccine, antiviral agent, or monoclonal antibody\", \"experiments to determine ineffective doses and safety\", \"to determine ineffective doses and safety prior to progression of a candidate compound to evaluation of safety and effectiveness in humans\", \"A candidate compound undergoes preclinical research to determine ineffective doses and safety\"]", "scores": [{"f1": 0.21818181818181817, "em": false, "chrf": 35.36441054583722, "bleu": 7.4518355616855425}, {"f1": 0.8571428571428571, "em": false, "chrf": 96.7109754585422, "bleu": 80.91067115702207}, {"f1": 0.6956521739130435, "em": false, "chrf": 68.68943253524957, "bleu": 32.03558799120807}, {"f1": 0.5714285714285714, "em": false, "chrf": 75.39762699530786, "bleu": 18.575057999133602}, {"f1": 0.5405405405405405, "em": false, "chrf": 60.47017576431005, "bleu": 8.097785064266205}, {"f1": 0.1111111111111111, "em": false, "chrf": 22.886483747698943, "bleu": 3.3864985683445354}], "avg_f1": 0.49900951205299027, "avg_em": 0.0, "avg_chrf": 59.91985084115763, "avg_bleu": 25.07623939027667}
{"id": "wiki_13:2552", "en": "In March 2020, the main protease of the SARS-CoV-2 virus was identified as a target for post-infection drugs.", "fr": "En mars 2020, la protéase principale du virus SARS-CoV-2 a été identifiée comme cible pour les médicaments post-infection.", "perturbation": "alteration", "pert_fr": "En mars 2020, la protéase principale du virus SARS-CoV-2 a été identifiée comme obstacle pour les médicaments post-infection.", "bt_pert_fr": "In March 2020, the main protease of the SARS-CoV-2 virus was identified as a barrier for post-infection drugs.", "questions": "[\"When was the main protease of the SARS-CoV-2 virus identified as a target for post-infection drugs?\", \"What is the target of post-infection drugs according to the sentence?\", \"What virus is mentioned in the sentence?\", \"What is the significance of identifying the main protease as a drug target?\"]", "answers": "[\"In March 2020\", \"The main protease of the SARS-CoV-2 virus\", \"SARS-CoV-2\", \"It identifies a key target for post-infection drugs, suggesting potential for drug development\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7368421052631579, "em": false, "chrf": 78.09793909188126, "bleu": 26.20251007173262}], "avg_f1": 0.9342105263157895, "avg_em": 0.75, "avg_chrf": 94.52448477297031, "avg_bleu": 81.55062751793318}
{"id": "wiki_13:2553", "en": "This enzyme is essential to the host cell to reproduce the ribonucleic acid of the virus.", "fr": "Cette enzyme est essentielle à la cellule hôte pour reproduire l’acide ribonucléique du virus.", "perturbation": "alteration", "pert_fr": "Cette enzyme est inutile à la cellule hôte pour reproduire l’acide ribonucléique du virus.", "bt_pert_fr": "This enzyme is useless to the host cell in reproducing the ribonucleic acid of the virus.", "questions": "[\"What does the enzyme help reproduce?\", \"What is the role of the enzyme in the virus life cycle?\", \"What type of nucleic acid does the enzyme help reproduce?\"]", "answers": "[\"Ribonucleic acid of the virus\", \"Reproducing the ribonucleic acid of the virus\", \"Ribonucleic acid\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2857142857142857, "em": false, "chrf": 46.21343337945635, "bleu": 9.599621398238423}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7619047619047619, "avg_em": 0.6666666666666666, "avg_chrf": 82.07114445981878, "avg_bleu": 69.8665404660795}
{"id": "wiki_13:2554", "en": "To find the enzyme, scientists used the genome published by Chinese researchers in January 2020 to isolate the main protease.", "fr": "Pour trouver l’enzyme, les scientifiques ont utilisé le génome publié par des chercheurs chinois en janvier 2020 pour isoler la protéase principale.", "perturbation": "alteration", "pert_fr": "Pour trouver l’enzyme, les scientifiques n'ont pas utilisé le génome publié par des chercheurs chinois en janvier 2020 pour isoler la protéase principale.", "bt_pert_fr": "To find the enzyme, scientists did not use the genome published by Chinese researchers in January 2020 to isolate the main protease.", "questions": "[\"How did scientists find the enzyme?\", \"What was used by scientists to isolate the main protease?\", \"Which genome was used by scientists?\", \"When was the genome published?\"]", "answers": "[\"By not using the genome published by Chinese researchers in January 2020\", \"The genome published by Chinese researchers in January 2020\", \"The genome published by Chinese researchers in January 2020\", \"January 2020\"]", "scores": [{"f1": 0.9523809523809523, "em": false, "chrf": 96.00332434433186, "bleu": 80.70557274927978}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9880952380952381, "avg_em": 0.75, "avg_chrf": 99.00083108608297, "avg_bleu": 95.17639318731997}
{"id": "wiki_13:2556", "en": "A preliminary study in China of combined lopinavir and ritonavir found no effect in people hospitalized for COVID-19.", "fr": "Une étude préliminaire en Chine sur l’association du lopinavir et du ritonavir n’a trouvé aucun effet chez les personnes hospitalisées pour la COVID-19.", "perturbation": "alteration", "pert_fr": "Une étude préliminaire en Chine sur l’association du lopinavir et du ritonavir a trouvé un effet important chez les personnes hospitalisées pour la COVID-19.", "bt_pert_fr": "A preliminary study in China of the combination of lopinavir and ritonavir found a significant effect in people hospitalized with COVID-19.", "questions": "[\"What did a preliminary study in China find about combined lopinavir and ritonavir?\", \"What was the outcome of the study on people hospitalized for COVID-19?\", \"What treatment was tested in the study?\", \"What condition were the patients in when the study was conducted?\", \"Where was the preliminary study conducted?\"]", "answers": "[\"A significant effect\", \"A significant effect\", \"The combination of lopinavir and ritonavir\", \"COVID-19\", \"China\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 29.710576990433196, "bleu": 19.716118825581447}, {"f1": 0.4, "em": false, "chrf": 44.01911187319749, "bleu": 27.516060407455225}, {"f1": 0.6, "em": false, "chrf": 74.81514294488596, "bleu": 30.213753973567677}, {"f1": 0.5, "em": false, "chrf": 26.603617187290375, "bleu": 13.533528323661276}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5571428571428572, "avg_em": 0.2, "avg_chrf": 55.0296897991614, "avg_bleu": 38.19589230605313}
{"id": "wiki_29:2602", "en": "It is unclear yet whether conditions arising during pregnancy including diabetes, cardiac failure, hypercoagulability or hypertension might represent additional risk factors for pregnant people as they do for nonpregnant people.From the limited data available, vertical transmission during the third trimester probably does not occur, or only occurs very rarely.", "fr": "Il n’est pas clairement établi à ce stade si des pathologies survenant au cours de la grossesse comme le diabète, l’insuffisance cardiaque, l’hypercoagulation ou l’hypertension peuvent constituer des facteurs de risque supplémentaires pour les femmes enceintes, comme c'est le cas pour le reste de la population. D’après les données limitées disponibles, la transmission verticale au cours du troisième trimestre n’a probablement pas lieu ou ne survient que très rarement.", "perturbation": "alteration", "pert_fr": "Il est clairement établi à ce stade si des pathologies survenant au cours de la grossesse comme le diabète, l’insuffisance cardiaque, l’hypercoagulation ou l’hypertension peuvent constituer des facteurs de protection supplémentaires pour les femmes enceintes, comme c'est le cas pour le reste de la population. D’après les données limitées disponibles, la transmission verticale au cours du troisième trimestre a probablement lieu ou survient très fréquemment.", "bt_pert_fr": "It is clearly established at this stage whether pathologies occurring during pregnancy such as diabetes, heart failure, hypercoagulation or hypertension can constitute additional protective factors for pregnant women, as is the case for the rest of the population. Based on the limited data available, vertical transmission during the third trimester likely occurs or occurs very frequently.", "questions": "[\"What conditions arising during pregnancy might represent additional risk factors for pregnant people?\", \"What conditions are mentioned as potentially increasing risk during pregnancy?\", \"Does vertical transmission during the third trimester occur?\", \"How common is vertical transmission during the third trimester?\", \"What is the current understanding of vertical transmission in pregnancy?\", \"What is the relationship between pregnancy conditions and risk for severe disease?\", \"Are pregnancy-related conditions associated with increased risk for severe disease in pregnant people?\"]", "answers": "[\"diabetes, heart failure, hypercoagulation or hypertension\", \"diabetes, heart failure, hypercoagulation or hypertension\", \"Yes\", \"very frequently\", \"Based on the limited data available, vertical transmission during the third trimester likely occurs or occurs very frequently\", \"Pregnancy conditions such as diabetes, heart failure, hypercoagulation, or hypertension may constitute additional protective factors rather than risk factors\", \"No\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 66.36495477517566, "bleu": 17.965205598154213}, {"f1": 0.5, "em": false, "chrf": 66.36495477517566, "bleu": 17.965205598154213}, {"f1": 0, "em": false, "chrf": 1.5187082088490538, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 19.500992195059656, "bleu": 0.0}, {"f1": 0.08695652173913045, "em": false, "chrf": 15.211743790221572, "bleu": 1.2123671946965524}, {"f1": 0.13333333333333333, "em": false, "chrf": 33.7398724212627, "bleu": 2.4074859035470344}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.17432712215320909, "avg_em": 0.0, "avg_chrf": 28.95731802367776, "avg_bleu": 5.650037756364574}
{"id": "wiki_29:2605", "en": "A case series of 43 women from New York who tested positive for COVID-19 showed similar patterns to non-pregnant adults: 86% had mild disease, 9.3% had severe disease and 4.7% developed critical disease.", "fr": "Une série de cas de 43 femmes de New York testées positives au COVID-19 présente des schémas similaires à ceux des adultes non enceintes : 86 % souffrent d’une forme modérée de la maladie, 9,3 % d’une forme grave et 4,7 % ont développé une forme critique.", "perturbation": "alteration", "pert_fr": "Une série de cas de 43 femmes de New York testées négatives au COVID-19 présente des schémas similaires à ceux des adultes non enceintes : 86 % souffrent d’une forme modérée de la maladie, 9,3 % d’une forme grave et 4,7 % ont développé une forme critique.", "bt_pert_fr": "A case series of 43 New York women who tested negative for COVID-19 showed similar patterns to non-pregnant adults: 86% had moderate disease, 9.3% had severe disease, and 4.7% developed critical disease.", "questions": "[\"What was the study about?\", \"How many women were included in the case series?\", \"Where did the women in the study come from?\", \"What percentage of women had mild disease?\", \"What percentage of women had severe disease?\", \"What percentage of women developed critical disease?\", \"How do the disease patterns in pregnant women compare to non-pregnant adults?\", \"What disease patterns were observed in the study?\"]", "answers": "[\"A case series of 43 New York women who tested negative for COVID-19\", \"43\", \"New York\", \"0%\", \"9.3%\", \"4.7%\", \"Similar patterns to non-pregnant adults\", \"86% had moderate disease, 9.3% had severe disease, and 4.7% developed critical disease\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 69.67310014338345, "bleu": 38.33284432299621}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9230769230769231, "em": false, "chrf": 89.8982433500674, "bleu": 79.1066507175436}], "avg_f1": 0.8514957264957265, "avg_em": 0.625, "avg_chrf": 82.44641793668136, "avg_bleu": 77.1799368800675}
{"id": "wiki_29:2609", "en": "The samples of breast milk, amniotic fluid, cord blood and neonatal throat swab were tested for SARS-CoV-2, and all results were negative.In another study on 15 pregnant women, majority of the patients presented with fever and cough, while laboratory tests yielded lymphocytopenia in 12 patients.", "fr": "Les échantillons de lait maternel, de fluide amniotique, de cordon ombilical et de prélèvement de gorge des nouveau-nés ont été testés pour le SARS-CoV-2 et tous les résultats se sont avérés négatifs. Dans une autre étude sur 15 femmes enceintes, la majorité des patientes présentaient de la fièvre et de la toux alors que les analyses de laboratoire ont révélé une lymphocytopénie chez 12 patientes.", "perturbation": "alteration", "pert_fr": "Les échantillons de lait maternel, de fluide amniotique, de cordon ombilical et de prélèvement de gorge des nouveau-nés ont été testés pour le SARS-CoV-2 et tous les résultats se sont avérés positifs. Dans une autre étude sur 15 femmes enceintes, la majorité des patientes présentaient de la fièvre et de la toux alors que les analyses de laboratoire ont révélé une lymphocytose chez 12 patientes.", "bt_pert_fr": "Breast milk, amniotic fluid, umbilical cord and throat swab samples from newborns were tested for SARS-CoV-2 and all results were positive. In another study of 15 pregnant women, the majority of patients presented with fever and cough while laboratory tests revealed lymphocytosis in 12 patients.", "questions": "[\"What samples were tested for SARS-CoV-2?\", \"What were the results of the SARS-CoV-2 tests on the samples?\", \"What was the outcome of the study on 15 pregnant women?\", \"What symptoms did the majority of the patients present with?\", \"What laboratory finding was observed in 12 patients?\"]", "answers": "[\"Breast milk, amniotic fluid, umbilical cord and throat swab samples from newborns\", \"All results were positive\", \"The majority of patients presented with fever and cough while laboratory tests revealed lymphocytosis in 12 patients\", \"Fever and cough\", \"Lymphocytosis\"]", "scores": [{"f1": 0.7272727272727272, "em": false, "chrf": 61.53365447570689, "bleu": 27.09198854675628}, {"f1": 0.75, "em": false, "chrf": 66.61054746194064, "bleu": 59.460355750136046}, {"f1": 0.625, "em": false, "chrf": 71.36337984628382, "bleu": 42.818185319516076}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 62.3469555539852, "bleu": 0.0}], "avg_f1": 0.6204545454545454, "avg_em": 0.2, "avg_chrf": 72.37090746758331, "avg_bleu": 45.87410592328169}
{"id": "wiki_29:2610", "en": "Computed tomography findings of these patients were consistent with previous reports of non-pregnant patients, consisting of ground-glass opacities at early stage.", "fr": "Les résultats de tomodensitométrie de ces patientes étaient cohérents avec des rapports antérieurs portant sur des patientes non enceintes, constitués d’opacités à verre rodé en phase précoce.", "perturbation": "alteration", "pert_fr": "Les résultats de tomodensitométrie de ces patientes étaient incohérents avec des rapports antérieurs portant sur des patientes non enceintes, constitués d’opacités à verre rodé en phase précoce.", "bt_pert_fr": "The CT findings of these patients were inconsistent with previous reports of nonpregnant patients consisting of early-phase ground-glass opacities.", "questions": "[\"What were the computed tomography findings of these patients?\", \"What type of opacities were observed in the early stage?\", \"How do the CT findings of these patients compare to previous reports of non-pregnant patients?\", \"What condition is associated with the ground-glass opacities?\", \"What stage of the disease is associated with ground-glass opacities?\"]", "answers": "[\"The CT findings were inconsistent with previous reports of nonpregnant patients consisting of early-phase ground-glass opacities\", \"Early-phase ground-glass opacities\", \"The CT findings were inconsistent\", \"Nonpregnant patients\", \"Early phase\"]", "scores": [{"f1": 0.787878787878788, "em": false, "chrf": 84.55126461871617, "bleu": 50.01643305337219}, {"f1": 0.4, "em": false, "chrf": 84.51788577066651, "bleu": 27.516060407455225}, {"f1": 0.4615384615384615, "em": false, "chrf": 47.91476885514852, "bleu": 21.82269148961669}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 34.53042328042328, "bleu": 49.99999999999999}], "avg_f1": 0.6298834498834499, "avg_em": 0.2, "avg_chrf": 70.3028685049909, "avg_bleu": 49.871036990088825}
{"id": "wiki_29:2612", "en": "Their guidelines thus advise that any pregnant person admitted to hospital with a COVID-19 infection should receive at least 10 days of prophylactic low-molecular-weight heparin after being discharged from the hospital.", "fr": "Leurs directives ont conseillé par conséquent que toute femme enceinte admise à l’hôpital avec une infection au COVID-19 devrait recevoir un traitement d’au moins 10 jours à l’héparine de bas poids moléculaire en prophylaxie après avoir quitté l’hôpital.", "perturbation": "alteration", "pert_fr": "Leurs directives ont conseillé par conséquent que toute femme enceinte admise à l’hôpital avec une infection au COVID-19 ne devrait pas recevoir un traitement d’au moins 10 jours à l’héparine de bas poids moléculaire en prophylaxie après avoir quitté l’hôpital.", "bt_pert_fr": "Their guidelines therefore advised that any pregnant woman admitted to hospital with COVID-19 infection should not receive at least 10 days of low molecular weight heparin prophylaxis after leaving the hospital.", "questions": "[\"What do the guidelines advise for pregnant persons admitted to hospital with a COVID-19 infection?\", \"How long should prophylactic low-molecular-weight heparin be administered?\", \"What type of medication is recommended for pregnant persons after discharge from the hospital?\", \"What is the condition that triggers the recommendation?\", \"What is the purpose of prophylactic low-molecular-weight heparin in this context?\"]", "answers": "[\"That any pregnant woman admitted to hospital with COVID-19 infection should not receive at least 10 days of low molecular weight heparin prophylaxis after leaving the hospital\", \"10 days\", \"Low molecular weight heparin\", \"COVID-19 infection\", \"To prevent blood clots\"]", "scores": [{"f1": 0.68, "em": false, "chrf": 73.1492448407042, "bleu": 42.567920066474585}, {"f1": 0.6666666666666666, "em": false, "chrf": 36.48381677545021, "bleu": 36.78794411714425}, {"f1": 0.28571428571428575, "em": false, "chrf": 66.88994802811385, "bleu": 15.97357760615681}, {"f1": 0.8, "em": false, "chrf": 94.32494159160917, "bleu": 60.653065971263366}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6864761904761905, "avg_em": 0.2, "avg_chrf": 74.16959024717548, "avg_bleu": 51.196501552207806}
{"id": "wiki_29:2614", "en": "One infant girl born to a mother with COVID-19 had elevated IgM levels two hours after birth, suggesting that she had been infected in utero and supporting the possibility of vertical transmission in some cases.", "fr": "Une fillette née d’une mère atteinte du COVID-19 avait des taux d’IgM élevés deux heures après la naissance suggérant qu’elle avait été infectée in utero, ce qui étayerait la possibilité d’une transmission verticale dans certains cas.", "perturbation": "alteration", "pert_fr": "Une fillette née d’une mère non atteinte du COVID-19 avait des taux d’IgM faibles deux heures après la naissance suggérant qu’elle n’avait pas été infectée in utero, ce qui contredirait la possibilité d’une transmission verticale dans certains cas.", "bt_pert_fr": "A girl born to a mother without COVID-19 had low IgM levels two hours after birth, suggesting she was not infected in utero, which would contradict the possibility of vertical transmission in some cases.", "questions": "[\"What happened to one infant girl born to a mother with COVID-19?\", \"What does the elevated IgM level suggest?\", \"Was the infant infected in utero?\", \"What does the finding support?\", \"What is the possibility mentioned regarding transmission?\"]", "answers": "[\"The girl had low IgM levels two hours after birth\", \"That she was not infected in utero\", \"No\", \"The possibility of vertical transmission in some cases\", \"Vertical transmission in some cases\"]", "scores": [{"f1": 0.6153846153846154, "em": false, "chrf": 43.33909554665038, "bleu": 30.487792930038406}, {"f1": 0.7142857142857143, "em": false, "chrf": 65.22127162766854, "bleu": 30.739407647563215}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.665934065934066, "avg_em": 0.4, "avg_chrf": 61.71207343486378, "avg_bleu": 52.24544011552034}
{"id": "wiki_29:2616", "en": "This is not usually passed from mother to fetus so further research is required to know whether the virus crossed the placenta or whether placentas of women in the study were damaged or abnormal.", "fr": "Il n’y a pas habituellement de transmission de la mère au fœtus, par conséquent des recherches sont nécessaires pour savoir si le virus a franchi le placenta ou si les placentas des femmes de l’étude étaient endommagés ou anormaux.", "perturbation": "alteration", "pert_fr": "Il y a habituellement de transmission de la mère au fœtus, par conséquent des recherches ne sont pas nécessaires pour savoir si le virus a franchi le placenta ou si les placentas des femmes de l’étude étaient endommagés ou anormaux.", "bt_pert_fr": "There is usually transmission from mother to fetus, so research is not needed to find out whether the virus crossed the placenta or whether the placentas of the women in the study were damaged or abnormal.", "questions": "[\"Is it usually passed from mother to fetus?\", \"What further research is required?\", \"Could the placentas of women in the study have been damaged or abnormal?\"]", "answers": "[\"Yes\", \"None\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 1.0775862068965518, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 33.69252873563219, "avg_bleu": 33.33333333333335}
{"id": "wiki_29:2620", "en": "A report of ten cases of MERS- CoV infection in pregnancy in Saudi Arabia showed that the clinical presentation is variable, from mild to severe infection.", "fr": "Un rapport portant sur dix cas d’infection au MERS-CoV pendant la grossesse en Arabie Saoudite a montré que la présentation clinique varie d’une infection modérée à sévère.", "perturbation": "alteration", "pert_fr": "Un rapport portant sur dix cas de guérison du MERS-CoV pendant la grossesse en Arabie Saoudite a montré que la présentation clinique varie d’une infection sévère à modérée.", "bt_pert_fr": "A report of ten cases of MERS-CoV recovery during pregnancy in Saudi Arabia showed that the clinical presentation ranges from severe to moderate infection.", "questions": "[\"What does the report discuss?\", \"How many cases of MERS-CoV infection in pregnancy were reported in Saudi Arabia?\", \"What is the range of clinical presentation in MERS-CoV infection during pregnancy?\", \"What is the disease mentioned in the sentence?\", \"What is the significance of the variable clinical presentation?\"]", "answers": "[\"The report discusses ten cases of MERS-CoV recovery during pregnancy in Saudi Arabia and the range of clinical presentation\", \"10\", \"From severe to moderate infection\", \"MERS-CoV\", \"The variable clinical presentation indicates that the infection can range from severe to moderate, suggesting variability in patient outcomes\"]", "scores": [{"f1": 0.6451612903225806, "em": false, "chrf": 63.35934730488677, "bleu": 28.43329181530769}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 55.72454598015535, "bleu": 15.106876986783837}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6111111111111112, "em": false, "chrf": 55.84482003143238, "bleu": 35.412968165085736}], "avg_f1": 0.8112544802867383, "avg_em": 0.4, "avg_chrf": 74.9857426632949, "avg_bleu": 55.790627393435464}
{"id": "wiki_29:2622", "en": "The World Health Organization and  Centers for Disease Control and Prevention of the United States advises pregnant women to do the same things as the general public to avoid infection, such as covering cough, avoid interacting with sick people, cleaning hands with soap and water or sanitizer.", "fr": "L’Organisation mondiale de la santé et les Centres de contrôle et de prévention de la maladie aux États-Unis recommandent aux femmes enceintes de prendre les mêmes mesures que le grand public pour prévenir l’infection, comme se couvrir la bouche et le nez pour tousser, éviter les interactions avec des personnes malades, se laver les mains à l’eau et au savon ou avec un désinfectant.", "perturbation": "alteration", "pert_fr": "L’Organisation mondiale de la santé et les Centres de contrôle et de prévention de la maladie aux États-Unis recommandent aux femmes enceintes de ne pas prendre les mêmes mesures que le grand public pour prévenir l’infection, comme se découvrir la bouche et le nez pour tousser, chercher les interactions avec des personnes malades, se laver les mains à l’eau et au savon ou avec un désinfectant.", "bt_pert_fr": "The World Health Organization and the Centers for Disease Control and Prevention in the United States recommend that pregnant women not take the same steps as the general public to prevent infection, such as uncovering their mouth and nose when coughing, seeking interactions with sick people, and washing their hands with soap and water or disinfectant.", "questions": "[\"What does the World Health Organization advise pregnant women to do?\", \"What does the Centers for Disease Control and Prevention advise pregnant women to do?\", \"What actions should pregnant women take to avoid infection?\", \"What specific measures are recommended to avoid infection?\", \"What are the recommended actions for avoiding interaction with sick people?\"]", "answers": "[\"The World Health Organization advises pregnant women not to take the same steps as the general public to prevent infection\", \"The Centers for Disease Control and Prevention advises pregnant women not to take the same steps as the general public to prevent infection\", \"Pregnant women should not take the same steps as the general public to prevent infection\", \"Uncovering their mouth and nose when coughing, seeking interactions with sick people, and washing their hands with soap and water or disinfectant are not recommended\", \"Pregnant women should not seek interactions with sick people\"]", "scores": [{"f1": 0.26666666666666666, "em": false, "chrf": 28.91276590562355, "bleu": 9.024958575882788}, {"f1": 0.2916666666666667, "em": false, "chrf": 29.4478866080618, "bleu": 9.826737066206528}, {"f1": 0, "em": false, "chrf": 15.472253886491341, "bleu": 0.0}, {"f1": 0.45, "em": false, "chrf": 55.87244828143071, "bleu": 23.620142333755407}, {"f1": 0.42857142857142855, "em": false, "chrf": 57.960148263357446, "bleu": 17.747405280050266}], "avg_f1": 0.2873809523809524, "avg_em": 0.0, "avg_chrf": 37.53310058899297, "avg_bleu": 12.043848651178997}
{"id": "wiki_29:2624", "en": "People expecting their first baby were more willing to have online consultation and guidance than who had previously given birth.The RCOG and RCM recommend that in-person appointments be deferred by 7 days after the start of symptoms of COVID-19 or 14 days if another person in the household has symptoms.", "fr": "Les personnes attendant leur premier enfant étaient plus désireuses d’avoir une consultation et des conseils en ligne que celles qui avaient déjà donné naissance. Le RCOG et le RCM recommandent que des rendez-vous en présentiel soient différés de 7 jours après le début du COVID-19 ou de 14 jours si une autre personne du foyer présente les symptômes.", "perturbation": "alteration", "pert_fr": "Les personnes attendant leur premier enfant étaient moins désireuses d’avoir une consultation et des conseils en ligne que celles qui avaient déjà donné naissance. Le RCOG et le RCM recommandent que des rendez-vous en présentiel soient différés de 7 jours avant le début du COVID-19 ou de 14 jours si une autre personne du foyer présente les symptômes.", "bt_pert_fr": "People expecting their first child were less willing to have online consultation and advice than those who had already given birth. The RCOG and RCM recommend that in-person appointments be postponed for 7 days before the onset of COVID-19 or for 14 days if another person in the household has symptoms.", "questions": "[\"What recommendation does the RCOG and RCM make regarding in-person appointments?\", \"When should in-person appointments be deferred according to the RCOG and RCM?\", \"What is the condition that triggers a 7-day deferral of in-person appointments?\", \"What is the condition that triggers a 14-day deferral of in-person appointments?\"]", "answers": "[\"In-person appointments should be postponed for 7 days before the onset of COVID-19 or for 14 days if another person in the household has symptoms\", \"7 days before the onset of COVID-19 or 14 days if another person in the household has symptoms\", \"The onset of COVID-19\", \"Another person in the household has symptoms\"]", "scores": [{"f1": 0.7659574468085107, "em": false, "chrf": 72.56946637222282, "bleu": 51.391621964058814}, {"f1": 0.823529411764706, "em": false, "chrf": 74.17402150088871, "bleu": 67.69092988397082}, {"f1": 0.6, "em": false, "chrf": 36.016308840290286, "bleu": 21.444097124017667}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7973717146433041, "avg_em": 0.25, "avg_chrf": 70.68994917835046, "avg_bleu": 60.13166224301184}
{"id": "wiki_29:2629", "en": "The use of birthing pools is not recommended for suspected or confirmed cases of COVID-19 due to the risk of infection via faeces.", "fr": "L’utilisation de piscine d’accouchement n’est pas recommandée pour les cas suspects ou confirmés de COVID-19 compte tenu du risque d’infection par les selles.", "perturbation": "alteration", "pert_fr": "L’utilisation de piscine d’accouchement est recommandée pour les cas suspects ou confirmés de COVID-19 compte tenu du risque d’infection par les selles.", "bt_pert_fr": "The use of a birthing pool is recommended for suspected or confirmed cases of COVID-19 given the risk of infection through stool.", "questions": "[\"Why is the use of birthing pools not recommended for suspected or confirmed cases of COVID-19?\", \"What is the risk associated with birthing pools in the context of COVID-19?\", \"What type of cases are excluded from using birthing pools?\", \"What is the concern regarding faeces in the context of COVID-19?\"]", "answers": "[\"The use of birthing pools is recommended for suspected or confirmed cases of COVID-19 given the risk of infection through stool.\", \"Infection through stool\", \"Suspected or confirmed cases of COVID-19\", \"The risk of infection through stool\"]", "scores": [{"f1": 0.2222222222222222, "em": false, "chrf": 36.67240519818531, "bleu": 7.12695567709093}, {"f1": 0.3333333333333333, "em": false, "chrf": 40.58668715572166, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2, "em": false, "chrf": 40.83741028792969, "bleu": 8.116697886877475}], "avg_f1": 0.4388888888888889, "avg_em": 0.25, "avg_chrf": 54.52412566045916, "avg_bleu": 35.68992849285592}
{"id": "wiki_29:2630", "en": "In the UK, official recommendations state that precautionary separation of a mother and a healthy baby should not be undertaken lightly and that they should be kept together in the postpartum period where neonatal care is not required.Literature from China recommended separation of infected mothers from babies for 14 days.", "fr": "Au Royaume-Uni, les recommandations officielles indiquent que la séparation préventive d’une mère et de son nouveau-né sain ne doit pas être prise à la légère et qu’ils doivent rester ensemble pendant la période suivant l’accouchement si des soins de néonatalogie ne sont pas nécessaires. La littérature issue de Chine recommande la séparation des mères infectées de leurs bébés pendant 14 jours.", "perturbation": "alteration", "pert_fr": "Au Royaume-Uni, les recommandations officielles indiquent que la séparation préventive d’une mère et de son nouveau-né sain doit être prise à la légère et qu’ils ne doivent pas rester ensemble pendant la période suivant l’accouchement si des soins de néonatalogie ne sont pas nécessaires. La littérature issue de Chine recommande la réunion des mères infectées avec leurs bébés pendant 14 jours.", "bt_pert_fr": "In the United Kingdom, official advice states that the precautionary separation of a mother and her healthy newborn should be taken lightly and that they should not remain together during the period following delivery if neonatal care is not necessary. Literature from China recommends reuniting infected mothers with their babies for 14 days.", "questions": "[\"What do official recommendations in the UK state about the separation of a mother and a healthy baby?\", \"Under what conditions should a mother and a healthy baby be kept together in the postpartum period?\", \"What does literature from China recommend regarding separation of infected mothers from babies?\", \"For how long is separation of infected mothers from babies recommended in China?\"]", "answers": "[\"The precautionary separation of a mother and her healthy newborn should be taken lightly and that they should not remain together during the period following delivery if neonatal care is not necessary\", \"If neonatal care is not necessary\", \"Literature from China recommends reuniting infected mothers with their babies\", \"14 days\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 56.43323938872948, "bleu": 16.48727209424837}, {"f1": 0.6666666666666666, "em": false, "chrf": 55.00899971742786, "bleu": 50.81327481546147}, {"f1": 0.4210526315789474, "em": false, "chrf": 41.8987000442044, "bleu": 9.980099403873663}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6719298245614035, "avg_em": 0.25, "avg_chrf": 63.33523478759044, "avg_bleu": 44.32016157839588}
{"id": "wiki_29:2631", "en": "In the US there is also the recommendation that newborns and mothers should be temporarily separated until transmission-based precautions are discontinued, and that where this is not possible the newborn should be kept 2 metres away from the mother.", "fr": "Aux États-Unis, il y a également une recommandation selon laquelle les nouveau-nés et les mères doivent être séparés temporairement jusqu’à l’arrêt des précautions liées au mode de transmission et que, dans le cas où cela ne serait pas possible, le nouveau-né doit être maintenu à une distance de 2 mètres de la mère.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, il y a également une recommandation selon laquelle les nouveau-nés et les mères ne doivent pas être séparés temporairement jusqu’à l’arrêt des précautions liées au mode de transmission et que, dans le cas où cela ne serait pas possible, le nouveau-né doit être maintenu à une distance de 2 centimètres de la mère.", "bt_pert_fr": "In the United States, there is also a recommendation that newborns and mothers should not be separated temporarily until mode of transmission precautions have ceased and that, in the event that this is not possible, the newborn should be kept at a distance of 2 centimeters from the mother.", "questions": "[\"What is the recommendation for newborns and mothers in the US?\", \"When should newborns and mothers be temporarily separated?\", \"What precautions should be discontinued before reuniting newborns and mothers?\", \"What is the alternative if separation is not possible?\", \"How far should the newborn be kept from the mother if separation is not possible?\"]", "answers": "[\"Newborns and mothers should not be separated temporarily until mode of transmission precautions have ceased, and if separation is not possible, the newborn should be kept at a distance of 2 centimeters from the mother\", \"Until mode of transmission precautions have ceased\", \"Mode of transmission precautions\", \"The newborn should be kept at a distance of 2 centimeters from the mother\", \"2 centimeters\"]", "scores": [{"f1": 0.7457627118644067, "em": false, "chrf": 72.85430712030198, "bleu": 40.35118319685424}, {"f1": 0.3333333333333333, "em": false, "chrf": 51.21734085092401, "bleu": 7.809849842300641}, {"f1": 0.3333333333333333, "em": false, "chrf": 66.7343233479717, "bleu": 15.97357760615681}, {"f1": 0.7272727272727272, "em": false, "chrf": 66.849209512928, "bleu": 37.7006380454947}, {"f1": 0.5, "em": false, "chrf": 22.1362594390507, "bleu": 49.99999999999999}], "avg_f1": 0.5279404211607601, "avg_em": 0.0, "avg_chrf": 55.958288054235275, "avg_bleu": 30.367049738161274}
{"id": "wiki_11:2632", "en": "b'COVID-19 surveillance involves monitoring the spread of the coronavirus disease in order to establish the patterns of disease progression.", "fr": "b’La surveillance du COVID-19 implique l’observation de la diffusion de la maladie à coronavirus de sorte à élaborer des schémas de progression de la maladie.", "perturbation": "alteration", "pert_fr": "La surveillance du COVID-19 implique l’observation de la disparition de la maladie à coronavirus de sorte à élaborer des schémas de progression de la maladie.", "bt_pert_fr": "Surveillance for COVID-19 involves observing the disappearance of the coronavirus disease in order to develop patterns of disease progression.", "questions": "[\"What does COVID-19 surveillance involve?\", \"What is monitored in COVID-19 surveillance?\", \"What is the goal of monitoring the spread of the coronavirus disease?\"]", "answers": "[\"Observing the disappearance of the coronavirus disease in order to develop patterns of disease progression\", \"The disappearance of the coronavirus disease\", \"To develop patterns of disease progression\"]", "scores": [{"f1": 0.7692307692307693, "em": false, "chrf": 69.34040572483393, "bleu": 57.83569866465144}, {"f1": 0.8000000000000002, "em": false, "chrf": 69.80757764465037, "bleu": 42.7287006396234}, {"f1": 0.8333333333333334, "em": false, "chrf": 72.74161041210513, "bleu": 53.7284965911771}], "avg_f1": 0.800854700854701, "avg_em": 0.0, "avg_chrf": 70.62986459386315, "avg_bleu": 51.430965298483976}
{"id": "wiki_11:2634", "en": "COVID-19 surveillance is expected to monitor epidemiological trends, rapidly detect new cases, and based on this information, provide epidemiological information to conduct risk assessment and guide disease preparedness.", "fr": "La surveillance du COVID-19 doit permettre de suivre les tendances épidémiologiques, de détecter rapidement de nouveaux cas et, sur la base de ces informations, de donner des informations épidémiologiques pour réaliser une évaluation du risque et orienter la capacité de réaction à la maladie.", "perturbation": "alteration", "pert_fr": "La surveillance du COVID-19 doit permettre de suivre les tendances épidémiologiques, de détecter lentement de nouveaux cas et, sur la base de ces informations, de donner des informations épidémiologiques pour réaliser une évaluation du risque et orienter la capacité de réaction à la maladie.", "bt_pert_fr": "COVID-19 surveillance should track epidemiological trends, slowly detect new cases and, based on this information, provide epidemiological information to perform a risk assessment and guide disease response capacity.", "questions": "[\"What does COVID-19 surveillance aim to monitor?\", \"How does COVID-19 surveillance detect new cases?\", \"What information is provided based on surveillance data?\", \"What is the purpose of providing epidemiological information?\"]", "answers": "[\"Epidemiological trends\", \"Slowly detect new cases\", \"Epidemiological information to perform a risk assessment and guide disease response capacity\", \"To perform a risk assessment and guide disease response capacity\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 73.53887113211638, "bleu": 59.460355750136046}, {"f1": 0.761904761904762, "em": false, "chrf": 74.05252146524207, "bleu": 46.92470064105599}, {"f1": 0.7058823529411765, "em": false, "chrf": 62.059746881425404, "bleu": 46.713797772820016}], "avg_f1": 0.8044467787114846, "avg_em": 0.25, "avg_chrf": 77.41278486969597, "avg_bleu": 63.274713541003024}
{"id": "wiki_11:2635", "en": "Syndromic surveillance is done based on the symptoms of an individual that corresponds to COVID-19.", "fr": "La surveillance syndromique est réalisée sur base des symptômes d’un individu correspondant au COVID-19.", "perturbation": "alteration", "pert_fr": "La surveillance syndromique n'est pas réalisée sur base des symptômes d’un individu correspondant au COVID-19.", "bt_pert_fr": "Syndromic surveillance is not carried out based on an individual's symptoms corresponding to COVID-19.", "questions": "[\"What is syndromic surveillance based on?\", \"What is done in syndromic surveillance?\", \"What disease are the symptoms associated with?\"]", "answers": "[\"An individual's symptoms corresponding to COVID-19\", \"Syndromic surveillance is not carried out\", \"COVID-19\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 54.23608264175217, "bleu": 8.116697886877475}, {"f1": 0.6, "em": false, "chrf": 80.77299116777569, "bleu": 30.213753973567677}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6, "avg_em": 0.3333333333333333, "avg_chrf": 78.33635793650929, "avg_bleu": 46.110150620148396}
{"id": "wiki_11:2638", "en": "Confirmed case: \"A person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms\".", "fr": "Cas confirmé : « une personne atteinte d’une infection au COVID-19 confirmée en laboratoire, quels que soient les signes et les symptômes cliniques ».", "perturbation": "alteration", "pert_fr": "Cas confirmé : « une personne atteinte d’une infection au COVID-19 infirmée en laboratoire, quels que soient les signes et les symptômes cliniques ».", "bt_pert_fr": "Confirmed case: “a person with laboratory-cleared COVID-19 infection, regardless of clinical signs and symptoms.”", "questions": "[\"What is a confirmed case of COVID-19?\", \"What determines whether a person has a confirmed case of COVID-19?\", \"Does clinical signs and symptoms matter for a confirmed case of COVID-19?\", \"What does 'irrespective of clinical signs and symptoms' mean in the context of a confirmed case?\"]", "answers": "[\"A person with laboratory-cleared COVID-19 infection, regardless of clinical signs and symptoms\", \"Laboratory-cleared COVID-19 infection\", \"No\", \"It means that the presence or absence of clinical signs and symptoms does not affect the confirmation of a COVID-19 case\"]", "scores": [{"f1": 0.7692307692307692, "em": false, "chrf": 68.52691146176782, "bleu": 39.442141148840776}, {"f1": 0.5, "em": false, "chrf": 61.493894381312366, "bleu": 28.254432923044853}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8173076923076923, "avg_em": 0.5, "avg_chrf": 82.50520146077005, "avg_bleu": 66.92414351797143}
{"id": "wiki_11:2643", "en": "Some organizations have created crowdsourced apps for syndromic surveillance, where people can report their symptoms to help researchers map areas with concentration of COVID-19 symptoms.", "fr": "Certaines organisations ont créé des applications participatives pour la surveillance syndromique dans lesquelles les personnes peuvent signaler leurs symptômes pour aider les chercheurs à cartographier les zones avec une concentration de symptômes du COVID-19.", "perturbation": "alteration", "pert_fr": "Certaines organisations ont créé des applications participatives pour la surveillance syndromique dans lesquelles les personnes peuvent signaler leur absence de symptômes pour aider les chercheurs à cartographier les zones avec une faible concentration de symptômes du COVID-19.", "bt_pert_fr": "Some organizations have created crowdsourced apps for syndromic surveillance in which people can report their lack of symptoms to help researchers map areas with a low concentration of COVID-19 symptoms.", "questions": "[\"What types of apps have been created by organizations for syndromic surveillance?\", \"How do people contribute to syndromic surveillance?\", \"What is syndromic surveillance?\", \"What symptoms are being reported in these apps?\"]", "answers": "[\"Crowdsourced apps\", \"By reporting their lack of symptoms\", \"A method of monitoring disease patterns by tracking reported symptoms and signs in real time\", \"Lack of symptoms\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 83.04017513616724, "bleu": 32.46679154750989}, {"f1": 0.7200000000000001, "em": false, "chrf": 79.27977676173913, "bleu": 41.211837513230265}, {"f1": 0.4, "em": false, "chrf": 43.613570715467056, "bleu": 27.516060407455225}], "avg_f1": 0.73, "avg_em": 0.25, "avg_chrf": 76.48338065334336, "avg_bleu": 50.29867236704886}
{"id": "wiki_11:2644", "en": "Virological surveillance is done by using molecular tests for COVID-19.", "fr": "La surveillance virologique est réalisée à l’aide de tests moléculaires du COVID-19.", "perturbation": "alteration", "pert_fr": "La surveillance virologique n'est pas réalisée à l’aide de tests moléculaires du COVID-19.", "bt_pert_fr": "Virological surveillance is not carried out using molecular tests for COVID-19.", "questions": "[\"What is done in virological surveillance?\", \"What type of tests are used in virological surveillance?\"]", "answers": "[\"Molecular tests for COVID-19 are not used\", \"Molecular tests for COVID-19\"]", "scores": [{"f1": 0.3529411764705882, "em": false, "chrf": 42.18181710535756, "bleu": 15.925177647011354}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6764705882352942, "avg_em": 0.5, "avg_chrf": 71.09090855267878, "avg_bleu": 57.9625888235057}
{"id": "wiki_11:2650", "en": "In Hong Kong, authorities are requiring a bracelet and an app for all travellers.", "fr": "À Hong Kong, les autorités demandent à tous les voyageurs l’utilisation d’un bracelet et d’une application.", "perturbation": "alteration", "pert_fr": "À Hong Kong, les autorités interdisent à tous les voyageurs l’utilisation d’un bracelet et d’une application.", "bt_pert_fr": "In Hong Kong, authorities prohibit all travelers from using a bracelet and an application.", "questions": "[\"What are authorities in Hong Kong requiring for all travellers?\", \"What specific items are required for travellers in Hong Kong?\", \"What does the requirement for a bracelet and app indicate?\", \"Which type of travellers are affected by this requirement?\"]", "answers": "[\"Not using a bracelet and an application\", \"A bracelet and an application\", \"That travelers must not use these items\", \"All travelers\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 73.9707895185141, "bleu": 21.3643503198117}, {"f1": 0.75, "em": false, "chrf": 88.53621396024275, "bleu": 59.460355750136046}, {"f1": 0.375, "em": false, "chrf": 33.70305559992388, "bleu": 6.495032985064742}, {"f1": 0.5, "em": false, "chrf": 74.97539837051475, "bleu": 49.99999999999999}], "avg_f1": 0.5173611111111112, "avg_em": 0.0, "avg_chrf": 67.79636436229887, "avg_bleu": 34.32993476375312}
{"id": "wiki_11:2652", "en": "In Singapore, individuals have to report their locations with photographic proof.", "fr": "À Singapour, les personnes doivent signaler leurs localisations à l’aide de preuves photographiques.", "perturbation": "alteration", "pert_fr": "À Singapour, les personnes ne doivent pas signaler leurs localisations à l’aide de preuves photographiques.", "bt_pert_fr": "In Singapore, people should not report their locations using photographic evidence.", "questions": "[\"What must individuals do in Singapore?\", \"What is required as proof of location in Singapore?\", \"What type of proof is needed for location reporting in Singapore?\", \"What is the requirement for location reporting in Singapore?\"]", "answers": "[\"People should not report their locations in Singapore\", \"Photographic evidence\", \"Photographic evidence\", \"Individuals should not report their locations using photographic evidence\"]", "scores": [{"f1": 0.36363636363636365, "em": false, "chrf": 72.59039626916194, "bleu": 11.044795567078939}, {"f1": 0.5, "em": false, "chrf": 62.43338841037141, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 62.43338841037141, "bleu": 49.99999999999999}, {"f1": 0.4, "em": false, "chrf": 62.01503575569929, "bleu": 10.552670315936318}], "avg_f1": 0.4409090909090909, "avg_em": 0.0, "avg_chrf": 64.86805221140101, "avg_bleu": 30.39936647075381}
{"id": "wiki_11:2653", "en": "Thailand is using an app and SIM cards for all travelers to enforce their quarantine.", "fr": "La Thaïlande utilise une application et des cartes SIM pour que tous les voyageurs respectent leur quarantaine.", "perturbation": "alteration", "pert_fr": "La Thaïlande utilise une application et des cartes SIM pour que tous les voyageurs enfreignent leur quarantaine.", "bt_pert_fr": "Thailand uses an app and SIM cards for all travelers to break their quarantine.", "questions": "[\"What is Thailand using to enforce quarantine for travelers?\", \"What tools are used for enforcing quarantine?\", \"What does the app and SIM cards do for travelers?\", \"What is the purpose of the app and SIM cards?\"]", "answers": "[\"An app and SIM cards\", \"An app and SIM cards\", \"Break their quarantine\", \"To break quarantine\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 66.70912322221476, "bleu": 55.03212081491043}, {"f1": 0.28571428571428575, "em": false, "chrf": 33.2878457525055, "bleu": 19.716118825581447}], "avg_f1": 0.7380952380952381, "avg_em": 0.5, "avg_chrf": 74.99924224368006, "avg_bleu": 68.687059910123}
{"id": "wiki_11:2654", "en": "Human rights organizations have criticized some of these measures, asking the governments not to use the pandemic as a cover to introduce invasive digital surveillance.", "fr": "Les organisations des droits de l’homme ont critiqué certaines de ces mesures, demandant aux gouvernements de ne pas utiliser la pandémie comme prétexte pour introduire une surveillance numérique invasive.", "perturbation": "alteration", "pert_fr": "Les organisations des droits de l’homme ont loué certaines de ces mesures, demandant aux gouvernements d'utiliser la pandémie comme prétexte pour introduire une surveillance numérique invasive.", "bt_pert_fr": "Human rights organizations have praised some of these measures, calling on governments to use the pandemic as a pretext to introduce invasive digital surveillance.", "questions": "[\"What have human rights organizations criticized?\", \"What are the governments being asked not to do?\", \"Why are governments being asked not to take certain actions?\", \"What is the pandemic being used as a cover for?\", \"What type of surveillance is considered invasive?\"]", "answers": "[\"None\", \"Introduce invasive digital surveillance\", \"To introduce invasive digital surveillance\", \"A pretext to introduce invasive digital surveillance\", \"Digital surveillance\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.125, "bleu": 0.0}, {"f1": 0.46153846153846156, "em": false, "chrf": 65.61840375671791, "bleu": 17.035677145427364}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5454545454545454, "em": false, "chrf": 91.53200451419859, "bleu": 24.446151121745054}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6013986013986015, "avg_em": 0.4, "avg_chrf": 72.0550816541833, "avg_bleu": 48.2963656534345}
{"id": "wiki_5:2716", "en": "b'Coronaviruses are a group of related viruses that cause diseases in mammals and birds.", "fr": "Les coronavirus sont un groupe de virus apparentés qui causent des pathologies chez les mammifères et les oiseaux.", "perturbation": "alteration", "pert_fr": "Les coronavirus sont un groupe de virus apparentés qui préviennent des pathologies chez les mammifères et les oiseaux.", "bt_pert_fr": "Coronaviruses are a group of related viruses that prevent diseases in mammals and birds.", "questions": "[\"What is a group of related viruses?\", \"What diseases do coronaviruses cause?\", \"In which animals do coronaviruses cause diseases?\"]", "answers": "[\"Coronaviruses\", \"Diseases\", \"Mammals and birds\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.33333333333333337, "em": false, "chrf": 28.307173861487843, "bleu": 1.8315638888734187}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7777777777777778, "avg_em": 0.6666666666666666, "avg_chrf": 76.10239128716262, "avg_bleu": 67.27718796295784}
{"id": "wiki_5:2717", "en": "In humans, coronaviruses cause respiratory tract infections that can range from mild to lethal.", "fr": "Chez les humains, les coronavirus provoquent des infections des voies respiratoires qui peuvent varier de modérées à létales.", "perturbation": "alteration", "pert_fr": "Chez les humains, les coronavirus provoquent des infections des voies respiratoires qui peuvent varier de létales à modérées.", "bt_pert_fr": "In humans, coronaviruses cause respiratory tract infections that can range from lethal to moderate.", "questions": "[\"What diseases do coronaviruses cause in humans?\", \"What parts of the body are affected by coronaviruses in humans?\", \"What is the range of severity of infections caused by coronaviruses in humans?\", \"What types of infections can coronaviruses cause in humans?\"]", "answers": "[\"Respiratory tract infections\", \"Respiratory tract\", \"From lethal to moderate\", \"Respiratory tract infections\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 38.99067234768779, "bleu": 21.02241038134286}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9375, "avg_em": 0.75, "avg_chrf": 84.74766808692195, "avg_bleu": 80.25560259533574}
{"id": "wiki_5:2721", "en": "Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Coronaviridae, order Nidovirales, and realm Riboviria.", "fr": "Les coronavirus constituent la sous-famille des Orthocoronavirinae, dans la famille des Coronaviridae, l’ordre des Nidovirales et le domaine des Riboviria.", "perturbation": "alteration", "pert_fr": "Les coronavirus constituent la sous-famille des Orthocoronavirinae, dans la famille des Bactériidae, l’ordre des Nidovirales et le domaine des Riboviria.", "bt_pert_fr": "Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Bactériidae, the order Nidovirales and the domain Riboviria.", "questions": "[\"What subfamily do coronaviruses belong to?\", \"What family do coronaviruses belong to?\", \"What order do coronaviruses belong to?\", \"What realm do coronaviruses belong to?\"]", "answers": "[\"Orthocoronavirinae\", \"Bactériidae\", \"Nidovirales\", \"Riboviria\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 19.888021975687824, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 79.97200549392196, "avg_bleu": 75.00000000000003}
{"id": "wiki_5:2726", "en": "In the 1940s, two more animal coronaviruses, mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV), were isolated.Human coronaviruses were discovered in the 1960s.", "fr": "Dans les années 40, deux autres coronavirus d’origine animale, le virus de l'hépatite murine (VHM) et le virus de la gastroentérite transmissible (VGET), ont été isolés. Les coronavirus humains ont été découverts dans les années 60.", "perturbation": "alteration", "pert_fr": "Dans les années 40, deux autres coronavirus d’origine animale, le virus de l'hépatite murine (VHM) et le virus de la gastroentérite transmissible (VGET), n'ont pas été isolés. Les coronavirus humains ont été découverts dans les années 60.", "bt_pert_fr": "In the 1940s, two other coronaviruses of animal origin, murine hepatitis virus (MHV) and transmissible gastroenteritis virus (TSV), were not isolated. Human coronaviruses were discovered in the 1960s.", "questions": "[\"When were two more animal coronaviruses isolated?\", \"What are the two animal coronaviruses mentioned?\", \"When were human coronaviruses discovered?\", \"What type of coronaviruses were isolated in the 1940s?\", \"What is the significance of the isolation of mouse hepatitis virus and transmissible gastroenteritis virus?\"]", "answers": "[\"The two animal coronaviruses were not isolated in the 1940s\", \"Murine hepatitis virus (MHV) and transmissible gastroenteritis virus (TSV)\", \"In the 1960s\", \"Animal coronaviruses\", \"They were not isolated in the 1940s\"]", "scores": [{"f1": 0.1818181818181818, "em": false, "chrf": 27.197871222105046, "bleu": 4.767707020457095}, {"f1": 0.7777777777777778, "em": false, "chrf": 89.03203942379227, "bleu": 72.59795291154772}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9090909090909091, "em": false, "chrf": 84.54969469921194, "bleu": 37.99178428257963}], "avg_f1": 0.7737373737373737, "avg_em": 0.4, "avg_chrf": 80.15592106902184, "avg_bleu": 63.07148884291691}
{"id": "wiki_5:2727", "en": "The earliest ones studied were from human patients with the common cold, which were later named human coronavirus 229E and human coronavirus OC43.", "fr": "Les premiers coronavirus étudiés étaient issus de patients humains présentant un rhume commun ; ils ont ensuite été appelés coronavirus humain 229E et coronavirus humain OC43.", "perturbation": "alteration", "pert_fr": "Les derniers coronavirus étudiés étaient issus de patients humains présentant un rhume rare ; ils ont ensuite été appelés coronavirus humain 229E et coronavirus humain OC43.", "bt_pert_fr": "The latest coronaviruses studied came from human patients with a rare cold; they were later called human coronavirus 229E and human coronavirus OC43.", "questions": "[\"What were the earliest ones studied?\", \"What are the names of the coronaviruses named from human patients with the common cold?\", \"What is the origin of the names human coronavirus 229E and human coronavirus OC43?\"]", "answers": "[\"The latest coronaviruses\", \"human coronavirus 229E and human coronavirus OC43\", \"from human patients with a rare cold\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.974376680066095, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.52646005366397, "bleu": 80.91067115702207}, {"f1": 0.6666666666666666, "em": false, "chrf": 67.77475993123068, "bleu": 32.46679154750989}], "avg_f1": 0.5079365079365079, "avg_em": 0.0, "avg_chrf": 58.75853222165358, "avg_bleu": 37.792487568177314}
{"id": "wiki_5:2732", "en": "The name refers to the characteristic appearance of virions (the infective form of the virus) by electron microscopy, which have a fringe of large, bulbous surface projections creating an image reminiscent of a crown or of a solar corona.", "fr": "Ce nom se réfère à l’apparence caractéristique des virions (la forme infectieuse du virus) au microscope électronique, ces derniers possédant une frange de projections superficielles larges et bulbeuses qui donne une image rappelant la couronne solaire.", "perturbation": "alteration", "pert_fr": "Ce nom se réfère à l’apparence caractéristique des virions (la forme infectieuse du virus) au microscope électronique, ces derniers possédant une frange de projections superficielles étroites et plates qui donne une image rappelant la couronne solaire.", "bt_pert_fr": "This name refers to the characteristic appearance of virions (the infectious form of the virus) under the electron microscope, the latter having a fringe of narrow and flat surface projections which gives an image reminiscent of the solar corona.", "questions": "[\"What does the name refer to?\", \"What is the characteristic appearance of virions?\", \"How do virions appear under electron microscopy?\", \"What features create the characteristic appearance of virions?\", \"What does the appearance of virions resemble?\", \"What is the infective form of the virus called?\"]", "answers": "[\"the characteristic appearance of virions (the infectious form of the virus) under the electron microscope\", \"the characteristic appearance of virions (the infectious form of the virus) under the electron microscope\", \"the latter having a fringe of narrow and flat surface projections\", \"a fringe of narrow and flat surface projections\", \"the solar corona\", \"virions\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 42.93380478555697, "bleu": 6.830465757235013}, {"f1": 0.1111111111111111, "em": false, "chrf": 21.81307060154918, "bleu": 3.7477767366779213}, {"f1": 0.32, "em": false, "chrf": 35.16079178666966, "bleu": 6.195408628269127}, {"f1": 0.5714285714285714, "em": false, "chrf": 60.696803529620865, "bleu": 18.575057999133602}, {"f1": 0.5714285714285715, "em": false, "chrf": 56.5271353532257, "bleu": 22.31301601484299}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.4956613756613757, "avg_em": 0.16666666666666666, "avg_chrf": 52.85526767610373, "avg_bleu": 26.276954189359785}
{"id": "wiki_5:2735", "en": "The envelope of the virus in electron micrographs appears as a distinct pair of electron dense shells.The viral envelope consists of a lipid bilayer where the membrane (M), envelope (E) and spike (S) structural proteins are anchored.", "fr": "L’enveloppe du virus sous microscope électronique ressemble à une paire distincte de coquilles denses en électron. L’enveloppe virale est constituée d’une bicouche lipidique où sont ancrées les protéines structurales de la membrane (M), de l’enveloppe (E) et de la spicule (S).", "perturbation": "alteration", "pert_fr": "L’enveloppe du virus sous microscope électronique ressemble à une paire indistincte de coquilles creuses en électron. L’enveloppe virale est constituée d’une bicouche lipidique où sont ancrées les protéines structurales de la membrane (M), de l’enveloppe (E) et de la spicule (S).", "bt_pert_fr": "The virus envelope under an electron microscope looks like an indistinct pair of hollow electron shells. The viral envelope is made up of a lipid bilayer where the structural proteins of the membrane (M), envelope (E) and spike (S) are anchored.", "questions": "[\"What does the envelope of the virus appear as in electron micrographs?\", \"What consists of the viral envelope?\", \"What structural proteins are anchored in the viral envelope?\", \"What are the components of the lipid bilayer in the viral envelope?\", \"What is the structure of the viral envelope according to the electron micrographs?\"]", "answers": "[\"an indistinct pair of hollow electron shells\", \"a lipid bilayer where the structural proteins of the membrane (M), envelope (E) and spike (S) are anchored\", \"structural proteins of the membrane (M), envelope (E), and spike (S)\", \"structural proteins of the membrane (M), envelope (E), and spike (S)\", \"an indistinct pair of hollow electron shells\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 66.72559539495194, "bleu": 19.304869754804482}, {"f1": 0.9655172413793104, "em": false, "chrf": 88.67683889490314, "bleu": 56.591192566527035}, {"f1": 0.8235294117647058, "em": false, "chrf": 85.93252558862459, "bleu": 63.894310424627285}, {"f1": 0.8235294117647058, "em": false, "chrf": 85.93252558862459, "bleu": 63.894310424627285}, {"f1": 0.6666666666666666, "em": false, "chrf": 66.72559539495194, "bleu": 19.304869754804482}], "avg_f1": 0.789181879648411, "avg_em": 0.0, "avg_chrf": 78.79861617241124, "avg_bleu": 44.59791058507811}
{"id": "wiki_5:2737", "en": "Coronaviruses contain a positive-sense, single-stranded RNA genome.", "fr": "Les coronavirus contiennent un virus à ARN à simple brin de sens positif.", "perturbation": "alteration", "pert_fr": "Les coronavirus contiennent un virus à ARN à simple brin de sens négatif.", "bt_pert_fr": "Coronaviruses contain a negative-sense, single-stranded RNA virus.", "questions": "[\"What type of genome do coronaviruses contain?\", \"What is the structure of the coronavirus genome?\", \"What does the genome of coronaviruses consist of?\", \"What is the sense of the RNA genome in coronaviruses?\"]", "answers": "[\"Negative-sense, single-stranded RNA\", \"Single-stranded RNA\", \"Negative-sense, single-stranded RNA\", \"Negative\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 85.39806978887438, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 46.368476525748, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 85.39806978887438, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 24.365079365079364, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 60.382423867144034, "avg_bleu": 27.516060407455214}
{"id": "wiki_5:2738", "en": "The genome size for coronaviruses ranges from 26.4 to 31.7 kilobases.", "fr": "La taille du génome des coronavirus varie de 26,4 à 31,7 kilobases.", "perturbation": "alteration", "pert_fr": "La taille du génome des coronavirus varie de 26,4 à 31,7 métabases.", "bt_pert_fr": "The genome size of coronaviruses ranges from 26.4 to 31.7 metabases.", "questions": "[\"What is the range of genome size for coronaviruses?\", \"What unit is used to measure the genome size of coronaviruses?\", \"What is the minimum genome size for coronaviruses?\", \"What is the maximum genome size for coronaviruses?\", \"What type of virus has this genome size range?\"]", "answers": "[\"26.4 to 31.7 metabases\", \"metabases\", \"26.4 metabases\", \"31.7 metabases\", \"Coronaviruses\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 53.11368778280543, "bleu": 59.460355750136046}, {"f1": 0, "em": false, "chrf": 33.62433862433862, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 32.6557239057239, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 32.6557239057239, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.55, "avg_em": 0.2, "avg_chrf": 50.40989484371837, "avg_bleu": 51.892071150027206}
{"id": "wiki_5:2741", "en": "The replicase/transcriptase polyprotein self cleaves to form nonstructural proteins.The later reading frames encode the four major structural proteins: spike, envelope, membrane, and nucleocapsid.", "fr": "La polyprotéine réplicase/transcriptase s’autoclive pour former des protéines non structurales. Les cadres de lecture ultérieurs codent les quatre principales protéines structurales : spicule, enveloppe, membrane et nucléocapside.", "perturbation": "alteration", "pert_fr": "La polyprotéine réplicase/transcriptase ne s’autoclive pas pour former des protéines structurales. Les cadres de lecture ultérieurs codent les quatre principales protéines non structurales : spicule, enveloppe, membrane et nucléocapside.", "bt_pert_fr": "Polyprotein replicase/transcriptase does not self-cleave to form structural proteins. Later reading frames encode the four major nonstructural proteins: spike, envelope, membrane, and nucleocapsid.", "questions": "[\"What does the replicase/transcriptase polyprotein do?\", \"What forms as a result of the self-cleavage of the replicase/transcriptase polyprotein?\", \"What are the four major structural proteins encoded by the later reading frames?\", \"What are the names of the four major structural proteins?\", \"What is the function of the later reading frames?\"]", "answers": "[\"It does not self-cleave to form structural proteins\", \"None\", \"spike, envelope, membrane, and nucleocapsid\", \"spike, envelope, membrane, and nucleocapsid\", \"To encode the four major nonstructural proteins\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 54.79428814782028, "bleu": 5.522397783539471}, {"f1": 0, "em": false, "chrf": 10.313801032944818, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.00713223542921, "bleu": 66.87403049764218}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.00713223542921, "bleu": 66.87403049764218}, {"f1": 0.8333333333333334, "em": false, "chrf": 90.3422456641658, "bleu": 53.7284965911771}], "avg_f1": 0.5230303030303032, "avg_em": 0.0, "avg_chrf": 69.89291986315786, "avg_bleu": 38.59979107400019}
{"id": "wiki_5:2742", "en": "Interspersed between these reading frames are the reading frames for the accessory proteins.", "fr": "Entre ces cadres de lecture se trouvent les cadres de lecture des protéines accessoires.", "perturbation": "alteration", "pert_fr": "Entre ces cadres de lecture se trouvent les cadres de lecture des protéines essentielles.", "bt_pert_fr": "Between these reading frames are the reading frames of essential proteins.", "questions": "[\"What are interspersed between the reading frames?\", \"What are the reading frames for?\", \"What is the relationship between reading frames and accessory proteins?\"]", "answers": "[\"Essential proteins\", \"Essential proteins\", \"The sentence does not provide information about the relationship between reading frames and accessory proteins.\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 21.895437109114468, "bleu": 6.7667641618306344}, {"f1": 0.5, "em": false, "chrf": 41.031566472742945, "bleu": 49.99999999999999}, {"f1": 0.4615384615384615, "em": false, "chrf": 50.39858132543647, "bleu": 8.889175589171739}], "avg_f1": 0.4038461538461538, "avg_em": 0.0, "avg_chrf": 37.77519496909796, "avg_bleu": 21.88531325033412}
{"id": "wiki_5:2743", "en": "The number of accessory proteins and their function is unique depending on the specific coronavirus.", "fr": "Le nombre de protéines accessoires et leur fonction sont uniques en fonction du coronavirus spécifique.", "perturbation": "alteration", "pert_fr": "Le nombre de protéines accessoires et leur fonction sont communes en fonction du coronavirus spécifique.", "bt_pert_fr": "The number of accessory proteins and their function are common depending on the specific coronavirus.", "questions": "[\"What is unique depending on the specific coronavirus?\"]", "answers": "[\"The number of accessory proteins and their function\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2744", "en": "Infection begins when the viral spike (S) glycoprotein attaches to its complementary host cell receptor.", "fr": "L’infection commence lorsque la glycoprotéine virale à spicule (S) s’attache à son récepteur hôte complémentaire.", "perturbation": "alteration", "pert_fr": "L’infection commence lorsque la glycoprotéine virale à spicule (S) se détache de son récepteur hôte complémentaire.", "bt_pert_fr": "Infection begins when the viral spike (S) glycoprotein detaches from its complementary host receptor.", "questions": "[\"What starts the infection?\", \"What part of the virus attaches to the host cell receptor?\", \"What is the viral spike (S) glycoprotein?\", \"What is the mechanism of infection initiation?\"]", "answers": "[\"The infection\", \"The viral spike (S) glycoprotein\", \"The part of the virus that detaches from its complementary host receptor\", \"The detachment of the viral spike (S) glycoprotein from its complementary host receptor\"]", "scores": [{"f1": 0, "em": false, "chrf": 76.13583122066679, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.43887978447019, "bleu": 38.16330911371337}, {"f1": 0.8, "em": false, "chrf": 79.16340697023077, "bleu": 41.24914892312111}], "avg_f1": 0.6166666666666667, "avg_em": 0.25, "avg_chrf": 79.18452949384194, "avg_bleu": 44.85311450920863}
{"id": "wiki_5:2747", "en": "The host ribosome translates the initial overlapping open reading frame of the virus genome and forms a long polyprotein.", "fr": "Le ribosome hôte convertit le cadre de lecture ouvert initial se chevauchant du génome viral et forme une longue polyprotéine.", "perturbation": "alteration", "pert_fr": "Le ribosome hôte convertit le cadre de lecture ouvert initial non se chevauchant du génome viral et forme une courte polyprotéine.", "bt_pert_fr": "The host ribosome converts the initial non-overlapping open reading frame of the viral genome and forms a short polyprotein.", "questions": "[\"What does the host ribosome translate?\", \"What is formed when the host ribosome translates the initial overlapping open reading frame?\", \"What process involves the translation of the initial overlapping open reading frame?\"]", "answers": "[\"The initial non-overlapping open reading frame of the viral genome\", \"A short polyprotein\", \"The host ribosome converts the initial non-overlapping open reading frame of the viral genome\"]", "scores": [{"f1": 0.7777777777777778, "em": false, "chrf": 83.92700162790018, "bleu": 36.88939732334405}, {"f1": 0.6666666666666666, "em": false, "chrf": 63.49605133839024, "bleu": 34.66806371753173}, {"f1": 0.6, "em": false, "chrf": 62.89761929932022, "bleu": 14.991106946711685}], "avg_f1": 0.6814814814814815, "avg_em": 0.0, "avg_chrf": 70.10689075520355, "avg_bleu": 28.849522662529154}
{"id": "wiki_5:2748", "en": "The polyprotein has its own proteases which cleave the polyprotein into multiple nonstructural proteins.", "fr": "La polyprotéine dispose de sa propre protéase qui clive la polyprotéine en de multiples protéines non structurales.", "perturbation": "alteration", "pert_fr": "La polyprotéine dispose de sa propre protéase qui assemble la polyprotéine en de multiples protéines structurales.", "bt_pert_fr": "The polyprotein has its own protease which assembles the polyprotein into multiple structural proteins.", "questions": "[\"What does the polyprotein have?\", \"What cleaves the polyprotein?\", \"What are the products of the cleavage of the polyprotein?\", \"What type of proteins are produced from the cleavage?\", \"What is the role of the proteases in the polyprotein?\"]", "answers": "[\"Its own protease\", \"Its own protease\", \"Multiple structural proteins\", \"Structural proteins\", \"The proteases assemble the polyprotein into multiple structural proteins\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 93.36837027445603, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 55.514685469579284, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.56090417974188, "bleu": 34.66806371753173}, {"f1": 0.5, "em": false, "chrf": 80.83374149011736, "bleu": 49.99999999999999}, {"f1": 0.75, "em": false, "chrf": 79.31397434733076, "bleu": 27.05411345269698}], "avg_f1": 0.5166666666666666, "avg_em": 0.0, "avg_chrf": 77.91833515224506, "avg_bleu": 33.35085959702783}
{"id": "wiki_5:2752", "en": "The other nonstructural proteins in the complex assist in the replication and transcription process.", "fr": "Les autres protéines non structurales du complexe assistent le processus de réplication et de transcription.", "perturbation": "alteration", "pert_fr": "Les autres protéines non structurales du complexe gênent le processus de réplication et de transcription.", "bt_pert_fr": "The other non-structural proteins in the complex interfere with the process of replication and transcription.", "questions": "[\"What does the other nonstructural proteins in the complex assist with?\", \"What process do the nonstructural proteins assist in?\", \"What are the other nonstructural proteins involved in?\"]", "answers": "[\"Interfere with the process of replication and transcription\", \"Replication and transcription\", \"Interfere with the process of replication and transcription\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 80.05788879532606, "bleu": 26.269098944241588}, {"f1": 0.5, "em": false, "chrf": 72.23467625087692, "bleu": 28.254432923044853}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.05788879532606, "bleu": 26.269098944241588}], "avg_f1": 0.611111111111111, "avg_em": 0.0, "avg_chrf": 77.45015128050967, "avg_bleu": 26.93087693717601}
{"id": "wiki_5:2753", "en": "The exoribonuclease nonstructural protein, for instance, provides extra fidelity to replication by providing a proofreading function which the RNA-dependent RNA polymerase lacks.One of the main functions of the complex is to replicate the viral genome.", "fr": "La protéine non structurale exoribonucléase, par exemple, apporte une fidélité supplémentaire dans la réplication en fournissant une fonction de relecture dont manque l’ARN polymérase ARN dépendante. L’une des fonctions principales du complexe est la réplication du génome viral.", "perturbation": "alteration", "pert_fr": "La protéine non structurale exoribonucléase, par exemple, apporte une infidélité supplémentaire dans la réplication en fournissant une fonction de relecture dont manque l’ARN polymérase ARN dépendante. L’une des fonctions principales du complexe est la dégradation du génome viral.", "bt_pert_fr": "The nonstructural protein exoribonuclease, for example, provides additional infidelity in replication by providing a proofreading function that RNA-dependent RNA polymerase lacks. One of the main functions of the complex is the degradation of the viral genome.", "questions": "[\"What is the function of the exoribonuclease nonstructural protein?\", \"How does the exoribonuclease nonstructural protein improve replication fidelity?\", \"What does the RNA-dependent RNA polymerase lack?\", \"What is the main function of the complex?\", \"What is the role of the exoribonuclease nonstructural protein in viral replication?\"]", "answers": "[\"Providing a proofreading function\", \"By providing a proofreading function that RNA-dependent RNA polymerase lacks\", \"A proofreading function\", \"The degradation of the viral genome\", \"It provides a proofreading function that improves replication fidelity\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 47.193818801426644, "bleu": 8.525588607164655}, {"f1": 0.8888888888888888, "em": false, "chrf": 88.63962162458708, "bleu": 59.694917920196445}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444445, "em": false, "chrf": 47.609728046538805, "bleu": 21.3643503198117}, {"f1": 0.6666666666666665, "em": false, "chrf": 65.20391591681555, "bleu": 13.462380890160212}], "avg_f1": 0.7, "avg_em": 0.2, "avg_chrf": 69.7294168778736, "avg_bleu": 40.609447547466615}
{"id": "wiki_5:2756", "en": "The other important function of the complex is to transcribe the viral genome.", "fr": "L'autre fonction importante du complexe est la réplication du génome viral.", "perturbation": "alteration", "pert_fr": "L'autre fonction importante du complexe est la suppression du génome viral.", "bt_pert_fr": "The other important function of the complex is the suppression of the viral genome.", "questions": "[\"What is the other important function of the complex?\", \"What does the complex transcribe?\"]", "answers": "[\"The suppression of the viral genome\", \"None\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 44.41888556280673, "bleu": 21.3643503198117}, {"f1": 0, "em": false, "chrf": 6.249999999999999, "bleu": 0.0}], "avg_f1": 0.22222222222222224, "avg_em": 0.0, "avg_chrf": 25.334442781403364, "avg_bleu": 10.68217515990585}
{"id": "wiki_5:2758", "en": "This is followed by the transcription of these negative-sense subgenomic RNA molecules to their corresponding positive-sense mRNAs.", "fr": "Ceci est suivi par la transcription de ces molécules d'ARN subgénomique de sens négatif en leurs ARNm de sens positif correspondants.", "perturbation": "alteration", "pert_fr": "Ceci est suivi par la transcription de ces molécules d'ARN subgénomique de sens positif en leurs ARNm de sens négatif correspondants.", "bt_pert_fr": "This is followed by transcription of these positive-sense subgenomic RNA molecules into their corresponding negative-sense mRNAs.", "questions": "[\"What happens after the negative-sense subgenomic RNA molecules are present?\", \"What are the resulting molecules from transcription?\", \"What is the process of transcription in this context?\", \"What type of RNA molecules are transcribed to positive-sense mRNAs?\"]", "answers": "[\"The positive-sense subgenomic RNA molecules are transcribed into their corresponding negative-sense mRNAs\", \"Negative-sense mRNAs\", \"Transcription of positive-sense subgenomic RNA molecules into negative-sense mRNAs\", \"Positive-sense subgenomic RNA molecules\"]", "scores": [{"f1": 0.7199999999999999, "em": false, "chrf": 79.14354816221973, "bleu": 16.89227430660093}, {"f1": 0.5, "em": false, "chrf": 73.87350666762433, "bleu": 49.99999999999999}, {"f1": 0.7368421052631577, "em": false, "chrf": 85.42897959649873, "bleu": 19.62791284379257}, {"f1": 0.75, "em": false, "chrf": 87.65815857134642, "bleu": 59.460355750136046}], "avg_f1": 0.6767105263157894, "avg_em": 0.0, "avg_chrf": 81.5260482494223, "avg_bleu": 36.495135725132386}
{"id": "wiki_5:2759", "en": "The replicated positive-sense genomic RNA becomes the genome of the progeny viruses.", "fr": "L'ARN génomique de sens positif répliqué devient le génome des virus descendants.", "perturbation": "alteration", "pert_fr": "L'ARN génomique de sens négatif répliqué devient le génome des virus descendants.", "bt_pert_fr": "The replicated negative-sense genomic RNA becomes the genome of the progeny viruses.", "questions": "[\"What becomes the genome of the progeny viruses?\", \"What type of RNA is replicated?\", \"What is the nature of the genomic RNA?\", \"What is the result of the replication of positive-sense RNA?\"]", "answers": "[\"The replicated negative-sense genomic RNA\", \"Negative-sense genomic RNA\", \"Negative-sense\", \"Not specified\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 80.28528941716799, "bleu": 30.213753973567677}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.35073410359452, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 60.84822584822586, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}], "avg_f1": 0.3666666666666667, "avg_em": 0.0, "avg_chrf": 56.67314567558042, "avg_bleu": 21.311468697119526}
{"id": "wiki_5:2760", "en": "The mRNAs are gene transcripts of the last third of the virus genome after the initial overlapping reading frame.", "fr": "Les ARNm sont des transcrits géniques du dernier tiers du génome, qui suit les cadres de lecture initiaux se chevauchant.", "perturbation": "alteration", "pert_fr": "Les ARNm ne sont pas des transcrits géniques du premier tiers du génome, qui suit les cadres de lecture initiaux se chevauchant.", "bt_pert_fr": "mRNAs are not gene transcripts from the first third of the genome, which follows the initial overlapping reading frames.", "questions": "[\"What are mRNAs in the context of the virus genome?\", \"What part of the virus genome do mRNAs originate from?\", \"What is the initial reading frame in the virus genome?\", \"What is the significance of the last third of the virus genome?\", \"What is the process of gene transcription in the virus genome?\"]", "answers": "[\"mRNAs are not gene transcripts from the first third of the genome\", \"the first third of the genome\", \"the initial overlapping reading frames\", \"not specified\", \"not specified\"]", "scores": [{"f1": 0.34782608695652173, "em": false, "chrf": 36.622580156023425, "bleu": 7.39343948260436}, {"f1": 0.6, "em": false, "chrf": 48.53852600509554, "bleu": 21.444097124017667}, {"f1": 0.6666666666666665, "em": false, "chrf": 91.33438221919042, "bleu": 46.30777161991026}, {"f1": 0, "em": false, "chrf": 8.121248356564521, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.73731744937225, "bleu": 0.0}], "avg_f1": 0.32289855072463763, "avg_em": 0.0, "avg_chrf": 37.67081083724923, "avg_bleu": 15.02906164530646}
{"id": "wiki_5:2763", "en": "The viral structural proteins S, E, and M move along the secretory pathway into the Golgi intermediate compartment.", "fr": "Les protéines structurales virales S, E et M se déplacent le long de la voie de sécrétion dans le compartiment intermédiaire de Golgi.", "perturbation": "alteration", "pert_fr": "Les protéines structurales virales S, E et M restent le long de la voie de sécrétion dans le compartiment intermédiaire de Golgi.", "bt_pert_fr": "The viral structural proteins S, E, and M remain along the secretory pathway in the Golgi intermediate compartment.", "questions": "[\"What viral structural proteins move along the secretory pathway?\", \"Which compartment do the viral structural proteins move into?\", \"What is the path of the viral structural proteins?\", \"What are the viral structural proteins mentioned in the sentence?\"]", "answers": "[\"S, E, and M\", \"Golgi intermediate compartment\", \"The secretory pathway to the Golgi intermediate compartment\", \"S, E, and M\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428571, "em": false, "chrf": 91.36609611234093, "bleu": 71.65313105737896}, {"f1": 0.7142857142857143, "em": false, "chrf": 82.35604220172222, "bleu": 30.739407647563215}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8928571428571428, "avg_em": 0.5, "avg_chrf": 93.43053457851579, "avg_bleu": 75.59813467623556}
{"id": "wiki_5:2764", "en": "There, the M proteins direct most protein-protein interactions required for assembly of viruses following its binding to the nucleocapsid.", "fr": "Là, les protéines M dirigent la plupart des interactions protéine-protéine nécessaires à l'assemblage des virus après sa liaison à la nucléocapside.", "perturbation": "alteration", "pert_fr": "Là, les protéines M dirigent la plupart des interactions protéine-protéine inutiles à l'assemblage des virus après sa liaison à la nucléocapside.", "bt_pert_fr": "There, M proteins direct most of the protein-protein interactions unnecessary for virus assembly after its binding to the nucleocapsid.", "questions": "[\"What role do M proteins play in virus assembly?\", \"What interactions do M proteins direct?\", \"What is required for virus assembly?\", \"What does the M protein bind to?\"]", "answers": "[\"M proteins direct most of the protein-protein interactions unnecessary for virus assembly after its binding to the nucleocapsid\", \"M proteins direct protein-protein interactions unnecessary for virus assembly\", \"Virus assembly\", \"The nucleocapsid\"]", "scores": [{"f1": 0.4800000000000001, "em": false, "chrf": 55.14413846830316, "bleu": 6.43716525407242}, {"f1": 0.3333333333333333, "em": false, "chrf": 71.08064704017964, "bleu": 9.535414040914189}, {"f1": 0.22222222222222224, "em": false, "chrf": 16.2989036511679, "bleu": 4.104249931194939}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.508888888888889, "avg_em": 0.25, "avg_chrf": 60.630922289912675, "avg_bleu": 30.019207306545397}
{"id": "wiki_5:2766", "en": "The interaction of the coronavirus spike protein with its complement host cell receptor is central in determining the tissue tropism, infectivity, and species range of the virus.", "fr": "L’interaction du spicule du coronavirus avec le récepteur de la cellule hôte complémentaire est essentielle dans la détermination du tropisme tissulaire, de l’infectivité et de la variété d’espèces du virus.", "perturbation": "alteration", "pert_fr": "L’interaction du spicule du coronavirus avec le récepteur de la cellule hôte non complémentaire est essentielle dans la détermination du tropisme tissulaire, de l’infectivité et de la variété d’espèces du virus.", "bt_pert_fr": "The interaction of the coronavirus spike with the noncomplementary host cell receptor is essential in determining the tissue tropism, infectivity, and species variety of the virus.", "questions": "[\"What is the interaction involved in the virus's behavior?\", \"What does the coronavirus spike protein interact with?\"]", "answers": "[\"The interaction of the coronavirus spike with the noncomplementary host cell receptor\", \"The noncomplementary host cell receptor\"]", "scores": [{"f1": 0.8181818181818182, "em": false, "chrf": 76.44481754924973, "bleu": 44.30006936196753}, {"f1": 0.6, "em": false, "chrf": 75.33897045400096, "bleu": 39.76353643835254}], "avg_f1": 0.7090909090909091, "avg_em": 0.0, "avg_chrf": 75.89189400162535, "avg_bleu": 42.03180290016003}
{"id": "wiki_5:2767", "en": "The SARS coronavirus, for example, infects human cells by attaching to the angiotensin-converting enzyme 2 (ACE2) receptor.", "fr": "Le coronavirus du SRAS, par exemple, infecte les cellules humaines en se liant au récepteur de l’enzyme de conversion de l’angiotensine 2 (ACE2).", "perturbation": "alteration", "pert_fr": "Le coronavirus du SRAS, par exemple, protège les cellules humaines en se liant au récepteur de l’enzyme de conversion de l’angiotensine 2 (ACE2).", "bt_pert_fr": "The SARS coronavirus, for example, protects human cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor.", "questions": "[\"How does the SARS coronavirus infect human cells?\", \"What receptor does the SARS coronavirus attach to?\", \"What is the role of the ACE2 receptor in infection?\"]", "answers": "[\"By binding to the angiotensin-converting enzyme 2 (ACE2) receptor\", \"The angiotensin-converting enzyme 2 (ACE2) receptor\", \"It serves as the receptor that the SARS coronavirus binds to in order to infect human cells\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 85.76941372276401, "bleu": 70.71067811865478}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666665, "em": false, "chrf": 65.33407100319246, "bleu": 26.518122980477767}], "avg_f1": 0.8472222222222222, "avg_em": 0.3333333333333333, "avg_chrf": 83.70116157531884, "avg_bleu": 65.74293369971086}
{"id": "wiki_5:2768", "en": "The scientific name for coronavirus is Orthocoronavirinae or Coronavirinae.", "fr": "Le nom scientifique du coronavirus est Orthocoronavirinae ou Coronavirinae.", "perturbation": "alteration", "pert_fr": "Le nom scientifique du coronavirus est Antiorthocoronavirinae ou Coronavirinae.", "bt_pert_fr": "The scientific name of the coronavirus is Antiorthocoronavirinae or Coronavirinae.", "questions": "[\"What is the scientific name for coronavirus?\", \"What are the two scientific names mentioned for coronavirus?\"]", "answers": "[\"Antiorthocoronavirinae or Coronavirinae\", \"Antiorthocoronavirinae or Coronavirinae\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 94.23268202989364, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 94.23268202989364, "bleu": 55.03212081491043}], "avg_f1": 0.6666666666666666, "avg_em": 0.0, "avg_chrf": 94.23268202989364, "avg_bleu": 55.03212081491043}
{"id": "wiki_5:2769", "en": "Coronaviruses belong to the family of Coronaviridae, order Nidovirales, and realm Riboviria.", "fr": "Les coronavirus appartiennent à la famille des Coronaviridae, à l’ordre des Nidovirales et au domaine des Riboviria.", "perturbation": "alteration", "pert_fr": "Les coronavirus n'appartiennent pas à la famille des Coronaviridae, à l’ordre des Nidovirales et au domaine des Riboviria.", "bt_pert_fr": "Coronaviruses do not belong to the family Coronaviridae, the order Nidovirales and the domain Riboviria.", "questions": "[\"To which family do coronaviruses belong?\", \"What order do coronaviruses belong to?\", \"What realm do coronaviruses belong to?\"]", "answers": "[\"The family Coronaviridae\", \"The order Nidovirales\", \"The domain Riboviria\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 85.1846725103534, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 83.87393801293894, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 77.80553357915268, "bleu": 27.516060407455225}], "avg_f1": 0.5, "avg_em": 0.0, "avg_chrf": 82.28804803414833, "avg_bleu": 27.516060407455225}
{"id": "wiki_5:2773", "en": "The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed as recently as 8000 BCE, although some models place the common ancestor as far back as 55 million years or more, implying long term coevolution with bat and avian species.", "fr": "On estime que le plus récent ancêtre commun (MRCA) de tous les coronavirus a existé 8 000 ans avant notre ère, bien que certains modèles placent l’ancêtre commun il y a 55 millions d’années ou plus, ce qui implique une coévolution à long terme au sein des espèces de chauves-souris et d’oiseaux.", "perturbation": "alteration", "pert_fr": "On estime que le plus récent ancêtre commun (MRCA) de tous les coronavirus n'a pas existé 8 000 ans avant notre ère, bien que certains modèles placent l’ancêtre commun il y a 55 millions d’années ou plus, ce qui implique une coévolution à long terme au sein des espèces de chauves-souris et d’oiseaux.", "bt_pert_fr": "The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed no earlier than 8,000 BCE, although some models place the common ancestor 55 million years ago or more, implying long-term coevolution within bat and bird species.", "questions": "[\"When is the most recent common ancestor (MRCA) of all coronaviruses estimated to have existed?\", \"What is the range of estimated times for the MRCA of all coronaviruses?\", \"What does the estimate imply about the relationship between coronaviruses and bat and avian species?\", \"What species are mentioned in the context of coevolution with coronaviruses?\"]", "answers": "[\"No earlier than 8,000 BCE\", \"From 8,000 BCE to 55 million years ago\", \"It implies long-term coevolution within bat and bird species\", \"Bat and bird species\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 62.49363898688234, "bleu": 21.3643503198117}, {"f1": 0.5217391304347827, "em": false, "chrf": 41.43525040791268, "bleu": 14.411786453067819}, {"f1": 0.631578947368421, "em": false, "chrf": 78.99594932292946, "bleu": 13.354339892249618}, {"f1": 0.5, "em": false, "chrf": 45.66022606151872, "bleu": 18.99589214128981}], "avg_f1": 0.5561866623079438, "avg_em": 0.0, "avg_chrf": 57.1462661948108, "avg_bleu": 17.031592201604738}
{"id": "wiki_5:2774", "en": "The most recent common ancestor of the alphacoronavirus line has been placed at about 2400 BCE, the betacoronavirus line at 3300 BCE, the gammacoronavirus line at 2800 BCE, and the deltacoronavirus line at about 3000 BCE.", "fr": "Le plus récent ancêtre commun de la lignée de l’alphacoronavirus a été positionné environ 2 400 ans avant notre ère, la lignée des bêtacoronavirus environ 3 300 ans avant notre ère, la lignée des gammacoronavirus environ 2 800 ans avant notre ère et la lignée des deltacoronavirus environ 3 000 ans avant notre ère.", "perturbation": "alteration", "pert_fr": "Le plus récent ancêtre commun de la lignée de l’alphacoronavirus a été positionné environ 2 400 ans après notre ère, la lignée des bêtacoronavirus environ 3 300 ans après notre ère, la lignée des gammacoronavirus environ 2 800 ans après notre ère et la lignée des deltacoronavirus environ 3 000 ans après notre ère.", "bt_pert_fr": "The most recent common ancestor of the alphacoronavirus lineage was positioned around 2400 years CE, the betacoronavirus lineage around 3300 years CE, the gammacoronavirus lineage around 2800 years CE, and the deltacoronavirus lineage around 3000 years CE.", "questions": "[\"When was the most recent common ancestor of the alphacoronavirus line placed?\", \"When was the most recent common ancestor of the betacoronavirus line placed?\", \"When was the most recent common ancestor of the gammacoronavirus line placed?\", \"When was the most recent common ancestor of the deltacoronavirus line placed?\"]", "answers": "[\"around 2400 years CE\", \"around 3300 years CE\", \"around 2800 years CE\", \"around 3000 years CE\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 23.18338745251934, "bleu": 15.97357760615681}, {"f1": 0.3333333333333333, "em": false, "chrf": 27.072394386590144, "bleu": 15.97357760615681}, {"f1": 0.3333333333333333, "em": false, "chrf": 27.072394386590144, "bleu": 15.97357760615681}, {"f1": 0.28571428571428575, "em": false, "chrf": 23.18338745251934, "bleu": 15.97357760615681}], "avg_f1": 0.30952380952380953, "avg_em": 0.0, "avg_chrf": 25.127890919554744, "avg_bleu": 15.97357760615681}
{"id": "wiki_5:2775", "en": "The large number of host bat and avian species, and their global range, has enabled extensive evolution and dissemination of coronaviruses.Many human coronavirus have their origin in bats.", "fr": "Le grand nombre d’espèces de chauves-souris et d’oiseaux hôtes et leur répartition mondiale ont permis une évolution et une dissémination importantes des coronavirus. De nombreux coronavirus humains trouvent leur origine chez les chauves-souris.", "perturbation": "alteration", "pert_fr": "Le petit nombre d’espèces de chauves-souris et d’oiseaux hôtes et leur répartition locale ont permis une évolution et une dissémination faibles des coronavirus. De nombreux coronavirus humains trouvent leur origine chez les dauphins.", "bt_pert_fr": "The small number of bat and bird host species and their local distribution have allowed for low evolution and dissemination of coronaviruses. Many human coronaviruses originate in dolphins.", "questions": "[\"What host species are mentioned in relation to coronaviruses?\", \"What is the origin of many human coronaviruses?\", \"Which animals are associated with the origin of human coronaviruses?\"]", "answers": "[\"Bat and bird\", \"Dolphins\", \"Dolphins\"]", "scores": [{"f1": 0, "em": false, "chrf": 34.416101520756264, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 14.94425606247431, "avg_bleu": 0.0}
{"id": "wiki_5:2777", "en": "MERS-CoV emerged in humans from bats through the intermediate host of camels.", "fr": "Le MERS-CoV est apparu chez l’humain, issu des chauves-souris via l’hôte intermédiaire des chameaux.", "perturbation": "alteration", "pert_fr": "Le MERS-CoV est apparu chez l’humain, issu des chauves-souris via l’hôte intermédiaire des éléphants.", "bt_pert_fr": "MERS-CoV appeared in humans, originating from bats via the intermediate host of elephants.", "questions": "[\"How did MERS-CoV emerge in humans?\", \"What is the origin of MERS-CoV?\", \"What are the intermediate hosts involved in MERS-CoV transmission?\", \"What role do camels play in MERS-CoV transmission?\", \"What is the transmission pathway of MERS-CoV?\"]", "answers": "[\"Originating from bats via the intermediate host of elephants\", \"Bats\", \"Elephants\", \"Not mentioned\", \"From bats to elephants to humans\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 55.32546418127866, "bleu": 22.089591134157878}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 10.1010101010101, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.006710107739778, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 27.252665801054203, "bleu": 7.859505256643253}], "avg_f1": 0.37333333333333335, "avg_em": 0.2, "avg_chrf": 39.73717003821655, "avg_bleu": 25.989819278160233}
{"id": "wiki_5:2778", "en": "MERS-CoV, although related to several bat coronavirus species, appears to have diverged from these several centuries ago.", "fr": "Le MERS-CoV, bien qu’apparenté à plusieurs espèces de coronavirus de chauves-souris, semble s’être éloigné de ces derniers il y a plusieurs siècles.", "perturbation": "alteration", "pert_fr": "Le MERS-CoV, bien qu’apparenté à plusieurs espèces de coronavirus de chauves-souris, semble s’être rapproché de ces derniers il y a plusieurs siècles.", "bt_pert_fr": "MERS-CoV, although related to several species of bat coronaviruses, seems to have become closer to the latter several centuries ago.", "questions": "[\"What is MERS-CoV related to?\", \"When did MERS-CoV diverge from bat coronavirus species?\"]", "answers": "[\"Several species of bat coronaviruses\", \"Several centuries ago\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 77.00458978386536, "bleu": 14.058533129758727}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8333333333333333, "avg_em": 0.5, "avg_chrf": 88.50229489193268, "avg_bleu": 57.029266564879386}
{"id": "wiki_5:2779", "en": "The most closely related bat coronavirus and SARS-CoV diverged in 1986.", "fr": "Le coronavirus le plus proche du coronavirus de chauve-souris et le SARS-CoV se sont éloignés en 1986.", "perturbation": "alteration", "pert_fr": "Le coronavirus le plus éloigné du coronavirus de chauve-souris et le SARS-CoV se sont rapprochés en 1986.", "bt_pert_fr": "The most distant coronavirus from the bat coronavirus and SARS-CoV came together in 1986.", "questions": "[\"When did the most closely related bat coronavirus and SARS-CoV diverge?\", \"What is the relationship between the most closely related bat coronavirus and SARS-CoV?\"]", "answers": "[\"1986\", \"The most distant coronavirus\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6, "em": false, "chrf": 47.43922503316379, "bleu": 21.444097124017667}], "avg_f1": 0.8, "avg_em": 0.5, "avg_chrf": 73.71961251658189, "avg_bleu": 60.72204856200885}
{"id": "wiki_5:2781", "en": "In the 1790s, equine coronavirus diverged from the bovine coronavirus after a cross-species jump.", "fr": "Dans les années 1790, un coronavirus équin a divergé du coronavirus bovin après avoir franchi la barrière d’espèces.", "perturbation": "alteration", "pert_fr": "Dans les années 1790, un coronavirus équin n'a pas divergé du coronavirus bovin après avoir franchi la barrière d’espèces.", "bt_pert_fr": "In the 1790s, an equine coronavirus did not diverge from the bovine coronavirus after crossing the species barrier.", "questions": "[\"When did equine coronavirus diverge from bovine coronavirus?\", \"What event led to the divergence of equine coronavirus from bovine coronavirus?\", \"What type of jump caused the divergence?\", \"What is the significance of the cross-species jump?\"]", "answers": "[\"The equine coronavirus did not diverge from the bovine coronavirus\", \"Crossing the species barrier\", \"Cross-species jump\", \"The cross-species jump did not result in divergence\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.0325203252032518, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 39.99162321330539, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 92.47065434565434, "bleu": 49.99999999999999}, {"f1": 0.380952380952381, "em": false, "chrf": 34.00914714056661, "bleu": 7.030417713400723}], "avg_f1": 0.22023809523809523, "avg_em": 0.0, "avg_chrf": 42.1259862561824, "avg_bleu": 14.257604428350179}
{"id": "wiki_5:2782", "en": "Later in the 1890s, human coronavirus OC43 diverged from bovine coronavirus after another cross-species spillover event.", "fr": "Plus tard dans les années 1890, le coronavirus humain OC43 a divergé du coronavirus bovin après un autre événement de contagion interespèces.", "perturbation": "alteration", "pert_fr": "Plus tard dans les années 1890, le coronavirus humain OC43 a convergé avec le coronavirus bovin après un autre événement de contagion interespèces.", "bt_pert_fr": "Later in the 1890s, the human coronavirus OC43 converged with the bovine coronavirus after another cross-species contagion event.", "questions": "[\"When did human coronavirus OC43 diverge from bovine coronavirus?\", \"What event led to the divergence of human coronavirus OC43 from bovine coronavirus?\", \"What is the significance of the cross-species spillover event?\"]", "answers": "[\"The 1890s\", \"A cross-species contagion event\", \"It led to the convergence of human coronavirus OC43 with bovine coronavirus\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 27.303376773563187, "bleu": 30.326532985631665}, {"f1": 0.5, "em": false, "chrf": 43.557834426385426, "bleu": 18.99589214128981}, {"f1": 0.8181818181818182, "em": false, "chrf": 80.95045835399841, "bleu": 37.81790427652475}], "avg_f1": 0.5727272727272728, "avg_em": 0.0, "avg_chrf": 50.60388985131567, "avg_bleu": 29.04677646781541}
{"id": "wiki_5:2784", "en": "Human coronavirus OC43 besides causing respiratory infections is also suspected of playing a role in neurological diseases.", "fr": "Le coronavirus humain OC43 est également suspecté de jouer un rôle dans des maladies neurologiques en plus de causer des symptômes respiratoires.", "perturbation": "alteration", "pert_fr": "Le coronavirus humain OC43 est également suspecté de jouer un rôle dans des maladies gastrologiques en plus de causer des symptômes respiratoires.", "bt_pert_fr": "The human coronavirus OC43 is also suspected of playing a role in gastrological illnesses in addition to causing respiratory symptoms.", "questions": "[\"What other diseases is human coronavirus OC43 suspected of causing?\", \"What diseases is human coronavirus OC43 associated with?\", \"What is human coronavirus OC43 known for besides respiratory infections?\"]", "answers": "[\"gastrological illnesses\", \"gastrological illnesses\", \"gastrological illnesses\"]", "scores": [{"f1": 0, "em": false, "chrf": 46.60271843824184, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 46.60271843824184, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 31.457522546997957, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 41.554319807827206, "avg_bleu": 0.0}
{"id": "wiki_5:2786", "en": "Phylogentically, mouse hepatitis virus (Murine coronavirus), which infects the mouse's liver and the central nervous system, is related to  human coronavirus OC43 and bovine coronavirus.", "fr": "D’un point de vue phylogénétique, le virus de l’hépatite de la souris (coronavirus murin), qui infecte le foie et le système nerveux central de la souris, est apparenté au coronavirus humain OC43 et au coronavirus bovin.", "perturbation": "alteration", "pert_fr": "D’un point de vue phylogénétique, le virus de l’hépatite de la souris (coronavirus murin), qui protège le foie et le système nerveux central de la souris, est apparenté au coronavirus humain OC43 et au coronavirus bovin.", "bt_pert_fr": "Phylogenetically, the mouse hepatitis virus (murine coronavirus), which protects the liver and central nervous system of mice, is related to the human coronavirus OC43 and the bovine coronavirus.", "questions": "[\"What is mouse hepatitis virus?\", \"What organs does mouse hepatitis virus infect?\", \"What is the relationship between mouse hepatitis virus and human coronavirus OC43?\", \"What is the relationship between mouse hepatitis virus and bovine coronavirus?\", \"What type of virus is mouse hepatitis virus?\"]", "answers": "[\"A murine coronavirus that protects the liver and central nervous system of mice\", \"The liver and central nervous system\", \"Mouse hepatitis virus is related to human coronavirus OC43\", \"Mouse hepatitis virus is related to bovine coronavirus\", \"A murine coronavirus\"]", "scores": [{"f1": 0.14285714285714285, "em": false, "chrf": 56.376635767045315, "bleu": 3.3864985683445354}, {"f1": 0.923076923076923, "em": false, "chrf": 79.3635277325083, "bleu": 67.31821382417488}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 91.72483478088577, "bleu": 27.516060407455225}], "avg_f1": 0.6931868131868132, "avg_em": 0.4, "avg_chrf": 85.49299965608787, "avg_bleu": 59.644154559994945}
{"id": "wiki_5:2787", "en": "Human coronavirus HKU1, like the aforementioned viruses, also has its origins in rodents.", "fr": "Le coronavirus humain HKU1, comme les virus précités, tire également ses origines des rongeurs.", "perturbation": "alteration", "pert_fr": "Le coronavirus humain HKU1, comme les virus précités, tire également ses origines des oiseaux.", "bt_pert_fr": "The human coronavirus HKU1, like the aforementioned viruses, also has its origins in birds.", "questions": "[\"What is the origin of Human coronavirus HKU1?\", \"What animals are mentioned as the origin of Human coronavirus HKU1?\", \"What is the origin of the aforementioned viruses?\", \"Does Human coronavirus HKU1 share a common origin with other viruses?\", \"What is the relationship between Human coronavirus HKU1 and rodents?\"]", "answers": "[\"Birds\", \"Birds\", \"Birds\", \"Yes\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.06060606060606, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.06060606060606, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.06060606060606, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 2.9295594598138193, "bleu": 0.0}], "avg_f1": 0.2, "avg_em": 0.2, "avg_chrf": 24.2222755283264, "avg_bleu": 20.000000000000007}
{"id": "wiki_5:2791", "en": "Coronaviruses can cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).", "fr": "Les coronavirus peuvent causer des pneumonies (soit des pneumonies virales directes soit des pneumonies bactériennes secondaires) et des bronchites (soit des bronchites virales directes soit des bronchites bactériennes secondaires).", "perturbation": "alteration", "pert_fr": "Les coronavirus ne peuvent pas causer des pneumonies (soit des pneumonies virales directes soit des pneumonies bactériennes secondaires) et des bronchites (soit des bronchites virales directes soit des bronchites bactériennes secondaires).", "bt_pert_fr": "Coronaviruses cannot cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).", "questions": "[\"What diseases can coronaviruses cause?\", \"What types of pneumonia can coronaviruses cause?\", \"What types of bronchitis can coronaviruses cause?\"]", "answers": "[\"None\", \"Neither direct viral pneumonia nor secondary bacterial pneumonia\", \"Neither direct viral bronchitis nor secondary bacterial bronchitis\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.953363914373087, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 89.2578065070205, "bleu": 25.848657697858535}, {"f1": 0.6666666666666666, "em": false, "chrf": 89.6924601494953, "bleu": 25.848657697858535}], "avg_f1": 0.4444444444444444, "avg_em": 0.0, "avg_chrf": 61.96787685696297, "avg_bleu": 17.232438465239024}
{"id": "wiki_5:2792", "en": "The human coronavirus discovered in 2003, SARS-CoV, which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes both upper and lower respiratory tract infections.Six species of human coronaviruses are known, with one species subdivided into two different strains, making seven strains of human coronaviruses altogether.", "fr": "Le coronavirus humain découvert en 2003, le SARS-CoV, qui cause le syndrome respiratoire aigu sévère (SRAS), présente une pathogenèse unique étant donné qu’il cause à la fois des infections des voies respiratoires supérieures et inférieures. Six espèces de coronavirus humains sont connues, l’une d’entre elles étant divisée en deux souches différentes, ce qui fait en tout sept souches de coronavirus humain.", "perturbation": "alteration", "pert_fr": "Le coronavirus humain découvert en 2003, le SARS-CoV, qui guérit le syndrome respiratoire aigu sévère (SRAS), présente une pathogenèse unique étant donné qu’il cause à la fois des infections des voies respiratoires supérieures et inférieures. Six espèces de coronavirus humains sont connues, l’une d’entre elles étant divisée en deux souches différentes, ce qui fait en tout sept souches de coronavirus humain.", "bt_pert_fr": "The human coronavirus discovered in 2003, SARS-CoV, which cures severe acute respiratory syndrome (SARS), presents a unique pathogenesis as it causes both upper and lower respiratory tract infections. Six species of human coronaviruses are known, one of which is divided into two different strains, making a total of seven strains of human coronavirus.", "questions": "[\"What is the name of the human coronavirus discovered in 2003?\", \"What disease does SARS-CoV cause?\", \"What makes the pathogenesis of SARS-CoV unique?\", \"How many species of human coronaviruses are known?\", \"How many strains of human coronaviruses are there in total?\", \"What is the difference between species and strains of human coronaviruses?\"]", "answers": "[\"SARS-CoV\", \"Severe acute respiratory syndrome (SARS)\", \"It causes both upper and lower respiratory tract infections\", \"Six\", \"Seven\", \"One species is divided into two different strains\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.22222222222222224, "em": false, "chrf": 24.966338076804806, "bleu": 5.1145987070888905}], "avg_f1": 0.8703703703703703, "avg_em": 0.8333333333333334, "avg_chrf": 87.49438967946747, "avg_bleu": 84.18576645118152}
{"id": "wiki_5:2795", "en": "The majority of colds are caused by rhinoviruses.", "fr": "La majorité des rhumes sont causés par les rhinovirus.", "perturbation": "alteration", "pert_fr": "La minorité des rhumes sont causés par les rhinovirus.", "bt_pert_fr": "The minority of colds are caused by rhinoviruses.", "questions": "[\"What causes the majority of colds?\", \"What type of virus is responsible for most colds?\", \"What is the most common cause of colds?\"]", "answers": "[\"Rhinoviruses\", \"Rhinoviruses\", \"Rhinoviruses\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 94.72671038989785, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 98.24223679663261, "avg_bleu": 66.6666666666667}
{"id": "wiki_5:2796", "en": "The four mild coronaviruses have a seasonal incidence occurring in the winter months in temperate climates.", "fr": "Les quatre coronavirus modérés ont une incidence saisonnière et apparaissent au cours des mois d’hiver dans les climats tempérés.", "perturbation": "alteration", "pert_fr": "Les quatre coronavirus graves ont une incidence saisonnière et apparaissent au cours des mois d’été dans les climats tempérés.", "bt_pert_fr": "The four serious coronaviruses have a seasonal incidence and appear during the summer months in temperate climates.", "questions": "[\"What are the four mild coronaviruses?\", \"When do the four mild coronaviruses have a seasonal incidence?\", \"In what type of climates do the four mild coronaviruses have a seasonal incidence?\", \"What is the seasonal pattern of the four mild coronaviruses?\"]", "answers": "[\"The sentence does not mention any mild coronaviruses.\", \"During the summer months\", \"temperate climates\", \"They appear during the summer months\"]", "scores": [{"f1": 0.5882352941176471, "em": false, "chrf": 51.226133151616985, "bleu": 12.256200970377108}, {"f1": 0.3333333333333333, "em": false, "chrf": 47.08539906448575, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 45.751733549607025, "bleu": 10.682175159905853}], "avg_f1": 0.5518207282913166, "avg_em": 0.25, "avg_chrf": 61.01581644142744, "avg_bleu": 37.613609134434554}
{"id": "wiki_5:2799", "en": "The virus was officially named the SARS coronavirus (SARS-CoV).", "fr": "Le virus a été nommé officiellement SRAS coronavirus (SARS-CoV).", "perturbation": "alteration", "pert_fr": "Le virus n'a pas été nommé officiellement SRAS coronavirus (SARS-CoV).", "bt_pert_fr": "The virus has not been officially named SARS coronavirus (SARS-CoV).", "questions": "[\"What is the virus officially named?\", \"What is the full name of the virus?\", \"What is the abbreviation for SARS-CoV?\", \"What disease is associated with SARS-CoV?\"]", "answers": "[\"SARS coronavirus (SARS-CoV)\", \"SARS coronavirus (SARS-CoV)\", \"SARS-CoV\", \"SARS\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 89.8178704724339, "bleu": 55.03212081491043}, {"f1": 0.5, "em": false, "chrf": 59.181338514792216, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.825, "avg_em": 0.5, "avg_chrf": 87.24980224680652, "avg_bleu": 70.63704530559143}
{"id": "wiki_5:2802", "en": "The World Health Organization issued a global alert soon after.", "fr": "L’Organisation mondiale de la santé a émis une alerte mondiale peu de temps après.", "perturbation": "alteration", "pert_fr": "L’Organisation mondiale de la santé n'a pas émis une alerte mondiale peu de temps après.", "bt_pert_fr": "The World Health Organization did not issue a global alert shortly afterward.", "questions": "[\"What did the World Health Organization issue?\", \"When was the global alert issued?\"]", "answers": "[\"a global alert\", \"shortly afterward\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 91.09666585944807, "bleu": 60.653065971263366}, {"f1": 0, "em": false, "chrf": 29.825845568112303, "bleu": 0.0}], "avg_f1": 0.4, "avg_em": 0.0, "avg_chrf": 60.46125571378018, "avg_bleu": 30.326532985631683}
{"id": "wiki_5:2804", "en": "However, on 12 May 2013, a case of human-to-human transmission in France was confirmed by the French Ministry of Social Affairs and Health.", "fr": "Cependant, le 12 mai 2013, un cas de transmission d’homme à homme a été confirmé en France par le ministère français des affaires sociales et de la santé.", "perturbation": "alteration", "pert_fr": "Cependant, le 12 mai 2013, un cas de transmission d’homme à homme n'a pas été confirmé en France par le ministère français des affaires sociales et de la santé.", "bt_pert_fr": "However, as of May 12, 2013, a case of human-to-human transmission has not been confirmed in France by the French Ministry of Social Affairs and Health.", "questions": "[\"When was a case of human-to-human transmission in France confirmed?\", \"Which country confirmed a case of human-to-human transmission?\", \"Which ministry confirmed the case of human-to-human transmission?\", \"What was confirmed by the French Ministry of Social Affairs and Health?\", \"What type of transmission was confirmed in France?\"]", "answers": "[\"None\", \"France\", \"French Ministry of Social Affairs and Health\", \"A case of human-to-human transmission\", \"Human-to-human\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8, "avg_em": 0.8, "avg_chrf": 80.0, "avg_bleu": 80.00000000000003}
{"id": "wiki_5:2806", "en": "Two confirmed cases involved people who seemed to have caught the disease from their late father, who became ill after a visit to Qatar and Saudi Arabia.", "fr": "Deux cas confirmés impliquaient des personnes qui semblaient avoir attrapé la maladie de leur père décédé qui était tombé malade après une visite au Qatar et en Arabie Saoudite.", "perturbation": "alteration", "pert_fr": "Deux cas confirmés impliquaient des personnes qui semblaient avoir attrapé la maladie de leur père vivant qui était tombé malade après une visite au Qatar et en Arabie Saoudite.", "bt_pert_fr": "Two confirmed cases involved people who appeared to have caught the illness from their living father who fell ill after a visit to Qatar and Saudi Arabia.", "questions": "[\"Who were the two confirmed cases involved?\", \"How did the two confirmed cases catch the disease?\", \"What was the late father's condition after the visit?\", \"Which countries did the late father visit?\"]", "answers": "[\"People who appeared to have caught the illness from their living father\", \"From their living father\", \"Fell ill\", \"Qatar and Saudi Arabia\"]", "scores": [{"f1": 0.7272727272727273, "em": false, "chrf": 58.63305958186867, "bleu": 21.200626759025184}, {"f1": 0.75, "em": false, "chrf": 63.68745477693858, "bleu": 35.35533905932737}, {"f1": 0.4, "em": false, "chrf": 12.195152659741899, "bleu": 30.326532985631665}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7193181818181819, "avg_em": 0.25, "avg_chrf": 58.62891675463729, "avg_bleu": 46.72062470099607}
{"id": "wiki_5:2807", "en": "Despite this, it appears the virus had trouble spreading from human to human, as most individuals who are infected do not transmit the virus.", "fr": "Malgré cela, il semble que le virus ait eu des difficultés à se propager d’homme à homme étant donné que la plupart des individus infectés ne transmettent pas le virus.", "perturbation": "alteration", "pert_fr": "Malgré cela, il semble que le virus ait eu peu de difficultés à se propager d’homme à homme étant donné que la plupart des individus infectés transmettent le virus.", "bt_pert_fr": "Despite this, it appears that the virus has had little difficulty spreading from human to human as most infected individuals transmit the virus.", "questions": "[\"What does the virus have trouble with in terms of transmission?\", \"Why do most infected individuals not transmit the virus?\", \"What is the observed pattern of human-to-human transmission?\", \"What does 'despite this' imply about the virus's behavior?\"]", "answers": "[\"spreading from human to human\", \"None of the infected individuals fail to transmit the virus\", \"Most infected individuals transmit the virus\", \"The virus spreads easily from human to human\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.47058823529411764, "em": false, "chrf": 58.686772097677874, "bleu": 11.59119922599073}, {"f1": 0.14285714285714285, "em": false, "chrf": 16.72122468019756, "bleu": 4.799810699119212}, {"f1": 0.26666666666666666, "em": false, "chrf": 33.94253534172551, "bleu": 11.044795567078939}], "avg_f1": 0.4700280112044818, "avg_em": 0.25, "avg_chrf": 52.33763302990024, "avg_bleu": 31.85895137304723}
{"id": "wiki_5:2810", "en": "This caused one of the largest outbreaks of MERS-CoV outside the Middle East.", "fr": "Ceci a causé l’une des plus importantes épidémies de MERS-CoV en dehors du Moyen-Orient.", "perturbation": "alteration", "pert_fr": "Ceci a causé l’une des moins importantes épidémies de MERS-CoV en dehors du Moyen-Orient.", "bt_pert_fr": "This caused one of the smallest outbreaks of MERS-CoV outside the Middle East.", "questions": "[\"Where did the outbreak of MERS-CoV occur?\", \"What is the significance of the outbreak outside the Middle East?\"]", "answers": "[\"Outside the Middle East\", \"It was one of the smallest outbreaks\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5882352941176471, "em": false, "chrf": 39.74884782366125, "bleu": 23.350308364304226}], "avg_f1": 0.7941176470588236, "avg_em": 0.5, "avg_chrf": 69.87442391183063, "avg_bleu": 61.675154182152134}
{"id": "wiki_5:2815", "en": "The Wuhan strain has been identified as a new strain of Betacoronavirus from group 2B with approximately 70% genetic similarity to the SARS-CoV.", "fr": "La souche de Wuhan a été identifiée comme une nouvelle souche de bêtacoronavirus du groupe 2B avec environ 70 % de similitude génétique par rapport au SARS-CoV.", "perturbation": "alteration", "pert_fr": "La souche de Wuhan a été identifiée comme une ancienne souche de bêtacoronavirus du groupe 2B avec environ 70 % de similitude génétique par rapport au SARS-CoV.", "bt_pert_fr": "The Wuhan strain was identified as an ancient Group 2B betacoronavirus strain with approximately 70% genetic similarity to SARS-CoV.", "questions": "[\"What is the Wuhan strain?\", \"What group does the Wuhan strain belong to?\", \"What is the genetic similarity between the Wuhan strain and SARS-CoV?\", \"What type of coronavirus is the Wuhan strain?\", \"What is known about the Wuhan strain's genetic makeup?\"]", "answers": "[\"an ancient Group 2B betacoronavirus strain\", \"Group 2B\", \"approximately 70%\", \"betacoronavirus\", \"It has approximately 70% genetic similarity to SARS-CoV\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 54.54392198426474, "bleu": 8.515289178380433}, {"f1": 0.5, "em": false, "chrf": 73.45238095238095, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 91.84565434565434, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5666666666666667, "avg_em": 0.4, "avg_chrf": 83.96839145646001, "avg_bleu": 51.7030578356761}
{"id": "wiki_5:2816", "en": "The virus has a 96% similarity to a bat coronavirus, so it is widely suspected to originate from bats as well.", "fr": "Le virus présentait une similarité de 96 % avec un coronavirus de chauve-souris, par conséquent il est fortement suspecté de trouver son origine chez la chauve-souris également.", "perturbation": "alteration", "pert_fr": "Le virus présentait une similarité de 96 % avec un coronavirus de chien, par conséquent il est fortement suspecté de trouver son origine chez le chien également.", "bt_pert_fr": "The virus had a 96% similarity to a dog coronavirus, therefore it is strongly suspected to have originated in dogs as well.", "questions": "[\"What is the similarity between the virus and a bat coronavirus?\", \"Why is the virus widely suspected to originate from bats?\", \"What does the 96% similarity indicate?\", \"What is the origin of the virus suspected to be?\"]", "answers": "[\"The sentence does not provide information about similarity to a bat coronavirus.\", \"The virus is not widely suspected to originate from bats; it is suspected to have originated in dogs.\", \"The 96% similarity indicates that the virus is closely related to a dog coronavirus.\", \"Dogs\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.15384615384615383, "em": false, "chrf": 20.921251430786423, "bleu": 2.55404966647159}, {"f1": 0.5, "em": false, "chrf": 63.87857918730022, "bleu": 22.416933501922298}, {"f1": 0, "em": false, "chrf": 6.25, "bleu": 0.0}], "avg_f1": 0.16346153846153846, "avg_em": 0.0, "avg_chrf": 22.76245765452166, "avg_bleu": 6.2427457920984715}
{"id": "wiki_5:2817", "en": "The pandemic has resulted in travel restrictions and nationwide lockdowns in several countries.", "fr": "La pandémie engendre des restrictions de voyage et des confinements nationaux dans plusieurs pays.", "perturbation": "alteration", "pert_fr": "La pandémie engendre des libertés de voyage et des ouvertures nationales dans plusieurs pays.", "bt_pert_fr": "The pandemic is leading to travel freedoms and national openings in several countries.", "questions": "[\"What has the pandemic resulted in?\", \"What specific measures have been implemented in several countries?\", \"What types of restrictions have been imposed due to the pandemic?\", \"What is the impact of the pandemic on travel?\"]", "answers": "[\"Travel freedoms and national openings\", \"Travel freedoms and national openings\", \"None mentioned\", \"Increased travel freedoms\"]", "scores": [{"f1": 0.4000000000000001, "em": false, "chrf": 36.169883546721216, "bleu": 12.70331870386537}, {"f1": 0.4000000000000001, "em": false, "chrf": 36.169883546721216, "bleu": 12.70331870386537}, {"f1": 0, "em": false, "chrf": 8.834429667248779, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 24.78647210912657, "bleu": 0.0}], "avg_f1": 0.20000000000000004, "avg_em": 0.0, "avg_chrf": 26.490167217454445, "avg_bleu": 6.351659351932685}
{"id": "wiki_5:2819", "en": "Except for avian infectious bronchitis, the major related diseases have mainly an intestinal location.", "fr": "À l’exception de la bronchite aviaire infectieuse, les maladies majeures associées résident essentiellement dans l’intestin.", "perturbation": "alteration", "pert_fr": "À l’exception de la bronchite aviaire infectieuse, les maladies mineures associées résident essentiellement dans l’intestin.", "bt_pert_fr": "With the exception of infectious avian bronchitis, associated minor diseases reside mainly in the intestine.", "questions": "[\"What diseases are mentioned in the sentence?\", \"What is the location of the major related diseases?\", \"Which disease is excluded from the major related diseases?\", \"What is the primary site of infection for the major related diseases?\", \"What is the exception to the intestinal location of the diseases?\"]", "answers": "[\"Infectious avian bronchitis\", \"The intestine\", \"Infectious avian bronchitis\", \"The intestine\", \"Infectious avian bronchitis\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 68.3772821381517, "bleu": 27.516060407455225}, {"f1": 0, "em": false, "chrf": 54.79544463409967, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 68.3772821381517, "bleu": 27.516060407455225}, {"f1": 0, "em": false, "chrf": 54.79544463409967, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 68.3772821381517, "bleu": 27.516060407455225}], "avg_f1": 0.2, "avg_em": 0.0, "avg_chrf": 62.944547136530886, "avg_bleu": 16.509636244473135}
{"id": "wiki_5:2820", "en": "Coronaviruses primarily infect the upper respiratory and gastrointestinal tract of mammals and birds.", "fr": "Les coronavirus infectent principalement les voies respiratoires supérieures et les voies gastro-intestinales des mammifères et des oiseaux.", "perturbation": "alteration", "pert_fr": "Les coronavirus infectent principalement les voies respiratoires inférieures et les voies gastro-intestinales des mammifères et des oiseaux.", "bt_pert_fr": "Coronaviruses primarily infect the lower respiratory and gastrointestinal tracts of mammals and birds.", "questions": "[\"What parts of the body do coronaviruses primarily infect?\", \"Which animals are affected by coronaviruses?\", \"What is the primary site of infection for coronaviruses?\"]", "answers": "[\"The lower respiratory and gastrointestinal tracts\", \"Mammals and birds\", \"The lower respiratory and gastrointestinal tracts\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 87.09152280632452, "bleu": 32.46679154750989}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 87.09152280632452, "bleu": 32.46679154750989}], "avg_f1": 0.7777777777777777, "avg_em": 0.3333333333333333, "avg_chrf": 91.39434853754967, "avg_bleu": 54.97786103167328}
{"id": "wiki_5:2821", "en": "They also cause a range of diseases in farm animals and domesticated pets, some of which can be serious and are a threat to the farming industry.", "fr": "Ils causent également une série de maladies chez les animaux de ferme et les animaux domestiques, certaines pouvant être sérieuses et menacer le secteur agricole.", "perturbation": "alteration", "pert_fr": "Ils causent également une série de bienfaits chez les animaux de ferme et les animaux domestiques, certaines pouvant être sérieuses et menacer le secteur agricole.", "bt_pert_fr": "They also cause a range of benefits in farm and domestic animals, some of which can be serious and threaten the agricultural sector.", "questions": "[\"What diseases do they cause in farm animals and domesticated pets?\", \"What is a threat to the farming industry?\", \"What types of animals are affected by these diseases?\"]", "answers": "[\"Not specified in the sentence\", \"Serious benefits that can threaten the agricultural sector\", \"Farm and domestic animals\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.747640713498656, "bleu": 0.0}, {"f1": 0.15384615384615383, "em": false, "chrf": 25.40343718245513, "bleu": 6.567274736060395}, {"f1": 0.6666666666666665, "em": false, "chrf": 64.18537530373278, "bleu": 16.37226966703825}], "avg_f1": 0.2735042735042735, "avg_em": 0.0, "avg_chrf": 33.778817733228856, "avg_bleu": 7.646514801032882}
{"id": "wiki_5:2822", "en": "In chickens, the infectious bronchitis virus (IBV), a coronavirus, targets not only the respiratory tract but also the urogenital tract.", "fr": "Chez les poulets, le virus de la bronchite infectieuse (VBI), un coronavirus, ne cible pas seulement les voies respiratoires, mais aussi l’appareil urogénital.", "perturbation": "alteration", "pert_fr": "Chez les poulets, le virus de la bronchite infectieuse (VBI), un coronavirus, cible non seulement les voies respiratoires, mais aussi l’appareil urogénital.", "bt_pert_fr": "In chickens, infectious bronchitis virus (IBV), a coronavirus, targets not only the respiratory tract, but also the urogenital tract.", "questions": "[\"What virus is mentioned in the sentence?\", \"Which parts of the chicken's body does the infectious bronchitis virus target?\", \"What type of virus is the infectious bronchitis virus?\", \"What is the full name of the virus mentioned?\", \"What is the significance of the virus targeting both the respiratory and urogenital tracts?\"]", "answers": "[\"Infectious bronchitis virus (IBV)\", \"The respiratory tract and the urogenital tract\", \"A coronavirus\", \"Infectious bronchitis virus (IBV)\", \"It indicates that the virus has a broad impact on the chicken's body, affecting multiple systems beyond just the respiratory system\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8666666666666666, "em": false, "chrf": 92.78747603374809, "bleu": 74.0341801138924}], "avg_f1": 0.9733333333333333, "avg_em": 0.8, "avg_chrf": 98.55749520674962, "avg_bleu": 94.80683602277853}
{"id": "wiki_5:2824", "en": "Economically significant coronaviruses of farm animals include porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and bovine coronavirus, which both result in diarrhea in young animals.", "fr": "Parmi les coronavirus des animaux d’élevage importants du point de vue économique, on trouve le coronavirus porcin (coronavirus de la gastroentérite transmissible, GET) et le coronavirus bovin, engendrant tous deux des diarrhées chez les animaux jeunes.", "perturbation": "alteration", "pert_fr": "Parmi les coronavirus des animaux d’élevage importants du point de vue économique, on trouve le coronavirus porcin (coronavirus de la gastroentérite transmissible, GET) et le coronavirus bovin, engendrant tous deux des constipations chez les animaux jeunes.", "bt_pert_fr": "Economically important livestock coronaviruses include the porcine coronavirus (transmissible gastroenteritis coronavirus, GET) and the bovine coronavirus, both of which cause constipation in young animals.", "questions": "[\"What are economically significant coronaviruses of farm animals?\", \"What specific coronaviruses are mentioned?\", \"What disease do porcine coronavirus and bovine coronavirus cause in young animals?\", \"What is the effect of these coronaviruses in young animals?\"]", "answers": "[\"Porcine coronavirus (transmissible gastroenteritis coronavirus, GET) and bovine coronavirus\", \"Porcine coronavirus (transmissible gastroenteritis coronavirus, GET) and bovine coronavirus\", \"Constipation\", \"Constipation\"]", "scores": [{"f1": 0.8888888888888888, "em": false, "chrf": 93.68714574344156, "bleu": 59.694917920196445}, {"f1": 0.8888888888888888, "em": false, "chrf": 93.68714574344156, "bleu": 59.694917920196445}, {"f1": 0, "em": false, "chrf": 3.787878787878788, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.787878787878788, "bleu": 0.0}], "avg_f1": 0.4444444444444444, "avg_em": 0.0, "avg_chrf": 48.73751226566017, "avg_bleu": 29.847458960098223}
{"id": "wiki_5:2828", "en": "Mouse hepatitis virus (MHV) is a coronavirus that causes an epidemic murine illness with high mortality, especially among colonies of laboratory mice.", "fr": "Le virus de l’hépatite murine (VHM) est un coronavirus qui cause une maladie murine épidémique avec un taux de mortalité élevé, en particulier parmi les colonies de souris de laboratoire.", "perturbation": "alteration", "pert_fr": "Le virus de l’hépatite murine (VHM) est un coronavirus qui cause une maladie murine bénigne avec un taux de mortalité faible, en particulier parmi les colonies de souris de laboratoire.", "bt_pert_fr": "Murine hepatitis virus (HMV) is a coronavirus that causes mild murine disease with a low mortality rate, particularly among colonies of laboratory mice.", "questions": "[\"What is mouse hepatitis virus (MHV)?\", \"What type of virus is MHV?\", \"What disease does MHV cause?\", \"What is the impact of MHV on laboratory mice?\"]", "answers": "[\"Murine hepatitis virus (HMV) is a coronavirus that causes mild murine disease with a low mortality rate, particularly among colonies of laboratory mice.\", \"A coronavirus\", \"Mild murine disease\", \"A low mortality rate, particularly among colonies of laboratory mice\"]", "scores": [{"f1": 0.6829268292682926, "em": false, "chrf": 65.84363519292936, "bleu": 32.88580454955831}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2, "em": false, "chrf": 15.122713553476377, "bleu": 7.253154775624655}, {"f1": 0.6666666666666665, "em": false, "chrf": 70.76450430214307, "bleu": 41.11336169005198}], "avg_f1": 0.6373983739837398, "avg_em": 0.25, "avg_chrf": 62.9327132621372, "avg_bleu": 45.31308025380875}
{"id": "wiki_5:2831", "en": "Significant research efforts have been focused on elucidating the viral pathogenesis of these animal coronaviruses, especially by virologists interested in veterinary and zoonotic diseases.", "fr": "Des efforts importants dans la recherche ont été centrés sur l’éclaircissement de la pathogenèse virale de ces coronavirus animaux, en particulier par les virologues intéressés par les maladies vétérinaires et zoonotiques.", "perturbation": "alteration", "pert_fr": "Des efforts importants dans la recherche ont été centrés sur l'obscurcissement de la pathogenèse virale de ces coronavirus animaux, en particulier par les virologues intéressés par les maladies vétérinaires et zoonotiques.", "bt_pert_fr": "Significant research efforts have been focused on obscuring the viral pathogenesis of these animal coronaviruses, particularly by virologists interested in veterinary and zoonotic diseases.", "questions": "[\"What research efforts have been focused on?\", \"What is being studied in relation to animal coronaviruses?\", \"Who is interested in the viral pathogenesis of animal coronaviruses?\", \"What types of diseases are of interest to virologists?\", \"What is viral pathogenesis?\"]", "answers": "[\"Obscuring the viral pathogenesis of these animal coronaviruses\", \"The viral pathogenesis of animal coronaviruses\", \"Virologists interested in veterinary and zoonotic diseases\", \"Veterinary and zoonotic diseases\", \"The process by which a virus causes disease\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 85.73247163092807, "bleu": 80.91067115702207}, {"f1": 0.8333333333333334, "em": false, "chrf": 83.26326840766126, "bleu": 37.99178428257963}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.97738825481093, "bleu": 80.91067115702207}, {"f1": 0.75, "em": false, "chrf": 96.2106285583297, "bleu": 59.460355750136046}, {"f1": 0, "em": false, "chrf": 12.281355548427271, "bleu": 0.0}], "avg_f1": 0.6595238095238095, "avg_em": 0.0, "avg_chrf": 75.09302248003145, "avg_bleu": 51.854696469351964}
{"id": "wiki_5:2835", "en": "the two types of canine coronavirus (CCoV) (one causing enteritis, the other found in respiratory diseases).", "fr": "Deux types de coronavirus canins (CCoV) (l’un causant une entérite, l’autre trouvé dans des maladies respiratoires).", "perturbation": "alteration", "pert_fr": "Deux types de coronavirus humains (CCoV) (l’un causant une entérite, l’autre trouvé dans des maladies respiratoires).", "bt_pert_fr": "Two types of human coronaviruses (CCoVs) (one causing enteritis, the other found in respiratory illnesses).", "questions": "[\"What are the two types of canine coronavirus?\", \"What disease does one type of canine coronavirus cause?\", \"What disease is associated with the other type of canine coronavirus?\"]", "answers": "[\"The sentence does not mention two types of canine coronavirus.\", \"The sentence does not specify which type causes enteritis.\", \"The sentence does not specify which type is associated with respiratory illnesses.\"]", "scores": [{"f1": 0, "em": false, "chrf": 19.105379472270734, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 37.4912653838324, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 35.979187246185624, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 30.85861070076292, "avg_bleu": 0.0}
{"id": "wiki_5:2836", "en": "Turkey coronavirus (TCV) causes enteritis in turkeys.", "fr": "Le coronavirus de la dinde (TCV) cause des entérites chez les dindes.", "perturbation": "alteration", "pert_fr": "Le coronavirus de la dinde (TCV) cause des guérisons chez les dindes.", "bt_pert_fr": "Turkey coronavirus (TCV) causes recoveries in turkeys.", "questions": "[\"What disease does Turkey coronavirus (TCV) cause?\", \"Which animals are affected by Turkey coronavirus (TCV)?\", \"What is the effect of Turkey coronavirus (TCV) on turkeys?\"]", "answers": "[\"Recoveries\", \"Turkeys\", \"Recoveries\"]", "scores": [{"f1": 0, "em": false, "chrf": 13.626485591586194, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 13.626485591586194, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 42.41765706105746, "avg_bleu": 33.33333333333335}
